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ABSTRACT 
Introduction 
Intermittent claudication (IC) is a condition which affects people with peripheral arterial 
disease in the lower limbs and causes calf muscle pain and limping due to the lack of blood 
supply to the gastrocnemius muscle in particular. This limits the distance people with IC 
(known as claudicants) can walk before having to stop because of the pain. The accepted best 
treatment currently is enrolment onto supervised exercise regimes, but these provide limited 
improvement and do not alter their antalgic gait. This study aims to investigate the effect of 
specific footwear designs on gait and lower limb muscle function with the intention of 
identifying which features would be recommended for inclusion in footwear designed to 
relieve their painful symptoms by offloading the calf muscles.  
Method                                                                                                                       
Fifteen volunteer healthy subjects, age range 20-29 years (mean 25.3 ± 2.73) undertook a 
series of gait laboratory trials with shoes adapted with specifically-chosen outsole features. 
High street shoes were adapted with the test conditions which included shoes with five 
different heel heights (varying from a 1.5cm to 5.5cm heels), two heel profile conditions 
(curved and semi curved heels), three traditional (angled) rocker soles with varying apex 
positions (55%, 62.5% and 70% of shoe length) and three with varying apex angles (10, 15, and 
20 deg.), plus three with different forepart sole stiffness (solid, semi-flexible and flexible). The 
baseline shoe was taken as being one with no heel curve, a heel height of 3.5mm, an apex 
position of 62.5% of shoe length, and apex angle of 15 deg. and a stiff forepart to the shoe. 
Measurement and comparisons were taken of lower limb kinetics and kinematics (Qualysis, 
Sweden) plus electromyographical (EMG) activity (Noraxon USA) of medial gastrocnemius, 
soleus, tibialis anterior, rectus femoris and biceps femoris during walking trials where the 
walking speed was controlled using timing gaits. Data were analysed using Visual3D and 
OpenSim software to enable interpretation of EMG activity to enable calculation of lower limb 
muscle function during gait.                   
Results                                                                                                                      
Changes from the baseline shoe were taken as being at a level of significance of p<0.05. The 
most effective footwear test condition in regards to offloading of the calf muscles compared to 
the control shoe was that with a 4.5cm heel, a 55% of shoe length apex position, and a 20° 
rocker apex angle; which demonstrated significant offloading to the calf muscles. The 55% 
apex position had a significant offloading influence on the calf muscles whilst at the same time 
not significantly altering knee and hip kinematics.                           
Conclusion                                                                                                                      
This study demonstrates that a potentially useful shoe design was identified for treatment of 
claudicant calf pain which did not adversely affect more proximal joint kinetics and kinematics. 
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CHAPTER 1   
1 INTRODUCTION 
1.1 Rocker-soled shoes 
Patients suffering from diseases such as diabetes mellitus (DM), spina bifida and rheumatoid 
arthritis are particularly susceptible to ulceration to the plantar surface of the foot resulting 
from excessive interface pressure between the foot and the inlay inserted in a shoe during 
walking. The use of rocker soles when added to footwear has historically been mainly 
targeted on the reduction of plantar foot pressures associated with these conditions during 
ambulation. Other applications for rocker soles have included the treatment of hallux rigidus 
by supplying a surrogate motion where lack of dorsiflexion of the first metatarsal head is 
experienced (Trepman and Yeo, 1995). They are also used to protect parts of the foot which 
have been surgically fused or become stiff and painful due to osteoarthritis (OA) in order to 
reduce the pain associated with walking. Such areas include the ankle, the rearfoot, the 
midfoot and the forefoot (Cracchiolo, 1979).  
 Forefoot plantar pressure in subjects with DM may be reduced using both traditional 
(angled) and curved rocker soles. The amount of forefoot pressure reduction achieved when 
analysing curved rocker soles in people with diabetes mellitus has been shown to be 
different for individual subjects. This is because it depends on the shape of the individual’s 
foot, and the subsequent position of the rocker sole apex relative to the metatarsal heads, 
and also its orientation angle transversely across the shoe; as well as its apex angle 
(Chapman et al., 2013). This means that each subject should ideally have a bespoke 
prescription. However, it has been shown that to achieve maximal plantar pressure 
reduction for the great toe using angled rocker soles, the rocker angle needs to be 30o and 
positioned behind the metatarsal heads at a position of 55% of shoe length (Geary and 
Klenerman, 1987). This prevents the distal end of the foot experiencing plantar loading until 
as late as possible during propulsion.  
This degree of rocker angle also makes the rocker sole very deep at its apex, but crucially 
theoretically makes the sole unit stiffest at that point so that it can rock without the shoe 
flexing. Rocker sole profiles which are comparatively less deep at their apex point tend to 
have lower apex angles, and this theoretically makes the shoe more flexible during stance 
phase than those with deeper profiles and larger rocker apex angles. However, the effect on 
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specific gait parameters of varying the thickness of the sole using rocker sole profiles in 
footwear and therefore also varying their stiffness is not well known and is analysed in this 
study. 
Rocker sole designs may also affect the kinetics and kinematics of gait and also muscle 
function and activity in the lower limbs. However, little evidence exists with regards to these 
points. Although alterations to rocker sole apex angles and orientations have been 
extensively studied with regards to plantar pressure reductions (Hutchins et al., 2009), their 
effect on muscle function and activity is not well understood. Compared to barefoot 
walking, ambulation in a shoe incorporating a heel unit significantly alters gait parameters, 
but currently little is known how this affects parameters associated with muscle tendon 
units (MTUs) in the lower limbs. The alterations to gait kinetics and kinematics when walking 
with shoes adapted with the more commonly-prescribed rocker sole units such as the toe-
only, the negative heel and the double rocker sole have been studied in the literature (Long 
et al., 2004, Van Bogart et al., 2005, Myers et al., 2006). However, these alterations have 
been shown to be clinically insignificant.  
Currently it is unknown whether specific alterations to bespoke rocker sole design 
parameters can significantly affect the kinetics and kinematics of gait, and how they alter 
the operation of specific lower limb MTUs and the magnitude alteration which may be 
expected. Many studies have shown that the length and velocity of contraction of muscle 
fibres can have a significant effect on muscle force generation (Arnold et al., 2013). 
However, there is limited evidence in the literature and little understanding with regards to 
how much the force-length and force-velocity properties of the main muscles acting on the 
ankle affect force generation during walking in different footwear conditions.  
Previous studies have provided limited contribution to the literature in this area, which 
would be potentially useful to enable footwear conditions for specific pathologies to be 
designed. Therefore, there is a need to expand the current knowledge in this area by 
analysing what effects rocker soles have on lower limb MTUs. Diseases such as intermittent 
claudication (IC) which adversely affect muscles acting on the ankle such as the triceps 
surae, may be responsive to orthotic intervention in the form of rocker soles, and evidence 
is needed as to which designs can, for instance, induce an offloading of this muscle group, or 
indeed increase loading in it for building up muscle strength. This may be achieved by 
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analysing a series of rocker sole profiles, which have targeted amendments to their profiles 
in order to identify these alterations. Therefore, muscle biomechanics and muscle 
parameters should be examined in relation to different footwear adaptations to understand 
how different designs can help in achieving the individual aims for different complications. 
In addition to the conditions previously mentioned, there are numerous other conditions 
which affect the lower limb and foot which have been shown to be amenable to treatment 
using rocker soles. For instance, subjects with plantar fasciitis have been successfully treated 
with the toe-only rocker sole in conjunction with functional foot orthoses (FFOs) by reducing 
the intensity of the pain associated with the condition (Fong et al., 2012). It has been 
hypothesised that this improvement in symptoms may be associated with a reduction in the 
windlass mechanism affecting the plantar fascia due to restriction in 1st 
metatarsophalangeal joint (MTP) dorsiflexion during the propulsive phase of gait (Lin et al., 
2013). However, analysis of the effect on the ankle plantarflexor MTUs with simultaneous 
analysis of kinetic and kinematics would have been useful in these studies, as it is known 
that subjects with plantar fasciitis may also have an ankle plantarflexor MTU contracture. 
Subjects with Achilles tendonitis may benefit from a reduction in the activity of the ankle 
plantarflexors during gait by using a rocker sole specifically designed to place the ankle in a 
relatively plantarflexed position during stance phase in order to reduce the work done by 
these muscles. This may be achieved by analysing the associated reduction in Achilles 
tendon lengthening and shortening during gait. 
One pathology which has received a great deal of attention in the literature in recent years,  
and one which is known to adversely affect the ankle plantarflexor musculature is 
intermittent claudication (IC). This is a condition where vascular supply to the lower limbs is 
compromised due to peripheral vascular disease (PVD); otherwise known as peripheral 
occlusive arterial disease (POAD) or peripheral arterial disease (PAD). IC limits a patient’s 
ability to walk because of pain being experienced in the calf muscles due to the muscle 
tissues becoming ischemic. This causes limping and eventually forces people with IC (known 
as claudicants) to stop walking in order to rest for a period of time after which they can 
continue to ambulate. This cycle of walking and resting typifies the gait of claudicants 
(Allaqaband et al., 2009, Wessler, 1955).  
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It is also important to look at muscle-tendon length changes during gait, because they 
actuate movement by developing force and generating internal moments (Delp, 1990). This 
may be an important factor when developing orthotic intervention for claudicants. Whilst 
the most commonly prescribed design of rocker sole profiles (such as the toe-only, double 
and negative heel rockers) have been shown to initiate small alterations to knee and ankle 
sagittal plane angles and ROMs during stance phase, little evidence exists regarding the 
ability of specific muscle groups to generate force when walking with rocker soles, because 
their effect on muscle-tendon lengths, muscle moment arms, and also their velocity of 
contraction is largely unknown.  This is because when a muscle-tendon unit is lengthened or 
shortened to a certain point, the muscle fibres may be too long or too short to generate the 
required amount of active force in the lower limb. Skeletal muscle develops only 50% of the 
maximum force when its length is shortened to 85% of its resting length (Panjabi and White, 
2001).  
In addition, the type of muscle contraction demonstrated by specific muscles in the lower 
limb (i.e. concentric eccentric or isometric) may also be altered by rocker sole profiles, along 
with the EMG activity levels detected and the subsequent forces generated about the joint 
the muscle is attached to. Specific rocker sole designs may therefore affect muscle activity, 
and also alter gait patterns. 
In order to evaluate the effects of muscle-tendon properties and skeletal geometry in 
determining moment-generating characteristics of selected muscles, a technique was 
developed by using Visual3D and OpenSim software. EMG data can indicate when a muscle 
is active or inactive and if larger groups of motor units are recruited to perform the task, but 
interpretation of EMG data does not determine what causes an increase muscle activity or 
which joint motion produced it.  
OpenSim allows researchers to analyse exported dynamic motion data from Visual3d and 
examine musculoskeletal dynamic motions using a specially-developed model of the adult 
lower limb. This model was initially developed from data that quantified muscle architecture 
in cadavers (Arnold et al., 2010). It allows the user to export data, which is scaled by 
segments, length, mass, the average geometrical shape of bones and the height of the 
subject. This computer model can feasibly assist in understanding the biomechanical 
consequences of musculoskeletal dynamic changes when walking with different footwear 
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rocker sole profiles and influence the design of future footwear with the specific aim of 
treating patients with IC and the other conditions previously mentioned. 
The focal aim of this research is to inform the development of rocker shoes for patients with 
IC. A significant percentage of claudicants are also diabetic. The starting age for vascular 
complications in the diabetic population is approximately 45 years of age. IC adversely 
changes claudicants’ quality of life and makes them more sedentary which can cause 
medical complications. Such complications include muscle atrophy, stiff joints and stiff 
MTUs, decreased storage of muscle fuel, de-capilliarisation in muscles, cardiovascular 
weakness, reduction in stroke volume performed by the heart to deliver oxygen, reduced 
oxygen extraction from the blood, reduced blood flow and distribution and increased blood 
pressure.  Claudicants’ main musculoskeletal symptom is the development of calf pain 
during ambulation due to vascular problems which makes them walk with a limp after 
walking a certain distance. 
Exercise training has provided improvement for claudicants in these factors (Abernethy et 
al., 2013, Katch et al., 2011). Rocker soled shoes, which, if specifically-designed, may prove 
to reduce the work done by the ankle plantarflexors during ambulation, could be beneficial 
for claudicants by increasing their pain-free walking distance, reducing the intensity of their 
pain whilst claudicating, and by fighting against a sedentary lifestyle and naturally improving 
their cardiovascular system and therefore increasing oxygen delivery to the muscles without 
the need to attend supervised exercise programs. Moreover, alternative designs of footwear 
which increase work done by the muscles acting on the ankle joint could be used for short 
distances to build up calf musculature, increase capillary density and develop muscle fibres, 
which would result in improvement in oxygen delivery and muscle fuel storage.  
Both these footwear features could replace supervised walking exercise programs, which 
are not always available or possible to attend for all patients. However, to achieve the 
optimal design to achieve this target would require extensive research. Before this could be 
achieved however, it would be necessary to more fully understand the muscular and 
biomechanical effects of different footwear features on muscle properties and walking 
patterns to inform the final designs. Therefore, in this thesis, one footwear feature was 
altered at a time in a series of tests to inform changes in parameters from identifiable shoe 
design alterations.  
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Walking speed was controlled within set limits during gait laboratory testing, and healthy 
young male subjects were recruited for the research to minimise any external influences and 
effects on the primary outcome measures. This approach is different from most previous 
studies because factors such as the control of walking speed, alteration of one distinct 
footwear feature at a time, and the ability to produce an analysis of muscle-tendon 
properties and force generation by novel use of OpenSim software during walking trials, 
would enable a direct comparison of shoe design alterations to be made.  
 
In summation, the research contained in this thesis is therefore aimed at systematically 
understanding the precise effects of altering parameters associated with different footwear 
rocker sole profiles on lower limb kinematics and kinetics, linked to muscle biomechanics 
and alterations to muscle activity in the lower limbs (especially for the calf group of muscles 
and anterior leg muscles). It was thought important for the purposes of this thesis to 
primarily examine the effect of such interventions on healthy subjects’ gait. This is because 
it would afford the opportunity to judge the results more precisely without other factors 
which may have an effect on the gait and muscle changes at the ankle and knee if subjects 
were to have varying amounts of disability. In addition, it would be necessary to perform 
gait laboratory testing on subjects who would be able to walk at similar speeds to negate 
the effects of walking speed on the comparative effects of altering the soles and heels of 
shoes. The intention was therefore to understand the precise effect of five different 
footwear design features (rocker sole apex position, rocker sole relative stiffness level, the 
type of heel shape, the rocker apex angle and alteration to heel height) on gastrocnemius 
medial head, soleus, tibialis anterior, rectus femoris and biceps femoris muscle activity and 
specific MTU parameters, plus temporal-spatial parameters during walking in adult healthy 
subjects. The results were intended to inform and make recommendations as to which 
footwear sole and heel unit design features would be suitable to alleviate symptoms 
associated with IC during rehabilitation protocols and also give indications for suitable 
intervention for various other pathologies. 
By reducing the work done by the calf muscles, patients with IC may improve their free-pain 
walking distance and at the same time exercise their cardiovascular system by walking 
greater distances. Footwear which increases the work done by the calf muscles could 
conversely be used for exercising and strengthening their calf muscles as a parallel 
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treatment to also improve their fitness as well as improving their pain-free walking 
distances.  
Therefore the overall hypothesis was, that by altering shoe features such as heel height, 
rocker apex position, addition of a curved heel, alteration to apex angle and relative rocker 
sole stiffness, this would produce significant alterations to lower limb muscle EMG activity, 
kinetics and kinematics, the type and velocity of muscle contractions in specific lower limb 
muscles and their MTUs, alteration to fibre and tendon length, joint rotations and temporal 
and spatial gait parameters.  
A design of shoe which incorporates sole and heel unit features which maintains the calf 
muscle-tendon length close to its optimal length whilst simultaneously reducing the velocity 
of concentric contraction in the calf muscles may significantly offload the calf muscle (i.e. 
affect ankle power generation and absorption) more than by simply reducing the sagittal 
plane moments about ankle during stance phase of gait. It is as yet unknown how variation 
in externally-applied sagittal plane moments via the ground reaction force (GRF) affect 
lower limb MTUs when walking with adapted shoes. This may prove in the future to be of 
benefit to subjects with plantar fasciitis, Achilles tendonitis as well as IC – indeed any 
pathology which adversely affects the muscles acting on the foot and ankle. However, it is 
the intention of this thesis to base its analysis on the specific needs of patients with IC. 
This study therefore presents data that permits the main muscles acting on the ankle to be 
studied by relating muscle fibre/tendon dynamics and force generation to the mechanical 
demands of walking in different footwear conditions. 
 
1.2 Thesis content 
Chapter 2 analyses how IC is diagnosed, its epidemiology, the risk factors involved and the 
clinical effects and known interventions for treating IC. It also presents a literature review 
regarding the existing evidence of the efficacy of treatment programmes and the known 
effects of footwear outsole features on specific gait parameters in claudicants such as heel 
raises and rocker soles.  
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Chapter 3 describes the biomechanics of normal adult gait. It also includes a section 
describing normal gait and the evidence to date regarding the effect of ageing on gait 
parameters in healthy adults and those with specific pathologies such as PAD and IC. 
Chapter 4 comprises of a literature review of footwear outsole features such as rocker sole 
profiles which are used in clinical practise, their application in the treatment of various 
pathologies and describes the process which determined the features used during the gait 
analysis investigations.   
Chapter 5 Describes the methodology used to capture the data and the software and 
hardware required to produce data required to accept or not accept the hypotheses stated; 
and also includes details on the research design and the methodology of the gait laboratory 
testing. 
Chapter 6 presents the results for all the parameters tested and a subsequent analysis. The 
results from the gait laboratory data and the subsequent analysis are contained in this 
chapter with regards to the effect of the footwear feature test conditions on the primary 
outcome measures during ambulation. 
Chapter 7 comprises of a discussion section which analyses and contrasts the results and 
makes recommendations regarding the potential relevance of performing future research 
using specific footwear outsole features for the potential benefit of claudicants and also 
those subjects with other relevant pathologies. In addition, recommendations are made for 
potential future research regarding other people with gait-limiting conditions such as 
Achilles tendonitis, diabetes and plantar fasciitis for whom the results of the gait analysis 
would indicate that they may benefit from interventions utilising rocker-soled shoes. 
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CHAPTER 2   
2 INTERMITTENT CLAUDICATION (IC) 
2.1 Chapter overview  
Chapter 1 described how patients suffering from various pathologies could benefit from 
orthotic intervention in the form of footwear adapted with rocker soles by altering gait 
parameters. It was also explained that there may be other potential benefits of walking with 
rocker-soled shoes; in particular beneficial alteration to power absorption and generation by 
specific lower limb joints and alteration to muscle activity and muscle length during stance 
phase. 
IC is a disease which causes specific alterations to muscle performance and also produces 
pain in the major ankle plantarflexor muscles. This chapter describes and contrasts the 
aetiology and symptoms associated with IC and the current treatments routinely available to 
claudicants. Treatment efficacy is discussed and an analysis is presented as to why new 
innovative treatments are needed to help alleviate the symptoms of IC and to potentially 
enable claudicants to attain higher fitness levels than can be achieved using conventional 
therapy. 
 
2.2  Intermittent Claudication (IC) 
IC is a disease caused by vascular insufficiency to the lower limbs; usually due to an 
occlusion in one of the proximal arteries of the leg (e.g. the superficial femoral artery, the 
iliac artery or the popliteal artery). IC is diagnosed by means of measuring the ankle brachial 
pressure index (ABPI), which is calculated by dividing the arterial blood pressure at the ankle 
by the reading obtained at the upper arm on the same side (Fowkes et al., 1991, McDermott 
et al., 1994, Norgren et al., 2007, Ramos et al., 2009, Feinglass et al., 1996). A positive 
diagnosis is recorded when the ratio of the two readings is 0.9 or less (Wang et al., 2005). 
Symptoms are most commonly experienced in the major calf muscles, and involve a cramp-
like pain which leads to limping. A period of pain-free walking before patients experience 
calf pain is a symptom of the disease (Kruidenier et al., 2009). These symptoms disappear 
with rest; usually within a few minutes, after which it is possible to commence walking 
again. This produces a constant cycle of pain-free walking, followed by painful walking and 
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then enforced rest. Leg pain occurs unilaterally in 40% of patients and bilaterally in 60% of 
patients. They may also experience fatigue or pain in the thighs and buttocks (Dorland, 1994, 
Manzano et al., 2009). 
IC is a manifestation of a more systemic disease known as peripheral arterial disease (PAD). 
Approximately 8 million American adults have PAD. When claudicants walk, the calf muscles 
receive insufficient oxygen which eventually leads to development of the muscle pain 
experienced by these patients. However, following a period of enforced rest, oxygen 
consumption in the calf muscle has been shown to return back to normal levels, which is 
why the pain disappears (Meru et al., 2006, NHS guidelines, 2006). Approximately 30-40% of 
patients diagnosed with PAD suffer from IC (Kupecz, 2000, Degischer et al., 2002).  IC is 
caused by atheroma (fatty deposits) in the walls of the arteries leading to reduced blood 
flow to the muscles and tissues (NHS guidelines, 2006).  
 There are number of known risks factors, which cause the development of IC which include:  
 Being over 45 years of age; 
 Being a long-term smoker; 
 Suffering from obesity; 
 Having a family history of IC or vascular complications; 
 The presence of cardiovascular disease and/or diabetes; 
 Suffering from hypertension; 
 Habitually following a poor diet; 
 Having hypercholesterolemia. 
 
IC is most commonly seen in older male subjects; especially if they are long term smokers. 
The Alzamora study demonstrated that the ratio between males and females with IC was 
approximately two to one (Alzamora et al., 2010). It has been reported that IC can affect 3% 
of people aged 45-64 and 18% - 27% of people over the age of 60 (Allaqaband et al., 2009).  
It is important to help treat patients with IC, because in 25% of patients, their symptoms 
worsen and unfortunately approximately 5% of them will require an amputation within 5 
years (Meru et al., 2006). IC has been associated with at least a three-fold increased risk of 
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coronary heart disease, stroke or cardiac failure when associated with diabetes (Stewart and 
Lamont, 2001).  
Patients with IC can also have a significantly reduced quality of life (QOL) due to their calf 
pain, lack of physical mobility and their adverse emotional status, and it can be equated to 
that seen in cancer patients (Klevsgård et al., 1999). Another study demonstrated that the 
QOL of claudicants in all the respects investigated was significantly reduced compared to 
normal subjects (Pell, 1995, Breek et al., 2001). The severity of the disease, as measured by 
their ability to walk before having to stop, was a significant predictor of general health, pain, 
vitality and in quantifying physical and social parameters. 
 
2.3 Treatment regimes 
A number of treatments have been developed in an attempt to reduce the symptoms of the 
disease. This section describes an analysis of current and previous treatments and postulates 
why further non-invasive treatment methods are needed for this patient group. 
2.3.1 Walking exercise therapy in the treatment of IC 
Walking exercise therapy for claudicants has historically been prescribed by either attending 
structured supervised exercise sessions or by unsupervised self-regulated walking.  Some 
studies have demonstrated that the best and safest treatment is a daily walking program; 
ideally 45-60 minutes per day (Stewart et al., 2002). It has been also previously stated that 
walking exercise programmes have clear benefits for many patients with IC (Mueller, 1998).  
Exercise training has been shown to be an effective treatment by significantly increasing 
walking distance for patients with IC; especially in the ageing population (Remijnse-Tamerius 
et al., 1999). Different mechanisms were thought to be involved in producing this beneficial 
effect. These included adaptation or redistribution of the peripheral blood flow (otherwise 
referred to as the development of collateral circulation), inhibition of the progression of the 
atherosclerotic disease, changes in blood rheology, metabolic changes, changes in skeletal 
muscle morphology, economisation of walking, a change in pain perception and a positive 
effect on the cardiovascular system.  
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Endurance exercises have also been shown to be beneficial to oxygen uptake in older people 
(Fitzgerald, 1985, Østerås et al., 2005). Carter indicated in his study that short-term exercise 
programmes could be a valuable treatment for patients with IC (Carter et al., 1989). The 
study conducted by Andriessen et al. (1989) subsequently demonstrated the efficacy of an 
intensive six-months of exercise therapy performed three times per day by patients with IC. 
Walking exercises are the most important treatment for IC, although drug therapy could 
beneficially be used in conjunction with it as well (Ernst et al., 1992, Hiatt, 2001).  NHS 
guidelines and Ekroth et al. (1978) both stated that changes in lifestyle such as 
discontinuation of smoking, weight loss and daily exercise are useful to prevent and treat IC 
(NHS guidelines, 2006). Patternson et al. (1997) in his paper reviewed and confirmed the 
evidence regarding the efficacy of exercise therapy for patients with IC. Patternson noted a 
337% increase in free-pain walking ability, and also illustrated the importance of supervised 
exercise regimes.  
However, Keltikangas-Jarvinen et al. (1987), stated that personality factors such as paranoid 
tendencies in patients with IC should be controlled in order to optimise treatment programs. 
Another cautionary statement was produced by Ernst and Fialka (1993), who demonstrated 
that long-term continuation of exercise regimes was important, as gains in walking distance 
could be lost if this was not done. 
A meta-analysis by Gardner and Poehlman (1995), indicated that the mean walking distance 
until the onset of claudication pain may be increased by an average of 179% (from 
125.9±57.3 m to 351.2±188.7 m) following exercise programmes that include walking. The 
exercise level attainable by individual patients was identified as being a measure of the 
severity of this disorder. Subsequent publications by Gardner et al. (2000) and Gardner et al. 
(2001c) demonstrated an improvement in ambulatory function in patients with IC following 
an exercise programme. Their findings were also confirmed by Stewart et al. (2001). A long 
term supervised exercises (12 months) improved on average by 171% in pain free walking 
time and 120% in maximal walking time in a study by Crowther et al. (2008). 
A previous systematic review published by Brandsma et al. (1998) investigating the effect of 
structured exercise programs indicated beyond doubt that walking exercises improved pain-
free walking distances in patients with IC. There was, however, a large range of percentage 
improvements measured by the studies finally selected for review, ranging from 28% to 
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210%, with a mean of 105% and STD 55.8 (Larsen and Lassen, 1966, Holm et al., 1975, Ernst 
and Matrai, 1987, Kiesewetter et al., 1987, Lundgren et al., 1989, Creasy et al., 1990, Hiatt et 
al., 1990b, Mannarino et al., 1991, Hiatt et al., 1994, Regensteiner et al., 1996). It was also 
demonstrated that supervised exercise regimes involving only walking were more beneficial 
than those involving walking with other forms of exercise. Exercise therapy program for 
patients with IC was also recommended by Binnie et al. (1999) and Wullink et al. (2001). 
Hunt et al. (1999), presented a regime of supervised exercise therapy for 42 claudicants 
which provided successful functional outcomes. Leng et al. (2000) undertook a Cochrane 
systematic review, and concluded that exercise therapy should be the treatment of choice 
for those patients with IC who were appropriately fit enough. Stewart and Lamont 
recommended in their editorial that exercise therapy should be widely available to IC 
patients in the UK (Stewart and Lamont, 2007). 
2.3.1.1 Supervised versus non-supervised walking exercise therapy 
The gold standard treatment for claudicants is considered to be the use of supervised 
exercise therapy (SET), and this is well documented in the literature. Supervised walking 
exercise improves the general cardio-vascular system which leads to an increased oxygen 
supply to the lower limbs and improvement in the maximum pain-free walking distances by 
claudicants. A number of studies have suggested that a significant improvement may be 
achieved in the pain-free walking distance using this intervention (Table 2.1). However, 
there is also some evidence to suggest that long term supervised walking training exercises 
with a duration of up to twelve months do not demonstrate more significant improvement 
when compared to shorter-termed treatments.  
Nevertheless, exercise programmes have been shown to be of significant benefit compared 
to usual care protocols in improving the walking time and distance achieved by subjects with 
IC (Watson et al., 2008). Fokkenrood et al. (2013) recently published a review which 
compared the effect of SET to that produced when following non-supervised walking 
therapy protocols. SET generally consisted of three exercise sessions per week, and their 
results suggested that SET had a statistically significant benefit with regards to treadmill 
walking distance (maximal and pain-free) compared with non-supervised programmes. 
However, the clinical relevance of this has not been demonstrated definitively. Additional 
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studies were therefore recommended which would focus on QOL or other disease-specific 
functional outcomes. They recommended that professionals in the vascular field should 
make SET available for all patients with IC. 
Parmenter et al. (2013), also recently published a systematic review of the effect of exercise 
and performance-based treatment on the walking ability of claudicants as evidenced in the 
literature. In total 924 participants (71 % male) were studied; with a mean ankle brachial 
index of 0.66 ± 0.06. Aerobic capacity was improved by 8.3 % ± 8.7 % on average by exercise 
therapy. Muscle strength was measured in only five trials, improving by 42 % ± 74 %. There 
was a strong significant relationship between change in ankle plantarflexor muscle strength 
and change in pain-free walking times (r = 0.99; p = 0.001) and absolute claudication time 
(r = 0.75; p = 0.05) when using a treadmill to measure this parameter. The six-minute 
walking  test distance was measured in only 14 % of trials.  
Table 2.1: Examples of exercise training rehabilitation programmes for claudicants. 
Source Method Walking test Increase in pain-
free walking 
distance 
Increase in 
maximum 
walking distance 
(Zwierska et 
al., 2005) 
Group 1: Leg training (n=37) 
plus cycling. 
Group 2: Arm training (n=34) 
plus arm cranking,  
Group 3: Control (n=33) 
groups 1 and 2 were trained 
for 24 weeks using supervised 
training for 40 min/twice per 
week. 
A shuttle test Group 1: 93% 
Group 2: 122% 
Group 3:  Not 
significant (NS) 
Group 1: 50% 
Group 2: 47% 
Group 3: NS 
(Gardner et 
al., 2001b) 
Group 1: n=28, treadmill 
supervised walking exercise 3 
times per week for 6 months. 
Group 2: n=24, the control 
group. 
A treadmill test at a 
speed of 3.2 km per 
hour and increased 
by 2% every 2 
minutes  
Group 1: 134% 
Group 2: 25% 
Group 1: 77% 
Group 2: 12% 
(Patterson 
et al., 1997) 
29 men, 26 women with IC. 
Group 1: 12 weeks supervised 
exercise using one hour of 
treadmill walking plus aerobic 
exercise three times weekly.  
Group 2: unsupervised walking 
3 times weekly plus lectures 
A treadmill test 
(1mph at a 5% 
incline); increasing 
at 5- minute 
intervals to 2.5mph 
and a 10% incline. 
Group 1: 337%  
Group 2: 131%  
unsupervised 
maintained the 
improvement at 
6 months 
Group 1:  207% 
supervised, 
Group 2: 70% 
unsupervised; 
maintained for 
six months. 
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(Jones et 
al., 1996) 
N=12 training for 12 weeks 
Group 1: (n=6) The Stair-
master 
Group 2: (n=6) a treadmill 
Treadmill testing at 
a  speed of 3.2 km 
per hour and 
increased by 3.5% 
every 3 minutes 
Group 1: 
Increased by 
35.5s 
Group 2: 
Increased by 
117.7s 
Group 1: NS 
Group 2: 
increased by 
171.7 s 
(Hiatt et al., 
1990a) 
Group 1: (n=10), 3 months of 
supervised training, 1 hour/ 3 
times per week walking on a 
treadmill at a speed of 2-
2.5mph, with a  0-14% incline 
Group 2: (n=9)- a  control 
group 
Treadmill test  
0-14% incline 
Group 1: 165% Group 1: 123% 
2.3.2  Progressive resistance training (PRT) 
The utilisation of walking allied to progressive resistance training (PRT) is a recent 
development which has also been shown to significantly improve claudication distances,  
(the point at which  calf pain commences), and maximum walking distances (before having 
to stop) by means of undertaking a six minute walking test. The benefits of PRT in 
conjunction with upper body exercise appear promising (Parmenter et al., 2011), but again, 
more evidence is needed. A further review by Parmenter et al. (2013) also suggested that 
there could be a significant relationship between increased ankle plantarflexor muscle 
strength and treadmill walking ability following a PRT regime plus regular exercise by 
claudicants. Modes of aerobic exercise other than walking appeared to be equally beneficial 
for claudicants. However, the longer term benefit of this type of intervention has not been 
proven, and indeed the appetite for claudicants to undergo repeated supervised exercise 
programmes is doubtful; but a recent study demonstrated some improvement in 
claudication distance using a home-based exercise programme (McDermott et al., 2013). 
Claudicants are now routinely screened and advised in the community setting as well as in 
hospital vascular units for lifestyle management factors like discontinuation of smoking, the 
need to take regular walking exercise, and control of other factors which may affect them 
such as diabetes, hypertension and blood colesterol levels. In addition, various drugs have 
been developed to help reduce the symptoms associated with IC. 
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2.4 Drug therapy 
Drugs such as trental, cilostazol, ramipril naftidrofuryl, pentoxifylline, inositol, nicotinate and 
cennarizine have been developed to potentially improve blood flow through narrowed 
vascular vessels and therefore increase oxygen supply to the calf muscles. Aspirin, (75mg 
daily) is also routinely prescribed as an anticoagulant for claudicants due to their general 
vascular disease. After 6 months of drug therapy using ramipril, Ahimastos et al. in their 
study demonstrated a 75-second ( 60-89 seconds) increase in mean pain-free walking time 
(P<0.001) and a 255-second (215-295 seconds) increase in maximum walking time (P< 0.001) 
compared to a placebo (Ahimastos et al., 2013). Another study demonstrated that ramipril 
was also associated with a 75-second increase in mean pain-free and a 255-second increase 
in maximum walking time following a 6 month RCT (Kurklinsky and Levy, 2013). 
The efficacy of pentoxifylline in reducing the symptoms of IC was investigated in a Cochrane 
review by Salhiyyah et al. (2012). There was very large variability in the reported findings 
between the 17 individual studies analysed even though there was no statistically significant 
difference in ankle brachial pressure index (ABPI) between the pentoxifylline and placebo 
groups. The authors therefore stated that the overall benefit of pentoxifylline for patients 
with IC remains uncertain. However, it was stated that drugs such as naftidrofuryl oxalate 
and cilostazol both appear to be effective treatments for IC patients, with the reservation 
that naftidrofuryl oxalate is the only treatment that is likely to be considered cost-effective, 
and that the long-term effectiveness of drug therapy for those analysed in the study is 
uncertain (Squires et al., 2011). 
The evidence therefore suggests that the use of drugs in the treatment of claudicants is still 
uncertain when analysing their effect on increasing pain-free walking distances and absolute 
maximum walking distances, and further trials are warranted to identify their efficacy in 
improving specific gait parameters.  
 
2.5 Discussion 
There is no doubt that walking exercise, either supervised or un-supervised, is effective in 
improving the symptoms associated with IC. However, the results demonstrated have varied 
significantly, and anecdotal evidence suggests that claudicants do improve to a certain level, 
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at which the improvement plateaus and no further improvement is possible just by using 
daily exercise. New interventions have attempted to obviate this by also introducing 
concurrent therapy such as progressive resistance training to increase calf muscle strength 
and improve walking distances. However, this infers that the calf muscle will need to be 
constantly exercised to maintain its improved strength in order to maintain the 
improvement in symptoms in conjunction with regular exercise. It is as yet unknown 
whether a strengthened calf muscle in claudicants can be maintained at that level purely by 
means of walking exercise therapy, or whether special exercise regimes will be needed for 
much longer periods. The ramifications of this and possible alternative treatments such as 
the use of orthotic intervention are discussed in chapter 3. However, there is some evidence 
in the literature which demonstrates that orthotic intervention may provide some 
improvement in walking distances which could be achieved by claudicants.  
 
2.6 Orthotic intervention 
2.6.1 Rocker-soled shoes 
The first investigation performed specifically to help increase pain free walking distances by 
claudicants was performed by Richardson, who investigated the effect of walking with 
angled rocker soled footwear in claudicants (n=15) and demonstrated improvement in 
walking distance (Richardson et al., 1989). However, the rocker was not accurately 
described. Richardson subsequently studied 21 claudicants and again compared the efficacy 
of angled rocker soled shoes to that demonstrated when walking with high street footwear 
(Richardson, 1991). The rocker sole used had a 15-degree angle with an apex positioned 6-7 
cm proximal to metatarsal heads. For a typical adult male size 9 shoe, this would place the 
rocker sole apex position at approximately 50% of shoe length (authors calculation). The 
total walking distance, known as either the absolute or maximum walking distance, as well 
as the distance covered before the onset of pain (referred to as “bothered” distance or “pain 
free distance”), were both significantly improved for patients with IC using the traditional 
rocker-soled shoes [i.e. rocker sole profiles with an angled apex rather than a curved apex 
(Tyrrell and Carter, 2008)]. 
However, the study found there was a substantial variability in the patients’ responses to 
the rocker-soled shoes. This variability was explained by differences in walking biomechanics 
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amongst the patients and was also found in a study by (Honet et al., 1968). It was found that 
because the rocker fulcrum was positioned proximal to the metatarsal heads, the shoes 
were effective in facilitating heel-off rather than toe-off during gait. Therefore, the authors 
hypothesised that patients who pushed off more vigorously in the late-stance phase of gait 
during the walking trials may not have significantly decreased the work of their calf 
musculature. The results indicated that further work needed to be done to optimise shoe 
design for this patient group and indicated that the fulcrum needed to be re-positioned in 
future studies. However, in an un-published report, Bell and MacBain (1998) using an 
identical rocker design as Richardson demonstrated a significant decrease in the “bothered 
distance” walked by claudicants. There is therefore variance in the literature and therefore 
this needs further investigation.  
Hutchins et al. (2012) performed a pilot study with a group of volunteer claudicants (n=8) 
using a shoe adapted with a rocker sole profile which comprised of three distinct circular 
curves in its design. This was designed to reduce the moments acting around the ankle, hip 
and knee joints during stance phase of gait by positioning the centres of the curves 
comprising the profile of the rocker sole at the sagittal plane anatomical joint centres of the 
ankle, hip and knee during specific parts of stance phase. This was done to encourage the 
ground reaction force (GRF) to pass through these joint centres and therefore to reduce 
moments acting on them. The study demonstrated that a significant increase in pain-free 
walking distance (mean 34.81m) and a significant mean percentage reduction in the 
intensity of calf pain once claudicating (57%) could be achieved by the claudicants in the 
study. 
2.6.2 Raised heels 
A study by Learmonth and Slessor (1952) recommended the use of raised heels for patients 
with PAD in the lower limbs. However, this was contradicted in a study by Chavatzas and 
Jamieson (1974), who added a 4cm heel raise to place the ankle in an equinous position to 
theoretically also reduce the amount of sagittal plane range of motion (ROM) and to unload 
the triceps surae muscle group. The results showed no significant improvement in pain-free 
walking distance in those patients tested. They also found that ankle systolic blood pressures 
before and after walking were not significantly affected. The onset of pain in 27 of 30 
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subjects tested did not alter when walking with the footwear with raised heels. This orthotic 
intervention was therefore not recommended by the authors. However, the reason for the 
lack of improvement in pain free walking distance using this type of intervention is as yet 
largely unknown. 
2.6.3 Specifically-designed rocker profiles 
The results demonstrated in the literature when utilising either rocker soled shoes or heel 
raises have therefore produced conflicting results. However, one study, which utilised a 
specifically-designed three-curve rocker sole modification has demonstrated, that in 
claudicants, pain-free walking distances can be significantly increased and the intensity of 
the calf pain experienced significantly reduced (Hutchins et al., 2012). It was thought that by 
reducing the power absorption and generation required to ambulate by the ankle 
plantarflexors in addition to reduced externally applied moments, improvements in 
claudication distance were achieved.   
The idea of altering ankle power and absorption may be developed and expanded so that 
footwear could indeed be developed to not only offload the calf muscles but also 
alternatively make them work harder to act in the same way as PRT. Exercise programs used 
in parallel with footwear specifically designed to stretch and increase calf muscle activity 
during walking may improve not only the cardio-vascular system, but build muscle fibres 
which may stimulate arteries to improve blood circulation and oxygen supply, and stimulate 
arteries to develop new channels of blood circulation around the narrowed sites (the so-
called collateral circulation). Theoretically, such a training approach could be beneficial for 
patients with IC. If this could be alternated with footwear developed to offload the calf 
muscles to enable claudicants to walk further before experiencing painful symptoms, and 
therefore get fitter anyway, this could prove to be a potentially novel treatment for 
claudicants. 
The studies assessing footwear adaptations have to date still given little evidence as to why 
these interventions altered pain-free walking distances in claudicants because of lack of 
available data regarding muscle biomechanics, and in some cases, limited information about 
gait alterations. 
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A training program which focused on quadriceps femoris muscle training using a bicycle for 
normal subjects during an 8 week programme has demonstrated that training specific 
muscle groups is a powerful tool to produce an increase in capillary density by up to 20% 
and also increase muscle fibres by up to 20% which results in a 16% increase in oxygen 
supply to the muscle (Andersen and Henriksson, 1977). Capillaries serve a variety functions, 
such as blood supply to the muscles and tissues and an exchange between them, 
maintaining normal blood pressure and circulation, and serving as blood reservoir (Alter, 
2004). 
Footwear designs which can be shown to increase calf muscle activity and stretch such 
MTUs may feasibly reduce any restriction of motion at the ankle and increase capillary 
growth. This may be achieved by using a so-called negative rocker sole profile, (where the 
heel is at a lower level than the metatarsal head area) which has been demonstrated to 
increase the maximum range of the ankle joint during walking (Li and Hong, 2007). The 
negative heel may place ankle into more dorsiflexion position and therefore stretch calf 
muscle. A study of stretching digitorum longus muscles in rats for 2 weeks demonstrated 
that the capillary to fibre ratio was increased by 33% and 60%, which indicates that 
stretching muscle may stimulate capillary growth (Egginton et al., 1998). 
This discussion therefore suggests that a new treatment approach for patients with IC may 
prove to be beneficial for this patient group. For instance, patients with IC may increase 
their pain-free and maximum walking distance (MWD) by wearing footwear which reduces 
calf muscle activity, and therefore their cardio-vascular system could be improved during 
normal walking. This may be utilised to replace supervised walking exercises and motivate 
claudicants to walk. Rocker soles which increase calf muscle activity could also be beneficial 
for more short-term walking training programs. However, before this can be proven, it will 
first be necessary to more succinctly understand the biomechanical and muscular 
consequences on human gait of walking with footwear adapted with different footwear 
features. 
The pilot claudicant walking trial by Hutchins et al. (2007) demonstrated that subjects with 
IC can increased their maximum pain-free walking distance when wearing three-curved 
rocker shoes when compared to a standard shoe pitched with a 2.5 cm heel height. It can be 
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seen that the range of percentage increase in pain-free walking distance increased by 
average 51.8% compared to a control shoe (table 2-2).  
The increase in maximum pain-free walking distance may have been due to reduced calf 
muscle activity and therefore a reduced oxygen demand required by the calf muscles. It may 
also have been due to the fact that the rocker profile placed the ankle into a relatively 
plantarflexed position, and this may have increased the ankle plantarflexor muscle moment 
arm via the Achilles tendon. However, to date this has not been investigated.  
Table 2.2: Percentage increase in pain-free walking distance when wearing a three-curve 
rocker-soled shoe test condition. 
Patient Number Claudication Distance 
Increase (%) 
1 40.8 
2 18.9 
3 75.1 
4 36.32 
5 116.9 
6 28.8 
7 92.1 
8 5.8 
Average increase 51.8 
2.6.4  Chapter summary 
The evidence therefore suggests that walking therapy using various protocols is undoubtedly 
effective in helping claudicants attain an increased “bothered” distance before experiencing 
calf pain, and also an increased maximum walking distance before having to stop due to the 
calf pain. However, limitations as to how much improvement may be expected have been 
noted and eventual outcomes still rely on the cooperation of the patient and their 
willingness to undergo treatment such as attendance at exercise training sessions. The use 
of drug therapy has shown some encouragement that it may improve their overall quality of 
life, but no evidence was found indicating that drugs can significantly increase their 
claudication distance. More evidence regarding the efficacy of drug treatment on improving 
the symptomatic gait associated with IC is needed and also regarding its cost effectiveness. 
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The use of orthotic intervention, whilst also not as yet proven, has the potential to offer an 
alternative adjunct therapeutic avenue for claudicants. This may take the form of 
specifically- adapted footwear to give the patient the choice of wearing shoes which offer a 
calf muscle training function to build up muscle bulk, aligned with alternative footwear to 
offload the ankle plantarflexors and facilitate increased pain free walking distances. 
However, research is needed to more fully understand which footwear outsole features 
increase ankle plantarflexor activity and therefore the power needed to walk and which 
ones reduce power generation at the ankle during propulsion.  
To achieve these aims it would be necessary to more fully understand the effect of, for 
instance, increasing the pitch of footwear by increasing the heel height whilst still 
incorporating a rocker sole, or the effect of reducing heel height (to form a so-called 
negative heel) on specific gait parameters. The effect of various rocker sole apex positions 
and apex angles also needs to be investigated along with altering outsole relative stiffness of 
footwear in order to more fully understand which specific features demonstrate the ability 
to produce alterations to muscle power generation and absorption in the lower limbs, their 
ranges of motion, and also their effect on specific gait parameters. In this way, claudicants 
may have access to an alternative treatment to potentially improve their symptoms and also 
their QOL. 
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CHAPTER 3 
3 ABLE-BODIED ADULT GAIT AND CLAUDICANT PATHOLOGICAL GAIT 
3.1 Phases of able-bodied adult gait 
The gait of able-bodied adults consist of two main phases; stance and swing. Stance phase 
normally comprises of 62% of the gait cycle with swing phase comprising of 38% (Winter, 
1987). For the purpose of this thesis, these phases have been segmented into distinct 
portions as described by (Perry, 1992). These are:      
 Heel strike (HS), otherwise known as initial contact (ICt);   
 Loading Response (LR); 
 Mid stance (MSt); 
 Terminal stance (TSt); 
 Pre Swing (PSw). 
Swing phase may be described using the following segments: 
 Initial Swing (ISw); 
 Mid swing (MSw); 
 Terminal Swing (TSw). 
 
Figure 3.1: The determinants of gait (Cuccurullo, 2004). 
 
Perry also described specific “rockers” of gait during stance phase. For the purposes of this 
thesis, these will be defined as the first rocker of gait, second rocker of gait and third rocker 
of gait, to distinguish them from rocker sole nomenclature. The first rocker of gait describes 
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ankle plantarflexion following heel strike and during loading response. The second rocker 
phase is designed to describe advancement of the shank over a stationary foot during mid-
stance. The third rocker phase denotes the period during which heel rise occurs and MTP 
joint dorsiflexion occurs. However, a fourth rocker of gait has recently been postulated 
which describes a virtually locked ankle but dorsiflexion of the metatarsal heads during 
propulsion prior to ankle plantarflexion; which would become the third of four rocker 
phases during stance phase of gait (Ayyappa, 1997, Owen, 2010). However, this has not 
been utilised as a determinant of gait in this thesis. 
 
3.2 Muscles of lower limb 
The main muscles of interest for this thesis in the lower limb are the gastrocnemius medial 
head, soleus, tibialis anterior, biceps femoris and semitendinosus muscles. Gastrocnemius 
and soleus are the main plantarflexors of the ankle, and gastrocnemius is also influenced by 
knee position due to its origin being proximal to the tibial plateau. Soleus is thought to be 
more of a postural muscle than gastrocnemius. Symptoms of IC mainly occur in the 
gastrocnemius muscle due to its high oxygen demand during ambulation. Symptoms may 
also occur in the thigh area – if the vascular occlusion is cited proximally.  
The primary reason for orthotic intervention when applied to alleviate the symptoms of IC 
would be to influence a reduction in the work done by the gastrocnemius and soleus 
muscles during stance phase, and also to reduce the intensity of their activity. However, it is 
unknown whether this would apply shunting of activity and power absorption or generation 
to the antagonist muscles (e.g. tibialis anterior). Another advantage would be the ability to 
reduce the power generation requirement for more proximal muscles such as the hip flexors 
and extensors whilst still simultaneously offloading the ankle plantarflexors as these are 
weak in claudicants (please refer to section 3.4). 
In addition, as an alternative adjunct therapy as stated in chapter 2,  regular use of a 
different design of rocker-soled shoes may be able to offer a training effect by increasing 
these parameters in place of undergoing supervised exercise therapy. In this case it could be 
theoretically possible to design footwear which would entice the ankle plantarflexors to 
work harder during the propulsive phase of gait as well as offering an alternative design of 
rocker sole profile which reduced their power generation requirement. This would be in 
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order to offer alternating therapy by building up muscle bulk on one hand and also 
offloading the muscle tissues during different treatment sessions to allow people with IC to 
become fitter by potentially reducing their painful symptoms. 
 
3.3 The role of the ankle plantarflexor muscles 
There are a number of theories pertinent to this thesis regarding the role of the ankle 
plantarflexors during gait. The gastrocnemius and soleus both act as the main plantarflexors 
of the ankle. However, the functional role of the ankle plantarflexors has been the subject of 
debate in the literature (Winter and Scott, 1991, Mueller et al., 1995, Nadeau et al., 1999, 
Winter, 2009). Three fundamental theories regarding their role during late stance have been 
postulated. The controlled roll-off theory (Sutherland et al., 1980, Perry, 1992) postulates 
that the ankle plantarflexor muscles decelerate tibial rotation and prevent knee flexion 
during stance by causing the body to rotate forward due to momentum and inertia. The 
active push-off theory (Winter, 1983) postulates that the energy generated by the ankle 
plantarflexors is applied to the trunk to provide active support and forward progression. 
Another theory supports the hypothesis that the ankle plantarflexors accelerate the legs 
into swing; so facilitating forward progression during late swing (Meinders et al., 1998, Hof 
et al., 1992). 
Neptune et al. (2001) utilised SIMM software using a modelling technique in an attempt to 
provide definitive evidence as to which theory was most valid. The results indicated that 
most of the energy delivered by the soleus muscle is delivered to the trunk whilst that of the 
gastrocnemius is delivered to the leg for swing initiation. This would therefore suggest that a 
combination of the theories would most suit human locomotion. However, both soleus and 
gastrocnemius have been quoted as providing active push-off for support and forward 
progression and in initiating swing (Hof et al., 1992, Meinders et al., 1998). 
The ankle plantarflexors therefore provide crucial power generation and absorption in order 
to not only propel the body forwards but also to control segmental rotations and enhance 
posture and support. People who suffer from the symptoms of IC are generally aged over 50 
years of age, and the effects of ageing contribute to their reduction in walking ability. The 
following section analyses the evidence to date regarding the effect of ageing on gait plus 
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the addition burden of how gait is affected in those patients suffering from IC as a result of 
suffering from PAD. 
 
3.4 The effect of IC on gait parameters and muscle strength in older people - a review of 
the literature regarding its effect and possible treatment regimes 
For the purposes of this thesis, ABPI values linked to subjects with PAD will be denoted as 
PAD-ABPI values, and subjects who have IC due to PAD will be denoted as suffering from 
PAD-IC.  
3.4.1 The effect of PAD severity and ABPI values on gait parameters and ambulatory 
function. 
ABPI values have been quoted as being unreliable when attempting to correlate their value 
with alteration to walking parameters in PAD – IC subjects during ambulation (Izquierdo-
Porrera et al., 2005, Chen et al., 2008). This is thought to be due to the view that ABPI values 
cannot reflect the effects and complexity of the effect of PAD on gait parameters (McKenna 
et al., 1991, Green, 2002). However, lower resting ABPI values have recently been 
significantly correlated with reduced bilateral hip extensor strength in claudicants [r=0.54 
p=0.007, Parmenter et al. (2013)], which also potentially adversely affects claudicant walking 
distances. A study by Hutchins et al. (2012), when investigating the effect on the pain-free 
walking distances of claudicants using specifically-developed footwear, showed no 
correlation between subject ABPI values and increases in pain-free walking distances when 
walking with the footwear. The value of ABPI readings has therefore not been conclusively 
established when predicting severity of gait anomalies in subjects with PAD-IC. A Cochrane 
review has also demonstrated that enrolment by claudicants in exercise regimes does not 
affect PAD-ABPI readings following completion of the programme even though exercise 
tolerance is improved (Watson et al., 2008). 
3.4.2  The effect of increasing age and PAD 
Ageing also changes muscle functions and muscle properties. The most noticeable changes 
associated with aging are progressive muscle atrophy, a decrease in the extent of nerve 
tissue, a decrease in muscle length and alteration to collagen fibres (Gutmann, 1977, 
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Gajdosik, November 1997, Alter, 2004). Various authors have shown that older adults 
demonstrate altered gait patterns, particularly at the hip and ankle joints (Kerrigan et al., 
1998, Graf et al., 2005). Older people have reduced hip extensor moments and reduced 
ankle plantarflexor moments compared to young adult subjects (Kerrigan et al., 1998, Riley 
et al., 2001, Kerrigan et al., 2001). However, the existence of PAD compounds these 
problems, as subjects with PAD use shorter swing times and longer stance times compared 
to age-matched controls (McCully et al., 1999).  
3.4.3  The effects of a PAD-IC 
3.4.3.1 The effect of PAD-IC on muscle pathology 
PAD can adversely affect skeletal muscle strength. Further weakening of lower limb skeletal 
muscles occurs in claudicants due to the development of muscle metabolic myopathy (Brass 
and Hiatt, 2000), which is in turn due to oxidative damage to skeletal muscle structures and 
components (Pipinos et al., 2006). An axonal polyneuropathy also occurs (Weber and 
Ziegler, 2002). An abnormal ultra-structure of mitochondria in muscle has been 
demonstrated (Marbini et al., 1986), which involves abnormal mitochondrial respiration and 
adenosine triphosphate (ATP) production (Kemp, 2004, Pipinos et al., 2006), plus axonal 
nerve loss (Koopman et al., 1996, Weber and Ziegler, 2002). The overall effect can produce a 
reduction in muscle power and control especially during the propulsive phase of gait in the 
lower limbs. This means that subjects with IC may be responsive to orthotic interventions, 
which act as a surrogate to reduce the muscle power needed to ambulate (such as reducing 
the ankle plantarflexion power needed during propulsion).  
3.4.3.2 The effect of PAD-IC on gait parameters 
When older subjects develop PAD - IC, a further deterioration in gait parameters occurs 
compared to matched control groups. The onset of IC shortens step length and slows 
walking velocity still further in older people (McCully et al., 1999). Whilst the type of control 
group has varied within papers, (age-matched controls may walk with different velocities) 
common conclusions have been noted. These include development of slower walking 
speeds, shorter step lengths (Scherer et al., 1998, Gardner et al., 2001a, McDermott et al., 
2001), reduced calf muscle ability (Mockford et al., 2010, Scott-Pandorf et al., 2007, 
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Crowther et al., 2009, Celis et al., 2009, Ayzin Rosoky et al., 2000) as well as decreased hip 
extension (Crowther et al., 2007). These gait adaptations are present even in the absence of 
pain in subjects with PAD, but worsen with the cramp-like calf pain associated with IC 
(Mockford et al., 2010, Scott-Pandorf et al., 2007). 
 
Patients with PAD display gait patterns where the ankle takes longer to reach maximum 
dorsiflexion during TSt - PSw compared to controls. The ankle is also unable to generate the 
same amount of power as previously needed during push-off as the prolonged time to reach 
maximum ankle dorsiflexion means that the time available for the ankle to plantarflex for 
propulsion is limited (McDermott et al. 2001). The typical trace of GRFs (the Pedotti 
diagram) shows a flattened trace between the typical two peaks and also a reduction in 
peak values; showing that braking and propulsion phases of gate are not only so distinctly 
defined but also are less pronounced. Peak ankle plantarflexor moments and powers are 
reduced in subjects with PAD, and linked to reduced ground reaction force (GRF) values, this 
demonstrates an inability of PAD subjects to propel themselves effectively. Significant gait 
impairment results – even when the disease is unilateral (Celis et al., 2009, Koutakis et al., 
2010). In comparison with controls, patients with PAD-IC, even whilst walking pain-free 
before claudicating, demonstrate a signiﬁcant decrease in average maximum hip ﬂexion (3.8 
degrees) and a signiﬁcantly mean increase in peak ankle plantar ﬂexion (1.2 degrees) during 
early stance, plus a signiﬁcantly increased peak ankle dorsiﬂexion (2.0 degrees) during late 
stance (Chen et al. 2008). In summary, PAD-IC subjects exhibit the following gait anomalies 
compared to controls: 
 
 They walk slower; 
 They have decreased cadence; 
 They have increased stance phase durations as a percentage of gait cycle; 
 They also have shorter step lengths and narrower step widths; 
 They have reduced maximum hip flexion; 
 They have increased maximum ankle plantarflexion during early stance; 
 They have increased ankle dorsiflexion during late stance phase; 
 They therefore have increased sagittal plane ankle ROM during stance phase; 
 They have reduced peak knee power absorption during loading response; 
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 They have reduced peak hip power absorption during mid stance; 
 They have significantly reduced peak power generation at the ankle during late stance 
and consequently a reduced energy output; 
 They have reduced hip extension power which could also lead to weaker propulsion 
and reduced hip flexion by the swing leg; 
 They have reduced peak power absorption at the knee during late stance. However, 
peak joint moments are not statistically different (Wurdeman et al. 2012); 
 They take longer to dorsiflex the ankle during late stance and have a shorter time 
frame during which they can generate ankle plantarflexion power for propulsion 
(McDermott et al. 2001); 
 The reduced peak knee power absorption in early stance is most likely caused by the 
increased ankle plantarflexion  found in subjects with PAD due to a relatively reclined 
shank;  
 The reduced hip power absorption during mid stance (which is an eccentric 
contraction of the hip extensors to control forward motion of the trunk) signifies weak 
hip musculature.  
 
Decreased ankle power generation and decreased power absorption at the knee during 
push-off have been demonstrated by (Wurdeman et al., 2012, Scott-Pandorf et al., 2007). 
This has been linked to PAD subjects having weak hip extensors and weak ankle 
plantarflexors. Wurdeman et al. (2012), demonstrated that PAD patients have reduced peak 
hip power absorption in midstance (p=0.017), reduced peak knee power absorption in early 
and late stance (p=0.037 and p=0.020 respectively), and reduced peak ankle power 
generation in late stance (p=0.021) when compared to subjects with comparable age and 
self-selected walking velocity. However, peak moments were not statistically altered, and 
indeed may not occur at the same point in the gait cycle as peak powers (as power is 
calculated from moments and angular velocities). Reduced knee power absorption at 
loading response was thought to correlate with the increased plantarflexion at the ankle; 
meaning shank control did not demand as much power from the knee extensors during that 
period.  
 
30 
 
The decreased ankle plantarflexion power generation during late stance noted by 
Wurdeman et al. (2012) agreed with the findings of Scott-Pandof et al (2007) and Koutakis et 
al. (2010), as well as those from Chen et al. 2008 and Celis et al. (2009). However, 
Wurdeman et al. (2012) demonstrated this phenomenon for the first time when matching 
PAD subjects and controls who ambulated with similar walking velocities. This is important, 
since it is well known that reduced walking velocity can reduce joint powers. It was 
therefore confirmed that subjects with PAD- IC exhibit reduced maximal power generation 
at the ankle compared to accurately matched control subjects which would lead to 
increased metabolic cost. However, the group recommended that further research was 
needed to demonstrate whether peak power deficits occur as a result of reduced joint 
moments or angular velocities.  
 
This led to the conclusion that there was a resultant weakness in the hip and calf muscles in 
subjects with PAD-IC even when not claudicating. This confirmed the  hypothesis proposed 
by  Chen et al 2008, who demonstrated that gait was altered during pain-free walking by 
claudicants compared to a control group, which was significantly worsened whilst 
claudicating. They described typical claudicant gait as being “sluggish and tired” due to the 
fact that the foot appeared to be in contact with the ground for a larger percentage of the 
gait cycle because of weak ankle plantarflexor muscles and weak propulsive muscles at the 
hip (the gluteal muscles). This study also confirmed previous work by Scott-Pandorf et al. 
(2007) and Scott-Okafor et al. (2001), who stated that the propulsion muscles of the leg 
were weaker than controls with reduced ankle plantarflexion strength in claudicants. 
3.4.4  The effect of exercise, drug therapy on claudicant gait parameters 
It is not well documented as to how exercise training can alter gait parameters in 
claudicants. King et al. (2012) demonstrated that there were no statistically significant 
alterations to any gait parameters (temporal-spatial parameters plus kinetics and 
kinematics) for a group of 12 claudicants following a three month supervised exercise 
programme, and postulated that longer exercise programmes (longer than 3 months) plus 
variations in intensity of training may improve gait parameters in these subjects. 
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With regards to drug therapy, a study by Yentes et al. (2012) found no significant 
improvements after 12 weeks of treatment with either cilostazol or pentoxifylline on 
the gait biomechanics of claudicants once the pain in the calf was felt. Huisinga et al. (2010), 
previously showed the same results for claudicants whilst being pain-free. This type of 
intervention also therefore appears to have limited potential in affecting the gait of 
claudicants in a positive way. 
The evidence therefore suggests that although exercise regimes of various designs produce 
an increase in pain-free walking distance and absolute walking distance, they do not in fact 
alter gait parameters whilst doing so. This means that walking patterns are not altered and 
improvements in more severely affected individuals who, due to generalised vascular 
disease including PAD are unable to respond to exercise treatment with regards to altering 
their gait to more typical of that demonstrated by age-matched controls, are limited. 
Whether the extended use of PRT is useful in improving gait parameters is as yet unknown. 
An alternative solution is therefore required, and gives relevance to the need for methods 
other than drug or exercise therapy to provide alternative treatment solutions for 
claudicants. One such intervention could be via the use of footwear adaptations such as 
rocker soles which may have the ability to simultaneously alter gait parameters whilst 
improving claudication distances. 
3.4.5 Overall analysis regarding gait parameters associated with PAD-IC 
As the primary contributor to push-off, the biomechanical abnormality measured at the 
ankle joint should be the main target of clinical attempts at restoration of gait, and provides 
a clear indicator for measuring interventions directed at PAD-IC patients. Alteration to ankle 
plantarflexor function or offloading of the ankle plantarflexors using a rocker sole profile 
during stance phase could result in improved closed chain kinetics throughout the entire 
stance limb if it is proven to reduce the calf pain associated with IC, which may also alleviate 
deficits occurring at more proximal joints. The increase in ankle dorsiflexion during late 
stance exhibited by claudicants should be reduced by influencing a relatively plantarflexed 
position to be achieved during the propulsive phase of gait via implementation of a 
surrogate motion which may be applied via a rocker-soled shoe. This would not only provide 
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a potentially less dorsiflexed ankle position during TSt, but also theoretically unload the 
ankle plantarflexors by placing the calf muscles in an advantageous position. 
An induced reduction in sagittal plane hip, knee and ankle joint power absorption and 
generation required for ambulation would theoretically reduce the need for the hip 
extensors and ankle plantarflexors to generate so much force to provide forward propulsion 
by claudicants. This may possibly be achieved using rocker sole profiles by positioning the 
joints in a more advantageous rotational position and in reducing their angular velocity of 
rotation in order to increase the respective muscle –joint moment arm at these joints which 
would therefore make propulsion and absorption more efficient. 
 The following sections detail the current knowledge regarding the effect of rocker soles on 
joint rotations and also their effects on muscle power generation and absorption. 
 
3.5 The effect of walking with shoes adapted with rocker sole profiles 
3.5.1 Reduction of plantar foot pressures 
Shoes adapted with rocker sole profiles have historically primarily been utilised to reduce 
foot plantar pressures for people with pathologies such as diabetic peripheral neuropathy 
and rheumatoid arthritis; with the rocker soles being either tradition (angled) in design or 
shaped using a curved surface (Bauman et al., 1963, Milgram, 1964, Grundy et al., 1975, 
Coleman, 1985, Geary and Klenerman, 1987, Nawoczenski et al., 1988, Schaff and Cavanagh, 
1990, Janisse, 1995, Stacpoole-Shea et al., 1999). 
To achieve forefoot plantar pressure reduction, the apex needs to be correctly positioned to 
offload the forefoot, which means it must not only be positioned behind the metatarsal 
heads, or indeed proximal to the area on the foot which requires offloading, but also be 
deep enough to reduce sagittal plane motion at the metatarsal heads to provide the 
necessary unloading and the rocker profile must also be adequately stiff (Janisse, 1995, 
Schaff and Cavanagh, 1990, Nawoczenski et al., 1988).  
The higher the rocker sole apex angle, the more offloading of the forefoot may be expected 
for a chosen apex position (Nawoczenski et al., 1988). However, practical considerations 
mean that maximum apex angles of 30-40 degrees for traditional (angled) rocker sole 
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profiles have been recommended by (Geary and Klenerman, 1987) for people with diabetic 
peripheral neuropathy. A 25-degree traditional metatarsal rocker was found to reduce 
plantar pressures more than the other designs in a study by (Stacpoole-Shea et al., 1999). To 
be effective, a rocker sole apex angle needs to be at least 20 degrees to be able to offer 
adequate forefoot unloading (Nawoczenski et al. 1988, Chapman et al. 2012).  
Curved rocker soles are thought to provide a more “natural” gait by allowing a smoother 
transition from heel-off to toe-off with advantage of a more cosmetic appearance 
(Nawoczenski et al. 1988), but this means that the GRF rolls forwards without “hesitating” at 
the apex of a traditional rocker sole design. 
Bauman et al. (1963) studied the effect on plantar pressures experienced by a range of 
patients using a variety of angled traditional rocker soled shoes, and demonstrated that a 
rigid soled shoe with a rocker placed 1.7cm proximal to the metatarsal heads was the most 
suitable for reducing pressure under the forefoot. Nawoczenski et al. (1988) recommended 
the use of a traditional rocker sole with the apex positioned at the metatarsal head level and 
an apex angle of 20 degrees. This was confirmed by (Coleman, 1985) and (Geary and 
Klenerman, 1987), but with a 30-degree apex angle for patients with diabetic neuropathy. 
Brown et al. (2004) also highlighted the fact that pressure shunting can occur when 
offloading the forefoot using a rocker sole adaptation. They demonstrated that plantar foot 
pressures may be reduced when walking with the negative heel and toe traditional rocker 
profiles as well as a double rocker sole. However, mid-foot pressures were increased when 
using the negative heel and toe type traditional rocker designs. 
A recent study by Chapman et al. (2012) confirmed that in diabetic subjects, a minimum 
rocker angle of 20 degrees with the apex positioned 60% of shoe length relative to the rear 
of the shoe is required to provide meaningful offloading of the forefoot.  
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3.5.1.1 Comment 
An apex position significantly proximal to the metatarsal heads (MTHs) could be 
advantageous in reducing loading at the rearfoot (particularly at the ankle) by reducing the 
externally-applied ankle dorsiflexion moment during late stance. Indeed, (Hampton, 1979), 
recommended that the rocker axis should be located near the centre of the foot and the 
rocker sole should be thick enough to minimise contact between the end of the shoe and 
the floor during the toe-off phase of gait. In addition, (Cavanagh et al., 1996), demonstrated 
that the lowest plantar pressure measured in their study was achieved with a traditional 
rocker sole apex positioned 55% shoe length from the posterior heel. This may therefore 
indicate a potentially useful position for a rocker sole not only to offload the forefoot but 
also to reduce the loading on the ankle plantarflexors; but to date this has not been 
ascertained.  
 
3.6 Alteration to lower limb joint kinetics and kinematics 
3.6.1 Joint Rotation 
The most commonly prescribed designs of rocker soles used in clinical practice do not 
produce significant alterations to lower limb joint kinematics. The most significant changes 
to kinetics  has been demonstrated at the ankle in the sagittal plane followed by the hip, but 
have been shown to be small in magnitude (Myers et al., 2006, Van Bogart et al., 2005, 
Brown et al., 2004, Long et al., 2004). Myers et al. (2005), demonstrated that the most 
significant kinematic changes with the negative heel shoe occurred at the ankle with 
increases in dorsiflexion during loading response and plantarflexion at terminal stance. The 
toe-only rocker profile has been shown to produce increased hip extension at late stance 
phase. At the ankle it produced increased dorsiflexion at initial contact and loading 
response, and increased plantarflexion during late stance (van Bogart et al. 2005). However, 
this was in variance with a later study in which a toe-only rocker sole produced an increase 
in late stance dorsiflexion prior to the plantarflexion phase during propulsion (Hutchins et 
al., 2009). 
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There is therefore evidence in the literature which suggests that rocker soled shoes can 
influence ankle joint plantarflexion or dorsiflexion during stance phase of gait, although 
more evidence is needed to clarify the effects of some designs. 
3.6.1.1 Negative heel rocker-soled shoes 
Negative heel rocker soles are deemed to be those where the heel height is lower than the 
depth at the tread (i.e. the point at which the sole unit contacts the ground during static 
standing). The same effect can be shown when walking with a cushioned heel adaptation; 
where soft material is added to the posterior heel area of the shoe.  
Some authors have recommended the use of a rocker profile in tandem with a cushioned 
heel in the treatment of patients with restricted ankle motion following surgical fusion or 
arthritic changes to the ankle or midfoot structures (Baker, 1970, Cracchiolo, 1979, Caron et 
al., 1999, Marzano, 2002, Long et al., 2007). The cushioned heel is designed to simulate 
plantarflexion (but may not in fact do so) and cause an early transition to second rocker of 
gait.  
Zamosky (1964), described the use of a solid ankle and cushioned heel (SACH) type 
adaptation with a metatarsal rocker bar combination in the treatment of patients with stiff 
ankle joints and limited motion. The SACH heel was described as acting as a shock absorber 
and by compressing, acted to bring the rocker bar into early contact with the ground. This 
compression of the SACH heel at heel strike afforded the patient a pseudo-plantar flexion 
without forcing the ankle towards plantar flexion. Since early ground contact was made at 
the apex of the rocker bar, the shoe was ready for roll over (i.e. second rocker of gait) and 
toe-off (third rocker of gait) so rapidly that motion of the tarso-metatarsal, talocrural or 
subtalar joints was precluded (Hutchins et al., 2009). 
The MBT (Masai Barefoot Technology) shoe also has a cushioned heel, but this in fact 
induces a relatively dorsiflexed ankle position during loading response, and does not 
therefore simulate plantarflexion, (Table 3). The evidence is therefore limited regarding the 
effect of rocker soled shoes on lower limb kinematics and requires further investigation. 
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Table 3.1: Ankle and knee kinematic data for studies which investigated the MBT shoe versus 
flat control shoes. 
Author Subjects and footwear Ankle and knee ROM(°) Muscle excursion 
MBT 
(Nigg et al., 
2006) 
N=8 healthy subjects, (5 
male). 
Walking  speed was 
controlled at 1.38 m/s;  
MBT (650g) vs. Adidas 
supernova running shoe 
(358 g) 
 
 
 
Ankle: The MBT shoes 
induced dorsiflexion 
during loading response 
and shortening of the 
ankle PF muscles. 
(Romkes et 
al., 2006) 
N=12 healthy subjects, (6 
male). 
4 weeks of MBT training.  
Self-selected speed of 
walking MBT vs. regular 
shoe 
 
 
 
 
 
Ankle: MBT shoes 
induced dorsiflexion of 
the ankle for the first 
30% of the gait cycle. 
Knee: These were 
relatively flexed for the 
first 40% of the gait 
cycle. 
 
3.6.1.2 Rocker soled shoes designed to reduce ankle joint rotation 
It may be prudent to reduce ankle sagittal plane rotation by claudicants when using a 
rocker-soled shoe. This could feasibly reduce power generation by the ankle plantarflexors 
provided the ankle was placed in an advantageous position to increase the moment arm 
between the Achilles tendon and the ankle joint centre of rotation. This theoretical 
hypothesis is investigated in this thesis in able-bodied adults. However, there is little 
currently-available evidence in the literature as to which rocker sole features can reduce 
ankle ROM; especially during stance phase of gait. 
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(Wang and Hansen, 2010) published a study which demonstrated that a rocker profile with a 
single circular rocker profile radius equivalent to 25% of leg length, could significantly reduce 
ankle joint sagittal plane total ROM during stance phase to approximately 15 degrees, and 
that smaller radii produced more reductions in sagittal plane ankle motion than those with 
larger radii. Arazpour et al. (2013) when utilising a rocker profile with a central apex of 50% 
of shoe length, and with a 10 degree curved rocker either side of the apex and a curved heel 
and increased toe spring, was capable of restricting ankle joint total ROM to 17 degrees. 
These two studies would therefore suggest that rocker soled footwear is capable of 
significantly affecting ankle joint plantarflexion and dorsiflexion.  
 
3.7 Alteration to externally-applied sagittal plane lower limb joint moments 
The following effects have been demonstrated in the literature regarding alteration to lower 
limb joint moments by commonly-used rocker sole designs. 
3.7.1 Sagittal plane knee joint moments 
 Van Bogart et al. (2005) using a toe only rocker profile demonstrated increased knee 
extensor moments throughout stance; 
 Long et al. (2007) demonstrated increased extension demand moment after LR  
when using the double rocker sole compared to baseline; 
 Sagittal plane ankle moments; 
 Myers et al. (2006) when testing the negative heel rocker profile showed that 
increased plantarflexion moments during LR occurred, but interestingly reduced 
plantarflexion demand moments at TSt, PSw and ISw;  
 Van Bogart et al. (2005), demonstrated decreased plantarflexion demand moments 
during MSt and TSt were initiated by the toe-only rocker (which they postulated was 
related to the forward position of the GRF which limited the ability to generate a 
moment about the ankle); 
 Long et al. (2007), demonstrated that the double rocker sole decreased 
plantarflexion demand moments between MSt. and MSw. 
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3.7.2 Sagittal plane ankle powers 
 Myers et al. 2006 (negative heel profile) demonstrated increased ankle power 
generation MSt. but reduced power generation at push-off; 
 Van Bogart et al. 2005 (toe-only rocker profile) demonstrated increased ankle power 
generation at MSt; 
 Long et al. 2007 (double rocker profile) demonstrated decreased ankle power 
absorption between LR and MSt. 
3.7.3 Alteration to EMG activity 
Various authors have demonstrated that the most commonly-used rocker profiles increase 
the activity of the ankle plantarflexors. Harris et al. (2000) demonstrated that the toe only 
rocker increases gastrocnemius activity by initiating earlier firing during mid-stance and 
double limb support, which is related to earlier anterior tibial rotation (second rocker of gait, 
Perry 1992). The double rocker also produces increased muscle activity in the gastrocnemius 
muscle group (Wertsch et al., 2000). Harris et al. (2000), also showed that the toe-only 
rocker reduced tabialis anterior muscle EMG activity both during mid stance and swing 
phases of gait, but most noticeably during mid-stance.   
A study by Romkes et al. (2006) investigated the kinematic and electromyographic changes 
when MBT training shoes were worn by 20 healthy volunteers. Their results indicated an 
increased loading to gastrocnemius medial head, soleus and tibialis anterior muscles whilst 
wearing the shoes. Sagittal plane ankle motion showed increased dorsiflexion at heel strike 
which increased gastrocnemius and soleus activity during stance phase, followed by 
increased plantarflexion during the remainder of stance phase with insignificant amounts of 
dorsiflexion prior to heel-off. 
When walking with a negatively heeled shoe, an increase in total and peak gastrocnemius 
muscle activity (+21%) during stance phase may be expected (Li and Hong, 2007).  
39 
 
 
Figure 3.2: Increase in EMG activity when walking with a negative heel rocker soled shoe 
[Adapted from (Li and Hong, 2007)]. 
Yamamoto et al. (2000), demonstrated significant increases in blood flow in the calf muscles 
when wearing a negative heel shoe versus regular shoes in able-bodied subjects (N=6) when 
walking at self-selected speeds of 1.33 m/s and above. This would also indicate increased 
calf muscle activity. 
 
 
Figure 3.3: A negative-heel rocker soled shoe [adapted from Yamamoto et al. (2000)].  
 
3.8 Comment 
The evidence suggests that the majority of rocker soled shoes tested to date (which include 
the most commonly-used designs) induce an increase in ankle plantarflexor muscle activity 
during stance phase of gait. Negative heel rocker soled shoes produce a relatively 
dorsiflexed position during initial contact and loading response which also increases ankle 
plantarflexor muscle activity. Shoes with a cushioned heel (such as the MBT shoe) also 
induce a relatively dorsiflexed position following heel strike and therefore will have the 
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potential to increase ankle plantarflexor activity during early stance in order to lift the heel 
and advance the foot into mid stance and propulsion. However, it may be possible to 
identify an angled rocker sole unit following gait laboratory testing which has a prudent apex 
angle and position to reduce these unwanted effects for the benefit of people with PAD-IC, 
but as yet this in un-proven. 
 
3.9 Alteration to oxygen consumption 
Hansen and Wang (2011) compared the effect of a single curve rocker profile radius (based 
on % of leg length) on the oxygen consumption rate in 11 adults. They demonstrated that a 
rocker profile with a radius equating to 40% of leg length was the most effective by 
significantly reducing oxygen consumption compared to a baseline regular shoe. 
 
3.10 Overall chapter analysis 
The overall aim of this thesis is to provide enhanced and novel knowledge as to how rocker 
soled shoes may be designed to reduce symptoms associated with IC, but which may also be 
of significant benefit for people with other pathologies where offloading of the ankle 
plantarflexors would be of benefit. Only a few studies were found which showed some 
improvement in symptoms and pain-free distances by claudicants may be obtained using 
rocker soled shoes. These previous studies have shown little information why these changes 
helped to increase free-pain walking distance. There has been no information provided 
about muscle biomechanics and limited information about gait parameters in most of the 
studies examined. 
It is important to look at the muscle-tendon length changes during gait, because they 
actuate movement by developing force and generating internal moments (Delp, 1990). For 
example, different footwear rocker sole profiles alter knee and ankle angles during stance 
phase. Therefore, when a muscle-tendon unit is lengthened or shortened to a certain point 
the muscle fibres may be too long or too short to generate enough active force in the lower 
limb. Skeletal muscle develops only 50% of the maximum force when its length is shortened 
to 85% of the resting length (Panjabi and White, 2001).  
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The type of muscle contraction may also be altered by footwear adapted with rocker soles, 
and they may also change EMG activity and forces generated about the joints which the 
muscles are attached to. This may change muscle activity, oxygen consumption and alter gait 
patterns. 
At present, there are few tools to evaluate the effects of muscle-tendon properties and 
skeletal geometry in determining moment-generating characteristics of individual muscles 
However, by using Visual3D and Simm/OpenSim software this gives the opportunity to 
analyse these effects and provide a clearer understanding as to which footwear features are 
capable of providing alteration to muscle performance for the potential benefit of specific 
patient groups.  
EMG data can only indicate when a muscle is active or not, but interpretation of EMG data 
does not help us to determine what caused an increase muscle activity or which joint motion 
produced it. OpenSim allows analysts to analyse exported dynamic motion data from 
Visual3D and look at the musculoskeletal dynamic motions using a model of the lower limb. 
This computer model can assist in understanding the biomechanical consequences of 
musculoskeletal dynamic changes wearing different footwear rocker sole profiles and to 
advance the knowledge in this area as to which designs are suitable for the specific aim of 
reducing the activity and work done by the ankle plantarflexors. This is needed in order to 
help reduce the painful calf muscle symptoms which can so drastically negatively affect a 
claudicant’s quality of life.  
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CHAPTER 4    
4 Muscle physiology and related biomechanics 
4.1 Chapter overview 
This thesis seeks to investigate the relationship between walking with different footwear 
outsole features and the resulting alteration to gait patterns and associated kinetic and 
kinematic changes, plus analysis of alterations to muscle biomechanical parameters and 
EMG data for the lower limbs during gait. Therefore, it is appropriate to review basic 
principles of gait and which factors are responsible for significant alteration of lower limb 
muscle parameters, especially for the calf muscles. Based on logical interpretation of human 
biomechanics, definition of walking patterns and the alterations caused by footwear 
features, hypotheses may be developed to provide an enhanced understanding of the logical 
concepts lying behind the alterations seen during gait. 
This chapter begins with basic terminology that is used when analysing the results which 
emanate from clinical gait analysis, plus muscle physiology, muscle mechanics and gait 
parameters. It finishes by presenting the information which was required to formulate the 
aims and hypotheses of the study to enable an investigation of the possible walking pattern 
alterations caused by rocker-soled shoes to be analysed.   
 
4.2 Basic terminology used in this thesis for muscle biomechanics and gait analysis  
4.2.1 Planes and axes 
Movements of the body segments are described in terms of their planes and axes. The body 
may be considered as being composed of segments. The motion of the segments takes place 
around three axes and therefore three planes known as the sagittal, frontal and transverse 
planes (figure 4.1).  
A sagittal plane is any plane which divides part of the body into right and left portions and 
describes movements such as flexion/extension of the knee and hip joints, and 
dorsiflexion/plantarflexion of the ankle joint. A frontal plane divides a body part into anterior 
and posterior and represents movement such as abduction/adduction. The transverse plane 
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divides body into upper and lower parts (Trew and Everett, 2005, Whittle, 2007, Kirtley, 
2006). 
 
Figure 4.1: The anatomical position, with three reference planes and six directions. 
There are additional terms, which are used to describe relationships between segments in 
gait analysis: 
 Medial means towards the midline of the body (closest to the median); 
 Lateral means away from the midline of the body (furthest away from the segment); 
 Distal means away from the centre of mass; 
 Proximal means the closer to the centre of mass (figure 4.2). 
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Figure 4.2: An example of a shank segment for medial/lateral aspects and proximal/distal 
ends of the segments. 
4.2.2 Lower limb skeletal structure and joint motions  
The skeletal system provides the overall shape of the body and supports its weight, whilst 
absorbing and dissipating stress generated by movement or external forces, facilitating 
movement through a network of different types of joints, and providing attachment to 
muscles and tendons (Trew and Everett, 2005, Palastanga and Soames, 2012). The lower 
body provides a locomotive function during walking whilst maintaining an upright posture. 
The shape and structure of individual segments are adapted to the function of supporting 
and resisting mechanical stresses. 
 
The lower limb consists of the femur, tibia and fibula connected to the foot distally and the 
pelvis proximally via the hip joint. It is important to have knowledge of anatomical structures 
and anatomical points in the body to be able to define and reconstruct segments and joints 
for gait analysis using motion capture software. Figure 4.3 represents the basic anatomical 
points, segments and joints of the lower body. 
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Figure 4.3: Basic anatomical points for lower limb bones, segments and joints for gait 
analysis. 
When performing gait analysis, the foot has historically been considered as a single rigid 
segment. However, the foot and ankle joint complex may be better described using rearfoot, 
midfoot, and forefoot segments. Modelling the foot as a multiple segmental structure, 
rather than a rigid single one, has a significant effect on the accuracy of instantaneous power 
calculation between segments (Richards, 2008). Therefore, with modern motion capture 
systems it is possible to track the movement of the tibia, rearfoot, midfoot and forefoot as 
separated segments in 6 degrees of freedom (DOF) for accurate ankle joint movement, 
interpretation and analysis. Figure 4.4 shows the basic osseous structure of the foot as a 
segmental entity and relevant anatomical points. 
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Figure 4.4: Osseous structure of the foot. 
Basic joint motions of the lower limbs in the sagittal plane, which are commonly used in gait 
analysis research, are represented in figure 4.5. 
 
Figure 4.5: Motion of the lower limb joints. 
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The actual movement performed at a joint can be described in terms of the number of 
degrees of freedom the joint allows. Most motion analysis software for biomechanical and 
clinical research such as Visual3D (C-motion, USA) uses a six degrees-of-freedom (6 DOF) 
model for gait analysis. 
Any body segment can theoretically move in six different ways independently and in human 
movement all these six often happen at the same time (Richards, 2008). Six degrees-of-
freedom means that a body segment can utilise linear or translational movement, vertically, 
medio-laterally and anterior-posteriorly. It can also perform three rotational or angular 
movements in the sagittal, frontal and transverse planes. The possible foot segment angular 
and linear movements are shown on the figure 4.6. 
 
Figure 4.6: Linear and angular movements for foot segment movement in all planes and 
directions. 
Joints can be classified into three groups based on the ROM allowed at the joint. 
Synathrosis-type joints are immovable (e.g. joints found between the bones of skull and 
teeth). Amphiarthosis joints allow slight movement such as the distal articulation between 
tibia and fibula. Diarthrosis or synovial joints allow considerable motion (Tözeren, 2000). 
There are different classifications for these type of joints (i.e. their DOF classification) which 
are also used for motion analysis, muscle simulation properties and in analysis software such 
as in OpenSim.  
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4.3 Muscle anatomy  
The largest organ in the human body is the skeletal muscle system which accounts for 
between 40 and 45% of total body weight (Nordin and Frankel, 2003). The human body has 
more than 430 skeletal muscles. The role of skeletal muscles is to cause or control 
movements at the joints as well as performing static work (i.e. maintaining posture or 
position). They are attached to bones and their main function is to produce movement of 
one bone relative to another, to control movements produced by external forces or to hold 
bones to maintain posture and balance. Most of the muscles have an origin and insertion 
point at their attachments and also cross joints (such as the gastrocnemius muscle). 
Ligaments connect bones together whereas tendon connect muscles to bones (Trew and 
Everett, 2005, Abernethy et al., 2013).  To perform a motor task, the central nervous system 
activates muscles that subsequently develop forces, which are transmitted by tendons to the 
skeleton to perform a task. An understanding of the properties of these structures, plus how 
to produce optimal or sub-optimal muscle performance and changes to this performance 
which may be demonstrated by different footwear features is potentially important to 
scientists who design special footwear for rehabilitation and treatment purposes.  
The fundamental structure of muscles acting on the lower limb which are of relevance to this 
thesis are demonstrated in figure 4.7. The ankle muscles highlighted in blue text are the 
main group acting at the ankle or knee joints which were targeted for data analysis in this 
research to more fully understand the effect of different footwear features on gait than that 
previously demonstrated in the literature. 
Rectus femoris (RF) forms part of the quadriceps muscle group which extend the knee, but it 
additionally flexes the hip. It originates from the anterior inferior iliac spine of the pelvis and 
inserts into the quadriceps tendon. Biceps femoris (BF) acts as a knee flexor and hip 
extensor. It has two origins – the long head comes from the ischial tuberosity and the short 
head from the middle of the shaft of the femur and it inserts into the lateral condyle of the 
tibia (Whittle, 2007). 
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Figure 4.7: The major muscles of the lower limbs. 
Muscles that plantarflex the ankle joint are the gastrocnemius, soleus, plantaris, fibularis 
longus, fibularis brevis, tibialis posterior, flexor digitorum longus and flexor hallucis longus 
muscles (Palastanga and Soames, 2012). The main plantarflexors of the ankle are known as 
the triceps surae muscle group. This comprises of the gastrocnemius medial and lateral 
heads, and soleus. The gastrocnemius muscle crosses the knee joint and originates from the 
posterior aspect of the medial and lateral condyles of the femur. Its tendon joins with that of 
the soleus to form the Achilles tendon, which inserts into the calcaneus as shown in figure 
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4.8. The gastrocnemius muscle also acts as a flexor of the knee whilst the soleus does not 
(Whittle, 2007).  
 
Figure 4.8: The main ankle plantar/dorsiflexion muscles which were investigated to seek 
further understanding of their mutual relationships in performing muscle work whilst 
wearing different footwear features in this research, (a) - posterior view of gastrocnemius 
muscles, (b)  posterior view of soleus muscle, (c) – anterior view of tibialis anterior muscle 
[picture adapted from (Palastanga and Soames, 2012)]. 
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The muscles which dorsiflex the ankle joint are tibialis anterior, extensor digitorum longus, 
extensor hallicus longus and fibularis tertius. Tibialis anterior is the main dorsiflexor of the 
ankle. It is a long fusiform muscle situated on the front of the leg lateral to the anterior 
border of the tibia as shown in figure 4.8. The muscle becomes tendinous in its lower third, 
passing downwards and medially over the distal end of the tibia (Palastanga and Soames, 
2012, Whittle, 2007). 
Intermittent claudication alters calf muscle function, and therefore the principle muscles 
acting on the ankle joint [medial gastrocnemius (GM), soleus (SOL) and tibialis anterior (TA)] 
were focused on during this research to understand their effect on gait following different 
footwear interventions.   
4.3.1 Skeletal muscle structure  
Skeletal muscle is specifically structured to meet the functional requirement for specific 
movement. The entire muscle is a composite of hundreds of fascicles, which in turn consist 
of hundreds of muscle fibres. The fibres are composed of myofibrils as shown in figure 4.9. 
 
Figure 4.9: basic muscle structure. 
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Muscle cells convert energy from fatty acids and blood sugar glucose into movement and 
heat. Skeletal muscles have a regular pattern of lines or striations. These striations 
correspond to the basic function unit of all skeletal muscle, the sarcomere. It is the smallest 
contractile unit of a myofibril. It contains two contractile proteins - actin and myosin (Rose 
and Gamble, 2006). The actin is called the thin filament and the myosin filament is called the 
thick filament. When viewed through a microscope, the myofibril has dark and light bands. 
The various light and dark bands in the myofibril are routinely identified by letters. At each 
end of the sarcomere is the Z disk. The thin, dark Z line is the origin of the slender actin 
filaments. The distance between the Z zones is defined as the sarcomere length. These are 
interleaved with the thicker myosin filaments, which form the A band.  
The I band and H zone change width during muscular contractions, as they represent the 
areas where the actin and myosin exist (Whittle, 2007). Relative translation between thick 
and thin filaments is responsible for much of the change in length of a muscle during 
contraction; figure 4.10. 
 
Figure 4.10: Diagram representing thick and thin filaments during two stages of contraction 
[adapted from (Tözeren, 2000)]. 
According to the “sliding filaments” theory of muscle contraction, myosin heads on the thick 
filaments (cross-bridges) interact with actin-binding sites on the thin filaments. These cross-
bridges are believed to generate force only when they are attached to actin as shown in 
figure 4.10 (Tözeren, 2000). Skeletal muscles are stimulated by the central nervous system 
before they contract. Signals which activate muscles are transmitted from the brain to the 
nervous system and to individual muscle fibres. Blood capillaries encircle the muscle fibres 
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and the terminal branches of the motor nerve connect around 150 muscle fibres. The 
smallest sub-unit that can be controlled is called a motor unit, which includes a single motor 
neuron and all of the muscle fibres innervated by it (Nordin and Frankel, 2003). The number 
of muscle fibres forming a motor unit is closely related to the degree of control required of 
the muscle. The amount of tension produced by a skeletal muscle depends on both the 
frequency of stimulation and the number of motor units involved in the activation (Winter, 
2009).  
The energy to contract the muscles comes from the release of a substance related to the 
high-energy phosphate group and is known as adenosine triphosphate (ATP). Failure to 
provide metabolic energy to the muscles which could be due to intense performance 
activities and the subsequent demand can result in muscle fatigue. There are two types 
metabolic pathways involved in regenerating ATP. One uses up chemicals stored within the 
cell (phosphocreatine and glucose), without the need for oxygen and is known as anaerobic. 
The other one requires oxygen and nutrients to enter the muscle fibre from the bloodstream 
and is known as aerobic (Whittle, 2007). An anaerobic processes can provide quick powerful 
bursts of energy, however it can also be exhausted very quickly. For sustained muscular 
work, an aerobic metabolic process is used, following an oxygen debt, which will need to be 
repaid by aerobic respiration, to remove lactic acid which accumulates in the muscle. Muscle 
such as gastrocnemius and soleus have different metabolic energy pathways (and are also 
therefore different muscle types), and it is important to understand this for the future 
footwear designs for patients with IC. It is discussed in more detail in the following sections. 
4.3.2 Tendons 
Muscles attach either directly to bones or via a tendon. The tendons and the connective 
tissues in and around the muscle belly are elastic structures which help determine the 
mechanical characteristics of the whole muscle-tendon unit (MTU) during contraction and 
also during passive extension which produces muscle force to move or stabilise joints 
(Nordin and Frankel, 2003). The tendon actuator can be defined by specifying its geometry 
and force-generating properties (Delp and Loan, 1995). The length of tendon at which force 
begins to develop when stretched is called the tendon slack length (Delp, 1990, Zajac, 1989). 
Results from previous papers suggest that the tendons of soleus and gastrocnemius can 
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generate maximum isometric force up to maximum of 10% strain and after that they lose 
force generation (Zajac, 1989, Hoy et al., 1990b, Delp, 1990, Delp and Loan, 1995, Arnold et 
al., 2013). A typical force-length relation curve for tendinous tissue is shown in figure 4.11. 
 
Figure 4.11: Typical normalised force-length relationships for a tendon. 
Tendon is more compliant in the lower region than in the linear region as depicted in the 
figure above, and failure occurs at approximately 10% of strain. Tendon force is normalised 
by peak isometric muscle force. Tendon strain is defined by tendon stretch divided by 
tendon slack length, (Zajac, 1989, Delp, 1990). In a recent study it was demonstrated that 
tendon strain values at which maximum isometric force is generated during simulations are 
up to 8% in soleus and 7% in gastrocnemius medialis and lateralis (Arnold et al., 2013). The 
musculoskeletal model which was used in their research contained very precise muscle 
architecture parameters using data obtained from 21 cadavers. 
 
4.3.3 Force generation  
When a nerve is given a single, short pulse to stimulate a muscle, it produces a characteristic 
response called a twitch. This is a short spasm of contraction which generates a small 
amount of force very quickly and then declines to zero over a long period. If a second 
impulse is generated before the twitch has decayed to zero then it appears as a summation 
effect with a peak force that is higher than a single twitch. This is known as a mechanical 
summation. With fast and multiple stimuli, the force curve will be higher if more fibres were 
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activated and the motor units contract. Muscle produces electrical activity, which can be 
recorded with electromyography. If a muscle is contracting very weakly, only a single motor 
unit may be activated and if tension is increased, it means additional motor units were 
recruited. An EMG data acquisition system was used in this research to more fully 
understand the force relationship generation and muscle activity when ambulating with 
different footwear conditions.  
4.3.4 Muscle fibre types 
There are now seven recognised types of skeletal muscle fibre (Abernethy et al., 2013). 
However, more than 95% of human muscles may be classified into one of three categories 
according to their relative speed of contraction and their metabolic properties (Katch et al., 
2011). The proportions of each type of muscle fibre vary from muscle to muscle and person 
to person. Type I fibres, also called slow twitch or slow oxidative fibres, are red, have a slow 
contraction velocity, are fatigue-resistant and have a high capacity to generate ATP by 
oxidative metabolic processes (Rose and Gamble, 2006, Katch et al., 2011). 
Type IIA fibres are called fast twitch or fast oxidative fibres (fast-oxidative-glycolic fibres) 
which exhibit fast shortening speeds and a moderately well-developed capacity for energy 
transfer from both aerobic and anaerobic sources (Katch et al., 2011). They are red in colour, 
contain many blood capillaries, and contract and relax rapidly, but are easily fatigued. They 
are mainly used for brief bursts of powerful contraction.  
Type IIB fibres, also called fast twitch or fast glycolytic fibres (Abernethy et al., 2013). 
However, they have less blood capillaries than Type I fibres and large amount of glycogen. 
Type IIB fibres are pale, generate ATP by anaerobic metabolic processes, and are easily 
fatigued.  
The main characteristics of muscle fibre types are summarised in table 4.1. 
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Table 4.1: Characteristics of muscle fibres types [adapted from (Rose and Gamble, 2006, 
Abernethy et al., 2013, Katch et al., 2011)]. 
Fibre Type Type I fibres Type II A fibres Type II B fibres 
Contraction time Slow Fast Very Fast 
Maximum duration of use Hours <30 minutes <1 minute 
Fibre colour Red Red White 
Size of motor neuron Small Medium Large 
Fatigue resistance High Moderate Low 
Activity Used for Aerobic Long term anaerobic Short term anaerobic 
Force production Low High Very High 
Mitochondrial density High High Low 
Capillary density High Moderately high Low 
Oxidative capacity High Moderately high Low 
Glycolytic capacity Low High High 
Major storage fuel Triglycerides 
Creatine phosphate, 
Glycogen 
Creatine phosphate, 
Glycogen 
Metabolism Oxidative Oxidative glycolytic Glycolytic 
 
The average human’s skeletal muscles comprise approximately 50% slow-twitch and 50% 
fast-twitch fibres; about 25% of fast-twitch muscle fibres are type IIA and 25% are type IIB. 
Fibre types develop depending on the muscle usage. Sprinters develop more fast twitch 
fibres and fewer slow twitch one (Abernethy et al., 2013). On average, sedentary children 
and adults possess about 50% slow-twitch fibres (Katch et al., 2011). Distance runners and 
cross-country skiers often have the greatest percentages of slow-twitch fibres; often as high 
as 90%. However, weight lifters, ice hockey players and sprinters have more fast-twitch 
fibres. Figure 4.12 shows typical muscle fibre compositions and maximal oxygen uptake rates 
in different athletes. 
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Figure 4.12: Muscle fibre composition and maximum oxygen uptake rates in athletes 
representing different sports (Katch et al., 2011). 
When muscles contracts, not all fibres are activated, or recruited, to produce force and 
muscle fibres are activated in proportion to the amount of force required. There is a pattern 
of muscle fibre recruitment which is called the size principle. Smaller slow-twitch fibres are 
activated first, followed by fast-twitch type IIA and then type IIB (Abernethy et al., 2013). 
Type IIB fibres are activated during forceful contractions requiring 70% of maximum 
muscular force (figure 4.13). 
 
Figure 4.13: Skeletal muscle fibre recruitment during a physical workout [adapted from 
(Abernethy et al., 2013)]. 
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The force of muscle activation varies from slight to maximal by means of the following 
mechanisms: 
1. Increasing the number of motor units recruited. 
2. Increasing the frequency of motor unit discharge (Katch et al., 2011). 
 
Evidence in the literature has demonstrated that patients with IC improve their maximum 
pain-free walking distance after walking rehabilitation programs and this could be due to 
building up different types of muscle fibres during the program which therefore increases 
capillary density, which improves blood supply to the calves. The literature has also 
demonstrated that different athletes build up different type of fibres. Weightlifters have 
around 70% type II fibres and distance runners have around 80% type I fibres (Katch et al., 
2011, Abernethy et al., 2013). Studies with humans and animals support the concept that 
skeletal muscle adapts to altered functional demands. Muscle fibre type transformation may 
occur with specific exercise training. That concept is useful to consider for patients with 
intermittent claudication.  
 
4.3.5 The pennation angle of muscles 
The internal structure or arrangement of muscle fibres is related to both the force of 
contraction and the range of movement required (Trew and Everett, 2005, Palastanga and 
Soames, 2012, Barlett, 2007). Co-linear muscles are those which have muscle fibres that are 
more or less parallel. When the line of the muscle action does not match the line of action of 
the fibres then the muscle is known as pennate [these muscles account for 75% of the 
body’s muscles, mostly in the large muscle groups, including muscles of the lower extremity 
(Barlett, 2007)]. An example of muscles with different architectural structures is shown in 
figure 4.14. 
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Figure 4.14: Muscle architecture of fibres: (A) fusiform, (B) sheet, (C) pennate (Palastanga 
and Soames, 2012). 
In unipennate muscle, the fibres attach to one side of the tendon only, extending diagonally 
as a series of short, parallel fasciles (tibialis posterior is an example); (Barlett, 2007). 
Bipennate muscles have a central septum with the muscle fibres attaching to both sides and 
to its continuous central tendon. This group includes the rectus femoris muscle of the thigh 
and the flexor hallicuis longus, which flexes the big toe. Mutlipennate muscles converge to 
several tendons. 
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The pennation angle of the muscle also affects the force generation properties of each 
muscle as it transmits force through the tendon. To understand basic muscle-tendon 
mechanics, the effect of pennation angle on muscle function can be ascertained from the 
arrangement shown in figure 4.15. 
 
Figure 4.15: The muscle-tendon actuator principle model where  𝐹𝑀 – muscle force, , 𝐹𝑇  – 
tendon force, α – pennation angle of the muscle, (𝑙𝑇 ) – tendon length, (𝑙𝑀) – muscle length 
(Zajac, 1989, Delp, 1990, Hoy et al., 1990a, Abernethy et al., 2013). 
Force will be finally transmitted through tendon to move the joint and tendon force would 
be equal to fibre force multiplied by the cosine of the pennation angle: 
𝐹𝑇 = 𝐹𝑀 ∗ (cos 𝛼) 
The pennation angle of gastrocnemius muscle changes with fibre length change as shown in 
figure 4.16. 
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Figure 4.16: Medial gastrocnemius pennation angle relationship with fibre length at rest 
(Narici et al., 1996). 
 
4.3.6 Muscle contraction 
The term ‘muscle contraction’ refers to the development of tension within the muscle by 
changing length of the fibres (Barlett, 2007). Within the sarcomere, the force generation is 
performed by interaction between the thin and thick filaments. This means that both 
filaments slide against each other which causes a reduction of the sarcomere length. There 
are special terms that have been used to describe the length changes in muscle fibres when 
the muscle is activated. 
Isometric contraction is termed when muscle force results in no movement visible of the 
bones. The internal tension generated by the muscle is equal to the external force and so 
balance is achieved (Everett, 2010).  
Isotonic contraction is subdivided using the terms concentric and eccentric. Concentric 
contraction when muscle is shortening or in another words when the active muscle 
generates an internal force that is greater than external force (Winter, 2009, Trew and 
Everett, 2005). 
Eccentric contraction when and active muscle generates less force than the external load 
and is lengthened by it. 
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The amount of oxygen demand during muscle activity varies according to the type of 
contraction. These characteristics are demonstrated in table 4.2. 
Table 4.2: The characteristics of three types of muscle contraction [adapted from (Trew and 
Everett, 2005)]. 
Type of 
contraction 
 
Function 
External force 
(relative to 
internal 
External work 
by muscle 
Force 
generated 
Energy cost 
(oxygen 
demand) 
Concentric Acceleration Less Positive Lowest Highest 
Isometric Fixation The same None Intermediate Intermediate 
Eccentric Deceleration Greater Negative Highest Lowest 
 
Eccentric muscle contraction in the literature is described as the type of contraction which 
consumes the least amount of oxygen compared to other contraction types. However, if this 
is followed by a concentric contraction this would then produce the highest oxygen demand. 
During both types of contraction, there would be muscle-tendon positions where the muscle 
is not at its most effective optimal size or position, and therefore the muscle will need to 
work harder to provide the same force generation and therefore consume more energy, 
which could result in more oxygen demand. Therefore, any footwear, which could influence 
muscle to act more as an isometric contraction and keep the muscle-tendon length at its 
optimal position (force generation efficient in relation to cost), would be ideal to reduce 
oxygen usage by the calf muscles. This means that the utilisation of different footwear 
features may have the potential to alter muscle force generation by altering the position of 
the muscle, its type of contraction and the velocity of contraction in order to affect muscle 
oxygen demand and the amount of power required to ambulate for specific muscles. Once 
this is more fully understood, it may be possible to also more fully understand how the type 
of muscle contraction can be altered to achieve a desirable effect using specifically-designed 
footwear. 
4.3.7 Force-length relationships of muscle fibres 
For a single sarcomere, the amount of tension it develops when it is stimulated to contract 
depends on its length. The force capacity of one sarcomere is very low. One million cross-
bridges are able to produce a force of just 0.001 N, therefore the overall amount of force is 
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related of the ability of the muscle fibre to provide a tremendous number of cross-bridges. 
There is also the important factor of the length for the sarcomere unit in relation to force 
generation. Muscle force varies as a function of initial sarcomere length, based upon the 
amount of myofilament overlap (Rose and Gamble, 2006, Winter, 2009, Hong and Bartlett, 
2008). At resting size, it can generate its maximum force. Sometimes muscle can be 
stretched or shortened and therefore it may recruit more muscle units to produce the 
required force. The ideal concept for footwear design to offload/load calf muscle would 
therefore be to manage the control of muscle-tendon length during stance phase to achieve 
the desirable effect. A representation of the tension produced by a sarcomere unit as it 
changes length about its resting length is shown on figure 4.17. 
 
Figure 4.17: The sarcomere isometric length-tension curve [adapted from (Winter, 2009, 
Hong and Bartlett, 2008, Rose and Gamble, 2006)]. 
Figure 4.18 shows different lengths and the corresponding forces. From a sarcomere length 
of approximate of 3.6 μm onwards, no force can be generated because there is almost no 
overlap between the actin and myosin filaments. The opposite effect occurs when the length 
is approximately 1.7 μm (Hong and Bartlett, 2008, Rose and Gamble, 2006). At a sarcomere 
length of 2.0-2.2 μm a maximum overlapping of the thin and thick filaments results in a 
maximal force generation. 
64 
 
4.3.8 Force-length relationships (for the entire muscle) 
For the entire muscle-tendon complex, the amount of force tension generated depends on 
the number of fibres recruited, their pennation angle, the velocity of contraction and on the 
relative length of the entire configuration with the respect of their optimal length (Hong and 
Bartlett, 2008). 
The force developed by the muscle during isometric contraction varies with its starting 
length. For each muscle there is an optimal length (the length it assumes in the body at rest) 
at which a muscle can generate maximal active contraction (Delp, 1990, Hoy et al., 1990b, 
Winter, 2009, Panjabi and White, 2001). It has been shown that muscle develops only 50% of 
its maximum force when its length is shortened to 85% of its resting length (Panjabi and 
White, 2001). The connective tissues that surround the contractile elements influence the 
force-length curve (called the parallel elastic components) act much like an elastic band 
(Winter, 2009). The summation of all the connective tissues in series with the contractile 
component, including the tendon, are called the series elastic elements. When the muscle-
tendon complex is at resting length or less, the parallel elastic component is in a slack state 
and is not tense. When the muscle-tendon lengthens, the elastic tension begins to build up 
in the muscle and tendon, slowly at first and then more rapidly. This is known as passive 
tension (force). The total tension is the sum of the active and passive tensions and depends 
on the amount of connective tissues (elastic elements) that a specific muscle-tendon 
complex has. For single joint muscles, the amount of stretch is less efficient with regards to 
passive tension when compared to two-joint muscles such as soleus and gastrocnemius. 
Therefore, the total force generated by two-joint muscles (i.e the sum of active and passive 
tension) may reach the maximum available tension in the stretched muscle. 
Figure 4.18 shows the total (passive and active) tension for a muscle-tendon isometric 
contraction. 
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Figure 4.18: Length-tension relationship for the whole muscle during isometric contraction 
[adapted from (Hong and Bartlett, 2008)]. 
 
 
Figure 4.19: Tendon tension resulting from various levels of muscle activation. Parallel elastic 
element generates tension independent of the activation of contractile element [adapted 
from (Winter, 2009)]. 
The typical overall force-length characteristics of an MTU as function of the percentage of 
excitation is shown in figure 4.19. 
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Arnold et al (2010) recently published the mechanical properties and architecture of lower 
limb muscles obtained from 21 cadavers (table 4.3) where PCSA represents their 
physiological cross-section areas, and where optimal fibre length denotes the resting size of 
the fibre at which it can generate maximum tension. 
Table 4.3: Muscle architecture parameters of 21 cadavers (Arnold et al., 2010). 
 
Muscle 
PCSA 
(cm) 
Peak 
force (N) 
Optimal fibre 
length (cm) 
Tendon slack 
length  (cm) 
Pennation 
Angle (°) 
Biceps femoris long head 11.6 705.2 9.8 32.2 11.6 
Rectus femoris 13.9 848.8 7.6 34.6 13.9 
Soleus 58.8 3585.9 4.4 28.2 28.3 
Tibials anterior 11.0 673.7 6.8 24.1 9.6 
Gastrocnemius medial 
head 
21.4 1308.0 5.1 40.1 9.9 
 
Tendon slack length is the length of tendon at which force begins to develop when 
stretched. This data can be used to calculate the maximum force of the entire muscle system 
and it can also be used to aid the development of gait analysis simulation software such as 
OpenSim to estimate the effect of gait alterations on muscle-tendon properties. It also 
means that this muscle-tendon unit position is the best to generate internal muscle force to 
perform the task with the less muscle work done. 
The maximum force (𝐹𝑚𝑎𝑥) for the whole muscle may be calculated as: 
𝐹𝑚𝑎𝑥 = 𝑃𝐶𝐴 ∗ 𝐾 
Where PCA is the physiological cross-section area and K is a constant (20 to 100 N*cm-2). 
For pennated muscles, PCA is calculated as: 
𝑃𝐶𝐴 =
𝑚 ∗ 𝑐𝑜𝑠𝛼
𝜌 ∗ 𝐿
 
Where m is the mass of the muscle, ρ is its density (1.056 g*cm-2), L is the length of the 
muscle fibres and α is pennation angle of the muscle (Winter, 2009). 
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4.4 Comment 
If a footwear test condition were designed to potentially keep the ankle plantarflexors at 
their optimal length during a powerful isometric contraction, this would be the most 
efficient tension, which would result in less muscle unit recruitment and therefore less 
oxygen consumption. It may not be comfortable for older people with IC to stretch their calf 
muscles by wearing an extremely negatively-pitched shoe in order to produce enough 
passive elastic force to achieve efficient tension generation in the calf muscle in order to 
reduce oxygen consumption. This would also alter their typical normal gait resulting in joint 
angle alterations in the knee, ankle and hip joints. Stretching the calf muscle would produce 
greater ankle dorsiflexion and would also cause different changes in knee angle. Dorsiflexion 
tends to be greater with a flexed knee than with it extended because of the influence of the 
gastrocnemius, which crosses both the ankle and knee joints. When the knee is flexed, the 
gastrocnemius is slacker at the knee, allowing it to stretch more at the ankle, and if the knee 
is extended, the gastrocnemius is more stretched proximally, allowing it to stretch less at the 
ankle [this is known as passive insufficiency - (Alter, 2004)].  
A negative heel may therefore not be able to produce significant elastic force as the knee 
could adapt to the walking pattern by being flexed to facilitate more comfortable walking. 
Soleus is a postural muscle and stretching it may not improve posture control. The other 
factor is ageing. As a result of ageing, elastic fibres lose their resiliency and undergo various 
other alterations (Bick, 1961). When the ankle is dorsiflexed, it has a smaller gastrocnemius 
muscle moment arm with respect to the ankle joint centre, and it may also reduce internal 
moment generation about ankle joint even if elastic energy is high.  
There is also evidence to suggest that older subjects tend to reduce their walking speed and 
it consequently reduces their soleus muscle length during the entire stance phase (Panizzolo 
et al., 2013). In one study, eight healthy subjects (aged 25.8 ± 3.5 years) and eight healthy 
older adults (66.1 ± 2.3 years) were compared by analysing their natural walking speed and 
matched walking speed in relation to soleus muscle lengthening using ultrasound and a 
motion analysis system in the gait laboratory. Natural walking speed for older subjects was 
reduced by 20% compared to healthy subjects. Also, because of walking speed adaptation, 
the kinematic data, EMG and soleus length data were very similar between elderly and 
young subjects (everyone walked with the comfortable their own walking speed). However, 
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when older subjects adjusted their walking speed to that of the younger subjects (20% 
faster), there were significant differences in soleus muscle lengths. For the older population, 
the soleus muscle was significantly stretched throughout the whole gait cycle as shown on 
the figure 4.20.  
 
Figure 4.20: Comparison of normalised soleus muscle length between young adults (YA) and 
old adults (OA) during walking: (A) – preferred walking speed in YA and OA, (B) matched 
walking speed between YA and OA [adapted from (Panizzolo et al., 2013)]. 
These results suggest that older people tend to reduce stretching their soleus muscle by 
slowing down their walking speed to keep optimal length and sustain a more natural gait 
pattern similar to younger people (Panizzolo et al., 2013). This could be due to muscle 
architecture changes related to the muscle aging process (for example, muscles tissues 
become stiffer) and older people tend to reduce soleus muscle stretching to compensate 
this effect.  
Further research which used the simulation software OpenSim and a newly developed 
muscle architecture data model, has demonstrated that with increasing walking speed, a 
reduction in soleus force generation is demonstrated (Arnold et al., 2013). Therefore, 
stretching muscles and walking faster would affect soleus force generation in elderly 
subjects and it could therefore be suggested that negative-heeled footwear may not be a 
good option to offload calf muscle by generating additional passive force (elastic energy) for 
elderly people and subjects with PAD. It is also unclear how calf muscle stretching 
adaptation can affect knee extension/flexion in relation to passive force generation by the 
ankle during walking and also muscle architecture changes for patients with IC in relation to 
walking pattern adaptation. Delp in his PhD demonstrated how elastic and inelastic Achilles 
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tendon tissue can affect the active and passive soleus force curves in relation to ankle angle 
as shown in figure 4.21. 
 
Figure 4.21: Active plus passive soleus forces versus ankle angle with elastic and inelastic 
tendon. The solid black line was calculated with nominal tendon elasticity. The dotted black 
curve shows the effect of making the tendon inextensible. 
Figure 4.21 shows that if tendon and fibres are less stiff, this tends to decrease the slope of 
the force versus angle curve during stretching of the Achilles tendon for the soleus muscle. 
From the picture above it is visibly clear that for a stiffer soleus MTU, more force would be 
generated when it is slightly plantarflexed and for an elastic muscle-tendon complex, it 
would be higher when it is stretched. It is known that the aging process is related to 
decreased muscle and tendon elasticity and they become stiffer compared with a young 
healthy population (Abernethy et al., 2013). These are contributing factors to the loss of 
joint range of motion. Therefore, ankle force generation for older subjects in relation to the 
level of ankle plantar/dorsiflexion would be different versus a younger population. Another 
study has demonstrated that in an older age group of females, peak active and passive 
torque values occurred at a relatively more plantarflexed joint angle (Gajdosik et al., 1996). 
This would all suggest that the muscle architecture for older subjects with specific 
complications or diseases should be studied in more detail to understand this relationship to 
ensure that an appropriate footwear rocker sole profile can be prescribed.  
70 
 
4.4.1 Force-velocity relationship 
The force developed by a specific muscle depends upon its length and critically on its 
velocity of contraction (Panjabi and White, 2001, Arnold et al., 2013), figure 4.22. 
 
Figure 4.22: Force-velocity characteristics of skeletal muscle for different levels of muscle 
activation: shown as 25%, 50%, 75%, and 100% levels of activation [adapted from (Winter, 
2009)]. 
The usual force-velocity muscle length curve is plotted for a maximum (100%) contraction. 
However, this condition is rarely seen in clinical practice and is reserved for athletes.  
It has been demonstrated that increasing walking speed is linked to increasing fibre 
shortening velocity in musculoskeletal simulations of the soleus and gastrocnemius muscles 
(Arnold et al., 2013). A faster walking speed has also been shown to decrease peak 
gastrocnemius and soleus muscle force generation (Neptune and Sasaki, 2005), but 
interestingly generates greater EMG activity of the gastrocnemius muscle compared to when 
subjects walk slower (Chiu and Wang, 2007, Sousa and Tavares, 2012, Neptune and Sasaki, 
2005). The results of previous studies therefore suggest that with increasing walking speed, 
the velocity of contraction changes along with muscle length. Force generation of the calf 
muscle is reduced but force which is required to perform the task is increased, thus it 
increases the calf muscle EMG activity. When subjects switch to a running gait, shortening 
velocity is decreased and gastrocnemius force generation is increased. It may therefore be 
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suggested that this is related to muscle length, the velocity of muscle contraction and the 
length of the muscle moment arm (which will be discussed later in this chapter). This 
indicates that that it is better if all subjects are tested with the same walking speed during 
research protocols in order to ensure that walking speed would not affect the data results 
whilst walking in different footwear conditions. It would help to understand more precisely 
the alteration to walking patterns and MTUs caused by footwear features without additional 
factors, which may influence the biomechanical data. 
4.4.2 Isometric force 
The force generated by a muscle is proportional to the contraction time and the longer the 
contraction time, the greater is the force generated, up to the point of maximum tension. 
Slower contraction leads to developing greater force, because increased contraction time is 
required for the tension created by the contractile components to be transferred. However, 
the tension production in the contractile component can reach a maximum in as little as 10 
but up to 300 milliseconds  may be needed for that tension to be transferred to the elastic 
components (Nordin and Frankel, 2003). Figure 4.23 demonstrates the relationship for a 
force-time curve for the whole muscle contracting isometrically. 
 
Figure 4.23: Force-time curve for a whole muscle contracting isometrically [adapted from 
(Nordin and Frankel, 2003)]. 
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4.4.3 Development of tension in a muscle 
The literature suggests that the main factors responsible for the force generation in a muscle 
depend on such parameters as: 
 The number of fibres recruited and their firing rate and synchrony; 
 The physiological cross-section area of the muscle; 
 The optimal muscle length (with an optimal pennation angle) and for some muscles 
elastic energy can have a significant effect; 
 The mechanical properties of the muscle such as the length-tension relationship, and  
velocity; 
 The fibre length: short fibres produce more force and long fibres produce less force. 
 
There are other factors such as the temperature of the muscle and muscle fatigue which can 
both affect muscle performance (Barlett, 2007). The force which is produced by the muscle 
is transmitted through tendon to the joint and therefore the muscle moment arm has a 
significant impact on the internal moment generation by muscles. 
There are many other factors, which can influence these parameters which will be discussed 
in the next sections such as age related changes in muscles, moments, and how footwear 
features can influence muscle-tendon properties. 
 
4.5  Ankle muscles mechanics and properties for gastrocnemius (GAS), soleus (SOL), 
tibialis anterior (TA)  
 
Tibialis anterior (TA) contributes over 50% of the total dorsiflexion moment over the entire 
range of ankle motion (Delp, 1990). The gastrocnemius, the most superficial calf muscle, 
comprises of two portions, or heads, and forms the greater bulk of the calf. The soleus is a 
postural muscle, and is a flat muscle situated immediately deep, or anteriorly, to the 
gastrocnemius. Together they form a muscle group called the triceps surae, which 
contributes 90% of the total plantar flexion force of the posterior calf muscles (Alter, 2004). 
Since gastrocnemius and soleus have short fibres relative to their moment arms, the fibres 
change length (force) significantly as the ankle is moved (Delp, 1990). The triceps surae 
connects to the Achilles tendon, which is the largest and strongest tendon in the body. The 
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distal end is attached to the posterior surface of the calcaneus. Although it is the strongest 
tendon, it can be injured. The most common injury to the Achilles tendon is tendinitis, 
mainly caused by overuse. Footwear features could feasibly be designed to effect walking 
patterns and therefore to potentially aid in the recovery of an Achilles tendon injury by 
offloading it during rehabilitation. Gastrocnemius and soleus muscles for the average adult 
(i.e. not athletes) comprise of different fibre types. Slow twitch fibres (type I) which are 
mainly used for postural control is primarily used in soleus muscle. It also contains a high 
amount of oxidative fibres (Alter, 2004, Abernethy et al., 2013).  
 
It is known that patients with IC experience pain in the calf region due to vascular 
complications, which results in an inadequate oxygen supply to the calf muscles. 
Theoretically, if footwear could be designed to offload the soleus muscle (type I muscle), it 
should increase pain-free walking distance, and also improve (train) the cardiovascular 
system. There could be benefits related to aerobic exercise and muscle performance that 
improve overall oxygen consumption, its delivery and muscle tissue as well as nutrition 
storage.  
The gastrocnemius muscle provides forceful contraction and contains a high proportion of 
fast twitch muscle (Type II). Regular strength training of the gastrocnemius muscle could 
theoretically build up more muscle fibres and store more nutrition for muscle performance 
provided the blood vessels grow with it. Thus, footwear, which makes muscle work harder, 
may be a good way to strengthen gastrocnemius and could be used for short periods of 
walking as an adjunct therapy to strengthen the ankle plantarflexors. 
Knowledge of muscle fibre types is therefore important for several reasons: 
 IC patients suffer from oxygen supply deficiency to the triceps surae muscle group. It 
may therefore help to understand what level of oxygen usage each muscle needs and 
which one can be trained or offloaded with a rocker shoe and/or training programs 
which could be targeted for subjects with vascular complications; 
 It may also help to understand what kind of footwear could be developed for IC 
patients. 
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The triceps surae’s critical phase of walking cycle is the push off phase. At this time, the 
gastrocnemius and soleus muscles are heavily activated in order to push the centre of mass 
of the body forward and upward just before the heel strike of the contra-lateral leg. Recent 
analysis has shown that gastrocnemius and soleus both develop their peak force at the same 
time during the push off phase (Abernethy et al., 2013). The peak force that can be 
generated by GAS is around 900N, whereas the peak force in SOL is around 2000N. However, 
the maximum peak isometric force is around 3500N generated by SOL and around 1350N 
generated by GAS (Arnold et al., 2010). 
4.5.1 The Achilles tendon moment arm 
The range of joint angles over which a muscle can develop active force depends on its fibre 
length and moment arm. The change in muscle-tendon length with joint angle depends on 
the moment arm. For a given range of a specific joint, muscle-tendon excursion increases 
with the moment arm. Thus, the ratio of a muscle’s fibre length to its moment arm 
determines the range of joint angles over which the muscle can develop active force (Delp, 
1990, Hoy et al., 1990b).  
 
The Achilles tendon moment arm length increases when the ankle moves from a dorsiflexed 
into a plantarflexed position (Nagano and Komura, 2003, Maganaris et al., 1998a). A  study 
investigating alteration to the Achilles tendon moment arm with respect to the ankle joint 
centre using MRI scanning has shown that its length changes (i.e. increases) from 4.4 cm to 7 
cm between -15° to +30° of plantarflexion (Maganaris et al., 1998a). This is one of the crucial 
factors for power generation and alteration to MTU moments about the ankle. Even if the 
triceps surae muscle force is high, if the moment arm is small, then this will cause a 
reduction in the internal ankle moment generated by the calf musculature. Therefore, it is 
crucial that MTU-joint centre moment arms be optimised and considered as one of the 
factors when deciding on the position the ankle joint needs to be in to reduce the work done 
by the calf muscles. 
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4.5.2 Optimal pennation angle for gastrocnemius and soleus during dynamic movement 
Muscle fibre pennation angle is an important parameter with regards to musculoskeletal 
function (force generation). Recent developments have used ultrasound to measure muscle 
pennation angle and simultaneous EMG during isometric contraction of the gastrocnemius 
muscle. The pennation angle for the gastrocnemius muscle varies between 14° to 20° during 
isometric plantarflexion (Zhou et al., 2012). Maximum torque is produced at a pennation 
angle of around 18°. It was also noticeable from the graphs that with higher values of 
pennation angle, EMG was significantly higher too. With low values pennation angle was 
significantly lower, however tendon force is equal to fibre force multiplied by cosine of 
muscle pennation angle. If the pennation angle is less it consequently should increase force 
transferred to the tendon. However, the results suggest that the muscle produce more 
active force when it is shortening. Further research with MRI scanning has shown that by 
lengthening muscles fibres, pennation angle is reduced (Narici et al., 1996). This would help 
to transmit elastic force to the joint; however the muscle moment arm may be short and it 
may reduce the effect. It is therefore interesting to test different heel heights in footwear 
designs in order to understand relationships between alteration to muscle-tendon lengths, 
and muscle moment arms in relation to EMG and ankle moments in the lower limb. 
Another study using ultrasound has calculated the pennation angle values for the 
gastrocnemius, soleus and tibialis anterior muscles (see table below) at rest and at maximum 
voluntary contraction for male and female adult subjects (Manal et al., 2006). 
Table 4.4: Pennation angle measured at rest and maximum voluntary contraction for the 
right (R) and left (L) legs of male and female subjects. Pennation angle is reported as degrees 
with standard deviations in parentheses  (Manal et al., 2006). 
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Optimal pennation angle angles of 8 males and 8 females for the GAS, SOL, and TA muscles 
were calculated. Joint angles were chosen to control muscle tendon lengths so that the 
muscles were near their optimal length within the length-tension relationship (figure 4.24). 
 
 
Figure 4.24: Mean values of optimal pennation angle with standard deviation for tiabialis 
anterior (TA), lateral and medial gastrocnemius, and soleus muscles  (Manal et al., 2006). 
 
Further ultrasound research has produced detailed measurement of the triceps surae 
complex architecture in six males across the muscle belly at rest and during maximum 
voluntary contraction trials at angles of -15° (dorsiflexion position), 0° (neutral position), 
+15°and +30° (plantarflexion position) (Maganaris et al., 1998b). The results demonstrated 
that pennation angle increases when the ankle is plantarflexing and GAS and SOL muscle 
fibres are shortening. Therefore, it is unclear which is the best ankle position to produce an 
optimal ankle moment force that would recruit less motor units to generate the internal 
moment by the ankle and therefore theoretically produce less oxygen consumption. This 
thesis was therefore designed to investigate this question using ambulatory activities with 
regards to footwear design by testing different footwear features, collecting kinematic, 
kinetic and by analysing muscle-tendon property data (lengths, velocities, Achilles moment 
arm) and EMG signals. 
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4.6  The effect of footwear features on muscle parameters 
4.6.1 Introduction 
Spanish cave drawings from 15,000 years ago show that people wore some kind of footwear 
in very ancient times (Kurup et al., 2012). The first custom-made shoes can be traced back to 
approximately 5500 years ago (Ravindra, 2012). Today footwear forms an integral part of our 
outward appearance and is also used as a functional and protective tool for walking in the 
modern environment. Despite this, little is known regarding the effect of footwear design on 
lower limb muscle function and its implications in altering gait parameters for the potential 
benefit of people suffering from different pathologies; especially those which affect lower 
limb muscle function. This chapter investigates the available evidence and discusses the 
biomechanical effect of different footwear features on the action of muscles such as the 
triceps surae group which act on the ankle, and forms subsequent hypotheses with regards 
to their effect on specific parameters. The chapter concludes with four over-arching 
hypotheses which informed the methodology and led to the subsequent results and 
discussion chapters. 
Three specific regions of the shoe were targeted when analysing evidence available in the 
literature. These were: 
 The rearfoot portion; 
 The midfoot region, and; 
 The forefoot and toe region. 
 
The impact of the applied GRF, which can affect lower limb muscle activity, may be 
manipulated and altered through wearing shoes with altered heel height, varying hardness of 
the midsole or outsole unit and also by changing the overall shape and pitch of the shoe. The 
literature suggests that these parameters can alter lower limb muscle activity in conjunction 
with the applied external forces, as well as kinematic and kinetic data and muscle-tendon 
properties, and therefore can potentially change the overall work done by lower limb 
muscles.  
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Footwear can have significant effects on the musculoskeletal system and this has therefore 
been the subject of interest in the literature, especially with regards to lower limb muscle 
activity during walking (Ravindra, 2012). However, there has been little research which has 
investigated how footwear features change muscle-tendon properties and function in 
relation to force generation when walking with different rocker-soled shoes. Muscle-tendon 
lengths and their velocity of contraction has a significant effect on muscle force generation 
(Zajac, 1989, Hoy et al., 1990b, Delp, 1990) and this is therefore of interest in this thesis. 
 
The next sections give a short analysis of the biomechanical effects of walking in shoes with 
various heel heights, different rocker sole apex positions relative to the length of the shoe, 
different apex angles, the effect of negatively-curved heels and variations in sole flexibility. 
 
4.6.2 Rocker sole designs, alteration to heel height and their biomechanical effect 
Various rocker soles designs have previously been prescribed for different pathologies and 
rehabilitation programs in an attempt to alter muscle working patterns, limit motion in the 
ankle during stance phase, or reduce pressure distribution over specific areas (Hutchins et al., 
2012, Richardson, 1991, Romkes et al., 2006, Shakoor et al., 2008, Viswanathan et al., 2004, 
Yung-Hui and Wei-Hsien, 2005).  
The actual shape of the sole unit varies in the literature according to the biomechanical 
effects required to be achieved, and the pathology presented. Some examples where rocker 
soled shoes have the potential to be used or have already been used as an orthotic 
intervention are: 
 To improve gait performance in sport and medicine; 
 To redistribute plantar foot pressures for subjects with diabetic peripheral neuropathy; 
 To improve the rehabilitation of the Achilles tendon injuries; 
 To improve the efficacy of rehabilitation programs in reducing pain in the ankle, knee, hip 
and back; 
 To provide compensation for weak muscles or altered gait patterns, and to train or 
offload muscles to influence the work done by them; 
 To alter gait parameters to make walking more efficient; 
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 To reduce energy expenditure, and improve comfort during walking. 
Improved performance relies on efficient transformation of mechanical power output 
produced by the musculoskeletal system through footwear design. Understanding the 
biomechanical implications of different rocker-soled shoes can help ensure that the 
appropriate footwear selection/prescription for people with different pathologies can be 
made and it may also assist in the understanding of causes of lower limb injury. The following 
section will describe the basic biomechanical effects on specific lower limb muscles caused 
by different footwear features. 
4.6.3 Alteration to heel height 
High-heeled shoes are extensively worn by women and are influenced by fashion trends. This 
type of footwear has been associated with a range of foot deformities. High heel shoes can 
increase forefoot plantar pressures, increase loading to the toes, (especially the first 
metatarsal head), increase the activity of leg muscles to maintain balance and increase the 
activity of muscles of the lower spine. They also alter posture and gait, cause muscles to 
fatigue and cause pain, induce kinematic and kinetic changes, increase the risk of ankle 
sprains, increase anterior pelvic tilt and reduce walking speed (Ravindra, 2012, Mika et al., 
2012, Stefanyshyn et al., 2000, Gefen et al., 2002, Gehlsen et al., 1986, Esenyel et al., 2003).  
However, high heeled shoes also have a ‘benefit’ in so far that they produce a positive 
cosmetic effect by making the legs and look slimmer and longer, and make the feet appear 
smaller.  
Conversely, negatively-heeled shoes increase the internal PF moment, cause premature 
activation of the calf muscles, and place the ankle in a more dorsiflexed position during 
walking. They therefore stretch the triceps surae muscles and are therefore not suitable for 
people with Achilles tendon injuries (Li and Hong, 2007, An and Lee, 2007).  
4.6.3.1 The effect of heel height on EMG activity 
The effect of different heel heights on muscle activity by using EMG analysis has been 
investigated in several studies. The results of these studies are presented in table 4.5. 
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The existing evidence demonstrates variation in results with regard to EMG activity by 
increasing heel height, and does not clearly justify why muscle activity is increased or 
decreased. This is because it is unclear what causes EMG activity to be higher or lower in 
magnitude by altering the heel height.  Gastrocnemius activity was shown by Lee et al (1990) 
to be reduced once the heel height exceeded 5cm, but tibialis anterior was increased once 
the heel height was less than 5cm. A separate study, however, showed that a 10cm heel 
increased EMG activity in the GM muscle compared to a 4cm heel height. Soleus increased 
activity with a 4cm heel compared to a 3.7cm heel. However, negatively pitched heels have 
been shown to increase gastrocnemius activity. 
The alterations to EMG values reported in the literature may have been due to the following: 
 The ankle moments and powers may have been altered or the velocity of specific muscle 
contractions  changed due to the different footwear test conditions; 
 Alteration to walking speed could have caused these consequential changes in the 
velocity of specific muscle contractions (Arnold et al., 2013), as velocity of contraction is 
related to force generation in muscles (Winter, 2009); 
 Muscle-tendon lengths may not have been close to their optimal length for certain 
footwear test conditions or the muscle moment arms were adversely altered by the 
change in heel height also.  
Table 4.5: The effect of heel height on lower limb muscle EMG activity. 
Author/s 
(Date) 
Subjects,  
Age 
Footwear 
features 
Task Muscles (EMG) 
tested 
Main findings 
HEEL HEIGHTS 
(Lee et al., 
1990) 
6 Women 
Age range: 
20-31 years 
Barefoot, 2.5 cm 
heel, 5.0 cm 
heel, 7.5 cm heel 
Walking Med. 
Gastroc. 
Tib. Anterior 
Med.gastroc - significantly lower 
mean peak EMG values with a 
2.5 cm and 5 cm heel height  
when compared to a  7.5 cm 
heel. 
Tib. anterior - significantly 
greater mean peak EMG with a 
2.5 cm heel compared to both 
5.0 cm and 7.5 cm heel heights.  
Both muscles showed 
significantly lower mean peak 
EMG for all heel heights versus 
barefoot. 
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(Stefanysh
yn et al., 
2000) 
13 female 
subjects 
Age: 40.6 
(±8.3) years 
Flat shoe 1.4 cm 
heel, Low-heeled 
shoe 3.7cm,  
5.4cm heel and 
8.5cm heel 
Walking 
at a speed of 
1.4 m/s 
Gastroc. 
Soleus 
Soleus showed a significantly 
greater RMS EMG amplitude 
with 1.4 cm heel versus a 3.7 cm 
heel.  
Soleus  - significantly greater 
RMS EMG amplitude with an 8.5 
cm heel versus all other shoes 
tested. EMG using a  5.4 cm heel 
was greater than 1.4 and 3.7  cm 
heel heights 
(Lee et al., 
2001) 
5 female 
subjects 
Age: in 
their 20s  
0 cm heel, 
4.5 cm heel and 
8 cm heel 
Walking 
at a speed of 
1.1 m/s 
Tib.  anterior Peak tib. anterior EMG values 
were significantly increased  with 
increased heel heights 
(Li and 
Hong, 
2007) 
13 female 
subjects 
Age: 23.1 
(±3.9) 
Normal shoes 
plus  negative-
heeled shoes 
Walking Tib. anterior 
Lat. gastroc. 
Lat. Gastroc and Tib. anterior – 
significantly greater EMG 
amplitude in negative-heeled 
shoes and duration of EMG 
activity was significantly longer 
for both muscles when walking in 
negative-heeled shoes versus 
normal. 
(An and 
Lee, 2007) 
15 male 
subjects 
Flat 15° heel 
20° heel 
Walking  
at a speed of 
1.33m/s 
Tib. anterior 
Med. gastroc. 
 
Both negative heel shoes showed 
significant increases in Tib. 
anterior EMG activity. 
Both negative-heel shoes 
showed an increase in peak EMG 
activity during stance phase but 
not significantly (p=0.08) 
(Mika et 
al., 2012) 
31 female 
subjects 
age: 20-25 
15 female 
subjects 
Age: 45-55 
Barefoot  
4 cm heel 
10 cm heel 
Walking 
(self-selected 
speed) 
Med. gastroc. 
Tib. anterior 
 
Tib. Anterior- significantly 
greater EMG amplitude using a 
10 cm heel compared to both 
barefoot and a 4 cm heel. 
Med. Gastrocnemius significantly 
greater mean peak EMG in 10 cm 
heel versus barefoot and 4 cm 
heel. 
(Simonsen 
et al., 
2012) 
14 female 
subjects 
Age range: 
21-38 
 
Barefoot 
9 cm heel 
Walking 
at 4km/h 
Med. gastroc. 
Soleus 
Tib. anterior 
Tib. anterior - significantly 
greater EMG amplitude in 9 cm 
heel versus barefoot. 
Soleus – significantly greater 
EMG amplitude in 9 cm heel and 
duration of EMG activity was 
significantly longer. 
Med. Gastroc – premature 
activation and greater EMG 
amplitude during mid-stance for 
9 cm heel versus barefoot 
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The answers to these assumptions are as yet unclear. Muscles produce movement at the 
joints. The forces which cause the joint to rotate produce the joint moment. External 
moments are produced by gravitational forces and internal moments are generated by 
muscles and usually oppose external forces (Kirtley, 2006, Trew and Everett, 2005, Whittle, 
2003). Muscle moments or moments about the ankle are calculated as the force (muscle or 
GRF) multiplied by its moment arm. Therefore, both the length of the moment arm and the 
magnitude of the force can change the joint moment or moment produced by the muscles. 
The triceps surae muscle group generate internal plantarflexion (PF) moments (muscle force 
x internal moment arm), which is opposed by an external dorsiflexion (DF) moment (ground 
reaction force x external moment arm) as shown in figure 4.25  (Sobhani et al., 2013). 
 
Figure 4.25: An example during stance phase of gait of how the external dorsiflexion 
moment is opposed by internal plantar flexion moment generated by calf muscles. 
From figure 4.25 above, it is clear that changing the muscle moment arm (denoted d2) and its 
projected point with the ground would also potentially change muscle force generation. 
High-heeled shoes place the ankle into a more plantarflexion position than flatter shoes 
(Simonsen et al., 2012, Esenyel et al., 2003).  That would result in an increased Achilles 
muscle moment arm relative to the ankle joint centre (Nagano and Komura, 2003, Maganaris 
et al., 1998a). High-heeled shoes have also been shown to decrease the internal ankle 
moment (Esenyel et al., 2003). Consequently, muscle force magnitude can be increased as 
the Achilles tendon moment arm is increased until the muscle-tendon length reaches the 
length at which it loses force generation (Delp, 1990). There is therefore the potential to 
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influence these two parameters by footwear features so that specific muscles produce more 
or less muscle force generation depending on the application required. 
Correlation between internal ankle moments and the related level of muscle activity at the 
ankle joint (i.e. the intensity of contraction and rate of motor unit recruitment) is not yet fully 
understood. For instance, skeletal muscles develop only 50% of its maximum available force 
when its length is shortened to 85% of the resting length (Panjabi and White, 2001). Figure 
4.26 demonstrates that as the moment arm of the point of application of the GRF to ankle 
joint centre is shortened when the ankle is in plantarflexion, the calf muscles potentially 
work harder to generate force as their muscle-tendon length is shortened. 
 
Figure 4.26: A visual example of EMG activity for the calf muscle during standing on the toes 
[adapted from (Kirtley, 2006)]. 
4.6.3.2 Heel Height (HH) hypothesis 
A feasibility pilot study investigating the effect of walking with shoes with different heel 
heights was performed for this thesis prior to the main biomechanical testing. It showed that 
the point of application of the GRF during initial contact can be significantly altered (figure 
4.27). These initial results resulted in the following analysis and the hypotheses being formed 
with regards to the effects of wearing footwear with different heel heights. 
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When walking with high heeled footwear, the ankle is more plantarflexed and therefore 
tibialis anterior (TA) muscle is stretched compare to when walking with the flat shoe. This 
would result in changes to TA muscle work and function. 
 
Figure 4.27: GRF point of application data during initial contact (ICt) obtained in a pilot study 
using visual3D software (C-Motion) for 3.5 and 5.5 cm heel heights. 
High heeled shoes when compared to low or negative heels may also change the velocity of 
TA contraction. For instance, a negative heel would keep the ankle in a dorsiflexed position 
relative to the ground, but the shank would still rotate forwards. The inclination velocity of 
the shank relative to the foot would be different in high heel shoes compared to a negative 
heel. It would consequently increase the eccentric contraction velocity of TA, and EMG 
activity may be higher in magnitude. Figure 4.28 demonstrates visual differences for 
negative-heeled and high-heeled shoes during ICt.  
 
Figure 4.28: Visual example of the position of the foot and ankle at ICt for negative heeled 
and high heeled shoes (where d1 and d2 are the muscle moment arms). 
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Different heel heights can therefore potentially offload or load the TA muscle and may also 
cause premature activation of the calf muscles.  
The sole thickness directly underneath ankle joint centre can also increase the ankle 
moment. The moment about ankle in the sagittal plane is calculated as summary of vertical 
GRF magnitude multiplied by the moment arm, and horizontal force multiplied by the 
moment arm (Richards, 2008). If the sole is thicker, it increases the vertical moment arm as 
shown in figure 4.29. 
 
Figure 4.29: An ankle moment calculation example. The red coloured section illustrates the 
extra sole thickness. 
However, a thicker sole may not have a significant effect on the total moment when the 
point of application of the GRF is moving away from the joint centre. 
At mid-stance and terminal stance phases of gait, the triceps surae muscles (attached to the 
Achilles tendon) may produce varying force when walking with negatively-heeled, flat or 
high-heeled shoes if participants are walking with the same speed. There are several reasons 
for this: 
 It can increase/decrease the external ankle moment during stance phase; 
 It can change the velocity of muscle contractions along with changes to ankle angle; 
 It can change passive/active muscle force generation; 
 It can place the ankle into a more DF or PF position during stance phase; 
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 It can alter muscle-tendon lengths during stance phase; 
 The calf muscle moment arm can be increased or reduced; 
 It can change walking patterns and adaptation mechanisms by other part of the 
body. 
 
Figure 4.30: demonstrates a simple visual geometrical example of how different heel heights 
change the ankle position during terminal stance and therefore muscle biomechanics. 
From the example above, the results of pilot/feasibility testing show that for a negative-heel 
shoe, the triceps surae requires around 2,918 N to perform the task, for a flat shoe 2,236 N 
and for a high heeled shoe 1,692 N. However, for the positively heeled shoe it requires less 
muscle force, but the muscles can also be shortened by 85% and consequently lose 50% of 
their force generation and therefore theoretically may require in excess of 3,384 N (1,692*2) 
of muscle force to oppose the external DF moment. This example does not include body 
adaptation such as knee flexion to the shoe. Gastrocnemius muscle length also depends on 
the knee flexion angle, and the total length can vary with force generation. 
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The following footwear design parameters were analysed in this study to understand their 
effect on muscle function: 
 
 Rocker sole apex angle and the apex position (i.e. the position along the shoe at 
which the outsole begins to curve or angle upwards);  
 The effect of altering the stiffness of the outsole; 
 Variation in heel height (and therefore also the overall pitch of the shoe); 
 Addition of a heel curve (otherwise known as a rolled, negatively-curved or 
chamfered heel) (figure 4.31). 
 
Only one footwear feature was changed at a time during the gait laboratory testing to 
demonstrate ensure it was clear which footwear features were responsible for alterations to 
muscle function.  
 
 
Figure 4.31:   An illustration of the footwear features analysed in this thesis. 
 
The methodology section describes in more detail the footwear rocker sole profile selection 
criteria for this research and illustrates the rocker sole designs, which were tested in this 
thesis. 
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4.6.3.3 Possible effects of varying heel height and resulting hypotheses 
1. There is a certain heel height level at which the muscle moment arm has an optimal 
position in relation to the muscle-tendon length during push off phase of gait. A heel 
height of between 3.0 and 4.5 cm is the estimated heel height at which triceps surae can 
produce maximum efficient force. This heel height along with other adaptations to the 
sole could be beneficial in offloading the calf muscles for patients with IC.  
2. High heeled shoes may increase triceps surae EMG activity even though the external 
ankle DF moment is reduced (this should be equal to the internal plantarflexion 
moment), but the muscle is too short to generate the force required compared when it 
is at optimal length, therefore the resulting energy cost may be increased with high-
heeled shoes. 
3. A negatively-heeled shoe may increase triceps surae muscle work, because it may 
increase the external DF ankle moment, reduce the muscle moment arm and keep the 
muscles stretched and therefore they may lose force generation. However, the muscles 
will work harder to compensate for the force required.  
4. A negatively-heeled shoe may prematurely activate the calf muscles which will result in 
increased external ankle moment during loading response and mid stance phase and 
therefore an increase in EMG muscle activity will result. 
5. A negatively-heeled shoe may reduce ankle ROM during loading response as the foot 
and shoe may not move relative to the ground, but the shank will still incline. 
6. A negatively-heeled shoe may reduce the time taken during loading response and also 
activate mid stance phase earlier due to a more dorsiflexed foot position. 
7. A high-heeled shoe may increase ankle plantarflexion during loading response because 
it may change the point of application of the GRF (more ankle movement could also 
result, for example a more inclined shank may result in order to achieve a more 
comfortable ankle position when compared to a low heeled shoe) and this will increase 
the external plantarflexion moment. 
8. A negatively-heeled shoe will stretch the calf muscles and therefore change their 
velocity of contraction, EMG activity, and keep the ankle more dorsiflexed through the 
entire gait cycle and also affect the knee and hip. 
9. A positive (high) heel will shift the ankle into a more plantarflexion position during the 
entire gait cycle and therefore change kinematic, kinetic, EMG and muscle function. 
89 
 
4.6.4 Rocker sole Apex Position (AP) 
Some studies have been conducted to more fully understand the effect of rocker sole apex 
positions (APs) on plantar pressures as well as kinematics, kinetics and EMG data (van Schie 
et al., 2000, Chapman et al., 2012, Sobhani et al., 2013). Two studies have analysed plantar 
pressures in relation to AP and they have reported results indicating which area was 
maximally offloaded for a given AP (van Schie et al., 2000, Chapman et al., 2012). Alteration 
to muscle activity has also been studied by comparing a standard shoe with rocker-soled 
shoes with APs positioned at 53% and 65% of length from the heel (table 4.6). The results 
demonstrated no significant difference in gastrocnemius EMG values but significantly greater 
EMG values for tibialis anterior with the apex positioned at 65% of shoe length. 
Table 4.6: The EMG results demonstrated by Sobhani et al (2003). 
Author/s 
(Date) 
Subjects, 
Age 
Footwear 
features 
Task Muscles 
(EMG) 
Main findings 
ROCKER SOLE APEX POSITION (AP) 
(Sobhani et 
al., 2013) 
8 females 
8 males 
Age: 29±9 
53%  shoe length 
from the heel 
65% shoe length 
from the heel 
(thicker sole) 
Walking at a 
controlled 
speed 
Med. 
Gastroc. 
Lat. Gastroc. 
Tib. anterior 
Med.gastroc – not significant 
Lat. Gastroc – not significant 
Tib. anterior significantly 
greater mean peak EMG with 
65% apex position  
 
There were therefore no significant change in triceps surae muscle activity for different apex 
positions; however, the external DF moment was significantly different for both shoes and a 
53% AP demonstrated reduction in mean values for this parameter. These results suggest 
that calf muscles work less hard according to the ankle moment in a 53% AP shoe, but there 
were no significant differences in data for their EMG activity. There was not enough evidence 
to arrive at a definitive conclusion to explain the reason for this. It could have been due to 
the velocity of contractions, muscle moment arm and/or muscle-tendon length changes. 
There were also other factors such as different shoe weights (467 ± 87g versus 805 ± 157g), 
different thicknesses of the sole units (65% AP shoe was thicker by 2.2 cm versus 53% AP) 
and different shoe sizes (36 to 46). Thicker-soled shoes demonstrated significant increases in 
mean EMG activity for the tibialis anterior muscle. It may therefore be suggested that it 
would be better to test shoes with different AP length but with the same thickness of the 
sole, as similar a weight as possible and similar sizes.  Lighter-weight shoes have 
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demonstrated an improvement in oxygen consumption by 1% for every 100g lost in weight 
(Williams and Cavanagh, 1987, Morgan et al., 1989). This may also result in less work done by 
lower limb muscles. 
4.6.4.1 Rocker sole apex position hypotheses 
Different rocker sole APs may therefore have following biomechanical implications: 
1. Shoes with more proximal APs can theoretically cause premature plantarflexion during 
late stance as shown in figure 4.32. 
 
Figure 4.32: An example of walking in shoes with different APs. 
This would also change ankle kinematics, moments, velocity of muscle contractions, GRF 
force direction, muscle-tendon lengths, and muscle moment arms. 
2. A short AP length may offload the triceps surae muscles because it may cause premature 
plantar flexion and therefore keep the ankle at a neural position near to where the 
muscle-tendon length is optimal, and consequently muscle fibres can generate force 
without less effort; 
3. By increasing AP length of the shoe it may load up the calf muscles as it may resist 
plantarflexion, and also increase the external ankle DF moment; 
4. A short AP may result in reduction of maximum DF and therefore stretch the triceps 
surae less than were it to be placed more distally. 
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4.6.5 Shoe forepart flexibility 
The foot is naturally a very flexible structure when walking barefoot. The kinematic and 
kinetic responses associated with barefoot walking, differ from those associated with rocker-
soled shoes. There have been many benefits reported related to extremely flexible running 
shoe designs (Ravindra, 2012). It has been reported that changes can occur in muscle cross-
section areas and increased strength after using such footwear for more than 5 months 
(Bruggemann et al., 2005). It has also been reported that well cushioned shoes reduced 
oxygen cost by up to 2.8% over stiffer shoes of the same weight whilst running, and may also 
have some effect during walking (Saunders et al., 2004). With increased shoe flexibility at the 
metatarsal joint area, a reduction in the load on the Achilles tendon and triceps surae muscle 
group may be expected as well as reduction in lever arm about the ankle in the sagittal plane 
(Ravindra, 2012).  
Table 4.7: EMG activity with varying shoe stiffness. 
Author 
(Date) 
Subjects, Age 
range 
Footwear 
features 
Task Muscles (EMG) Main findings 
 
ROCKER SOLE STIFFNESS 
(Kersting et 
al., 2005) 
8 males  
Age: 27.9±2.3 
8 females  
Age: 23.9 ± 2 
Standard shoe 
with a stiff 
midsole; 
Neutral shoe 
with a flexible 
midsole; 
Shoe with soft 
midsole 
Walking Med. gastroc. 
Tib. anterior 
Med. gastrconemius 
– significantly greater 
EMG with a stiff 
midsole compared to 
a soft midsole. 
Tib. anterior – not 
significantly altered 
(Bohm and 
Hosl, 2010) 
15 healthy 
males 
Age: 29±5 
Stiff shafted 
boot; 
Soft shafted 
boot. 
Walking  
 
Med. Gastroc. 
Tib. anterior 
Med.gastroc – not 
significant 
Tib. anterior – not 
significant 
 
Kersting et al. (2005) investigated three shoes with different midsole stiffness during walking. 
He showed that increased stiffness of the outsole resulted in significantly greater muscle 
effort by the gastrocnemius muscle. Bohm et al. (2010) tested two boots; one with a stiff 
shaft and one with a soft shaft. The results did not show any significant changes in 
gastrocnemius EMG activity. However, this study mentioned that the stiff-shafted boot 
decreased the ankle range of motion as well as the eccentric energy absorbed at the ankle 
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(Bohm and Hosl, 2010). Therefore, the efficiency of the stiff boots might be decreased as 
they may have influenced oxygen consumption. There has been significant research done on 
investigating the effect of running with a stiff-soled shoe but there is little information 
regarding their effect on walking in different stiffness level of shoes with regards to muscle 
function. 
4.6.5.1 Shoe forefoot stiffness hypotheses 
The above analysis means that the following may occur during adult gait: 
1. A very stiff mid-sole area of the shoe may load the calf muscles, because the sole will 
resist metatarsal joint motion (figure 4.23), and therefore may also alter knee flexion, 
ankle angle, ankle moments, muscle tendon-lengths, the velocity of muscle contraction, 
produce a reduced stride length, and change walking speed. 
 
 
Figure 4.33: An example of late stance ankle angle kinematics for flexible and solid shoes. 
2. A soft-soled shoe can achieve a more natural walking (barefoot) pattern, and therefore 
walking can be adapted to most comfortable way and muscle function will vary 
according to adaptation and walking speed. 
4.6.6 Rocker Angle (RA) 
The effect of different rocker angles (RAs) on plantar pressure, kinetics and kinematics have 
been investigated in several studies (van Schie et al., 2000, Van Bogart et al., 2005, Chapman 
et al., 2012). Van Bogart’s study found that angled rocker soles increased the plantarflexion 
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angle during late stance phase and decreased the internal rotation moment during mid-
stance and terminal stance. The results suggested that the ankle was more plantarflexed and 
therefore could be at more natural position at which fibres and tendons are closer in length 
to the optimal size. Internal PF moments were also reduced (figure 4.34). 
 
 
Figure 4.34: Alteration to ankle plantarflexion with a 10° rocker angle shoe versus a 20° 
rocker angle during late stance phase. 
 
Therefore, specifically angled (between 10°- 25°) rocker soles may offload the calf muscles. 
4.6.6.1 Hypothesis for alteration to rocker angle (RA) 
The hypothesis would be that for a given AP, the RA would alter the kinematics of the ankle 
during late stance phase. The foot could be more dorsiflexed or plantarflexed, and therefore 
muscle length, velocity of contraction, muscle force generation, and moments would be 
affected. A flat and stiff shoe (i.e. with zero RA) may increase the load applied to the calf 
muscle as the shoe will resist ankle plantarflexion. 
4.6.7 The posterior heel curve (HC) 
The heel curve modification is routinely applied to the design of training shoes as well as 
contemporary footwear such as so-called “unstable shoes”; an example of which is the MBT 
shoe. However, most unstable shoes have reinforcement placed in the shoe upper around 
94 
 
the heel to provide shock absorption during initial contact and loading response (Ravindra, 
2012). It has been demonstrated that MBT shoes reduce peak EMG activity for tibialis 
anterior muscle (Sacco et al., 2012, Romkes et al., 2006, Nigg et al., 2006). However, the MBT 
shoe has a cushioned heel and during loading response it partly acts as negative heel, and 
therefore it offloads the TA muscle (figure 4.35). 
 
Figure 4.35:The Masai barefoot technology shoe (MBT) during loading response [picture 
adapted from (Sacco et al., 2012)]. 
The reasons why unstable shoes such as the MBT shoe reduce tibialis anterior muscle activity 
are as follows:  
1. A curved heel changes point of application of the GRF with the ground by moving it 
anteriorly nearer to the ankle joint, and therefore the internal DF moment is reduced 
(figure 4.34).  
 
Figure 4.36: An example of GRF position for curved and flat-heeled shoes during loading 
response. 
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2. The heel curvature could theoretically reduce the velocity of the tibialis anterior 
eccentric contraction during IC and LR, and therefore tension generation by the muscle is 
reduced. 
4.6.8 Hypothesis for curved heeled shoes  
A curved-heel shoe may offload tibialis anterior muscle. Due to the geometrical construction 
of the curved heel it may shift the point of application with the ground to the ankle joint as 
well as the GRF direction to be closer to the centre of the ankle joint, and consequently it 
might lead to offloading of the TA muscle but premature activation of triceps surae. Figure 
4.37 demonstrates that a curved heel may shift the point of application of the GRF, and 
therefore remove the internal DF moment, and thus overall muscle work by the triceps surae 
may be increased. 
               
Figure 4.37: Internal DF/PF ankle moments during stance phase when comparing curved 
heels to non-curved heeled shoes.  
If the internal DF moment was removed/reduced by a curved heel it may prematurely 
activate the calf muscles. A1 – represents the total area of the internal PF moment and A2 
the area which can be transposed by alteration to the heel. The sum of areas A1+A2 may 
increase the total work done by the triceps surae by transposing the initial internal DF 
moment into a PF one. 
4.7  Summary 
Footwear profiles were designed in this research so that only one footwear feature was 
altered. For example, previous studies have investigated the effect of altering the apex 
position, but at the same time they also changed the thickness of the sole and the resulting 
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weight. This may have resulted in an additional parameter alteration (i.e. large differences in 
weight) which could have affected the results. Therefore this research has a systematic 
approach to more fully understand the precise effect of footwear features by reducing 
factors that can influence the results (such as walking speed, previous injuries and current 
pathologies, and differences in age groups).  
This research used same standard shoe profile without changing thickness of the sole or 
significant weight of the shoe, to facilitate a better understanding than previously as to how 
rocker shoes alter gait and muscle function. Additional software was used to analyse muscle 
properties and it is discussed in the methodology chapter. The summary biomechanical 
result of footwear features, which can result in alteration of triceps surae muscle work, is 
presented in table 4.8 below. 
Table 4.8: Biomechanical evidence of footwear features. 
Footwear 
features (FF) 
Definition (Biomechanical 
explanation in text) 
Hypotheses Measures 
Back of heel 
Heel Height 
(HH)  
The heel height of shoes 
can be varied by increasing 
the heel height or reducing 
it. Different heel heights 
will have an effect on the 
anatomical shape of the 
shoe and raised heels can 
also affect apex position in 
relationship to the toe 
angle. 
A high heel places the ankle 
in a plantarflexion position 
during the whole stance 
phase as it alters the pitch 
of footwear as well.  
A low heel shoe may be 
called negative shoe as the 
sole apex position is lower 
than heel height level with 
the shoe on a level surface 
(the heel is lower than the 
front of the foot). 
 
A Heel height profile would 
theoretically alter direction of ground 
reaction force (GRF), moment arm of 
external moment and therefore 
reduce/increase moment generation 
about the ankle and knee. Heel height 
can shift the ankle kinematics to be 
into more dosiflexion or plantarfelxion 
position during stance phase. It may 
change muscle-tendon properties, 
velocity and type of muscle 
contraction during stance phase. 
Consequently, it may change the 
magnitude of the EMG for lower leg 
muscles. Gastrocnemius is responsible 
for knee flexion as well and increased 
HH of the shoe will place the knee 
into a more flexed position during 
stance phase, therefore it may also 
affect the gastrocnemius muscle 
activity. Heel height can change the 
triceps surae muscle moment arm. 
When moving from a DF position into 
PF, the  muscle moment arm is 
increasing. There should be an 
optimal heel height at which the MTU 
can be at its optimal length during 
Different heel heights in 
relationship to different 
measurements  detailed 
below: 
1. GRF point of 
application. 
2. GRF direction. 
3. Kinematic and kinetic 
data. 
4.  EMG activity during 
stance phase. 
5. Muscle-tendon length 
and velocity of 
contraction. 
6. The type of muscle 
contraction. 
7. The muscle moment 
arm. 
8. Shank angle (reclined 
or inclined). 
9. Walking speed. 
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mid-stance and terminal-stance to 
make the calf muscles work efficient 
and offload them. 
Curved heel 
(CH) or SACH 
heel 
A curved heel could be 
designed purely by shape 
or changing the material 
property of the heel. For 
example, a SACH heel will 
also allow the heel to 
deform into a curved heel 
shape during IC phase. 
 
A curved heel places the 
ankle into a more 
dorsiflexion position after 
IC phase (in MBT) 
compared with normal 
shoes. 
CH changes the point of application 
during IC and shifts it closer to the 
ankle, and therefore it reduces the 
dorsiflexion moment (as ankle 
moment arm is reduced) which can 
result in tibialis anterior (TA) muscle 
activity being reduced during 0-10% of 
the gait cycle. If the point of 
application of the GRF is closer to or 
forwards of the ankle it may activate 
triceps surae group prematurely. 
Therefore, CH may alter kinematics, 
kinetics, muscle-tendon length and 
contraction velocity of the muscles 
acting on the ankle, which may result 
in EMG changes for the lower limb 
during IC, LR and partly mid-stance 
phases. 
Different material 
properties of the heel in 
relationship to different 
measurements below: 
1. Point of application. 
2. GRF direction. 
3. Kinematic and kinetic 
data. 
4. Level of EMG during 
stance phase. 
5. Muscle-tendon 
length, velocity. 
6. Type of muscle 
contraction 
7. Muscle moment arm. 
8. Shank angle (reclined 
or inclined). 
9. Walking speed. 
Midsole area 
Bending 
flexibility or 
stiffness (BF) 
Stiffness of the sole is 
defined by how much force 
is required to bend the mid 
sole of the shoe. Baseline 
stiffness occurs during 
barefoot walking, and an 
extremely stiff sole is 
produced when reinforced 
by steel plating or by a 
deep rocker sole. A low 
level of stiffness (i.e. a 
more easily bent sole) 
approximates more to 
barefoot walking. 
Shoe flexibility of the mid-shoe area 
may alter plantar flexor moment 
during end of mid stance, terminal 
stance and pre-swing phases, and 
therefore alter lower limb (particularly 
calf muscle) activity. If the sole is 
more flexible, it may require less 
plantarflexor moment and power to 
plantarflex the ankle during the end of 
mid stance, terminal stance and pre-
swing phases. If the sole has increased 
the level of bending stiffness in the 
middle of the sole it means bending 
resistance is increased and it can alter 
walking strategy, for example, it may 
affect the knee and increase flexion 
during second half of the stance 
phase. Stiffness of the sole may alter 
calf muscle firing patterns during the 
end of mid stance, terminal stance 
and pre-swing phases, and it may also 
alter type of contraction, velocity of 
muscle contraction, reduce ankle 
range of motion, muscle-tendon 
properties and consequently EMG 
activity. 
Different flexibility levels 
of the mid area of the 
sole in a relationship to 
different measurements 
below: 
 
1. Point of application. 
2. GRF direction. 
3. Kinematic and kinetic 
data. 
4. Level of EMG during 
stance phase. 
5. Muscle-tendon 
length, velocity. 
6. Type of muscle 
contraction 
7. Muscle moment arm. 
8. Shank angle (reclined 
or inclined). 
9. Walking speed. 
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Apex position 
(AP) 
Shoes with angled rocker 
soles have a single apex 
position on the sole where 
the shoe contacts a level 
surface. In a baseline shoe 
this defined by the last the 
shoe is made from and 
decided by heel height and 
toe spring. In the MBT 
shoe, the apex position is 
positioned at approx 50% 
shoe length as a result of 
the curve shape of the sole. 
The apex position of a shoe 
may be varied by adding a 
rocker sole, and the apex 
position will still be the 
point at which the sole 
contacts the ground on a 
level surface. If there is a 
flat surface from heel to 
apex position, it is the 
position after which the toe 
shape raises above the flat 
surface. The apex position 
can be anywhere between 
the heel and the sole. 
 
 
Moving the apex position alters 
direction of ground reaction force 
(GRF) during different percentages of 
the stance phase, and changes 
kinematics and kinetic data of lower 
limbs as well. It can also affect the 
flexibility by changing the thickness of 
the sole at the apex position. If the 
apex is further forwards towards the 
toe, there is more material behind the 
apex position and therefore the shoe 
may be stiffer. An apex position at 
50% of shoe length may alter stability, 
because the metatarsal head area 
during plantar flexion phase, 
positioned at the area of 60% of the 
shoe would be shaped upward. This 
may force an increased acceleration 
of the ankle and increase muscle 
activity of the ankle and knee to 
control balance. Muscle tendon 
properties and the type of contraction 
can be rapidly changed. AP can be 
varied and tuned to be optimal at the 
stance phase by keeping muscle fibres 
and tendons close to their optimal 
length, and therefore muscle force 
can be more efficiently applied. Also, 
less oxygen can be used. 
1. Point of application. 
2. GRF direction. 
3. Kinematic and kinetic 
data. 
4. Level of EMG during 
stance phase. 
5. Muscle-tendon 
length, velocity. 
6. Type of muscle 
contraction. 
7. Muscle moment arm. 
8. Shank angle (reclined 
or inclined). 
9. Walking speed. 
Toe (forefoot) area 
Angle of the 
toe area (toe 
spring angle) 
The toe spring angle is 
determined by the position 
and orientation of the sole 
at the apex. The higher the 
angle the deeper the sole 
unit and stiffer the sole for 
a given material. 
This will have an effect on the GRF 
position and direction. Therefore 
ankle external ankle dorsiflexion 
and/or plantarflexion moments may 
be altered. 
1. Point of application. 
2. GRF direction. 
3. Kinematic and kinetic 
data of ankle, knee and 
pelvis. 
4. Level of EMG during 
stance phase. 
5. Muscle-tendon 
length, velocity and 
acceleration. 
6. Type of muscle 
contraction 
7. Muscle moment arm. 
8. Shank angle (reclined 
or inclined). 
9. Walking speed. 
Curve level of 
the toes area 
(toe spring). 
Same as above Same as above Same as above 
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4.8 Overarching and specific hypotheses 
 
The first overarching null hypothesis (Ho1) therefore states the following: 
There is no statistically significant difference between specific lower limb kinetic and/or 
kinematic measures caused by walking whilst wearing shoes adapted with specific rocker 
profiles or different heel heights or forepart outsole stiffness compared to a baseline control 
shoe. 
 
The alternative overarching hypothesis (Hal) states that: 
There is a statistically significant difference between specific lower limb kinetic and/or 
kinematic measures caused by walking whilst wearing shoes adapted with specific rocker 
profiles or different heel heights, heel curves or different forepart outsole stiffness compared 
to a baseline control shoe. 
 
The second overarching null hypothesis (Ho2) states the following: 
There is no statistically significant difference between lower limb EMG RMS values of 
targeted muscles caused by walking whilst wearing shoes adapted with specific rocker 
profiles or different heel heights, heel curves or different forepart outsole stiffness compared 
to a baseline control shoe. 
 
The alternative hypothesis (Ha2) states that: 
There is a statistically significant difference between lower limb EMG RMS values of targeted 
muscles caused by walking whilst wearing shoes adapted with specific rocker profiles or 
different heel heights, heel curves or different forepart outsole stiffness compared to a 
baseline control shoe. 
 
The third overarching null hypothesis (Ho3) states the following: 
There is no statistically significant difference between lower limb temporal and spatial 
parameter values caused by walking whilst wearing shoes adapted with specific rocker 
profiles or different heel heights, heel curves or different outsole stiffness compared to a 
baseline control shoe. 
 
100 
 
The alternative hypothesis (Ha3) states that: 
There is a statistically significant difference between lower limb temporal and spatial 
parameter values caused by walking whilst wearing shoes adapted with specific rocker 
profiles or different heel heights, heel curves or different outsole stiffness compared to a 
baseline control shoe. 
 
The fourth overarching null hypothesis (Ho4) states the following: 
There is no statistically significant difference between specific lower limb muscle/tendon 
lengths, muscle moment arms, velocity of contractions, fibre lengths caused by walking whilst 
wearing shoes adapted with specific rocker profiles or different heel heights, heel curves or 
different outsole forepart stiffness compared to a baseline control shoe. 
 
The alternative hypothesis (Ha4) states that: 
There is a statistically significant difference between specific lower limb muscle/tendon 
lengths, muscle moment arms, velocity of contractions, fibre lengths caused by walking whilst 
wearing shoes adapted with specific rocker profiles or different heel heights, heel curves or 
different outsole forepart stiffness compared to a baseline control shoe  
 
Definitive hypotheses 
 
The first definitive null hypothesis (Ho1a) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
maximum ankle plantarflexion during LR, caused by walking whilst wearing shoes adapted 
with specific rocker profiles or different heel heights, heel curves or forepart outsole stiffness 
compared to a baseline control shoe. 
 
The alternative definitive hypothesis (Hala) states that: 
There is a statistically significant difference between lower limb kinematic measures for 
maximum ankle plantarflexion during LR, caused by walking whilst wearing shoes adapted 
with specific rocker profiles or different heel heights, heel curves or different forepart outsole 
stiffness compared to a baseline control shoe. 
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The second definitive null hypothesis (Ho1b) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
maximum ankle ROM during LR, caused by walking whilst wearing shoes adapted with 
specific rocker profiles or different heel heights, heel curves or forepart outsole stiffness 
compared to a baseline control shoe. 
 
The alternative definitive hypothesis (Halb) states that: 
There is a statistically significant difference between lower limb kinematic measures for 
maximum ankle ROM during LR, caused by walking whilst wearing shoes adapted with 
specific rocker profiles or different heel heights, heel curves or different forepart outsole 
stiffness compared to a baseline control shoe. 
 
The third definitive null hypothesis (Ho1c) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
maximum ankle dorsiflexion during second rocker of gait, caused by walking whilst wearing 
shoes adapted with specific rocker profiles or different heel heights, heel curves or forepart 
outsole stiffness compared to a baseline control shoe. 
 
The alternative third definitive hypothesis (Halc) states that: 
There is a statistically significant difference between lower limb kinematic measures for 
maximum ankle dorsiflexion during second rocker of gait, caused by walking whilst wearing 
shoes adapted with specific rocker profiles or different heel heights, heel curves or different 
forepart outsole stiffness compared to a baseline control shoe. 
 
The fourth definitive null hypothesis (Ho1d) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
maximum ankle ROM during second rocker of gait, caused by walking whilst wearing shoes 
adapted with specific rocker profiles or different heel heights, heel curves or forepart outsole 
stiffness compared to a baseline control shoe. 
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The alternative definitive hypothesis (Hald) states that: 
There is a statistically significant difference between lower limb kinematic measures for 
maximum ankle ROM during second rocker of gait, caused by walking whilst wearing shoes 
adapted with specific rocker profiles or different heel heights, heel curves or different forepart 
outsole stiffness compared to a baseline control shoe. 
 
The fifth definitive null hypothesis (Ho1e) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
maximum ankle plantarflexion during third rocker of gait, caused by walking whilst wearing 
shoes adapted with specific rocker profiles or different heel heights, heel curves,  or forepart 
outsole stiffness compared to a baseline control shoe. 
 
The alternative definitive hypothesis (Hale) states that: 
There is a statistically significant difference between lower limb kinematic measures for 
maximum ankle plantarflexion during the third rocker of gait, caused by walking whilst 
wearing shoes adapted with specific rocker profiles or different heel heights, heel curves or 
different forepart outsole stiffness compared to a baseline control shoe. 
 
The sixth definitive null hypothesis (Ho1f) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
maximum overall ankle ROM during stance phase of gait, caused by walking whilst wearing 
shoes adapted with specific rocker profiles or different heel heights, heel curves  or forepart 
outsole stiffness compared to a baseline control shoe. 
 
The alternative definitive hypothesis (Half) states that: 
There is a statistically significant difference between lower limb kinematic measures for 
maximum overall ankle ROM during stance phase of gait, caused by walking whilst wearing 
shoes adapted with specific rocker profiles or different heel heights, heel curves or different 
forepart outsole stiffness compared to a baseline control shoe. 
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The seventh definitive null hypothesis (Ho1g) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
maximum ankle ROM during third rocker of gait, caused by walking whilst wearing shoes 
adapted with specific rocker profiles or different heel heights, heel curves or forepart outsole 
stiffness compared to a baseline control shoe. 
 
The alternative definitive hypothesis (Halg) states that: 
There is a statistically significant difference between lower limb kinematic measures for 
maximum ankle ROM during third rocker of gait, caused by walking whilst wearing shoes 
adapted with specific rocker profiles or different heel heights, heel curves or different forepart 
outsole stiffness compared to a baseline control shoe. 
 
The eighth definitive null hypothesis (Ho1h) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
maximum knee flexion during LR, caused by walking whilst wearing shoes adapted with 
specific rocker profiles or different heel heights, heel curves or forepart outsole stiffness 
compared to a baseline control shoe. 
 
The alternative definitive hypothesis (Halh) states that: 
There is a statistically significant difference between lower limb kinematic measures for 
maximum knee flexion during LR, caused by walking whilst wearing shoes adapted with 
specific rocker profiles or different heel heights, heel curves or different forepart outsole 
stiffness compared to a baseline control shoe. 
 
The ninth definitive null hypothesis (Ho1i) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
maximum knee extension during stance, caused by walking whilst wearing shoes adapted 
with specific rocker profiles or different heel heights, heel curves or forepart outsole stiffness 
compared to a baseline control shoe. 
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The alternative definitive hypothesis (Hali) states that: 
There is a statistically significant difference between lower limb kinematic measures for 
maximum knee extension during stance, caused by walking whilst wearing shoes adapted 
with specific rocker profiles or different heel heights, heel curves or different forepart outsole 
stiffness compared to a baseline control shoe. 
 
The tenth definitive null hypothesis (Ho1j) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
maximum knee flexion at TO, caused by walking whilst wearing shoes adapted with specific 
rocker profiles or different heel heights, heel curves  or forepart outsole stiffness compared to 
a baseline control shoe. 
 
The alternative definitive hypothesis (Halj) states that: 
There is a statistically significant difference between lower limb kinematic measures for 
maximum knee flexion at TO, caused by walking whilst wearing shoes adapted with specific 
rocker profiles or different heel heights, heel curves or different forepart outsole stiffness 
compared to a baseline control shoe. 
 
The eleventh definitive null hypothesis (Ho1k) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
maximum knee flexion during swing, caused by walking whilst wearing shoes adapted with 
specific rocker profiles or different heel heights, heel curves or forepart outsole stiffness 
compared to a baseline control shoe. 
 
The alternative definitive hypothesis (Halk) states that: 
There is a statistically significant difference between lower limb kinematic measures for 
maximum knee flexion during swing, caused by walking whilst wearing shoes adapted with 
specific rocker profiles or different heel heights, heel curves or different forepart outsole 
stiffness compared to a baseline control shoe. 
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The twelve definitive null hypothesis (Ho1l) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
maximum knee ROM late stance, caused by walking whilst wearing shoes adapted with 
specific rocker profiles or different heel heights, heel curves or forepart outsole stiffness 
compared to a baseline control shoe. 
 
The alternative definitive hypothesis (Hall) states tha: 
There is a statistically significant difference between lower limb kinematic measures for 
maximum knee ROM late stance, caused by walking whilst wearing shoes adapted with 
specific rocker profiles or different heel heights, heel curves or different forepart outsole 
stiffness compared to a baseline control shoe. 
 
 
The thirteenth definitive null hypothesis (Ho1m) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
maximum knee ROM during stance, caused by walking whilst wearing shoes adapted with 
specific rocker profiles or different heel heights, heel curves or forepart outsole stiffness 
compared to a baseline control shoe. 
 
The alternative definitive hypothesis (Halm) states that: 
There is a statistically significant difference between lower limb kinematic measures for 
maximum knee ROM during stance, caused by walking whilst wearing shoes adapted with 
specific rocker profiles or different heel heights, heel curves or different forepart outsole 
stiffness compared to a baseline control shoe. 
 
The fourteenth definitive null hypothesis (Ho1n) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
sagittal knee angle position at ICt, caused by walking whilst wearing shoes adapted with 
specific rocker profiles or different heel heights, heel curves or forepart outsole stiffness 
compared to a baseline control shoe. 
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The alternative definitive hypothesis (Haln) states that: 
There is a statistically significant difference between lower limb kinematic measures for 
sagittal knee angle position at ICt, caused by walking whilst wearing shoes adapted with 
specific rocker profiles or different heel heights, heel curves or different forepart outsole 
stiffness compared to a baseline control shoe. 
 
The fifteenth definitive null hypothesis (Ho1o) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
sagittal hip angle position at ICt, caused by walking whilst wearing shoes adapted with 
specific rocker profiles or different heel heights, heel curves or forepart outsole stiffness 
compared to a baseline control shoe. 
 
The alternative definitive hypothesis (Halo) states that: 
There is a statistically significant difference between lower limb kinematic measures for 
sagittal hip angle position at ICt, caused by walking whilst wearing shoes adapted with 
specific rocker profiles or different heel heights, heel curves or different forepart outsole 
stiffness compared to a baseline control shoe. 
 
The sixteenth definitive null hypothesis (Ho1p) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
maximum sagittal hip angle during LR, caused by walking whilst wearing shoes adapted with 
specific rocker profiles or different heel heights, heel curves or forepart outsole stiffness 
compared to a baseline control shoe. 
 
The alternative definitive hypothesis (Halp) states that: 
There is a statistically significant difference between lower limb kinematic measures for 
maximum hip flexion angle during LR, caused by walking whilst wearing shoes adapted with 
specific rocker profiles or different heel heights, heel curves or different forepart outsole 
stiffness compared to a baseline control shoe. 
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The seventeenth definitive null hypothesis (Ho1q) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
maximum hip extension, caused by walking whilst wearing shoes adapted with specific rocker 
profiles or different heel heights, heel curves or forepart outsole stiffness compared to a 
baseline control shoe. 
 
The alternative definitive hypothesis (Halq) states that: 
There is a statistically significant difference between lower limb kinematic measures for 
maximum hip extension, caused by walking whilst wearing shoes adapted with specific rocker 
profiles or different heel heights, heel curves or different forepart outsole stiffness compared 
to a baseline control shoe. 
 
The eighteenth definitive null hypothesis (Ho1r) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
maximum hip ROM during stance, caused by walking whilst wearing shoes adapted with 
specific rocker profiles or different heel heights, heel curves or forepart outsole stiffness 
compared to a baseline control shoe. 
 
The alternative definitive hypothesis (Halr) states that: 
There is a statistically significant difference between lower limb kinematic measures for 
maximum hip ROM during stance, caused by walking whilst wearing shoes adapted with 
specific rocker profiles or different heel heights, heel curves or different forepart outsole 
stiffness compared to a baseline control shoe. 
 
The nineteenth definitive null hypothesis (Ho1s) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
maximum hip ROM during the gait cycle, caused by walking whilst wearing shoes adapted 
with specific rocker profiles or different heel heights, heel curves or forepart outsole stiffness 
compared to a baseline control shoe. 
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The alternative definitive hypothesis (Hals) states that: 
There is a statistically significant difference between lower limb kinematic measures 
maximum hip ROM during the gait cycle, caused by walking whilst wearing shoes adapted 
with specific rocker profiles or different heel heights, heel curves or different forepart outsole 
stiffness compared to a baseline control shoe. 
 
The twentieth definitive null hypothesis (Ho1t) states the following: 
There is no statistically significant difference between lower limb kinematic measures for 
maximum hip ROM during the gait cycle, caused by walking whilst wearing shoes adapted 
with specific rocker profiles or different heel heights, heel curves or forepart outsole stiffness 
compared to a baseline control shoe. 
 
The alternative definitive hypothesis (Halt ) states that: 
There is a statistically significant difference between lower limb kinematic measures 
maximum hip ROM during the gait cycle, caused by walking whilst wearing shoes adapted 
with specific rocker profiles or different heel heights, heel curves or different forepart outsole 
stiffness compared to a baseline control shoe. 
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CHAPTER 5 
5 METHODOLOGY 
5.1 Chapter overview 
The purpose of this thesis is to investigate the differences in gait caused by altering 
footwear outsole features during ambulation in healthy male volunteer subjects. The 
specific objective of this thesis was to especially target analysis on the alterations 
demonstrated to soleus (SOL), tibialis anterior (TA) and medial gastrocnemius (MGAS) 
muscle activity and the performance of their MTUs. This information should lead to new 
clinical treatments and further research; for example to recommend techniques to offload 
the ankle plantarflexors for patients with IC or other complications by using this innovative 
database to inform the design of new footwear features. 
The aim of this chapter is to introduce the methods which were utilised in order to collect 
and investigate the primary outcome measures which were changes in the movement 
(kinematics), forces (kinetics) and muscle activation (EMG) and muscle properties of the 
lower limbs whilst walking in different specifically-chosen footwear test conditions. Ethical 
approval was granted by the University of Salford ethics committee to perform the walking 
trials and the experimental protocol (ethics application HSCR12/04).   
Various footwear features were examined by changing one outsole or heel feature at a time, 
and were compared to a baseline shoe test condition.  
Walking speed was controlled within defined limits for all subjects during the testing 
procedure to ensure that it was not a factor in influencing alteration to ankle kinematic 
data, nor muscle-tendon properties or the work done by the muscles. This would then not 
add additional factors which could influence the gait pattern detected; apart from when 
ambulating with different footwear conditions (Kirtley et al., 1985, Kirtley, 2006). 
Participants were trained to walk with speeds within specific limits during the initial test 
walks using timing gates. 
5.2 The motion analysis system 
Motion analysis involves specific methods and techniques to systematically analyse 
movement. Modern gait laboratories use motion analysis systems to acquire dynamic 
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changes in the three-dimensional coordinates of specific body landmarks from the images 
recorded by each camera. Three-dimensional kinematic data were obtained during this 
study with ten high-speed SXGA OQUS ™ 3+, five OQUS3 and one OQUS1 Qualysis infrared 
cameras with 1.3 megapixel (1280x1024) resolution and passive retro-reflective markers 
using Qualisys Track Manager ™ software (Qualisys AB, Gothenburg,  Sweden).  
The Qualisys cameras used are based on video technology. The lens is surrounded by diodes 
which emit strobed infra-red light which cannot be seen by the human eye. This is reflected 
back from the markers, and the sensors of the camera record that information. The gait 
laboratory set up used is illustrated in figure 5.1.  
 
Figure 5.1: Camera set-up in the gait laboratory with an example of a typical image produced 
by the Qualisys software. 
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The measurement frequency of the cameras was set at 100Hz with a 1.3 megapixel 
resolution. A high resolution for the sensors was utilised to achieve precise marker position 
recognition in the coordinate system in order to enable the ability of the system to measure 
small changes in marker position (Whittle, 2007). 
5.2.1 Camera setup 
Each marker must be seen by at least two cameras during data recording (Payton and 
Bartlett, 2008). All cameras are permanently mounted in specific positions, which allow all 
anatomically-placed body markers to be clearly visible and accurately processed by the 
Qualisys software. The measurement volume was fully visible for body marker placement 
within two gait cycles within a volume of 8 m (x) by 3.5 m (y) by 2 m (z) (figure 5.2). 
Camera focal lengths, apertures and the sensitivities of each camera were adjusted to 
ensure that calibration and tracking of the retro-reflective markers could achieve the 
optimal results for each testing session. Each camera lens direction was positioned to 
prevent any opposing cameras from detecting each other’s infrared light. If this was not 
possible, then a mask area was placed in Qualisys software to ensure that camera views 
were adjusted to avoid stray reflection from being picked up, as if a reflection were to be 
picked up by more than one camera, it would be reconstructed as a marker and static 
calibration would fail. 
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Figure 5.2: Depiction of the Qualisys cameras location, the measurement volume and 
walking distances available. 
5.2.2 Oqus 3+ Qualisys calibration 
As with any motion analysis system, the volume space to be used for data collection must be 
calibrated before use. The purpose of the calibration is to define the precise position of 
markers in a three dimensional (3D) coordinate system during static and dynamic movement 
by using one of the direct linear transformation (DLT) techniques as recommended in the 
literature (Abdel-Aziz and Karara, 1971, Miller et al., 1980). Each camera was synchronised 
and recorded x-y coordinates which were then reconstructed into a single set of X, Y, Z real-
life coordinates. This technique was achieved using DLT. This method does not require 
careful camera positioning and therefore allows more flexibility in the choice of camera 
location. The DLT algorithm establishes the linear relationship between the 2D image 
coordinates and 3D real world coordinates of markers; thus an object space or data 
collection volume must be defined by using calibration technique (Grimshaw et al., 2006). 
To perform that task, two calibration frames were used. The first static reference frame was 
‘L’ shaped with four reflective markers mounted on it in known locations and with a known 
distance between them (figure5.3).  
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Figure 5.3: The L-shaped frame set-up position for calibration. 
The static L-shaped frame defined the location of the origin and the orientation of the 
laboratory reference frame (Payton and Bartlett, 2008). The L-shaped frame was placed on 
top of the first force platform in the direction of travel to match the corners and sides of the 
frame according to the calibration rules recommended during use of the Qualisys software 
(figures 5.3 and 5.4). 
 
Figure 5.4: Qualisys calibration settings configuration. 
For dynamic calibration, a hand-held T-shaped wand with reflective markers positioned with 
an exact wand length of 749.3 mm was used to calibrate the walking volume to be used 
during the subject walking trials (figure 5.5).  
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Figure 5.5: Calibration procedure used in the gait laboratory. 
It was important to manually move the wand throughout the 3D space volume where data 
were recorded by using as many orientations as possible in all three orthogonal directions. A 
capture time was set for 60 seconds to calibrate the measurement volume to ensure that 
both the lower limbs and torso were covered completely during kinematic data recording 
for the walking trials. The T-shape wand was dynamically moved by hand in the area where 
data were captured. 
This then created a calibration volume to enable marker position tracking of the body and 
lower limbs (Figure 5.6). 
 
Figure 5.6: Representation of the calibration volume. 
 
115 
 
5.2.3 Calibration results 
The most important parameter for successful calibration is low error accuracy, which 
describes the relationship between where the reflective markers are and where the system 
shows they are. The calibration procedure showed the magnitude of the errors present 
during calibration, and if the process was successful. Result figures were given for each 
camera, such as the average residual of each camera, which demonstrated the error 
between static marker positions and also in dynamic movement and it also showed the 
standard deviation of the wand length (figure 5.7). The aim was to obtain calibration results 
numerically as low as possible and to cover the full volume where kinematic data were 
recorded. A good calibration is fundamental to the collection of high quality of data. 
Therefore, the higher the residual number; the less accurately the calibration was 
performed. 
 
Figure 5.7: Typical Qualisys calibration results. 
If a dynamic calibration is performed according to the manufacture rules, the accuracy of 
residual values should be no more than 1 mm (Grimshaw et al., 2006). In this study, the 
average residuals of the calibration trials were accepted if all the camera average residual 
values were ≤ 0.8 mm as this indicated that a marker’s position in space was located within 
0.8 mm of its true position. Earlier systems had typical measurement errors of 2-3 mm in all 
three dimensions (Whittle, 1982). 
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5.3 The force Platforms  
During quiet standing on the force platform, a ground reaction component acts in 
opposition to body weight. During dynamic walking the ground reaction vector magnitude 
and direction is further influenced by three vector forces as shown on figure 5.8 (Richards, 
2008).  
 
Figure 5.8: Ground reaction vector components. 
Forces acting on the human body can be divided into external and internal forces. The 
Internal forces are those transmitted by body tissues, which include muscular forces, 
ligaments forces and forces transmitted through joint contact. The external forces represent 
all physical interactions between the body and the environment such as gravitational, 
ground reaction and inertial forces (Bronstein et al., 2004). 
The largest of the forces acting during normal walking speed is the support force and the 
second largest is the friction force. The force platform was used to measure the ground 
reaction force (GRF) or body’s response to gravitational forces as subjects walked across it. 
The ground reaction vector magnitude in the horizontal plane is calculated as:  
GRV = √Fx2 + Fy2 + Fz2 
In this research, the gait laboratory coordinate system used was different from that used by 
The International Society of Biomechanics (ISB) system, (figure 5.9). For the purposes of this 
thesis, the gait laboratory was set up with the vertical direction denoted as the “z” direction 
and the transverse, the “y” direction. 
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Figure 5.9: The three components of the ground reaction force (GRF), with (a) the coordinate 
system adopted by (ISB) and (b) the coordinate system used in this research. 
GRF data were collected using four AMTI force plates (AMTI, Watertown, MA, USA, model 
BP600400). They were mounted to be flush with the gait laboratory floor and at the same 
level as the floor to minimise them being noticeable by subjects during the walking trials. To 
obtain good quality data, the whole of the subject’s foot must land on the platform (Kirtley, 
2006). Therefore, the walking patterns of all the subjects were observed, and slight 
adjustment in the starting position using markers on the floor was used to ensure that a 
clean foot-strike occurred on the force platforms without alteration to their walking pattern 
at that time. The location of force platforms used in the gait laboratory for kinetic data 
collection is demonstrated in figure 5.10. 
 
Figure 5.10: Force platform set-up positions. 
Force platforms were used to define gait events from heel strike (HS) [otherwise known as 
initial contact (ICt)] to toe off (TO) to enable calculation of kinematics, external ankle/knee 
moments, EMG plus muscle-tendon property data during stance phase of gait. The force 
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platform system used was factory-calibrated, but manual calibration was also performed 
during each testing session by pressing the calibration button or null ground when there was 
no load acting on of the force plates to ensure that the reading was equal to zero weight. 
Caltester was routinely applied in the gait laboratory with errors of less than 1 degree in 
orientation angle and <1 mm in centre of pressure (COP).            
5.3.1 Reflective marker set selection 
Lightweight reflective markers of 14 mm diameter were used in all of walking trials in the 
gait laboratory. The markers were attached to the skin at specifically chosen anatomical 
landmarks using hypo-allergenic double-sided tape (figure 5.11). 
 
Figure 5.11: A 14 mm retroreflective marker attached to the skin using double-sided tape. 
The marker set used was configured as recommended by Cappozzo et al. (2005). Two 
markers can only define a line and cannot fully provide information about movement in 3D 
nor indicate whether rotation about that line is occurring. A minimum of three non-collinear 
markers is required per rigid segment for three-dimensional analysis with 6 degrees-of-
freedom (Cappozzo et al., 1995).  
For the purpose of the thesis, OpenSim 3.0 software was used to analyse the properties of 
the muscle movements. Visual3D 4.0 allows the export of OpenSim-compatible motion files 
designed for use in OpenSim gait models. Therefore, Visual3D was used to export a scaled 
model using body segment and motion data for further analysis in OpenSim, hence 
providing the software requirements used to build up static models in the C-Motion 
software. The Visual3d model used for OpenSim output must include the right foot (RFT), 
right shank (RSK), right thigh (RTH), left foot (LFT), left shank (LSK), left thigh (LTH), pelvis 
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(RPV) and a Thorax/Ab. Full body marker landmark positioning was required in this research 
to be able to do so, according to exportation standards by Visual3D (C-Motion, Rockville, 
MD, USA). To build up a static model, Visual3d does not require the adoption of a special 
marker configuration. The skeletal model defined in it has a precise definition that can be 
followed to create any number of segments within a model. Two rules should be followed to 
allow Visual3D to calculate the six degree of freedom motion of every segment using 
optimal techniques. The two basics rules are: 
 At least 3 tracking markers must be attached to each segment and recorded during the 
movement trial; 
 A standing trial must identify four static markers that represent medial and lateral 
locations at the proximal end of the segment, and the medial and lateral locations at 
the distal end of the segment. 
A number of studies have demonstrated that if markers are placed directly onto the skin, 
soft tissue motion artefacts can be produced during dynamic motion data collection (Fuller 
et al., 1997, Reinschmidt et al., 1997, Holden et al., 1997b). These studies showed that that 
data contained less noise if markers were mounted on pins which were inserted directly to 
the bones. Additional artefacts are also produced by the weight of the marker (Karlsson and 
Tranberg, 1999). Therefore, very light-weight markers were used in this research. Although 
direct attachment of the markers to the bones has been shown to be the most accurate 
technique to measure of motion of that segment, it was not practical for this research due 
to ethical and safety considerations. In previous gait analysis techniques, researches have 
placed non-collinear markers on a rigid structure and attached that rigid marker cluster to 
the body segment (Hutchins, 2007, Jones, 2010). The markers were therefore fixed to rigid 
anatomically-shaped polypropylene plates on the anterior thigh and lower leg to prevent 
the markers moving independently from each other (as they would have done had they 
been individually attached to the skin). This meant that the system had the advantage that 
the markers in each individual cluster would not move relative to each other. Manal et al. 
(2000) compared marker clusters for tibia rotation versus surface mounted markers and 
discovered that the rigid structure of marker placement produced less skin artefacts and 
produced more accurate data.  
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5.3.2 The Calibration Anatomical System technique (CAST) 
The CAST technique enables a local coordinate system defined by external markers to be 
given anatomical relevance (Cappozzo et al., 1995). The CAST protocol also offers the ability 
to model each body segment in six degrees of freedom as long as the segments have an 
anatomical frame by using the static markers and a cluster of dynamic tracking markers 
(Richards, 2008). 
This technique requires two sets of markers. One group of markers needed to be worn in all 
the trials (these included the marker clusters) whilst anatomical markers were used to 
define the coordinate system and body segments. The first group of markers were not 
related to any anatomical points, but defined segments and also 3D motion while 
performing the walking activities. Therefore, there were not less than three non-collinear 
markers placed on a segment and normally positioned on the rigid cluster approximating to 
the mid-point of the segment. The anatomical markers were positioned and related to 
define anatomical characteristics at the proximal and distal end, lateral and medial sides of 
lower leg segments; for example at the tibial tuberosity, fibular head, medial and lateral 
malleoli; and therefore rigid segments could be defined. A modified version of the CAST 
method was used to reconstruct segments of lower limbs during walking trials, using 
clusters of markers mounted on polypropylene plates on the anterior thigh and shin 
bilaterally and the pelvis. The anatomical markers were used to build body segments while 
marker clusters were placed on segments also.  
Static trials were initially recorded and then reflective markers could be removed, leaving 
only the marker clusters used to define motion, which also allowed reconstruction of the 
global coordinates of each anatomical marker in each frame of all dynamic trials from the 
coordinates of the marker cluster by the C-Motion software (Cappello et al., 1997). This 
method is now being integrated into movement analysis software Visual3D (motion analysis 
software by C-Motion), which allows this method of anatomical referencing to be applied 
simply and quickly.  
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Figure 5.12: The positioning of the anatomical and technical markers. 
The marker clusters were placed on the right/left thigh and the right/left shank. Direct skin 
mounted markers were used for dynamic motion tracking for the foot, pelvis and thorax 
segments.  
5.3.3 Definition of the segment coordinate systems 
5.3.3.1 The Foot segment model 
Direct marker placement on the skin of the foot was used in this study. The barefoot 
position of the foot segment should be parallel to the ground for all shoes, to ensure that 
static offsets caused by sole design would be removed. It was very important to do so, 
because small angular changes in the position of the shank and foot segment would cause a 
significant change in muscle property data and these data would not have any meaning for 
the further analysis and comparison. Therefore, it was important to ensure that all markers 
were placed on the same position on the foot during walking trials for all footwear 
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conditions. Hence, anatomical markers were kept on the same landmark positions during 
entire testing procedure. There was only one potential complication that markers of the 
foot segment were constantly replaced after changing footwear conditions. To ensure that 
all markers were placed on the same location on the foot, the circumference outline of the 
marker base was drawn on the skin of the foot where it was to be attached (figure 5.13). 
That technique ensured that foot markers were placed and re-placed on the exact same 
position with an estimated standard deviation of ±0.5 mm. Therefore, only one static model 
was used for all footwear conditions to be able to export motion data without static shifts 
caused by the shape of the soles and shank position.  
 
Figure 5.13: Direct skin-marking technique used for the reflective marker placement. 
The foot model for the foot segment was defined as a single rigid body. Three non-collinear 
markers were attached directly to the skin of the foot to define motion of the foot segment. 
Three holes were cut (figure 5.14) for each of the fifteen same-sized pair of shoes used 
during the testing to enable reflective markers to be placed at the following points:  
 The dorsal aspect of the great toe (first metatarsal denoted as 1MT); 
 The fifth metatarsal head  (5MT); 
 The posterior aspect of the heel counter of the shoe (proximal calcaneus). 
 
 
 
Figure 5.14: Anatomical cut-outs utilised on the footwear. 
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The second reason of using the method of directly attaching skin markers on the foot was to 
be sure that a precise foot segment tracking motion technique was used for different 
footwear conditions, rather than if markers were placed on the leather uppers of the shoe. 
This is because it would not be possible to place markers on exactly the same position on all 
footwear conditions, and therefore muscle property data would be less precisely captured 
than when compared to the method used in this thesis. 
 
Figure 5.15: An illustration of marker placement for the foot segment for Visual3D. 
Figure 5.15 shows the retroreflective marker positions on the foot and ankle. The centre of 
the ankle joint was taken to be the midpoint between the apices of the lateral and medial 
malleolus. The calcaneus, the first metatarsal head (1st MTH) and the fifth metatarsal head 
(5th MTH) were used as anatomical points to represent the skin cluster for dynamic motion 
tracking for foot the segment. Three markers were also placed on the shoes to compare the 
kinematic data of the ankle when markers were attached on the skin of the foot inside the 
shoe and also with markers attached to the shoe uppers. However, the results derived from 
this data are not presented in the thesis.  
5.3.3.2 The shank segment 
The shank segment model was adopted from that described by (Cappozzo et al., 1995). The 
centre of the knee joint was taken to be the midpoint between the femoral epicondyles. The 
shank segment was defined as a rigid structure. The proximal knee joint position was 
defined by lateral and medial epicondyle markers. The distal end of the shank was defined 
by the lateral and medial malleolus positions. Marker clusters were placed on the shank to 
reconstruct the segment during movement trials recording (figure 5.16).  
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Figure 5.16: Marker placement to define the shank segment for Visual3D. 
This technique was utilized to reconstruct the segment and reduce marker motion artefacts. 
If dynamic motion had been calculated by using a skin knee marker placement technique, 
skin displacement of the individual markers relative to the knee could have been as much as 
40 mm (Reinschmidt et al., 1997).  
5.3.3.3 The thigh segment  
The thigh segment was defined by the position of the thigh anatomical markers relative to 
the knee joint centre. The proximal anatomical landmarks were the greater trochanter and 
hip joint centre. To locate the greater trochanter it was required to detect movement of one 
segment relative to another segment - in this case the thigh relative to the pelvis. The distal 
end of the thigh was defined as centre of the knee joint (based on the position of the lateral 
and medial epicondyles); figure 5.17. 
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Figure 5.17: The thigh segment marker placement used for Visual3D. 
Marker clusters were used for the thigh and shank with the markers mounted on 
polypropylene plates moulded to provide a close fit to the thigh and leg. The plates on 
which the reflective markers were mounted were initially attached to the skin with double 
sided tape, and then elastic rubber bandage was also applied over the top of the plates and 
around the leg to ensure that they were prevented from moving during the walking trials.  
The bandage was applied so that it did not cover any of the reflective markers. 
5.3.3.4 The pelvic segment 
The pelvic geometry was estimated by using the most accurate procedure described by 
(Seidel et al., 1995) who conducted an anthropometric study of the adult pelvis using 65 
cadaveric specimens (thirty males and thirty five females) to investigate the relationship 
between the hip joint centre and selected aspects of pelvic geometry. For this study, the hip 
joint centre was calculated using markers which were placed on the anterior superior-iliac 
spine (ASIS), the iliac crests and the sacrum (mid-PSIS); figure 5.18. 
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Figure 5.18: the pelvic segment marker placement used for Visual3D. 
For dynamic motion tracking of the pelvic segment, four markers were therefore used: 
R.ASIS, L.ASIS, R.PSIS, L.PSIS. 
5.3.3.5 The Trunk segment 
The Thorax/Ab segment was built up according to Visual3D instructions. The proximal end of 
the thorax was created at the same location as the proximal end of pelvis. The distal end of 
the thorax was built up with right and left acromium (figure 5.19).  
 
Figure 5.19: Trunk segment marker placement.  
To track trunk motion, three markers were used: R.ACROMIUM, L.ACROMIUM and CHEST as 
shown on the figure 5.19. Markers were also placed on the arms, however results were not 
included in this research. 
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5.4 Electromyography (EMG) data collection 
5.4.1 Electromyography equipment 
Electromyography is a technique used for recording changes in the electrical potential of 
muscle fibres that are associated with their contraction at a given electrode location (Payton 
and Bartlett, 2008). Electromyographic data for lower leg muscles were recorded in this 
study by the 8-channel Noraxon wireless EMG system (Noraxon TeleMyo™ 2400T G2) (figure 
5.20)  
 
Figure 5.20: The Noraxon TeleMyo™ 2400T G2 system. 
EMG data were collected at sample rate of 3000 Hz to ensure optimal quality of the data. 
The TeleMyo™ 2400T G2 is a real-time EMG system that sends analogue signals across a 
distance of up to 100 meters by wireless transmission to a desktop computer. Every subject 
was asked to wear a neoprene vest to which the Noraxon TeleMyo™ 2400T G2 system could 
be conveniently attached (figure 5.21), which also offered a convenient position for the 
electrode leads to be attached in a central point of the torso. 
 
Figure 5.21: Noraxon TeleMyo™ 2400T G2 attachment during testing procedures. 
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5.4.2 Data collection procedure 
With regards to the targeted muscles in the lower limbs, the aim of the thesis was to 
investigate the changes in EMG activity in conjunction with an analysis as to what type of 
contraction was occurring concurrently with alteration to muscle length when walking with 
different footwear conditions. Since it was deemed important to target the main muscles 
acting on the ankle and knee, as well as the lower back, surface EMG data were therefore 
obtained from the following six muscles on the right side of the body only:  
 Medial Gastrocnemius (GAS); 
 Soleus (SOL); 
 Tibialis anterior (TA); 
 Rectus femoris (RF); 
 Biceps femoris (BF); 
 Erector spinae (ES). 
The EMG signal was collected via six Noraxon dual hypo-allergenic surface gel adhesive 
Ag/AgCl electrodes; with the EMG signal being recorded as the voltage difference between 
the two electrodes. Motion capture data, GRF and EMG data were synchronised during 
walking trials. Before placing electrodes on the muscles, the skin was shaved, rubbed with 
abrasive skin preparation gel (Nuprep tm ECG & EEG) and then cleaned with alcohol 
(Isopropyl Alcohol 70%) to reduce skin impedance. Skin preparation and surface electrode 
placement was performed according to the guidelines issued by SENIAM (surface EMG for a 
non-invasive assessment of muscles), (Hermens et al., 2000). The electrodes were attached 
along the line of muscle action and over the area of the greatest muscle bulk during muscle 
contraction and overlaid with elastic bands to minimise movement artefacts as per the 
SENIAM guidelines. These guidelines were followed, which recommended the placement of 
dual electrodes in a distal to proximal orientation over the muscle bulk as shown in figure 
5.22 and table 5.1 with a separation distance of 2cm. 
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Figure 5.22: Dual electrode locations on muscles recommended by SEMIAN guidelines 
(adopted from Noraxon guidelines). 
The gastrocnemius medial head muscle is attached to the proximal and posterior part of 
medial condyle and the adjacent part of the femur, and the capsule of the knee joint. The 
electrodes were attached over the greatest muscle bulk on the medial gastrocnemius 
muscle belly by asking the subjects to plantarflex the ankle during standing (i.e. standing on 
their toes). If this task was not successful subjects were asked to lie on the table with flexed 
knee and with a plantarflexed ankle. The perceived optimal location was then marked with a 
pen for the subsequent electrode attachment procedure. The location of the soleus muscle 
was taken as two-thirds along the line between the medial condyle of the femur to the 
medial malleolus. The electrodes were placed at the most prominent muscle bulk using the 
method of platarflexing and inverting the ankle whilst seated and with the knee flexed (as 
per SENIAM recommendations). Tibialis anterior (TA) muscle bulk position was taken as 
being one-third along the line joining the tip of the fibula and the tip of the medial 
malleolus. The electrodes were again attached over the area of greatest muscle bulk. Rectus 
femoris arises by two tendons: one is a straight head from the anterior inferior iliac spine 
and another one from a groove above the rim of the acetabulum (SENIAM). To locate the 
rectus femoris electrode position, subjects were asked to sit on the table with knees in slight 
flexion and the upper body tilted slightly backwards (table 5.1).  
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Table 5.1: The electrode placement location over six muscles according to SENIAM guidelines 
(Hermens et al 1999). 
Muscle Placement position           Electrode orientation 
Medial Gastrocnemius  
The electrodes need to be placed on 
the most prominent bulge of the 
muscle. 
 
Soleus 
The electrodes need to be placed at 
2/3 of the line between the medial 
condyles of the femur and the medial 
malleolus. 
 
Tibialis Anterior  
The electrodes need to be placed at 
1/3 on the line between the tip of the 
fibula and the tip of the medial 
malleolus. 
 
Rectus Femoris 
The electrodes need to be placed at a 
position 50% along a line from the 
anterior superior iliac spine to the 
superior part of the patella. 
 
 
 
Biceps Femoris 
The electrodes need to be placed at 
50% along the line between the ischial 
tuberosity and the lateral epicondyle 
of the tibia. 
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Erector Spinae 
The electrodes need to be placed at 2 
finger width lateral from the upper 
lumbar spine 
 
 
Biceps femoris long head originates from the distal part of sacrotuberous ligament and the 
posterior part of the tuberosity; the short head originates from the lateral lip of linea 
aspera, the proximal two-thirds of the supracondylar line and the lateral intramuscular 
septum. To attach electrodes to biceps femoris subjects were asked to lie in a prone position 
face down with the thigh down on the table and knees flexed (to less than 90 degrees). This 
meant they could flex their knee with the hand holding the ankle and to resist flexion, which 
allowed the muscle location to be marked with a pen. 
5.4.3 Study Design 
This was a randomised, one visit study design. Test conditions were randomised to minimise 
any carry-over effects, although these have been shown to be minimal in previous rocker 
shoe studies. 
5.4.4 Participants 
Healthy young male subjects were recruited via a poster and information sheet, and after 
giving informed consent, were tested in the gait laboratory. This subject group was chosen 
to minimise data variability in walking patterns which could be caused by previous injury or 
age differences in the test subjects. The exclusion criteria included subjects with a history of 
any orthopaedic or other pathology which could adversely affect ambulation, evidence of 
previous back pain, injury to the lower limbs, leg length discrepancy, or loss in sensation in 
the lower limbs. Subject demographics are demonstrated in the results section. All subjects 
gave informed consent and signed a consent form and were also given a subject information 
sheet. They also understood that they were free to remove themselves from the study at 
any time. 
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5.5 Footwear selection criteria  
 
It was decided to select footwear test conditions which could feasibly be used in clinical 
practise and reflected the designs commonly seen in rocker sole and other outsole designs.  
The literature suggests that footwear features regarding their outsole design may be divided 
into three regions (van Schie et al., 2000); namely: 
1. The back of the heel (or the so-called rearfoot portion); 
2.  The midfoot region, and; 
3. The forefoot region and toes. 
The results of the literature review suggested that alteration to lower limb muscle activity 
can be achived by varying footwear features, which alter the internal and external forces 
acting on the body segments, and therefore alter muscle-tendon properties and muscle 
activity. 
The following outsole features were therefore investigated: 
 The rocker apex angle at the distal (toe) end and the apex position (the position along 
the shoe at which the outsole begins to curve or angle upwards);  
 The relative stiffness of the outsole (the relative amount of force required to bend the 
shoe or deform it); 
 The heel height (and also the overall pitch of the shoe); 
 The heel curve (otherwise known as a rolled or chamfered heel) (figure 5.23). 
 
 
 
Figure 5.23: An illustration of the footwear features analysed in this thesis. 
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Most of the research found in the literature has investigated ambulation using single designs 
of footwear rocker profiles and most papers using this approach have not demonstrated any 
evidence of systematic changes to the human musculoskeletal gait pattern. It was thought 
that by varying one parameter at a time for each design in this study, the interpretation of 
the resulting gait changes would be more efficiently analysed and obvious than previously. 
Therefore, in this research, each rocker sole was modified with the intention to enable 
identification of the causes and effects of altering specific design parameters on the primary 
outcome measures. There were fifteen footwear profiles tested which are described in table 
5.2. Illustrations for each rocker sole profile test conditions are shown in figure 5.26.  
 
Table 5.2: Footwear specifications. 
Shoe Heel 
Height 
(HH) 
Sole Stiffness (SS) Rocker Apex 
Position (AP) 
Rocker Toe 
Angle 
(TA) 
Heel Curve 
(HC) 
Rearfoot heel height  
1 Heel Height 1.5 cm stiff sole 62.5% 15° No curve 
2 Heel Height 2.5 cm stiff sole 62.5% 15° No curve 
3 (HH3) (control)  3.5 cm stiff sole 62.5% 15° No curve 
4 Heel Height 4.5 cm stiff sole 62.5% 15° No curve 
5 Heel Height 5.5 cm  stiff sole 62.5% 15° No curve 
Rocker profile stiffness  
8 Sole stiffness 3.5 cm medium flexibility 62.5% 15° No curve 
10 (SS) (control) 3.5 cm stiff sole 62.5% 15° No curve 
11 Sole stiffness 3.5 cm flexible sole 62.5% 15° No curve 
Apex position  
9 Apex position 3.5 cm stiff sole 55% 15° No curve 
10 (AP) (control) 3.5 cm stiff sole 62.5% 15° No curve 
12 Apex position 3.5 cm stiff sole 70% 15° No curve 
Apex angle   
14 Toe Angle 3.5 cm stiff sole 62.5% 10°  No curve 
15 (TA2) (control) 3.5 cm stiff sole 62.5% 15°  No curve 
15 Toe Angle 3.5 cm stiff sole 62.5% 20°  No curve 
Heel curve    
16 Heel Curve 3.5 cm stiff sole 62.5% 15° Small curve 
17 (HC)(control) 3.5 cm stiff sole 62.5% 15° No curve 
18 Heel Curve 3.5 cm stiff sole 62.5% 15° Big curve 
Baseline condition   
19 Standard  2.5 cm Medium flex 62.5% 15° No curve 
20 Barefoot - - - - - 
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5.6 Procedure used to adapt shoes with rocker sole profiles 
High street footwear was obtained for use in the study. The shoe selected was a four-hole 
tie Gibson-styled shoe with semi-brogue punching, padded collars, synthetic lining and a 
moulded polyurethane sole and heel unit. All were size eight adult UK fitting. The shoes had 
an initial heel height of 2.5cm, a toe box depth of 30mm and a forefoot width suitable for 
use by people with an average forefoot width (figure 5.24). 
 
Figure 5.24: The Standard high street shoe (size 8 adult UK) which was used as the base 
structure for adaptation. 
To manufacture the shoe test conditions, the waist area of the shoe (the area between the 
breast of the heel and the tread point of the sole where the sole contacted the ground with 
the heel also in full contact) was initially roughened slightly to provide an adherent surface, 
and filled in with sheets of 10 mm thick high density plastazote (HDP), (Algeo UK Ltd, 
Liverpool UK). This material is a high density expanded polyethylene which is ideally suited 
to footwear adaptation. It is mouldable at a temperature of 120°C and is easily ground to 
provide a flat or curved surface. In addition, it does not compress easily under load which 
makes it ideal for the addition to the base of shoes for such adaptations such as external 
raises and rocker profiles. The HDP material and the shoe surface were both brushed with 
contact adhesive and then placed under ultraviolet light heaters to activate the adhesive 
and to heat up the HDP to make it flexible. Once the HDP was flexible enough it was applied 
underneath the waist area of the shoe and left to cool. 
Once cool and adhered to the waist area, it was ground down on a flat grinder to make a 
flush surface with the base of the heel and the sole. This then facilitated the addition of 
extra layers of 25 mm HDP to be adhered to this base shape and which could be ground to 
the desired shape required according to the design of rocker sole selected.  
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The rocker profile designs utilized are shown on the footwear specification table (table 5.3). 
The rocker profile and its orientation to the pitch and plantar shape of the un-adapted shoe 
was drawn on the HDP using a template derived from a scale drawing generated from a 
computer programme which accounted for apex position, heel height, toe angle and heel 
shape. Following this, they were all ground according to the line structure drawn on the 
HDP.  The final thickness of the added material made the rocker sole rigid enough to allow 
the rocker profile to act as a rigid shape. 
Once the shoe was appropriately adapted with the rocker sole profile a final layer of 1 mm 
vibram material was adhered to the base of the rocker sole to ensure that the surface in 
contact with the ground was non-slip and also to ensure the plantar surface did not wear 
down. 
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Figure 5.25: Sole and heel adaptation procedure. 
 
The footwear test conditions which were used in this research are illustrated in figure 5.26. 
 
137 
 
 
1.5 cm heel  
1.5 cm heel 
 
2.5 cm heel 
 
2.5 cm heel 
 
Control shoe, 62.5% Apex position, solid, 15° 
Toe angle 
 
Control shoe, 62.5% Apex position, solid, 
15° Toe angle 
 
4.5 cm heel  
4.5 cm heel 
 
5.5 cm heel  
5.5 cm heel 
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10° Toe angle 
 
10° Toe angle 
 
20° Toe angle 
 
20° Toe angle 
 
Medium flexible sole  
Medium flexible sole 
 
Flexible sole  
Flexible sole 
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Half heel curve 
 
Half heel curve 
 
Full heel curve 
 
Full heel curve 
 
  
Standard shoe before adaptation 
 
Three-curve (Hutchins, 2007) 
 
 
The data for the three-curve, standard shoe 
and barefoot is not demonstrated in this 
PhD, however there is an intension to 
publish in the journals. 
Figure 5.26 Test footwear conditions which were used in this research. 
 
The comparison results for three-curve and standard shoe without adaptation, which are not 
presented in result section are planned to be published in journals. 
5.7 Gait laboratory testing procedure  
The gait laboratory was prepared before each testing session to ensure that all of the 
equipment was working correctly. An acceptable calibration of the Qualysis was performed, 
and the timing gates were tested. It was ensured that all the batteries required for the 
walking test equipment were fully charged that the EMG system was synchronised with the 
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gait laboratory software, and that the trigger was able to start simultaneous kinematic, 
kinetic and EMG data collection.  
Retro-reflective markers were prepared with double-sided tape, and elastic bandages to 
bind on top of the marker clusters were made available. EMG electrodes, shaving razors, 
EMG gel and alcoholic wipes, cleaning wipes, scissors, a pen, and towels were all made 
ready in preparation for testing.  
On attendance at the gait laboratory, each participant was familiarised with the testing 
procedure and agreed to undertake the gait laboratory test protocol by signing a consent 
form. Once everything was prepared, each participant was then instructed to change into 
tight fitting shorts (or swimming underwear). The ambient temperature in the laboratory 
was adjusted to be comfortable for each participant. The testing procedure and walking 
direction was explained to each participant, who was then asked to repeatedly walk over 
force plates where recording was to be performed to assess their walking speed and to 
ensure it was within the envelope set of 5 kilometres per hour ± 5%. The walking speed was 
checked using the timing gate system. Once the participants’ speed was proven to be 
constant, the starting point of gait initiation was adjusted to make sure that they stepped in 
centre area of the first right hand platform in the direction of travel with the right foot first 
without looking down. Subjects were asked to look straight ahead whilst walking. It was 
possible to record two gait cycles for most of the walking trials. The walk was adjusted so 
that the right foot struck the first force platform, followed by a left heel strike on the next 
platform; meaning a second right heel strike could then occur on the subsequent right hand 
platform (denoted number 1) as show in figure 5.27. 
 
Figure 5.27: Force plates used to record GRF showing the subjects’ walking direction. 
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The walking trials confirmed symmetry between the left and right lower limb data for all the 
subjects as the individuals were healthy. Therefore, only the right side was eventually 
chosen for analysis. In addition, there were only eight EMG channels available, and six of 
them were already used for the right side lower limb and the back muscles.  
After familiarisation, SENIAM recommendations were used to locate and mark the targeted 
muscles for surface EMG recording for the right leg and the lower back. The subject’s skin 
surface was prepared to reduce electrical resistance by shaving the skin surface of the 
muscle belly area, and removal of dead skin cells was performed using gel (Nuprep tm ECG 
& EEG) and alcohol (Isopropyl Alcohol 70%) (Sousa and Tavares, 2012). 
Once this was done, participants were asked to don the neoprene vest to which the 
Noraxon TeleMyo™ 2400T G2 EMG system was attached posteriorly with six numbered 
electrode leads connected. The EMG for each muscle was collected by an eight-channel unit 
at a frequency of 3000 Hz. The measurement electrodes were placed over the muscle belly 
of the medial gastrocnemius, soleus, tibialis anterior, rectus femoris, biceps femoris and 
erector spinae muscles according to the quoted anatomical references, and positioned with 
adhesive tape (as per SENIAM recommendations).  
Each electrode was marked with a number to ensure to which muscle it belonged for the 
further data processing. Each subject wore cushioned socks manufactured by Nike to make 
sure blisters did not form during the testing procedure, as this had occurred during the pilot 
study. Holes were made in the socks to enable the reflective markers to be placed directly 
onto the skin covering the first and fifth metatarsal heads and the superior aspect of the 
calcaneus. Participants were then asked to wear the control shoe to which the holes had 
been made to ensure that these holes matched the position of circular rings depicting the 
position of the plastic base onto which the reflective markers were placed which had been 
drawn on the foot with a pen. The next step was to place anatomical markers. The total 
amount of markers was 46; however additional markers were placed on the arms and shoe 
uppers. The shoe uppers were altered by making holes in the uppers at strategic places and 
markers were placed on the skin of the foot which protruded through these holes cut in the 
uppers, as detailed in section 5.3.3.1. All the markers and electrodes were positioned by the 
author.  An assistant helped to press the trigger and to name the trial data acquired by 
Qualysis during the walking trials.  
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With the markers and electrodes in situ, the EMG system was then tested to ensure full 
functionality. Participants were asked to stand up on their toes to ensure that the electrodes 
were accurately positioned over the muscle bellies of medial GAS and SOL, and that an 
adequate signal was being recorded by the data acquisition system. They were then asked 
to dorsiflex the foot to check the electrodes were correctly positioned over the tibialis 
anterior muscle (TA), and also asked to bend their knees to check that the muscle firing for 
the more proximal leg muscles were being detected adequately. All the connecting leads 
were arranged to be appropriately positioned without interfering with gait and were taped 
to the leg and torso to reduce motion artefacts.  
5.7.1 Static tests 
Static tests were performed for each subject and for each footwear condition prior to 
undertaking the walking trials in the gait laboratory. Participants stood on force platform 
number 3 with their feet parallel to each other and then stepped onto force platform 
number 2 to ensure that the static test was of good quality and that all the markers were 
visible for data analysis. Each subject was asked to stand up straight with their knees fully 
extended, their feet pointing forward towards the walking direction and with both legs 
symmetrically positioned.  
5.7.2 Dynamic tests 
Barefoot recording was undertaken after the static capture and at the beginning of the 
testing. Ten walking trials of acceptable quality were recorded and saved for further analysis 
for each subject. Once data collection for barefoot was finished, one of the shoes used was 
randomly selected as a test condition and donned, and the retro-reflective markers were 
repositioned again on the area where the circles had previously been drawn on the foot and 
through the holes cut in the uppers of the shoes. The testing order for each shoe test was 
randomised for all subjects throughout their walking trials. After donning each pair of shoes, 
a static test was recorded and then a small number of walking trials were performed to 
monitor the walking speed for repeatability and to identify the optimal gait initiation point 
before walking data were recorded. It typically took five minutes to record the walking trials 
and five minutes to replace the shoes for each footwear test condition and to ensure that 
143 
 
the leg muscles being tested were not getting fatigued. A five minute period of habituation 
was given for each test condition, and also a number test runs were performed for each 
shoe test condition to ensure each subject could walk confidently for each run by striking 
the force plates in the correct area and also maintaining gait speed within the set time 
parameters using the timing gates. 
At the end of the testing session the subject’s weight and height was measured with the 
clinical equipment available in the gait laboratory. 
5.7.2.1 Walking speed 
Various sources from the literature and scientific articles for the effect of walking speed on 
kinematic, kinetic and EMG data for lower limb suggest that it has a significant impact on 
these changes (Kirtley et al., 1985, Chen et al., 1997, Holden et al., 1997a, Waters and 
Mulroy, 1999, Hof et al., 2002, den Otter et al., 2004, van Hedel et al., 2006, Byrne et al., 
2007, Chiu and Wang, 2007, Stoquart et al., 2008, Chung and Wang, 2010, Sousa and 
Tavares, 2012). 
It was therefore decided that the best method for kinematic, kinetic and EMG data 
collection for this study was to closely control walking speed during the gait laboratory 
trials. Previous studies have demonstrated that speed of walking effects gait patterns and 
EMG data, and would therefore have an effect on the results obtained with regards to 
muscle properties, which were based on Qualisys kinematic motion capture data. Chung and 
Wang (2010) conducted research to investigate the gait performance of subjects aged 
between 20-60 years of age utilising walking speeds of 80%, 100%, 120%, 140% of their 
preferred walking speed. The most significant alterations to gait parameters were noted 
once subjects attained walking speeds greater than 20% of their preferred walking speed.  
Holden et al (1997a) demonstrated that if subjects walk at lower natural speed by a factor of 
25%, it results in reduced knee flexion and lower knee moments. Additional research, which 
investigated the effect of varying walking speed and the effects of additional weight on 
lower limb muscles and gait, has demonstrated that significant changes in joint kinematics 
for healthy subjects at walking speeds slower than 3 km/h (kilometres per hour) versus the 5 
km/h figure (van Hedel et al., 2006) can occur. 
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Figure 5.28: Influence of walking speed on joint trajectories for (a) hip, (b) knee and (c) ankle 
joint at 10 different walking speeds (van Hedel et al., 2006). 
Chiu and Wang investigated the effect of speed and gender on muscle activity, joint motion 
in lower extremity plus GRF values and demonstrated that walking speed had a significant 
influence on the perceived extension of the whole body, as well as the buttock, rear thigh, 
front thigh and rear shank areas. An increased walking speed caused significant increases in 
the muscle activity of erector spinae, bicepc femoris, and medial gastrocnemius, as well as 
GRF values as shown in figure 5.29. 
 
Figure 5.29: The gait speed effect on (a) EMG activity, (b) vertical ground reaction force (Chiu 
and Wang, 2007). 
One recent study of the effect of gait speed on muscle patterns and magnitude during 
stance phase on thirty-five healthy individuals for gastrocnemius medialis, bicepcs femoris 
and rectus femoris muscles showed significant changes due to walking speed. In general, 
muscle activity was significantly higher at + 25% of self-selected walking speed and 
significant lower at -25% of self-selected walking speed (Sousa and Tavares, 2012). 
Most adults prefer to walk at a speed of between 3600 and 6012 metres/hour. The average 
walking speed observed by Walters and Mulroy (1999) for adult pedestrians aged between 
20-60 years old (who were unaware they were observed) was 4932 meters per hour. The 
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participants who volunteered for this thesis were young, aged 25.3 ± 2.73 years with an 
average height of 1.74 ± 0.06 m, and were healthy. Therefore, the ideal selected walking 
speed for all subjects to attain during the walking trials in this study was chosen as 5 
kilometres per hour. The evidence demonstrates that walking speeds within a range of ±5% 
have no significant comparative effects on knee and ankle kinematics or EMG readings for 
lower extremities during stance phase. Therefore, the acceptable speed range within the 
trials was set at 5km/h ± 5% for this research. 
5.7.2.2 The timing gates 
Timing gates were utilised to ensure each walk taken with each footwear test condition was 
performed within set time parameters. A short period of habituation was allowed for each 
subject prior to walking in each test condition. No evidence was found in the literature of 
the existence of carry-over effects when walking with rocker-soled footwear. The timing 
gates utilised were manufactured by Brower SpeedTrap II (figure 5.30) and gave an audible 
sound when passed through by the subject both on commencement and completion of the 
walk in question. 
 
Figure 5.30: The Brower SpeedTrap II timing gate system. 
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The speed of walking was shown using the remote controller of the system. If a walk was 
seen to not be within the prescribed limits of time, then further walks were undertaken to 
ensure an adequate number of walks for subsequent analysis were performed. 
 
5.7.2.3 Gait laboratory synchronisation equipment setup 
Qualisys Track Manager (QTM) software and hardware had complete integration with the 
Noraxon’s wireless EMG system. All the basic settings below were selected: 
 The muscle channel name; 
 The sampling rate; 
 The channel output; 
 Trigger synchronisation; 
 Device setup and synchronisation check. 
The EMG settings for EMG devices were set using the QTM software and all data were 
captured directly to the Qualisys software. Only one single desktop computer was used for 
integration. The EMG integration was added to the existing integration with four force 
plates. It was possible to start Qualisys recording EMG, force and motion capture data from 
the QTM software. An external trigger was used to control the start of recording. The basic 
experimental setup for the gait analysis and synchronisation is shown on figure 5.31. The 
EMG capture frequency was set at 3000 Hz. Motion data capture frequency was set at 100 
Hz and the force plate frequency for all plates was set at 100 Hz. 
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Figure 5.31: The experimental set-up for gait analysis. 
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5.8 Data analysis 
5.8.1 Data processing overview 
Kinematic, kinetic and EMG data were collected and stored by Qualisys Track Manager 
(QTM) software. All markers were labelled and checked for any errors in QTM. Thus use of 
numerous cameras meant that all markers were visible for each frame during motion 
capturing for the most part. Typically, there were no any gaps at all and if there were 
missing gaps in the tracking data, they were reconstructed within 10 frames by system 
default. Static trials were prepared for each footwear condition and they were exported 
within 1-2 frame range. Motion data were exported with at least 10 frames before heel-
strike on the force platform. The exportation format was C3D for the further processing in 
Visual3D software. All data were then imported to Visual3D. Static models were built for 
each footwear condition and assigned with motion files. Each static model for each subject 
was scaled with mass and height. Kinematic data were smoothed using a 4th order 
Butterworth low-pass filter with a cut off frequency of 6 Hz and kinematic data were filtered 
with the same filter of frequency 25 Hz. Once it was finished, automatic gait events were 
generated in pipeline and then checked to be correct for each trial. Following this, EMG data 
were processed using a linear envelope technique and a moving root mean square 
technique (RMS). Kinematic, kinetic and EMG data were then analysed and presented in the 
reports. To export data to OpenSim, one barefoot static model was used for all motion files. 
Five trials per shoe condition were exported with a low-pass filter of 12 Hz being applied. 
Once it was finished all data were imported to OpenSim and the following parameters were 
analysed for GAS, SOL, TA, RF, BF and ES muscles: 
 Fibre length, tendon length, muscle-tendon length; 
 Fibre and tendon lengthening velocities and acceleration; 
 Fibre force, tendon force; 
 Muscle moment arm. 
Once all analysis was finished for each subject, it was then exported to an ASCI file and 
imported back to Visual3D for further definition of gait event and normalisation process. 
Once all data analysis was completed in Visual3D, it was exported to ASCI format for the 
further processing in Excel and statistical analysis in SPSS. The mean values were calculated 
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in Excel. Each mean value was obtained for each trial separately and the average of the 
means were calculated for each footwear condition and subject. This was done because the 
mean value for each line can be different in time/frame scale, therefore the mean value for 
the same point in time might be different for each trial as shown in the figure 5.32.  
 
Figure 5.32: The example of mean value calculation technique. 
5.8.2 Kinematic data processing 
The Oqus 3+ system incorporates Qualisys Track Manager (QTM) software, which handled 
the motion capturing process. The QTM software allowed the use of the following features 
for this research:  
 2D / 3D / 6DOF data tracking; 
 Marker / high-speed video data; 
 Real-time streaming; 
 Automatic marker identification; 
 Marker masking; 
 Passive markers; 
 Supported all Oqus 3+ cameras, Noraxon EMG system and AMTI force plates to be 
synchronised. 
The kinematic, kinetic and EMG data were collected simultaneously and captured by QTM 
software and kept in the single trial which could be exported for further analysis by 
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Visual3D. An automatic identification of markers (AIM) function was utilised to expedite 
data processing. In order for this method to be valid, the first walking trial was labelled to 
allow the rest of the trials be automatically labelled afterwards. The data were subsequently 
inspected for any marker labelling errors and corrected. Numerous cameras were used for 
this research, and therefore most of time, all the dynamic markers were visible throughout 
the measurement volume during data recording. However, QTM allows the user to pre-
define gap-missing markers and fill with acceptable level of ten frames. These data were 
then exported via C3D files at least 10 frames before the heel strike on the force platform to 
be analysed by Visal3D software. 
5.8.3 Visual3D 
Visual3D is designed and developed by C-Motion. Inc (Maryland, USA), and is one of  
Qualisys’ global, strategic partners for research application. This software can process 
complex motion capture data and analogue signals (e.g. force platforms and EMG signals) 
and provides informative reports. For this study, Visual3D was used for: 
 6 degrees of freedom modelling; 
 Defining gait event from heel strike (HS) to toe off (TO) for every trial for data analysis 
during stance phase; 
 Filtering/smoothing data and normalising data for standard biomechanical analysis; 
 EMG analysis; 
 Kinematic and kinetic data analysis; 
 Exporting kinematic data to OpenSim software; 
 Muscle property data synchronisation with OpenSim; 
 Report design; 
 Exporting kinematic, kinetic, EMG data and muscle property data to Excel. 
5.8.3.1 Modelling 
The Visual3D biomechanical model defines each joint as having six degrees of freedom. The 
kinematics of the model were calculated by determining the transformation from the 
recorded tracking targets to the pose of the model using an optimal approach (Cappello et 
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al., 1997). The trunk, pelvis, thigh, shank and foot were modelled in Visual3D as rigid 
segments, which were linked with joints. Each segment is specified by a proximal endpoint, 
which is defined as being the closest point to the centre of mass and the distal endpoint, 
which is further away. The following picture illustrates a segment definition, and shows the 
terminology used for defining segments in anatomy and Visual3D (figure 5.33). 
 
Figure 5.33: Naming standards and conventions in Visual3D. 
The segmental coordinate system in visual3D is defined by the location of the proximal 
and/or distal ends of the segment and lateral/medial aspects. The coordinate system of the 
segment in Visual3D shows at the proximal end of the joint centre as shown in figure 5.33.  
 
In section 5.3, the anatomical marker placements method utilised was explained in detail, 
and also marker placement for building up the segments in Visual3D. The picture below 
illustrates the full body model which was built in Visual3D using this method (figure 5.34). 
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Figure 5.34: An example of the full body model in Visual3D used for this research. There 
were additional markers on the arms, however data acquired from these were not included 
in this research. 
One limitation to the model used was that the foot was modelled as one rigid segment and 
therefore, did not distinguish between the ankle and subtalar joints. 
5.8.4 Signal Processing in Visual3D 
5.8.4.1 Kinematic and kinetic data 
Filtering is an important consideration with human movement data. The cut-off frequency 
of the filter can have a significant effect on the shape of the marker trajectory line in three-
dimensional movement. If the frequency were to be set too low, the curve may become 
over-smoothed and peaks could be flattened. For example, if the ankle angle curve were to 
change shape and duration during loading response, too low a filter value could cut out too 
much data and useful information (such as muscle-tendon length, velocity, muscle moment 
arm etc.) and could therefore be partially lost.  If the cut-off frequency used is too high, the 
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curve will contain noise. Walking  data are typically filtered at 6 Hz, and running at 8 to 12 Hz 
(Payton and Bartlett, 2008).  
Three pilot studies were conducted for this thesis with at least 10 trials being collected for 
each footwear condition. The results showed that a filter with a 6 Hz cut-off frequency, cut 
the maximum ankle range of motion (ROM) during 0-20% of stance phase by 17% for 
different shoes and a 12 Hz filter reduced it on average by a figure of 2%.  Therefore, a 12 Hz 
filter was chosen to be used on all raw kinematic data. 
 
Figure 5.35: Filtration level example of the effect on maximum range of motion loss during 0-
20% of stance phase for single trials for 12 mm rocker shoe and control shoe, which were 
used in the pilot study. 
Table 5.3 below demonstrates a pilot study example for kinematic data of maximum ankle 
angle range of motion smoothing levels with different cut-off frequencies for three different 
shoes during 0-20% of the stance phase.  
Table 5.3: Filtration levels effect on maximum ankle angle range of motion. 
Shoe type Cut-off frequency 
0-20% stance 
phase 
Cut-off frequency 
0-20% stance 
phase 
Cut-off frequency 
0-20% stance 
phase 
12 mm rocker shoe 0 Hz 6 Hz 12 Hz 
Max ankle ROM (deg.)  12.6 10.5 12.4 
Reduction in ROM 0% 17% 1% 
Control shoe 0 Hz 6 Hz 12 Hz 
Max ankle ROM (deg.)  11.9 9.6 11.7 
Reduction in ROM 0% 19% 2% 
Scholl shoe 0 Hz 6 Hz 12 Hz 
Max ankle ROM (deg.)  12.3 10.3 12.3 
Reduction in ROM 0% 16% 0% 
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Kinetic data for the force platforms is usually filtered with a 15 or 25 Hz low pass filter. A 
cut-off frequency of 25 Hz was used for this research. 
5.8.4.2 EMG analysis in Visual3D 
Visual3D software processes electromyography signals, which were stored as analogue data 
in Qualisys motion capture trials and within the exported *.c3d file.  
Raw EMG signals can be processed in numerous ways and the most common technique is 
use of the average rectified EMG, Root Mean Square (RMS) or Linear Envelope (Payton and 
Bartlett, 2008, Winter, 2009, Konrad, 2005). All these techniques are recognised as 
appropriate processing methods by researchers. Some authors have claimed that they 
prefer the RMS evaluation technique over other EMG analysis techniques for the reason 
that the RMS is a measure of the power of the signal and has a clear physical meaning; so 
that a low level isometric contraction shows less variability than the average rectified value 
(ARV) when calculated over successive time windows. The RMS method has the potential to 
detect signal changes that could be masked by the greater variability of the ARV (Payton and 
Bartlett, 2008, De Luca, 1997). The RMS and linear envelope techniques were therefore 
tested to analyse EMG data. The typical settings for the RMS technique in Visual3d were: 
 A high pass filter with 50 Hz cut-off was applied (surface EMG signals typically have a 
frequency content between 50 and 500 Hz. These signals may have a DC bias. It is 
common to apply a high pass filter with a cut-off frequency of 50 Hz to EMG signals 
prior to any other processing.); 
 A low pass filter of 500 Hz (this can only can be used if the EMG signal frequency is 
greater 1500 Hz) was used to remove electrode and equipment noise; 
 Moving RMS with 100ms window was used (to detect rapid changes in muscle activity in 
a short distance within a time frame of 100ms); 
 A 4th order Butterworth low-pass filter with a cut off frequency of 8 Hz was applied to 
smooth the resulting signal. 
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For the linear envelope technique: 
 A full wave rectified EMG signal; 
 The 4th order Butterworth low-pass filter with a cut off frequency of 8 Hz was applied 
to smooth the resulting signal. 
Both methods showed no significant change in the shape of the signal during the pilot study. 
However, the RMS technique demonstrated more power in the signal and therefore the 
moving RMS analysis technique was used in this research to process EMG data, (figure 5.36).  
 
Figure 5.36: Example of Medial Gastrocnemius EMG analysis  from the pilot study using the 
RMS and linear envelope techniques for different shoes during stance phase. 
5.8.4.3 EMG normalisation  
Comparison of the EMG signals between footwear trials and participants can be difficult. 
The EMG normalisation technique, which has been used extensively, is the maximum 
voluntary contraction. This involves recording a maximal isometric contraction and relating 
the EMG data subsequently obtained to this value. However, this technique has the 
drawback that it is unknown if the subject did indeed give their maximal possible 
contraction.. In addition, it is also difficult to compare and relate concentric and eccentric 
contractions to isometric contractions which produce different EMG signals (Richards, 
2008). Therefore, another technique was used to normalise the EMG data obtained. 
All participants’ EMG data were collected within a 2-hour period. Within this time, each five-
minute duration of walking was followed by five minutes of rest to minimise muscle fatigue. 
The baseline shoe was the control shoe. All data were compared to the baseline shoe to 
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enable the effect of small changes in footwear features to be detected. The averaged values 
of all control EMG signal values were calculated and scaled to 0-100% signal (from minimum 
to maximum). 
5.8.5 Modelling requirements for OpenSim from Visual 3D 
The following model requirements were completed before exporting data to OpenSim: 
 The Visual3d model used for OpenSim output must include the right foot (RFT), right 
shank (RSK), right thigh (RTH), left foot (LFT), left shank (LSK), left thigh (LTH), pelvis 
(RPV) and a Thorax/Ab; 
 The positions denoting the proximal end the thorax segments were created at the exact 
same location as the proximal end of pelvis and if the coordinate system of trunk was 
different from the rest of the segments it was altered to be exactly the same to avoid 
trunk segment being 180 degrees out of phase (i.e upside down); 
 The coordinate system of pelvic motion in Visual3D is different from OpenSim, and 
therefore a virtual lab (named as the v3d_lab) was created with +Y direction of walking, 
+Z axis in vertical direction and +X axis pointing to the right to be able to use the correct 
motion data and model in OpenSim. 
5.8.6 Exporting data to OpenSim 
Visual3D exports an OpenSim motion *.mot file which is compatible with gait23*.osim 
models in OpenSim software. Motion file bypasses the scaling and Inverse Kinematics (IK) in 
OpenSim. Visual3D’s writes OpenSim comparable .mot files, which are based on Visual3D’s 
own inverse kinematics algorithm solutions which are based on the implementation by Lu 
and O'Connor (1999). A three-stage process was necessary to achieve that: 
 During exportation, Visual3D created the scale factors, which scaled the OpenSim gait 
model (mass and height) to the Visual3D static calibration model. These scale factors 
were written to a special OpenSim scale set file named Visial3d_Scale_ScaleSet.xml; 
 Visual3D used IK to fit the scaled OpenSim gait model to the Visual3D static calibration 
model; 
 Visual3D then used IK to fit the gait data to the newly calibrated model. 
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Inverse kinematics is the process of determining the parameters of a jointed flexible object 
(a kinematic chain) in order to achieve a desired pose (Visual3D guidelines). 
The IK steps through each time frame of experimental data and positions the model in a 
pose that ‘best matches’ experimental marker and coordinate data for that time step. This 
‘best match’ is the pose that minimizes a sum of weighted squared errors of markers and/or 
coordinates. Obtaining accurate results from the IK is essential for using OpenSim (OpenSim 
help guidelines). 
5.8.7 OpenSim 
In the 1990s Delp and Loan introduced a musculoskeletal modelling software that allows the 
user to create, alter and evaluate models of many different musculoskeletal structures 
(Delp, 1990). This software is used  extensively to create computer models of 
musculoskeletal structures and to simulate movements (Delp et al., 2007). Models of the 
lower and upper extremities have been developed to examine the following biomechanical 
parameters in gait laboratory testing: 
 Studying how surgical changes in musculoskeletal geometry (e.g. origin-to-insertion 
path) and muscle-tendon parameters (e.g. optimal muscle-fibre length and tendon slack 
length) can affect the moment-generating capacity of the different muscles on the 
human body(Hoy et al., 1990b); 
 Examining the biomechanical consequences of surgical procedures including tendon 
surgeries, osteotomies and joint replacements (Delp and Maloney, 1993, Delp and 
Zajac, 1992, Delp et al., 1995, Erdemir and Piazza, 2004); 
 The lower-extremity models have been used to estimate muscle-tendon lengths, 
velocities, moments arms during normal and pathological gait (Arnold et al., 2000, 
Arnold et al., 2006, Jonkers et al., 2006, Kimmel and Schwartz, 2006); 
 To investigate the causes of abnormal gait (Piazza and Delp, 1996, Kerrigan et al., 1998, 
Higginson et al., 2006).  
OpenSim is an open-source platform for modelling, simulating and analysing the 
neuromusculoskeletal system. It includes low-level computational tools that are 
invoked by an application (figure 5.37). 
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Figure 5.37: A screenshot from OpenSim, which includes a musculoskeletal model of the 
lower extremities. 
5.8.7.1 The OpenSim model 
The Gait2392 model is a three-dimensional, 23 degree of freedom computer model of the 
human musculoskeletal system was used for muscle property data analysis. It is also 
compatible with Visual3D *.mot exported files and scaling procedure. The model was 
created by Darryl Thelen (University of Wisconsin-Madison) and Ajay Seth, Frank C. 
Anderson, and Scott L. Delp (Stanford University). It features 92 musculo-tendon actuators 
to represent 76 muscles in the lower extremities and torso (figure 5.38). 
 
Figure 5.38: The Gait2392 musculoskeletal model in OpenSim. 
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The musculoskeletal model describes not only the geometric relationships of the muscles 
and bones (the musculoskeletal geometry), but also the muscle-tendon parameters and it 
consists of coordinates for muscle attachments and a model for each muscle tendon 
compartment.  
The model’s bone geometry of the shank and foot were adopted from (Stredney, 1982).  
The model of the lower extremity consists of seven rigid-body segments:  pelvis, femur, 
patella, tibia/fibula, talus, foot (which includes the calcaneus, navicular, cuboid, cuneiforms, 
metatarsals), and toes. Reference frames are fixed in each segment (Delp, 1990). Figure 5.39 
shows location of the body-segmental reference frame. 
 
Figure 5.39: The coordinate systems of the bone segments (Delp, 1990). 
 Pelvis: The pelvic reference frame is fixed at the midpoint of the line connecting the 
two anterior superior iliac spines; 
 Femur: The femoral frame is fixed at the centre of the femoral head; 
 Tibia: The tibial frame is located at the midpoint of the line between the medial and 
lateral femoral epicondyles; 
 Patella: The patellar frame is located at the most distal point of the patella; 
 Talus: The talar frame is located at the midpoint of the line between the apices of the 
medical and lateral malleoli; 
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 Calcaneus: The calcaneal frame is located at the most interior, lateral point on the 
posterior surface of the calcaneus;  
 Toe: The toe frame is located at the base of the second metatarsal. 
5.8.7.2 Ankle, subtalar, and metatarsophalangeal joints 
The ankle, subtalar and metarsophalangeal joints are represented as a frictionless revolutes 
as shown in figure 5.40. 
 
Figure 5.40: The ankle (ANK), subtalar (ST) and metatarsophalangeal (MTP) joints with axes 
and orientation (Delp, 1990). 
Each foot is modelled using two segments: a hindfoot and the toes. The hindfoot joins with 
the shank via a two degrees of freedom (dof) joint and the toes joins with the hidfoot via a 
one degree of freedom hinge joint. The metatarsophalangeal axis is rotated by – 8 degrees 
on a right-handed vertical axis to minimize disarticulation of the joint. In this research, the 
entire foot segment was rigid due to the need to place marker positions through holes 
drilled in shoe uppers. The foot segment was used as a single rigid body in this research. 
5.8.7.3 Muscle geometry  
The paths of the muscles were based on geometric data (i.e., musculo-tendon origin and 
insertion sites) as reported by (Delp, 1990). In all case, tendons were assumed to attach at a 
point to the bone. The muscle-tendon actuators in the lower extremity portion of the model 
were defined on the anatomical landmarks on the bone surface models. In some cases, for 
example the soleus, origin and insertion landmarks are sufficient for describing the muscle 
path. In other cases, where muscle wraps over bone or is constrained by retinacula, 
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intermediate points or “via” points are introduced to represent the muscle path more 
accurately. The number of points activated for the muscle can depend on body position. 
Straight-line segments were used whenever an actuator can run freely from one point to 
another (for example SOL muscle), with intermediate or via points introduced to model 
contact of the muscle with bony prominences. Cylinders were used to model the path of 
muscle when the muscle wraps completely around the underlying bone and/or other 
muscles (for example a medial and lateral GAS cylinder was utilised to simulate the tissues 
swapping around the medial and lateral condyles of the femur). This was designed because 
by using a via-cylinder rather than a series of via-points, muscle moment arms at some of 
the joints can be represented more accurately (Anderson and Pandy, 1999). The parameters 
for the cylinders at the knee were estimated by inspecting MR images of the hamstrings and 
gastrocnemius muscles as reported by (Reicher, 1993). 
5.8.7.4 Model Anthropometry  
The model mass and inertial properties for all segments, except for foot segment, were 
based on average anthropometric data of the five male subjects who participated in that 
study (age 26 ± 3 years, height 177 ± 3 cm and weight 70.1 ± 7.8 kg). All data were recorded 
according to the methods described by (McConville et al., 1980). The mass, position of the 
centre of mass and principal moments of inertia for each segment in the model except for 
foot segment were calculated by averaging the anthropometric data for the subjects 
(Anderson and Pandy, 1999).  
The mass of the rearfoot and toes in the models were similar to the mass of the whole foot 
reported by (McConville et al., 1980) plus the mass of a size 10 tennis shoe. 
 
5.9 Properties and models of muscles (Muscle-tendon dynamics) 
A muscle-tendon unit is defined by specifying its geometry and force generating properties. 
Muscle force is transmitted to the skeleton via tendon. The properties of muscle and tendon 
were integrated in OpenSim into a model of the muscle-tendon complex (muscle-tendon 
actuator). In the model, muscles were considered as a set of equally-long fibres that were in 
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series with the tendon. The fibres are in the line with the tendon, as in a parallel-fibred 
muscle, or at an angle (the pennation angle, α to the tendon) - figure 5.41 
 
Figure 5.41: Relationship between muscle fibres and tendon in a pennated muscle. 
 Muscle fibres (shaded region) lie in parallel, have the same length and are oriented at an 
angle α to the tendon axis of pull. Tendon consists of a component internal (i.e., the 
aponeurosis) and external to the muscle belly (Zajac, 1989, Hoy et al., 1990a). 
The static properties of tendon were included in the muscle-tendon model. The force-length 
property of the tendon were determined by specifying peak active force 𝐹𝑜
𝑀  and its tendon 
slack length 𝑙𝑠
𝑇 (Zajac, 1989). Tendon length was considered to consist of both internal and 
external portions and it included the length of internal and external tendon. The length of 
tendon at which force begins to develop when stretched is called the tendon slack length 𝑙𝑠
𝑇. 
The model’s muscle and tendon force-length properties were summarised. These properties 
were scaled to represent individual muscle-tendon complex by specifying four parameters: 
 Peak isometric force 𝐹𝑜
𝑀 and optimal fibre length 𝑙𝑜
𝑀 scale the muscle force-length 
property; 
 Peak isometric force 𝐹𝑜
𝑀 and tendon slack length 𝑙𝑠
𝑇 scale the tendon force-length 
property; 
 Pennation angle (α) specified the angle between the muscle fibres and the tendon. 
 
The Muscle-tendon actuator principle model, which is used in the 2392gait model is shown 
in figure5.42. 
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Figure 5.42: The muscle-tendon actuator model [adapted from (Zajac, 1989, Delp, 1990, Hoy 
et al., 1990a)]. 
The isometric properties of muscle are represented by an active contractile element (CE) in 
parallel with a passive elastic element. Isometric muscle force is assumed to be the sum of 
muscle force when it is inactive (passive) and when it is active. The muscle is in series with 
tendon, which is represented by a non-linear elastic element. The forces in muscle 𝐹𝑀 and 
tendon 𝐹𝑇  are normalised by peak isometric muscle force (𝐹𝑜
𝑀). Tendon length (𝑙𝑇 ) and 
muscle-fibre length (𝑙𝑀) are normalised by optimal muscle-fibre length (𝑙𝑜
𝑇). Note that: 
𝑙𝑀𝑇 = 𝑙𝑇 + 𝑙𝑀 ∗ (cos 𝛼) and 𝐹𝑇 = 𝐹𝑀 ∗ (cos 𝛼) where 𝑙𝑀𝑇  is the muscle-tendon length and 
α is the pennation angle. 𝑙𝑠
𝑇 is the tendon slack length. For a given muscle-tendon length and 
activation level the model determines muscle and tendon forces (Zajac, 1989, Delp, 1990, 
Hoy et al., 1990a). 
Muscle-tendon parameters for 43 lower-limb muscles used in the model based on data 
reported by Delp is demonstrated in table 5.4. 
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Table 5.4: Muscle modelling parameters. 
 
Muscle 
Peak 
force (N) 
Optimal fibre 
Length (cm) 
Pennation 
Angle (°) 
Tendon slack 
length  (cm) 
Tendon length, 
fibre length(cm) 
Gluteus medius1a 550 5.4 8 7.8 1.4 
Gluteus medius2a 380 8.4 0 5.3 0.6 
Gluteus medius3a 435 6.5 19 5.3 0.8 
Gluteus minimus1a 180 6.8 10 1.6 0.2 
Gluteus minimus2a 190 5.6 0 2.6 0.5 
Gluteus minimus3a 215 3.8 1 5.1 1.3 
Gluteus maximus1a 380 14.2 5 12.5 0.9 
Gluteus maximus2a 550 14.7 0 12.7 0.9 
Gluteus maximus3a 370 14.4 5 14.5 1 
Adductor magnus1a 345 8.7 5 6 0.7 
Adductor magnus2a 310 12.1 3 13 1 
Adductor magnus3a 445 13.1 5 26 2 
Adductor longusa 420 13.8 6 11 0.8 
Adductor brevisa 285 13.3 0 2 0.2 
Pectineusa 175 13.3 0 0.1 0.1 
Iliacusa 430 10 7 9 0.9 
Psoasa 370 10.4 8 13 1.3 
Quadratus femorisa 255 5.4 0 2.4 0.4 
Gemellia 110 2.4 0 3.9 1.6 
Piriformisa 295 2.6 10 11.5 4.4 
Rectus femorisb 780 8.4 5 34.6 4 
Semimembranosusb 1030 8 15 35.9 4.5 
Semitendinosusb 330 20.1 5 26.2 1.3 
Biceps femorisb 720 10.9 0 34.1 3.1 
Gralcilisb 110 35.2 3 14 0.4 
Sartoriusb 105 57.9 0 4 0.1 
Tensor fasciae lataeb 155 9.5 3 42.5 4.5 
Vastus medialisb 1295 8.9 5 12.6 1.4 
Vastus intermediusb 1235 8.7 3 13.6 1.6 
Vastus lateralisb 1870 8.4 5 15.7 1.9 
Biceps femorisb 400 17.3 23 10 0.6 
Medial gastrocnemiusc 1115 4.5 17 40.8 9 
Lateral gastrocnemiusc 490 6.4 8 38.5 6 
Soleusd 2830 3 25 26.8 8.9 
Tibialis posteriore 1270 3.1 12 31 10 
Flexor digitorum longuse 310 3.4 7 40 11.8 
Flexor hallucis longuse 320 4.3 10 38 8.8 
Peroneus brevise 350 5 5 16.1 3.2 
Peroneus longuse 755 4.9 10 34.5 7 
Tibials anteriore 600 9.8 5 22.3 2.2 
Peroneus tertiuse 90 7.9 13 10 1.3 
Extensor digitorum longuse 340 10.2 8 34.5 3.4 
Extensor hallucis longuse 110 5.4 6 30.5 2.6 
a Peak force derived from (Brand et al., 1986); fibre length and pennation from (Friederich 
and Brand, 1990). b Peak force, fibre length and penation angle derived from (Wickiewicz et 
al., 1983). c Peak force derived from (Brand et al., 1986); fibre length and pennation derived 
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from (Wickiewicz et al., 1983). e Peak force derived from (Wickiewicz et al., 1983) multiplied 
by 0.8; fibre length from(Friederich and Brand, 1990). 
 
5.10 Calculation of the outcome measures 
5.10.1 Introduction 
Using data analysis software Visual3D, OpenSim and Excel, the following desired gait 
outcome variables were analysed for all test conditions and compared to baseline data with 
regards to kinematics, kinetics, EMG activity and muscle-tendon properties data acquired 
from gait laboratory tests. The outcome results for the stance phase were: 
 Kinematic data in the sagittal plane: ankle angle, knee angle, hip angle, foot 
plantar/dorsiflexion, shank incline/decline, flexion velocities; 
 Kinetic data: GRF, ankle moment, knee moment, ankle power, knee power, area under 
the curve (impulse) for ankle moment; 
 EMG activity: EMG signals (for medial GAS, SOL, TA), area under the curve (impulse) for 
medial GAS, SOL and TA muscles; 
 Muscle-tendon properties: Fibre/tendon lengths and velocities, fibre/tendon forces, 
medial GAS and SOL muscle moment arms. 
5.10.2 Joint angles 
Visual3D software was used for kinematic data analysis. Segments of the body were defined 
as a rigid body with a local coordinate system defined to coincide with the set of anatomical 
axes by knowing the coordinates of the proximal and distal end of a body segment in 
particular plane. The segments angles were then found by using simple trigonometry. The 
foot was aligned in the sagittal plane by Visual3D software. The ankle motion in the sagittal 
plane was then calculated as an angular relationship of foot and shank segment by 
subtracting the two angles (figure 5.43). 
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Figure 5.43: Foot and shank segment angular relationships (ZX - sagittal plane, ZY - frontal 
plane and XY- transverse plane). 
Knee motion in the sagittal plane was calculated as the angular relationship between the 
shank and thigh segments. Hip motion data were calculated as pelvis versus the thigh 
segment. Shank incline/decline and foot flexion were obtained as relationship those rigid 
segment with the ground surface (for example force platforms) and it was 0 degrees. 
5.10.3 Kinetic data 
All the joint moments, powers and GRFs were calculated in Visual3D. The anthropometric 
data such as segment lengths were calculated by the transformation from the tracking of 
markers to the position and orientation of each segment. The mass of the segments were 
scaled by weight of the individual subject. To calculate joint moment data such as point of 
application, and GRF moment arms to joint centres were obtained from the data processed 
in Visual3D (figure 5.44). 
Joint moments are commonly used in gait analysis by researches. Factors like height and 
body mass, gender can influence these moments (Moisio et al., 2003). Joint moments may 
be normalised to the participants’ body weight and height or just body weight. 
Normalisation by mass decreasing variability by about 50% (Winter, 2009). As there is only 
one gender the ankle and knee moments were normalised by body mass (Nm/kg) (Moisio et 
al., 2003). The ground reaction force and powers by default were normalised by bodyweight 
in Visual3D.  
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Figure 5.44: Example of an ankle joint moment calculation. Joint moments, powers and GRFs 
were calculated in Visual3D. 
 
5.10.4 Muscle-tendon properties 
Muscle tendon properties were calculated in OpenSim software. Each muscle has a unique 
set of muscle tendon parameters (peak force, optimal fibre length, pennation angle and 
tendon length) which determine its isometric force-generating characteristics. Muscle 
architecture parameters and bone geometry were obtained in the literature and applied in 
the model, which was included in OpenSim software. Muscle insertion points and muscle 
geometry were used in the model in OpenSim based on the research from Delp. Each gait 
model used in this research was scaled by body weight and height for each participant in 
OpenSim.  
 
168 
 
5.10.5 OpenSim algorithm for calculation muscles moment arm, muscle-tendon length 
and force 
For every joint that a muscle is connected to via tendon, the muscle has a moment arm. For 
example, medial gastrocnemius connects to both the rearfoot and the knee and it has a 
moment arm for both the ankle and knee angle. OpenSim calculates these moment arms 
using the “partial velocity” method, which is defined by equations (1) – (4) below. 
 
Figure 5.45: Definition of terms used in moment arm calculations. Point P1 through Pn define 
the muscle path. P1 thought Pm-1 are fixed in body A. Pm through Pn are fixed in body B. V  is 
the vector from point Pm-1 to Pm. r expresses point Pm in reference frame A. In general, six 
generalised coordinates (three rotational angles: q1, q2, q3 and three translation coordinates, 
not shown) are needed to characterise the orientation and position of body A relative to 
body B.  The moment arm for each generalised coordinate is given by equation (4) (Delp, 
1990). 
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u is the translational component of the partial velocity and defined as: 
𝑢 = (𝜕𝑡𝑥 𝜕𝑞𝑖⁄ )𝑥 + (𝜕𝑡𝑦 𝜕𝑞𝑖⁄ )𝑦 + (𝜕𝑡𝑧 𝜕𝑞𝑖⁄ )𝑧        (1) 
where tx, ty and tz are the constants of kinematic functions that define the translation 
between the two reference frames. ω is the angular component of the partial velocity and 
defines as: 
𝜔 = (𝜕𝑟1 𝜕𝑞𝑖⁄ )𝜆1 + (𝜕𝑟2 𝜕𝑞𝑖⁄ )𝜆2 + (𝜕𝑟2 𝜕𝑞𝑖⁄ )𝜆3      (2) 
where r1, r2 and r3 are the constants or kinematic functions that define the rotations about 
λ1 (axis1), λ2 (axis2) and λ3 (axis3) respectively. Then APVPm the partial velocity of the muscle 
point Pm in reference frame A is: 
𝑃𝑉𝑃𝑚𝐴 = 𝜔 ∗ 𝑟 + 𝑢     (3) 
where r is Pm in reference frame A (figure …). And the moment arm (ma) of the muscle for 
generalised coordinate qi was calculated as: 
𝑚𝑎 = 𝑃𝑉𝑃𝑚𝐴 ∗ 𝑉        (4) 
where V is the vector along the muscle line of action (figure….). If the muscle line of action 
connects more than one joint (i.e., biarticular muscles) the moment arm was computed by 
summing the partial velocity terms for each joint connected (Delp, 1990). Equation (3) was 
used to determine the component of partial velocity at each joint. These components were 
then summarised to determine  APVPm which was used in equation (4). 
This method is equivalent to computing moment arms with a vector cross-product for ball 
and socket and revolute joints (Hoy et al., 1990a). This method calculates the moment arm 
of a muscle about the instant centre of rotation as determined from the joint kinematics. 
The partial velocity method calculates a muscle moment arm (ma) equal to the change in 
muscle-tendon length (𝜕𝑙𝑀𝑇) with respect to a change in the generalised coordinate (𝜕𝑞𝑖). 
That is, (4) is equivalent to  
𝑚𝑎 = (𝜕𝑙𝑀𝑇 𝜕𝑞𝑖⁄ )          (5) 
This method provides a consistent technique to calculate moment arms for all types of joints 
(Delp, 1990, Hoy et al., 1990a). 
170 
 
Muscle-tendon length was calculated as the sum of the length of the line segments that 
connect the point defining the muscle path. If a muscle path was defined by points P1 
through Pn, then muscle-tendon length (𝑙𝑀𝑇) was determined by first transforming the 
muscle points to a common reference frame and the computing 
𝑙𝑀𝑇 = ∑ |𝑃𝑖+1 − 𝑃𝑖|0<𝑖<𝑛     (6) 
Muscle-tendon actuator force for the gait2392 model was used following an interactive 
algorithm. Once the muscle-tendon length was computed, an initial estimation of the 
muscle and tendon length was made. The force in the muscle was found by summing active 
and passive forces, each of which was calculated by using the length estimation to 
interpolate the appropriate force-length curve. Similarly, the force in the tendon was found 
by using its length to interpolate the force-length curve of the tendon. In static equilibrium, 
the force in the tendon (FT) and muscle (FM) were related by: 
𝐹𝑇 = 𝐹𝑀 (cos 𝛼)            (7) 
where α is the pennation angle. If the computed muscle and tendon force satisfy the 
equation, then the muscle and tendon force have been found. Otherwise, the muscle and 
tendon lengths are adjusted based on the slopes of their force-length curves at their 
respective lengths and the process is repeated. A more detailed algorithm of this muscle-
tendon properties calculation which was adopted in the model has been explained in the 
literature (Zajac, 1989, Hoy et al., 1990b, Delp, 1990). 
There some important problems for using models to study individual patients as: 
Models represent anatomy and function of average healthy adult subjects (no deformities, 
altered joint kinematics, age difference). 
5.10.6 Area under the curve (impulse) 
The area under the curves were calculated for ankle moment and EMG data to understand 
and compare changes in the summary of EMG activity and moment data during stance 
phase. It can demonstrate clearly if a muscle has worked harder overall and if more muscle 
force used to generate an internal ankle moment for ankle movement. This information is 
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valuable to understand effect on muscle overall work whilst walking with different rocker 
shoes. 
The simplest method to calculate the area under the curve is the trapezoid rule (Liengme, 
2009). If the area under the curve is divided into a sufficient large number or parts (figure 
5.46), then the area under the curve (the approximate integral) is given by: 
 
 
Figure 5.46: Example of a segment of the curve area, which is divided into areas. 
𝐼 = ∫ 𝑓(𝑥)𝑑𝑥 ≈ ∑ 𝐴𝑖
𝑛
𝑖=1
𝑏
𝑎
 
It effectively approximates the representative strip to a trapezoid. For a clearer explanation 
only a few strips were used in this example. More, and smaller strips are needed for a good 
approximation. The area of a typical strip is equivalent to: 
𝐴𝑖 = ∆𝑥
𝑦𝑖 + 𝑦𝑖+1
2
 
Combining the two equations, the area under the curve will be equivalent to: 
𝐼 ≈ ∆𝑥
𝑦1 + 𝑦2
2
+ ∆𝑥
𝑦2 + 𝑦3
2
+. . . +∆𝑥
𝑦𝑛 + 𝑦𝑛+1
2
 
or  
𝐼 ≈
∆𝑥
2
(𝑦1 + 2𝑦2 + 2𝑦3 + 2𝑦4 + ⋯ + 2𝑦𝑛 + 𝑦𝑛+1) 
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or 
𝐼 ≈
∆𝑥
2
(𝑦1 + 2 ∑ 𝑦𝑖 + 𝑦𝑛+1
𝑛
𝑖=2
) 
The last equation is called the trapezoid rule and it was used to calculate the area under the 
curves. To calculate 𝐼 EMG and moment data were not normalised to 100% time scale. The 
data contained enough “strips” to be accurate, as EMG was recorded at a 3000 Hz frequency 
and therefore there were around 3000 strips in the graph. Walking speed was controlled by 
time and therefore walking pattern was consistent. The 𝐼 for ankle moment was calculated 
with approximately 65 strips per stance phase. Data were consistent and followed the same 
pattern for each trial to be more accurate.  
Every single raw trial was analysed without normalising it to the 0-100% time scale. It was 
important to do so, because time scale normalisation was interpolating the curves areas and 
therefore data would not be valid, it could contain more area or less. Data were tested and 
showed that if normalised curve could contain up to 25% more area under the curve versus 
raw data. For that reason, each trial was analysed separately. 
5.11 Data normalisation 
Stance phase is the most important phase of gait in this study. During stance phase, it was 
possible to evaluate rocker sole shapes, which would have influenced forward propulsion 
generation and absorption by the muscles. Stance phase was subdivided into the following 
phases according to (Perry, 1992): 
 Initial contact (weight acceptance 0-2% of gait cycle); 
 Loading response (weight acceptance 0-10% of gait cycle); 
 Mid-stance (single limb support 10-30% of gait cycle); 
 Terminal stance (single limb support 30-50% of gait cycle); 
 Pre-swing phase (50-60% of gait cycle). 
The five stance phase gait events [initial contact (ICt), loading response (LR), mid-stance 
(MSt), terminal stance (TSt) and pre-swing (PS)], were expressed as a percentage of gait 
cycle. The gait cycle was defined as a gait event from heel strike to heel strike and stance 
phase was event from heel strike to toe-off. All data were normalised on a 0-100% time 
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scale. Force platforms were used to define gait events from heel strike to toe-off. The mean 
values were analysed within five gait events for all trials. 
To normalise data to one standard for all participants in Visual3D is a challenging task. If the 
ankle angle during static barefoot standing is at neutral position (i.e. not plantarflexed or 
dorsiflexed), it will be equal to 0° or 90° with one expectation; that the shank segment is not 
inclined/declined and foot has full contact with the ground for a healthy person. If the 
person were to be standing barefoot on the force platform to record a static trial in 
visual3D, ankle angle would be around 73.1°.  In Visual3D barefoot static posture (which has 
full contact with the force platform or in parallel to the ground) of the foot segment relative 
to the ground is not equal to 0° but equal to around 25.5° (data derived from one of the 
participants). The reason for this, is that the foot segment is built up in Visual3D, with the 
proximal end starting at the ankle joint centre and the lateral end along a line joining the 
metatarsal heads. Therefore, the segment line direction does not lie parallel to the ground 
(force plates), but has 25.5° inclination. In other words, the segments’ line direction is 
coming from the ankle joint centre to metatarsals heads. The shank also had an inclination 
of 8.6° for this participant during static standing recording.  Figure 5.47 shows why the static 
ankle joint angle is equal to 73.1° in Visual3D in more detail.  
 
Figure 5.47: Visual3D default static ankle angle representation. 
This is the default reference posture of the coordinate system for a barefoot static trail 
when standing on a force platform. The example for barefoot ankle kinematics derived from 
it is shown in figure 5.48, and it was not close to 90° or 0°. One of the manual ways available 
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to normalise ankle angle to the neutral position (0 degrees) to be able to define 
plantarflexion/dorsiflexion, is by subtracting 90° from raw kinematic data, then subtract the 
shank incline of 8.6 degrees and adding a 25.5° foot offset caused by defining the foot 
segment in visual3D. The overall equation for this example is - 90°- 8.6°+25.5°. This would 
set a 0 degrees position of the ankle joint angle in the sagittal plane (Z-X plane).  
 
Figure 5.48: Normalisation procedure for the ankle. 
Ninety degrees was subtracted because the foot segment default coordinate system in 
Visual3D is rotated anticlockwise by 90 degrees in the Z-X plane versus the laboratory. Other 
segments in the coordinate system are shown in figure 5.49. 
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Figure 5.49: Default Visual3D coordinate system for the lab, shank segment and 
anticlockwise-rotated foot segment in the Z-X axis plane. 
Results from the pilot study and the literature suggested that it would not be prudent to 
change between global and segment coordinate systems as this can lead to errors (Richards, 
2008), figure 5.50. 
 
Figure 5.50: Pilot study example for changing the coordinate system of the ankle segment. 
Therefore, the coordinate system for calculating segments were kept to the Visual3D default 
without changing them. 
Depending on how the ankle angle is desired to be presented, researchers choose their own 
techniques for ankle kinematic data interpretation. In this thesis, ankle joint neutral position 
was considered to be at 0 degrees. Ankle angle was calculated as an angular relationship of 
the shank and foot segments.  
Different static postures caused by different footwear conditions, would set 3 offsets from a 
reference posture (0 degrees joint angles). All statics trials recorded in this research have 
different static positions for all the segments. One subject stood with shank incline of 2° in 
the high heeled shoe with the foot plantarflexed at 35 degrees relative to the ground and 
with the barefoot shank at 10 degrees and foot segment at 25.5° (figure 5.51). 
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Figure 5.51: Example of how a rocker shoe can change posture for an ankle joint compared 
to a barefoot static trial. 
A total of 160 trials were collected per subject and 16 different footwear conditions were 
used, and therefore 16 different static positions were recorded. All static body positions 
were altered in all 3 axes during standing postures. This could have been due to the shoes or 
just the participant being comfortable in that standing position at that time. Each static 
position was linked to 10 walking trials. Therefore, to analyse the precise relationship if the 
ankle was more in a plantar or dorsiflexed position when comparing different rocker shoes 
would not make any sense without a default segmental reference system for all footwear 
conditions and participants. The ideal case scenario would be if all statics were the same (all 
joints were set as 0 degree). In this case, joint kinematic data contained offsets in the 
coordinate system for each segment when compared to each other.  
New updated software Visual3D versions 4.9xx and 5xx have included improved automatic 
features to remove static offsets between different static positions in data. Therefore, if all 
dynamic trials (with different shoes) are assigned to one barefoot static it would not 
theoretically be different if all trials were assigned to their own statics, unless marker 
positions were not the same. To investigate that, the test was conducted using one walking 
trial with the 70 % apex position shoe compared to two different statics; the first static was 
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a 1.5 cm heel (negative shoe) and the second was a 5.5 cm heel (high heel shoe). These both 
shoes made a big difference to the standing position for the foot segment, with the negative 
heel foot segment being dorsiflexed and in the high heel shoe it was plantarflexed relative 
to the ground. If all markers were placed at the same location for each static then after 
exporting data from Visual3D, it should not show any differences in kinematic data and no 
offsets caused by reference statics. Figure 5.52 demonstrates a visual example of static 
posture alteration caused by different rocker soles in Visual3D.  
 
Figure 5.52: Demonstration of segmental positions. 
Ankle angle kinematic data for the 70 % apex position shoe walking trial was assigned with 
1.5 cm heel and 5.5 cm heel static trials and then data were exported to be compared. The 
data looked the same (average angle difference mean STD ± 0.095° for the full gait cycle) as 
shown in figure 5.53, even though for both shoes, static positions were different, the 5.5 cm 
heel was more plantarflexed by 17.4 degrees compared to the 1.5 cm heel shoe, and shank 
incline differences were 2.3 degrees, Visual3D removed static offset by default.  
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Figure 5.53: Comparison of test conditions. 
However, there were some factors which were unclear: 
 This method does not show the joint angles in relation to the real coordinate system 
as we see;  
 If the data have to be normalised between different participants and therefore 
statics, there is no information about what the foot or shank positioning relative to 
the lab coordinate system was, or which reference segment was used for 
normalising statics offsets and therefore how different it is between the subjects. 
For this reason, a new method of normalisation joint kinematics was tested and used to 
solve both uncertainties. Before that, the question was raised: if different statics were 
assigned for the walking trial wearing completely different shoes, how it can be guaranteed 
that all markers were placed at the same location? 
Previously the method of marker placement was described that all footwear conditions had 
holes and markers location were drawn on to the skin, where markers were to be re-
attached (only for the foot segments) after changing footwear conditions. If marker 
locations were wrong, it would change the shape of the joint kinematics. Figure 5.54 
demonstrates the ankle joint angle result data on effect of marker relocation for several 
different rocker shoes. In this example, it shows that the walking trial wearing a 1.5 cm 
negative heel and 5.5 cm heel was compared versus a barefoot static trial, (1.5 cm heel 
static and 5.5 cm heel static trial). The shape of kinematic data were almost identical with 
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differences in average mean for the 1.5 cm heel STD of ± 0.0106 degrees and for 5.5 cm heel 
raise mean STD of ± 0.0185 degrees. It means that markers were positioned very precisely. 
 
Figure 5.54: Comparison of rocker soled shoe test conditions versus barefoot statics. 
Figure 5.54 demonstrates that there is no difference in the shape of the ankle joint 
kinematics if markers were reattached for different static trials and it means that markers 
were attached very close to the previous one. (a) -  1.5 cm walking trial compared versus 
barefoot and 1.5 cm heel static trials (STD ± 0.0106°), (b) – 5.5 cm walking trial compared 
versus barefoot and 5.5 cm heel static trials (STD ± 0.0185°). 
That proves that marker placement for each footwear conditions was almost identical for 
this example or very close to the true and there is no significant change in kinematic data 
caused by relocating markers.  
5.11.1 Normalisation techniques for the ankle joint 
Ankle joint angle normalisation explained by Visual3D guidelines involve making virtual foot 
segments, which remove offsets in all three components (X-Y-Z). This means that the 
procedure sets joint angles at 0 degrees. By using virtual segments, it switches static offsets 
normalisation between footwear conditions and it adds to each static trial and consequently 
in kinematic data. When a virtual foot is applied, foot segment coordinate systems become 
similar as for all segments and therefore there is no 90 degrees coordinate system change in 
the sagittal plane. The difference between foot segment and virtual foot is that virtual foot 
markers are all at the same level as force platform and therefore it sets foot segment angle 
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as 0° relative to the ground as shown in the figure 5.53, the virtual segments were also built 
up for shank, thigh and hip.  
 
Figure 5.55: Visual3D virtual foot example based on the C-Motion guidelines. 
The next step for normalisation was to make virtual segments whose segment coordinate 
systems were consistent. Visual3d guidelines explains how to make virtual foot segments in 
detail. Figure 5.56 demonstrates that creating virtual segments applies static offsets for 
shank and foot segments in the ankle joint kinematic data. In this example a 1.5 cm heel 
height static trial was built with virtual shank and virtual foot to test normalisation effect on 
ankle joint data. The static foot segment for the 1.5 cm heel had a 20° angle (barefoot 25.4° 
and in negative it was slightly dorsiflexed) and the shank had a 6.3° angle compared to the 
gait laboratory coordinate system. When the virtual foot was applied, it can be seen that the 
ankle angle default data were shifted by 20° upwards relative to the raw data and when the 
virtual shank and virtual foot were applied together, then the shank incline was also 
subtracted from the data in Visual3D. This technique is designed to remove automatic shift 
correction between static trials in kinematic data in Visual3D, and angles are compared 
versus one reference pose with postural offsets added to the data. These static offsets 
should be subtracted manually for each static condition depending on the amount of offset. 
Each static angular pose was calculated versus virtual segments to know the offset of the 
shoes for each static.   
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Figure 5.56: This example shows how the ankle joint data were shifted by virtual foot, with 
virtual shank added to the static model. The raw line represents the export from visual3D 
and 90 degrees were subtracted to fix coordinate system rotation. The orange line shows 
that the virtual foot subtracted the foot segment difference between normal position and 
virtual foot (which lies in parallel with the ground). The blue line shows that the virtual foot 
and shank segments offsets were added to the ankle angle if compared with data without 
normalising joint angle to 0 degree. 
Virtual segments represent default reference system for all static trials and participants, 
however all segments offsets were applied to the joint kinematic data and therefore each 
static offset cause by footwear conditions should be subtracted. The final graph obtained for 
that example is shown in figure 5.57. It shows the ankle joint data versus default coordinate 
system (as we see) in the gait laboratory.  
 
Figure 5.57: Resulting graph following normalisation. 
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Normalisation demonstrates that the 1.5 cm negative heel shoe placed the ankle into 6.5 
degrees of dorsiflexion during IC and kept the ankle in a dorsiflexion position during stance 
phase; this would also lengthen the calf muscles.  
The next pictorial example demonstrates five different heel heights for ankle kinematic data 
and a comparison versus Visual3D automatic offset normalisation. One barefoot static was 
applied to different footwear dynamic trials, five own statics and the new technique of 
normalisation ankle joint, which was used in this thesis. Figure 5.58 shows statics trial offset 
angles for different shoes in Visual3D during static trials recording for 5 different footwear 
test conditions. 
 
Figure 5.58: Foot-shank relationships for five footwear test conditions. 
5.11.2 The first technique analysed for ankle joint normalisation   
The next example shows the first normalisation technique investigated. Raw kinematic data 
were exported for the 1.5, 2.5, 3.5, 4.5, 5.5 cm heel height (HH) shoes. Each footwear 
condition was assigned with the static shoe trial, which was used for walking trials. Then 90 
degrees was subtracted from the data and then a barefoot foot segment angle of 25.4° was 
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added. In this example, no static footwear segment offsets were applied as Visual3D does it 
automatically. 
Figure 5.57: Ankle joint kinematic data exported for 1,2,3,4,5 heel heights shoe walking trials 
using their own statics in Visual3D. (a) – raw ankle joint data; (b) – raw ankle data - 90° + 
barefoot foot segment position 25.4° relative to the ground. 
Figure 5.57 shows that static positions for different shoes had shank inclines and it is unclear 
which angle should be used to normalise it to 0 degrees, therefore this method was not 
used in this thesis.  
5.11.3 The second technique for ankle joint normalisation   
Virtual segments were used in static models to have one reference system for all statics and 
participants (to keep segments at 0 or 90 degrees relative to the force platforms). Static 
offsets were calculated for each shoe static trial relative to the barefoot. Then offsets were 
subtracted from kinematic data to be normalised to barefoot static position (when foot 
segment is in parallel to the ground). After that, barefoot shank incline was subtracted from 
the data and it made ankle joints to be at neutral position. Figure 5.59 demonstrates this 
procedure for normalising ankle joint data. 
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Figure 5.59: Ankle joint kinematic data exported for 1,2,3,4,5 heel heights shoe walking trials 
using their own statics with virtual segments applied in Visual3D. (a) –ankle joint data with 
statics offsets; (b) – ankle joint data with subtracted static offsets for foot and shank.  
Figure 5.59 (b) shows a neutralised ankle joint angle and this represents real ankle angles as 
we see them or as a coordinate system of the gait laboratory. The results show that a 1.5 cm 
negative heel keeps the ankle more dorsiflexed and during initial contact the angle is about 
5 degrees of dorsiflexion. With increasing the heel height the ankle becomes more 
plantarflexed and with the 5.5 cm heel ankle angle at around 10° (100°) degrees of 
plantarflexion at initial contact and keeps the ankle more plantarflexed thoughout stance 
phase. 
All statics offsets were calculated and were removed to normalise it to barefoot static with 
no shank incline.  All kinematic data such as ankle angle, knee angle and hip angle used the 
second technique for data normalisation which used the laboratory coordinate system as 
reference for all trials and participants. 
The next example is a comparison of shoes with 1.5, 2.5, 3.5, 4.5, 5.5 cm heel heights 
walking trials which were assigned to 1 barefoot static and to their own statics without 
normalisation.  
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Figure 5.60: Raw ankle joint data from Visual3D for 1.5, 2.5, 3.5, 4.5, 5.5 heel height walking 
trials; (a) – all walking trials were assigned with one barefoot statics, (b) – each footwear 
condition was assigned with same footwear static trial. 
One barefoot static was used for all trials in Visual3D to export kinematic data to OpenSim. 
There are no other techniques available that allow manual removal of static offsets in the 
OpenSim software, and therefore barefoot static was the best option for the following 
reasons: 
 An OpenSim requirement for Visual3D statics is that the foot should be parallel to 
the ground; 
 Visual3D use an IK process which makes the foot segment to be parallel with the 
ground; and if statics were used for different rocker shoes, it would add offsets in the 
data and therefore muscle-tendon property data would not be valid.  
5.11.4 Kinetic data normalisation 
Joint moments are commonly used in gait analysis by researchers. Factors like height and 
body mass, plus gender can influence these moments (Moisio et al., 2003). Joint moments 
may be normalised to the participants’ body weight and height or just body weight. 
Normalisation by mass decreases variability by about 50% (Winter, 2009). As there was only 
one gender tested in this study, the ankle and knee moments were normalised by body 
weight (Nm/kg) (Moisio et al., 2003). The ground reaction force and powers by default were 
normalised by bodyweight in Visual3D.  
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CHAPTER 6 
6 RESULTS AND STATISTICAL ANALISIS: KINEMATICS, KINETICS, 
ELECTROMYOGRAPHY AND MUSCLE FUNCTION DATA 
6.1 Subject demographics 
Fifteen healthy male subjects, with an age range between 20 and 29 years of age 
volunteered for this research. It was decided to analyse healthy participant data to minimise 
the effects of additional factors, which could influence the effect of different footwear 
features on gait patterns and musculoskeletal biomechanics of the lower limbs during gait. 
All the subjects tested stated they were healthy with no previous history injuries or 
pathology that would result in an abnormal walking patterns. Table 6.1 demonstrates the 
subject demographics. 
Table 6.1: Subject demographics. 
Male Subject 
No. 
Age on testing date 
(years) 
Body Mass 
(kg) 
Height 
(m) 
1 22  65 1.78 
2 24  81 1.77 
3 29  71 1.83 
4 23  65 1.70 
5 29  67 1.72 
6 26  64 1.68 
7 25  81 1.77 
8 24  77 1.83 
9 29  84 1.72 
10 27  88 1.71 
11 24  63 1.68 
12 25  66 1.75 
13 27  63.5 1.62 
14 20  68 1.76 
15 27  66 1.74 
Mean value 25.3 ± 2.73 71.3 ± 8.50 1.74 ± 0.06 
 
6.2 Trial conditions analysed  
Lower limb kinematic, kinetic and muscle function data were analysed to ascertain 
alterations produced by walking with footwear adapted with features using the method 
described in section 5.5. Footwear features were divided and analysed in groups. The short 
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abbreviations chosen for the footwear testing conditions and testing grouping are described 
in table 6.2.  
Table 6.2: Footwear test conditions analysed and their acronyms. 
Footwear condition Short name 
1. Rearfoot heel height 
1.5 cm heel height (Negative heel) 1.5HH 
2.5 cm heel height (almost flat) 2.5HH 
3.5 cm heel height (control shoes) 3.5HH (control) 
4.5 cm heel height (heel raised by 1cm) 4.5HH 
5.5 cm heel height (heel raised by 2cm) 5.5HH 
2. Rocker Apex position (AP) 
Apex position 55% of shoe length (from rear of shoe) 55AP 
Apex position 62.5% of shoe length 62.5AP (control) 
Apex position 70% of shoe length 70 AP 
3. Rocker Apex Angle (RA) 
10°  10° toe 
15°  15° toe (control) 
20°  20° toe 
4. Heel Curve Type (HC) 
A half-curved heel (the curve ended half way between the posterior 
heel line and the ankle joint centre position) 
Half curve 
A full curve (the curve ended directly beneath ankle joint centre) Full curve 
The control shoe (no heel curve) Control (no curve) 
5. Rocker profile stiffness at metatarsal area 
A stiff sole (inherent in the control shoe) Solid (control) 
Medium flexibility (half the sole thickness was removed at the 
metatarsal arcade area) 
Med flex 
A flexible shoe (transverse incisions were cut into the sole across the 
metatarsal arcade area to a depth of almost the entire thickness leaving 
a small base layer; making it very flexible in that area only) 
Flex sole 
 
6.3 Gait cycle terms of reference 
The results were collated and analysed with reference to specific points during the gait cycle 
in order to systematically interpret and clarify the effect of different rocker sole test 
conditions on gait patterns and muscle function. Stance phase was sub-divided into the 
following phases according to (Perry, 1992): 
 Initial contact (weight acceptance 0-2% of gait cycle); 
 Loading response (weight acceptance 0-10% of gait cycle); 
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 Mid-stance (single limb support 10-30% of gait cycle); 
 Terminal stance (single limb support 30-50% of gait cycle); 
 Pre-swing (50-60% of gait cycle). 
The abbreviations used for these distinct phases are illustrated in table 6.3. 
Table 6.3: Nomenclature used for parts of stance phase. 
Initial contact IC 
Loading response LR 
Mid-stance MSt. 
Terminal stance TSt. 
Pre-swing phase PSw. 
 
6.3.1 Ankle, knee and hip kinematics, kinetics, EMG and muscle function results 
6.3.1.1 The effect of heel height alteration  
The following figures show plots with and without standard deviation (STD) demonstrated in 
colour shading. This was done to show the range of STD for each plot to confirm that the 
plot can be represented by single line. 
Following the analysis of STD values for the figures illustrated in this thesis. It was confirmed 
that a single line would represent the data obtained. The result shows that the STD were 
consistent and single line was valid. 
 
Figure 6.1 represents the average ankle angle for all the walking trials utilised for assessing 
the different heel heights (HHs). It can be seen that through the first and second rockers of 
gait, shoes with lower heel heights kept the ankle joint relatively dorsiflexed and in those 
with raised heels the ankle joint shifted into a more plantarflexed position compared to the 
control shoe test condition (denoted as 3.5HH). However, at maximum plantarflexion (point 
4) this effect was not so significant except for the 1.5HH test condition.  
189 
 
 
Figure 6.1: Sagittal plane ankle motion during the five heel height test conditions where the 
control shoe is 3.5 HH. (a) – without standard deviation (STD), (b) – with the lines shadowed 
to represent STD ranges. 
The 0° degree horizontal line represents the barefoot static stance position with the foot 
parallel to the ground and with the shank positioned with a 0° incline/recline angle. Legend 1 
indicates ankle angle at initial contact; legend 2 indicates the area where maximum ankle 
plantarflexion occurred during LR; legend 3 indicates the point at which maximum ankle 
dorsiflexion angle occurred during the second rocker of gait during MSt and legend 4 
indicates the position where maximum ankle plantarflexion at toe-off (TO), during the third 
rocker of gait, occurred. The mean sagittal plane ankle angles at ICt and other specific points 
during stance phase are shown in table 6.4. 
Table 6.4: Mean (±SD) sagittal plane ankle motion for shoes with five different heel heights 
during stance phase. 
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Ankle angle (degrees) at ICt 
(deg): (+) DF/(-) PF 
5.1 (0.9) 1.0 (0.9) 0.1 (1.0) -2.4 (1.0) -4.2 (1.3) 
Max ankle PF angle during LR 
(deg) 
-1.9 (3.5) -9.4 (2.4) -11.2 (3.0) -14.4 (2.7) -16.7 (2.5) 
Max ankle DF angle during 
stance phase (deg) 
12.3 (1.0) 7.0 (1.0) 5.1 (1.0) 3.0 (0.8) 1.2 (0.8) 
Max ankle PF angle at TO (deg) -12.9 (1.5) -18.0 (1.4) -18.6 (1.4) -19.6 (1.2) -21.6 1.0) 
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6.3.1.2 Ankle position at initial contact (ICt) and during loading response (LR) 
At IC, the 1.5 cm negative heel test condition increased the ankle dorsiflexion angle by 5.1° 
(SD: 0.9) compared to the control shoe (0.1°, SD:1.0). However, when walking with shoes 
incorporating heels of more than 3.5 cm in height, a plantarflexion shift appeared at the 
ankle joint for this point in the gait cycle. A distinct pattern emerged during the first two 
rockers of gait whereby lower-heeled shoes produced a dorsiflexion shift whilst higher 
heeled shoes produced a plantarflexion shift compared to the control test condition.  
During loading response (LR), all shoe test conditions demonstrated significant changes in 
maximum mean plantarflexion relative to each other (table 6.5) and a gradual plantarflexion 
shift from the negative heel shoe (1.5 cm) to the positive heel (5.5 cm) occurred (table 6.4) 
during stance phase overall. 
Table 6.5 demonstrates relevant data and the significance value of comparison between the 
five heel height test conditions for maximum PF angle of the ankle during LR. These display 
the mean and standard deviations for the test conditions parameters concerned, and the 
significance level of the mean difference between footwear conditions. A 95% confidence 
interval (CI) was utilised. The results for one-way ANOVA pairwise comparisons with 
Bonferroni correction in this chapter will be presented in a similar format as below for 
clarity. All data followed a normal distribution. 
Table 6.5: Pairwise comparisons of shoe conditions for mean maximum ankle PF angle 
during LR phase. 
Cond. Cond. 
Mean 
Difference  Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH 7.441* 0.655 0.000 5.261 9.621 
3.5HH 9.259* 0.503 0.000 7.585 10.934 
4.5HH 12.486* 0.581 0.000 10.552 14.420 
5.5HH 14.647* 0.602 0.000 12.644 16.651 
2.5HH 1.5HH -7.441* 0.655 0.000 -9.621 -5.261 
3.5HH 1.818* 0.316 0.000 0.768 2.869 
4.5HH 5.045* 0.311 0.000 4.012 6.078 
5.5HH 7.206* 0.353 0.000 6.031 8.382 
3.5HH 1.5HH -9.259* 0.503 0.000 -10.934 -7.585 
2.5HH -1.818* 0.316 0.000 -2.869 -0.768 
4.5HH 3.227* 0.289 0.000 2.266 4.187 
5.5HH 5.388* 0.370 0.000 4.156 6.620 
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4.5HH 1.5HH -12.486* 0.581 0.000 -14.420 -10.552 
2.5HH -5.045* 0.311 0.000 -6.078 -4.012 
3.5HH -3.227* 0.289 0.000 -4.187 -2.266 
5.5HH 2.161* 0.360 0.000 0.965 3.357 
 
Table 6.5 confirms significance (one-way ANOVA with Bonferroni correction) for any value of 
0.05 or less in bold font. The greatest difference in maximum ankle plantarflexion value was 
between the 1.5 cm heel test condition and all the other test conditions (7.5 – 14.8 deg.) 
during LR. 
6.3.1.3 Ankle angle at the point of maximum dorsiflexion during stance phase 
Maximum ankle dorsiflexion angle during second rocker of gait also demonstrated significant 
differences between all heel heights when compared to each other (table 6.6). Negatively-
heeled shoes placed the ankle into more dorsiflexion compared to the control shoe; but with 
increases in heel height, the ankle was gradually shifted into being less dorsiflexed.  
Table 6.6 demonstrates the significance of the differences demonstrated between the heel 
height test conditions at the point of maximum ankle dorsiflexion during stance phase. A 
plantarflexion shift again occurred for this parameter with increasing heel height, and 
significance was noted between all the test conditions. 
 
Table 6.6: Pairwise comparisons of shoe conditions for max ankle DF angle during second 
rocker of gait. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH 5.242* 0.923 0.001 2.173 8.311 
3.5HH 7.186* 1.047 0.000 3.705 10.667 
4.5HH 9.242* 1.047 0.000 5.760 12.725 
5.5HH 11.077* 1.014 0.000 7.707 14.448 
2.5HH 1.5HH -5.242* 0.923 0.001 -8.311 -2.173 
3.5HH 1.944* 0.477 0.011 0.359 3.529 
4.5HH 4.000* 0.388 0.000 2.710 5.291 
5.5HH 5.835* 0.311 0.000 4.802 6.868 
3.5HH 1.5HH -7.186* 1.047 0.000 -10.667 -3.705 
2.5HH -1.944* 0.477 0.011 -3.529 -0.359 
4.5HH 2.056* 0.317 0.000 1.003 3.110 
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5.5HH 3.891* 0.457 0.000 2.373 5.410 
4.5HH 1.5HH -9.242* 1.047 0.000 -12.725 -5.760 
2.5HH -4.000* 0.388 0.000 -5.291 -2.710 
3.5HH -2.056* 0.317 0.000 -3.110 -1.003 
5.5HH 1.835* 0.381 0.003 0.569 3.100 
 
6.3.1.4 Maximum plantarflexion angle at TO 
At toe-off, the 1.5 cm heel shoe was significantly less plantarflexed when compared to the 
3.5 cm heel control shoe (p=0.002) and indeed all the other test conditions. There were 
significant differences between 2.5HH and 4.5HH and 5.5HH, but no significant differences 
between the 2.5 HH and 3.5HH, and 3.5HH and 4.5 HH and 4.5HH and 5.5HH shoes. The 
5.5HH shoe was significantly more plantarflexed versus all footwear conditions except for 
the 4.5 cm heel test condition (table 6.7). 
Table 6.7: Pairwise comparisons of shoe conditions for max ankle PF angle during late 
stance. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH 5.065* 1.192 0.008 1.101 9.028 
3.5HH 5.629* 1.130 0.002 1.873 9.386 
4.5HH 6.699* 1.153 0.000 2.865 10.533 
5.5HH 8.673* 1.126 0.000 4.929 12.418 
2.5HH 1.5HH -5.065* 1.192 0.008 -9.028 -1.101 
3.5HH 0.565 0.483 1.000 -1.043 2.172 
4.5HH 1.634* 0.483 0.045 0.027 3.242 
5.5HH 3.609* 0.575 0.000 1.697 5.520 
3.5HH 1.5HH -5.629* 1.130 0.002 -9.386 -1.873 
2.5HH -0.565 0.483 1.000 -2.172 1.043 
4.5HH 1.070 0.414 0.216 -0.307 2.446 
5.5HH 3.044* 0.392 0.000 1.742 4.346 
4.5HH 1.5HH -6.699* 1.153 0.000 -10.533 -2.865 
2.5HH -1.634* 0.483 0.045 -3.242 -0.027 
3.5HH -1.070 0.414 0.216 -2.446 0.307 
5.5HH 1.974 0.634 0.076 -0.134 4.082 
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6.3.2 Ankle sagittal plane ROM 
Table 6.8 demonstrates the ankle ROMs produced when walking with shoes adapted with 
different heel heights.  
Table 6.8: Mean values for maximum ankle ROM during specific points and also the 
complete gait cycle for shoes with different heel heights. 
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Ankle ROM during  LR (points 1-2) 
degrees  
7.2  
(0.8) 
10.4 
 (0.9) 
11.4 
 (0.9) 
12.1  
(0.9) 
12.5  
 (1.1) 
Ankle ROM between points 2 and 3 
(end of LR to max  DF during stance 
phase) degrees 
14.3  
(1.2) 
16.5  
(1.3) 
16.3  
(1.2) 
17.5  
(1.2) 
17.9 
 (1.2) 
Ankle ROM between max DF and 
maximum PF during late stance 
(between points 3 and 4) 
25.2  
(1.5) 
25.0  
(1.5) 
23.7  
(1.6) 
22.7  
(1.2) 
22.8  
(1.1) 
Maximum ROM during gait cycle (deg) 26.5  
(1.6) 
25.2  
(1.4) 
23.8  
(1.5) 
23.4  
(1.1) 
23.0  
(1.1) 
 
6.3.2.1 Ankle ROM during LR 
The 1.5 cm and 2.5cm heel test conditions both significantly reduced ankle ROM during LR 
compared to all the other heel height test conditions (table 6.9). The 3.5cm, 4.5 cm and 5.5 
cm heeled shoes did not show any significant increase in ROM between themselves. 
 
Table 6.9: Pairwise comparisons of shoe conditions versus ankle sagittal plane ROM during 
LR. 
Cond. Cond. 
Mean 
Difference  Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH -3.278* 0.405 0.000 -4.624 -1.931 
3.5HH -4.220* 0.421 0.000 -5.621 -2.819 
4.5HH -4.924* 0.600 0.000 -6.918 -2.930 
5.5HH -5.382* 0.630 0.000 -7.478 -3.286 
2.5HH 1.5HH 3.278* 0.405 0.000 1.931 4.624 
3.5HH -0.942* 0.226 0.009 -1.694 -0.190 
4.5HH -1.647* 0.424 0.017 -3.057 -0.236 
5.5HH -2.105* 0.542 0.016 -3.906 -0.303 
3.5HH 1.5HH 4.220* 0.421 0.000 2.819 5.621 
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2.5HH 0.942* 0.226 0.009 0.190 1.694 
4.5HH -0.704 0.388 0.909 -1.994 0.586 
5.5HH -1.162 0.506 0.376 -2.845 0.521 
4.5HH 1.5HH 4.924* 0.600 0.000 2.930 6.918 
2.5HH 1.647* 0.424 0.017 0.236 3.057 
3.5HH 0.704 0.388 0.909 -0.586 1.994 
5.5HH -0.458 0.356 1.000 -1.643 0.727 
 
It was hypothesised in chapter 5, that with low heel heights, the sagittal plane ankle ROM 
during LR would be reduced. Table 6.9 confirms that this did indeed occur.  
6.3.2.2 Ankle ROM during second rocker of gait (i.e. between points 2 and 3) 
The ankle ROM between points 2 and 3 was significantly increased for the 5.5 cm heel versus 
3.5 cm control shoe.  
Table 6.10: Pairwise significance comparisons between shoe conditions and ankle ROM 
angle between point 2 and 3 of the gait cycle. 
Cond. Cond. 
Mean 
Difference  Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH -2.158 1.033 0.554 -5.593 1.277 
3.5HH -2.033 1.079 0.804 -5.620 1.554 
4.5HH -3.203 1.136 0.137 -6.982 0.576 
5.5HH -3.528* 1.052 0.047 -7.025 -0.030 
2.5HH 1.5HH 2.158 1.033 0.554 -1.277 5.593 
3.5HH 0.125 0.429 1.000 -1.301 1.552 
4.5HH -1.045 0.339 0.081 -2.171 0.081 
5.5HH -1.370* 0.334 0.011 -2.479 -0.260 
3.5HH 1.5HH 2.033 1.079 0.804 -1.554 5.620 
2.5HH -0.125 0.429 1.000 -1.552 1.301 
4.5HH -1.170 0.473 0.268 -2.743 0.403 
5.5HH -1.495* 0.387 0.017 -2.781 -0.209 
4.5HH 1.5HH 3.203 1.136 0.137 -0.576 6.982 
2.5HH 1.045 0.339 0.081 -0.081 2.171 
3.5HH 1.170 0.473 0.268 -0.403 2.743 
5.5HH -0.325 0.396 1.000 -1.642 0.993 
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6.3.2.3 Ankle ROM during third rocker of gait (i.e. between points 3 and 4) 
The ankle ROM between maximum dorsiflexion and maximum plantarflexion during late 
stance (between points 3 and 4) showed a significant increase for the 2.5 cm heel height 
versus the 4.5 and 5.5 cm heeled shoes. No other significance was found. 
 
Table 6.11: Pairwise comparisons of shoe conditions for the ankle ROM between maximum 
dorsiflexion and maximum PF during late stance (between points 3 and 4). 
Cond. Cond. 
Mean 
Difference  Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH 0.178 0.706 1.000 -2.169 2.524 
3.5HH 1.557 0.832 0.825 -1.211 4.325 
4.5HH 2.543 0.903 0.138 -0.461 5.548 
5.5HH 2.404 0.778 0.080 -0.183 4.992 
2.5HH 1.5HH -0.178 0.706 1.000 -2.524 2.169 
3.5HH 1.379 0.505 0.162 -0.299 3.058 
4.5HH 2.366* 0.479 0.002 0.773 3.959 
5.5HH 2.227* 0.502 0.006 0.557 3.896 
3.5HH 1.5HH -1.557 0.832 0.825 -4.325 1.211 
2.5HH -1.379 0.505 0.162 -3.058 0.299 
4.5HH 0.987 0.503 0.701 -0.687 2.660 
5.5HH 0.847 0.467 0.912 -0.706 2.401 
4.5HH 1.5HH -2.543 0.903 0.138 -5.548 0.461 
2.5HH -2.366* 0.479 0.002 -3.959 -0.773 
3.5HH -0.987 0.503 0.701 -2.660 0.687 
5.5HH -0.139 0.490 1.000 -1.768 1.490 
 
6.3.2.4 The overall ankle ROM during the complete gait cycle 
The total ankle sagittal plane mean ROM differences during the full gait cycle are shown in 
table 6.12. Overall ankle ROM angle during the full gait cycle was significantly increased for 
the 1.5 cm heel versus the control shoe, the 4.5 cm and the 5.5 cm heel height test 
conditions. The shoe with the 5.5 cm heel height produced a significant reduction in overall 
ankle ROM compared to the 1.5cm and 2.5cm heel heights. The shoes with heels higher than 
the control shoe (3.5mm) did not demonstrate any significant difference in ankle joint ROM 
when compared to the control shoe or between themselves. 
 
196 
 
Table 6.12: Pairwise statistical significance comparisons between shoe conditions versus 
maximum ankle ROM angle during the full gait cycle.  
Cond. Cond. Mean Difference Std. Error Sig. 
95% Confidence Interval for 
Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH 1.268 0.811 1.000 -1.429 3.965 
3.5HH 2.680* 0.726 0.024 0.266 5.093 
4.5HH 3.123* 0.820 0.019 0.398 5.849 
5.5HH 3.473* 0.809 0.007 0.783 6.164 
2.5HH 1.5HH -1.268 0.811 1.000 -3.965 1.429 
3.5HH 1.412 0.512 0.154 -0.290 3.114 
4.5HH 1.855* 0.548 0.045 0.031 3.680 
5.5HH 2.205* 0.570 0.017 0.311 4.100 
3.5HH 1.5HH -2.680* 0.726 0.024 -5.093 -0.266 
2.5HH -1.412 0.512 0.154 -3.114 0.290 
4.5HH 0.444 0.473 1.000 -1.130 2.017 
5.5HH 0.794 0.465 1.000 -0.753 2.340 
4.5HH 1.5HH -3.123* 0.820 0.019 -5.849 -0.398 
2.5HH -1.855* 0.548 0.045 -3.680 -0.031 
3.5HH -.444 .473 1.000 -2.017 1.130 
5.5HH .350 .371 1.000 -.884 1.584 
 
6.3.2.5 Summary of sagittal plane ankle joint angles for shoes with different heel heights 
One of the aims of the thesis was to determine whether different rocker sole profiles may be 
specifically designed to place the ankle joint at an optimal position at which the plantarflexor 
muscles keep the loading to the calf muscles to a minimum for a given gait speed; especially 
during the propulsive phase. Therefore, the following results for heel height conditions are 
pertinent to this thesis: 
 Despite a reduction in sagittal plane ankle ROM for lower-heeled shoes 
demonstrated when compared to higher-heeled shoes  during the LR phase, walking 
in lower-heeled shoes produced significant increases in overall ROM during the full 
gait cycle; 
 Lower heel heights significantly increased ankle ROM between maximum dorsiflexion 
and maximum plantarflexion during stance phase of gait. Low-heeled shoes caused 
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the ankle to be more dorsiflexed during the whole gait cycle compared to high-
heeled ones; 
 High heeled shoes placed the ankle into a relatively more PF position during the gait 
cycle compared to low-heeled shoes; 
 The 1.5 cm heel placed the ankle at an angle so that the calf muscle MTU would be 
theoretically stretched where maximum DF occurred during the end of second rocker 
of gait. However, the 1.5 cm heel, the 2.5 cm, 3.5 cm and 4.5 cm heel kept the ankle 
closer to its natural resting position, and indeed, the 5.5 cm heel only produced less 
than 20  of dorsiflexion at this point in the gait cycle. 
 
Therefore, with regards to hypotheses Ha1a to Ha1g, these hypotheses are accepted with 
regards to the effect of alteration to shoe heel height as demonstrated in table 6.13.  
Table 6.13: Alternative hypotheses accepted/not accepted for alteration to heel height test 
condition. 
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Maximum PF during LR (Ha1a) Accepted Accepted control Accepted Accepted 
Ankle ROM during  LR (points 
1-2) degrees (Ha1b) 
Accepted Accepted control Not accepted Not 
accepted 
Max DF during 2nd rocker 
(Ha1c) 
Accepted Accepted control Accepted Accepted 
Ankle ROM  2nd rocker of gait 
(Ha1d) 
Not 
accepted 
Not 
accepted 
control Not accepted Accepted 
Max. PF 3rd rocker of gait 
(Ha1e) 
Accepted Not 
accepted 
control Not accepted Accepted 
Ankle ROM 3rd rocker of gait 
(Ha1g) 
Not 
accepted 
Not 
accepted 
control Not accepted Not 
accepted 
Maximum ROM during gait 
cycle (Ha1f) 
Accepted Not 
accepted 
control Not accepted Not 
accepted 
 
6.3.3 The effect of altering rocker sole apex position (AP) 
Sagittal plane ankle angle  plots are shown in figure 6.2, which compares the effect on ankle 
kinematics with shoes adapted with different rocker apex positions but the same heel 
height. These demonstrate that the shoe with a 55% apex rocker position (55AP), shifted the 
ankle into a more plantarflexed position during LR compared to the control shoe (where the 
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control shoe is 62.5AP) and also produced less maximum dorsiflexion during second rocker 
of gait. Additionally, it placed the ankle into more plantarflexion during third rocker of gait 
compared to both the other test conditions. This meant that a plantarflexion shift occurred 
during the whole of stance as well as during swing phase. 
 
Figure 6.2: Sagittal plane ankle motion when walking with the three apex position test 
conditions. (a) – without standard deviation (STD), (b) – with the lines shadowed to 
represent STD ranges. 
 
 
Table 6.14: Mean (±SD) sagittal plane ankle motion (deg) for three different rocker apex 
position test conditions. 
 55AP 62.5AP 70AP 
Ankle angle at initial contact (-)plantar/(+)dorsiflexion -0.9 (1.0) 0.1 (1.0) 0.1 (1.0) 
Max ankle PF angle during LR (deg) -12.6 (0.9) -11.3 (0.9) -11.0 (0.9) 
Max ankle DF angle during double support (deg) 3.5 (0.8) 5.1 (1.0) 7.7 (0.9) 
Max ankle PF angle at toe-off (deg) -20.5 (1.1) -18.6 (1.4) -16.4 (1.4) 
 
Pairwise comparison between AP conditions (table 6.15) shows that mean maximum ankle 
PF angle for the 55% apex rocker was significantly more plantarflexed than the other two 
test conditions during LR. The 70 AP rocker shoe did not show any significant difference 
compared to the control shoe (62.5% AP). 
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Table 6.15: Pairwise comparisons of apex positions for mean maximum ankle PF angle 
during LR. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
55AP 62.5AP -1.320* 0.268 0.001 -2.050 -0.591 
70 AP -1.607* 0.164 0.000 -2.052 -1.161 
62.5AP 55AP 1.320* 0.268 0.001 0.591 2.050 
70 AP -0.286 0.222 0.656 -0.890 0.318 
6.3.3.1 Alteration to ankle angle at maximum dorsiflexion during stance for different 
rocker APs 
Table 6.16 demonstrates that compared to the control shoe, the 55AP rocker test condition 
produced significantly less maximum dorsiflexion during the second rocker of gait when 
compared to the control shoe, whilst the 70AP shoe produced significantly more 
dorsiflexion. This means that all test conditions using different apex positions demonstrated 
statistically significant differences in maximum dorsiflexion during stance compared to each 
other. 
 
Table 6.16: Pairwise comparisons of rocker APs for maximum ankle DF angle during second 
rocker of gait). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
55AP 62.5AP -1.571* 0.441 0.009 -2.769 -0.372 
70 AP -4.234* 0.306 0.000 -5.067 -3.402 
62.5AP 55AP 1.571* 0.441 0.009 0.372 2.769 
70 AP -2.663* 0.425 0.000 -3.820 -1.507 
 
6.3.3.2 Alteration to maximum plantarflexion during stance for different rocker APs 
At the end of the third rocker of gait (toe-off phase) the 55% AP shoe produced significantly 
more PF compared to the control shoe, but in comparison, the shoe with the 70% AP 
induced significantly less PF . 
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6.3.3.3 Ankle ROM for different rocker APs 
The sagittal plane ankle ROM data did not show any significant differences (p>0.05) between 
any rocker APs during LR. Table 6.17 shows the mean and standard deviation values for 
ankle ROM for the AP conditions at specific points in the gait cycle. 
Table 6.17: Mean values for ankle ROM during gait cycle for different AP conditions. 
 55AP 62.5AP 70AP 
Ankle ROM during loading response (1-2) degrees 11.7 (1.2) 11.4 (0.9) 11.4 (1.0) 
Ankle ROM between point 2 and 3 (including LR to 
maximum angle DF phase) degrees 
16.1 (1.1) 16.4 (1.2) 18.7 (1.1) 
Ankle ROM between max DF and max PF during late 
stance (between points 3 and 4) degrees 
24.0 (1.1) 23.7 (1.6) 24.1 (1.4) 
Max ROM during gait cycle (deg) 24.1 (1.1) 23.8 (1.5) 24.5 (1.3) 
 
Ankle ROM during second rocker of gait (i.e. between points 2 and 3) did not show any 
statistical significance between the 55% and 62.5% rocker AP test conditions. However, the 
70% AP shoe increased ankle ROM significantly compared to the other two test conditions 
(table 6.18). 
Table 6.18: Pairwise statistical significance comparisons between shoe AP conditions and 
ankle ROM angle between point 2 and 3 of the gait cycle. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
55AP 62.5AP -0.251 0.502 1.000 -1.614 1.113 
70 AP -2.628* 0.321 0.000 -3.499 -1.756 
62.5AP 55AP 0.251 0.502 1.000 -1.113 1.614 
70 AP -2.377* 0.398 0.000 -3.458 -1.296 
 
With regards to maximum ROM within points 3 and 4 and maximum ROM during full gait 
cycle results did not show any significant differences between any apex length conditions.  
6.3.3.4 Summary: ankle kinematics for different rocker AP conditions 
 The 70% AP condition increased ankle ROM during stance phase up to pre-swing. 
However overall ROM during the full gait cycle was not significantly changed; 
201 
 
 The 55% AP shoe kept ankle significantly more plantarflexed during the gait cycle 
compared to the other AP but this did not significantly reduce ankle ROM; 
 Compared to the control shoe, a more distal apex position produced a more 
dorsiflexed  ankle joint except during LR; 
 The 55% apex position cause earlier plantarflexion motion during late stance phase 
(as was hypothesised in chapter 5).  
 
Table 6.19: Alternative hypotheses accepted/not accepted for alteration to apex position 
(AP) test conditions. 
 55% 62.5 % 70% 
Maximum PF during LR (Ha1a) Accepted control Not accepted 
Ankle ROM during  LR (points 1-2) degrees 
(Ha1b) 
Not accepted control Not accepted 
Max DF during 2nd rocker (Ha1c) Accepted control Accepted 
Ankle ROM  2nd rocker of gait (Ha1d) Not accepted control Accepted 
Max. PF 3rd rocker of gait (Ha1e) Accepted control Accepted 
Ankle ROM 3rd rocker of gait (Ha1g) Not accepted control Accepted 
Maximum ROM during gait cycle (Ha1f) Accepted control Not accepted 
 
6.3.4 The effect of altering rocker apex angle (toe angle-TA) 
6.3.4.1 Alteration to sagittal plane ankle kinematics 
In chapter 5 it was discussed and hypothesised that for rocker apex angles, higher angles 
would cause the ankle to be more plantarflexed during third rocker of gait (and also produce 
premature PF during late stance phase) and lower apex angles would cause the opposite 
effect.  
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Figure 6.3: sagittal plane ankle motion during the three apex angle conditions (TAs). (a) – 
without standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
 
6.3.4.2 Alteration to maximum plantarflexion and dorsiflexion during stance phase caused 
by different TA conditions. 
The mean values of ankle angle for the rocker sole TA conditions during stance phase are 
shown in table 6.20. 
Table 6.20: Mean (±SD) sagittal plane ankle motion for the three apex angles (TAs) tested.                                   
                 10° TA 15° TA 20° TA 
Ankle angle at initial contact (+)PF/(-)DF (deg.) 0.0 (1.0) 0.1 (1.0) -0.2 (1.1) 
Max ankle plantarflexion angle during LR (deg) -11.5 (0.9) -11.3 (0.9) -11.7 (0.7) 
Max ankle dorsiflexion angle during stance (deg) 6.7 (0.9) 5.1 (1.0) 4.3 (1.0) 
Max ankle PF angle at toe-off phase (deg) -17.9 (1.4) -18.6 (1.4) -20.3 (1.6) 
 
There were no significant differences between test conditions for maximum plantarflexion 
during LR. Table 6.21 demonstrates the relevant data and the significance value of 
comparison between test conditions utilising different toe angles for maximum dorsiflexion 
of the ankle during second rocker of gait during stance phase. It shows significance for the 
10°TA rocker shoe for maximal DF compared to the control condition (15°) and the 20° test 
condition. The 20° rocker sole TA test condition heel did not show any significance that it 
was less dorsiflexed compared to the control shoe. 
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Table 6.21: Pairwise comparisons of rocker toe angles (TAs) for maximum ankle DF angle 
during stance phase. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
10° TA 15° TA 1.643* 0.377 0.002 0.620 2.667 
20° TA 2.412* 0.416 0.000 1.282 3.542 
15° TA 10° TA -1.643* 0.377 0.002 -2.667 -0.620 
20° TA 0.769 0.497 0.432 -.581 2.118 
 
During toe-off phase (third rocker of gait) the 20° test condition produced significantly more 
maximum PF compared to the other two rocker apex test conditions. These results confirm 
the toe angle hypothesis alteration. 
 
6.3.4.3 Ankle ROM when walking with shoes adapted with different rocker TAs 
Table 6.22 shows the effect of different rocker apex angles on ankle ROM during the 
complete gait cycle. Ankle ROM between point 2 and 3 (LR to late stance phase at which 
maximum DF occurs) did not show any statistical significance between the 15° apex angle 
test condition (control) and the 20° test condition. However, the 10° apex angled-shoe 
increased ROM significantly compared to the other two test conditions during second rocker 
of gait, as shown in table 6.22. 
Table 6.22: Mean values for ankle ROM during the gait cycle for different apex-angled shoes. 
 10° TA 15° TA 20° TA 
Ankle ROM during loading response (1-2) (deg.) 11.5 (0.9) 11.4 (0.9) 11.5 (1.0) 
Ankle ROM between point 2 and 3 (including LR to 
max angle DF phase degrees) 
18.2 (1.3) 16.4 (1.2) 16.0 (1.3) 
Ankle ROM between max DF and max PF during 
late stance (between points 3 and 4 degrees) 
24.6 (1.3) 23.7 (1.6) 24.6 (1.6) 
Max ROM during gait cycle (deg) 25.3 (1.2) 23.8 (1.5) 24.7 (1.6) 
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Table 6.23: Pairwise statistical significance comparisons between apex angle conditions and 
ankle ROM between points 2 and 3 of the gait cycle. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
10° TA 15° TA 1.881* 0.334 0.000 0.974 2.788 
20° TA 2.191* 0.422 0.000 1.045 3.337 
15° TA 10° TA -1.881* 0.334 0.000 -2.788 -0.974 
20° TA 0.310 0.513 1.000 -1.083 1.704 
 
There were no statistically significant differences in ankle ROM between maximum 
dorsiflexion and maximum plantarflexion during stance phase. However, the 10° test 
condition increased maximum ROM during the whole gait cycle to a significant level 
compared to the control shoe (p=0.013). 
6.3.4.4 Summary of sagittal ankle angle for the different rocker TA conditions 
 The 10° TA shoe increased the maximum ankle DF angle during stance and also 
significantly increased the maximum ankle ROM during the full gait cycle compared 
to the control test condition; 
 The 20° TA caused premature plantarflexion during late stance phase, and produced 
a plantarflexion shift throughout the remainder of stance phase and most of swing 
phase compared to both the other test conditions up to the point of TSw., at which 
point the ankle angle at IC was not significantly different from the other two test 
conditions. 
Table 6.24 demonstrates the significance of the TA conditions relative to the control 
condition (15° TA). 
Table 6.24: Alternative hypotheses accepted/not accepted for alteration to apex position 
(AP) test conditions. 
 10° TA 15° TA 20° TA 
Maximum PF during LR (Ha1a) Not accepted control Not accepted 
Ankle ROM during  LR (points 1-2) degrees (Ha1b) Not accepted control Not accepted 
Max DF during 2nd rocker (Ha1c) Accepted control Not accepted 
Ankle ROM  2nd rocker of gait (Ha1d)  Accepted control Accepted 
Max. PF 3rd rocker of gait (Ha1e) Not Accepted control Accepted 
Ankle ROM 3rd rocker of gait (Ha1g) Not accepted control Not accepted 
Maximum ROM during gait cycle (Ha1f) Accepted control Not accepted 
205 
 
6.3.5 The effect of adding heel curves 
The sagittal plane ankle joint kinematics (Figure 6.4, Table 6.25, Table 6.26) demonstrate 
that a dorsiflexion shift occurred for both curved heel test conditions during LR, MS and TS. 
It also can be seen that a significant (p<0.001) reduction in ROM occurred for the half curved 
heel shoe and greater reduction for full curve profile and mean PF values during LR between 
all conditions.  
 
Figure 6.4: Sagittal plane ankle motion for the complete gait cycle during walking with 
curved heels compared to a control shoe. (a) – without standard deviation (STD), (b) – with 
the lines shadowed to represent STD ranges. 
 
The 0° degree line represents the barefoot static position with the foot in parallel to the 
ground and the shank has a 0° incline/recline. Legend 1 indicates the point at which the 
ankle is at ICt; legend 2 indicates the area where maximum ankle plantarflexion occured 
during LR; legend 3 indicates the area at which maximum ankle dorsiflexion angle occurred 
during MSt; and legend 4 indicates the position where maximum ankle plantarflexion at toe-
off occurred. 
 
Table 6.25: Mean (±SD) sagittal plane ankle rotation demonstrated by the three different 
curved heel test conditions. 
 Full curve Half curve control 
Ankle angle at initial contact (deg) 
(-)plantar/(+)dorsiflexion 
0.3 (1.0) 0.4 (1.0) 0.1 (1.0) 
Max ankle PF angle during LR (deg) -7.8 (0.9) -9.5 (0.9) -11.3 (0.9) 
Max ankle DF angle during stance phase (deg) 6.4 (0.9) 6.2 (1.0) 5.1 (1.0) 
Max ankle PF angle at toe-off phase (deg) -18.0 (1.7) -17.5 (1.4) -18.6 (1.4) 
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Table 6.26: Mean values for sagittal plane ankle ROM during the complete gait cycle for 
different curved heel shoe test conditions. 
 Full curve Half curve control 
Ankle ROM during loading response (1-2) degrees 8.0 (1.0) 9.9 (0.8) 11.4 (0.9) 
Ankle ROM between point 2 and 3 (including LR to 
maximum angle DF phase) degrees 
14.2 (1.3) 15.7 (1.3) 16.4 (1.2) 
Ankle ROM between maximum dorsiflexion and 
maximum plantarflexion during late stance (between 
points 3 and 4) degrees 
24.4 (1.5) 23.7 (1.5) 23.7 (1.5) 
Maximum ROM during gait cycle (deg) 24.6 (1.6) 23.9 (1.4) 23.8 (1.5) 
 
The full curve and half curve-heeled shoes produced a statistically significant increase in 
maximum ankle DF angle during stance phase compared to the shoes with no heel curve as 
shown in the table 6.25. However, there was no significant difference between the curved 
heels for this parameter. Whilst ankle angle at IC was not significantly altered between any 
of the test conditions, a dorsiflexion shift appeared during loading response commensurate 
with a reduction in ankle plantarflexion ROM during LR, and continued through second 
rocker of gait for both the curved heel test conditions to produce the dorsiflexion shift noted 
at the maximum DF position (table 6.27). 
Table 6.27: Pairwise comparisons of curved heel shoe test conditions for maximum ankle DF 
angle during stance phase. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
Full curve Half curve 0.237 0.200 0.764 -0.305 0.779 
No curve 1.364* 0.436 0.022 0.179 2.548 
Half curve Full curve -0.237 0.200 0.764 -0.779 0.305 
No curve 1.127* 0.392 0.037 0.060 2.193 
 
During toe-off phase the half curved heel showed significance in reduction of max PF 
(P=0.043). 
Ankle ROM between point 2 and 3 (second rocker of gait) for the full- curved heel showed a 
statistically significant increase in ankle ROM when compared to both the half- curved heel 
and baseline control shoes as shown in table 6.25. 
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Table 6.28: Pairwise statistical significance comparisons between curved heel conditions and 
ankle ROM angle between point 2 and 3 of the gait cycle. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
Full curve Half curve -1.494* 0.266 0.000 -2.217 -0.771 
No curve -2.137* 0.456 0.001 -3.375 -0.898 
Half curve Full curve 1.494* 0.266 0.000 0.771 2.217 
No curve -0.643 0.380 0.339 -1.676 0.391 
 
There were no statistical significant differences between any footwear conditions for 
maximum ROM between point 3 and 4 and during full gait cycle. 
 
6.3.5.1 Summary of sagittal plane ankle angle alterations produced by curved heel test 
conditions 
 Both curved heel test conditions shifted the ankle joint into a more DF position 
during  LR, second rocker of gait and the majority of swing phase and therefore calf 
muscle lengths would have been lengthened compared to the control condition; 
 The curved heels reduced the maximal ankle plantarflexion angle during third rocker 
of gait and also reduced ankle ROM during LR. 
 The curved heels not only altered the beginning of the stance phase but also full gait 
cycle kinematics.  
 
Table 6.29: Alternative hypotheses accepted/not accepted for alteration to heel curve test 
conditions. 
 Full curve Half curve control 
Maximum PF during LR (Ha1a) accepted accepted control 
Ankle ROM during  LR (points 1-2) degrees (Ha1b) accepted accepted control 
Max DF during 2nd rocker (Ha1c) Accepted accepted control 
Ankle ROM  2nd rocker of gait (Ha1d) Accepted Not accepted control 
Max. PF 3rd rocker of gait (Ha1e) Not Accepted Accepted control 
Ankle ROM 3rd rocker of gait (Ha1g) Not accepted Not accept control 
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6.4 The effect of altering rocker sole stiffness at the metatarsal arcade area 
6.4.1 Alteration to sagittal plane ankle kinematics 
Sagittal plane ankle kinematics did not show any statistical significant differences during the 
gait cycle except during the third rocker of gait. A plantarflexion shift occurred during third 
rocker of gait, which continued into swing phase for the two more flexible test conditions, 
but even this was limited to less than 2 degrees at the point of maximal ankle plantarflexion 
during third rocker of gait.         . 
 
Figure 6.5: Sagittal plane ankle motion for shoes adapted to be more flexible at the 
metatarsal area compared to the control shoe. (a) – without standard deviation (STD), (b) – 
with the lines shadowed to represent STD ranges. 
 
Table 6.30: Kinematic data produced when walking with shoes with different forefoot sole 
stiffness. 
 Flexible sole Medium 
flexibility 
Solid 
Ankle angle at initial contact  (deg) 
(+)plantar/(-)dorsiflexion 
0.0 (1.0) -0.7 (1.0) 0.1 (1.0) 
Max ankle PF angle during LR (deg) -11.9 (0.8) -11.6 (0.8) -11.3 (0.9) 
Max ankle DF angle during stance phase (deg) 5.2 (0.9) 5.1 (0.9) 5.1 (1.0) 
Max ankle PF angle at toe-off phase (deg) -20.1 (1.4) -20.0 (1.5) -18.6 (1.4) 
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Table 6.31: Mean (±SD) sagittal plane ankle ROM (degs) for three different flexibility levels of 
the rocker sole at the metatarsal arcade area. 
 Flex sole Med. flex Solid 
Ankle ROM during LR (1-2) 11.1 (0.9) 10.9 (0.8) 11.4 (0.9) 
Ankle ROM between point 2 and 3 (including LR to 
max angle DF phase) 
17.1 (1.1) 16.7 (1.1) 16.4 (1.2) 
Ankle ROM between max DF and max PF during late 
stance (between points 3 and 4) 
25.3 (1.5) 25.1 (1.6) 23.7 (1.6) 
Max ROM during gait cycle. 25.7 (1.4) 25.2 (1.5) 23.8 (1.5) 
 
During toe-off phase the most solid rocker sole kept the ankle significantly less plantarflexed 
compared to the flexible and semiflexible footwear conditions (P<0.04) as shown in the table 
6.32. 
Table 6.32: Pairwise statistical significance comparisons for maximum ankle plantarflexion 
angle at toe-off phase between the forefoot shoe flexibility conditions. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
Flex sole Med. flex -0.117 0.615 1.000 -1.789 1.556 
Solid -1.515* 0.461 0.016 -2.767 -0.263 
Med. flex Flex sole 0.117 0.615 1.000 -1.556 1.789 
Solid -1.398* 0.494 0.040 -2.741 -0.056 
 
6.4.2 Alteration to ankle ROM produced by different forefoot sole flexibilities 
The more flexible and semi-flexible sole units demonstrated significant increase in maximum 
ROM between point 3 and 4 compared to the control solid shoe condition as shown in table 
6.33. 
Table 6.33: Pairwise statistical significance comparisons for maximum ankle ROM during 
third rocker of gait between flexible and semi-flexible sole unit conditions. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
Flex sole Med. flex 0.217 0.527 1.000 -1.216 1.650 
Solid 1.675* 0.509 0.016 .291 3.058 
Med. flex Flex sole -0.217 0.527 1.000 -1.650 1.216 
Solid 1.458* 0.474 0.025 .170 2.745 
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Maximum ankle ROM angle was increased to significant level for flexible shoe (p<0.001) and 
increased for medium flexible shoe (p=0.037) versus solid shoe. 
6.4.3 Summary of ankle angle results for variation in shoe forefoot flexibility 
 The shoes with semi-flexible and flexible areas at the metatarsal head area produced 
an increase in the maximum PF angle during toe-off phase to a statistically-significant 
level compared to the less flexible control shoe condition; 
 The footwear conditions (flexible and that with medium flexibility) increased 
maximum ROM during push off phase (between max DF at terminal stance and max 
PF at toe-off phase). That would also alter the concentric contraction velocity and of 
the calf muscle and alter the MTU length of travel of the calf muscles; 
 The flexible profile shoe increased the maximum range of motion detected during 
the whole gait cycle. 
Table 6.34: Alternative hypotheses accepted/not accepted for alteration to heel curve test 
conditions. 
 Flex sole Med. flex Solid 
Maximum PF during LR (Ha1a) Not accepted Not accepted control 
Ankle ROM during  LR (points 1-2) degrees (Ha1b) Not accepted Not accepted control 
Max DF during 2nd rocker (Ha1c) Not accepted Not accepted control 
Ankle ROM  2nd rocker of gait (Ha1d) Not accepted Not accepted control 
Max. PF 3rd rocker of gait (Ha1e) Accepted Accepted control 
Ankle ROM 3rd rocker of gait (Ha1g) Accepted Accepted control 
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6.5 SAGITTAL PLANE KNEE KINEMATICS 
6.5.1 The effect of walking with different heel heights 
In figure 6.6, legend 1 indicates where maximum knee flexion occurs during LR; Legend 2 
indicates the point at which maximum knee extension angle occurred during stance phase; 
legend 3 indicates the point at which maximum knee flexion angle occurred during toe-off 
and legend 4 indicates the position where maximum knee flexion occurs during swing phase 
of normal adult gait. 
Figure 6.6 shows the average of the data (n=15) analysed for knee kinematics in the sagittal 
plane for footwear with different heel heights acquired during the walking trials. It can be 
seen that the 1.5 cm heel increased knee flexion during IC and the LR phase and also caused 
premature maximal knee flexion during LR; and consequently caused a reduction in the time 
taken for LR. This could have been due to alteration to the ankle ROM resulting in the 
shorter time taken during LR phase. The 1.5 cm heel also induced maximum knee extension 
prematurely (at point 2 in figure 6.6) compared to the other heel height test conditions and 
also increased knee flexion during 40%-62% of the gait cycle including toe-off phase, which is 
the main interest for the calf muscle work. The opposite effect was produced by wearing 
shoes with the higher heel test conditions during late stance. 
 
Figure 6.6: Sagittal plane knee motion during the five heel height test conditions where the 
control shoe is 3.5 HH. (a) – without standard deviation (STD), (b) – with the lines shadowed 
to represent STD ranges. 
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6.5.1.1 Sagittal plane knee kinematics during IC 
At ICt, the 1.5 cm negative heel test condition increased knee flexion by 2.9° (SD:1.4°) when 
compared with the control shoe (table 6.29). The 5.5 cm heel test condition kept the knee 
more extended when compared to the negative heels tested and the control shoe. 
6.5.1.2 The effect of heel height test conditions during loading response (LR) 
During LR, there were no statistically significant differences in maximum knee flexion values. 
Premature knee flexion occurred when walking with the 1.5 cm heel and slightly increased 
knee extension for the high-heeled shoes. 
Table 6.35: Mean (±SD) sagittal plane knee kinematics (degs) when walking with shoes with 
five different heel height test conditions.  
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Knee angle at ICt  (deg) 8.2 (1.4) 5.4 (1.2) 5.3 (1.4) 4.5 (1.2) 4.0 (1.4) 
Maximum knee flexion angle 
during LR  (deg) 
23.0 (1.5) 21.8 (1.1) 22.4 (1.4) 21.3 (1.1) 21.1 (2.0) 
Max knee extension during 
stance  (deg) 
7.2 (1.3) 6.8 (1.2) 7.4 (1.3) 6.8 (1.2) 5.7 (1.2) 
Max knee flexion angle at toe-
off  (deg) 
58.1 (2.8) 52.3 (2.4) 50.7 (2.6) 46.7 (3.0) 43.6 (3.2) 
Max knee flexion angle during 
swing  (deg) 
72.5 (1.6) 72.5 (1.0) 70.9 (0.9) 68.6 (1.1) 66.8 (2.5) 
Max Knee ROM between point 
2-3  (deg) 
50.9 (2.7) 45.6 (2.5) 43.3 (2.9) 39.9 (3.1) 37.9 (3.3) 
Max knee ROM during support 
(deg) 
55.6 (2.8) 50.8 (2.7) 48.9 (2.7) 45.1 (3.2) 42.2 (3.4) 
 
 
6.5.1.3 The effect of heel height test conditions on knee angle during late stance 
During late stance, the 5.5 cm heel height produced significantly increased knee extension 
compared to the control shoe (p=0.025) and the maximum extension phase was delayed 
versus control and negative-heel test footwear conditions. 
213 
 
6.5.1.4 The effect of heel height test conditions on knee angle at TO (maximum knee 
flexion) 
At toe-off, the 1.5 cm heel was significantly more flexed when compared to the 3.5 cm heel 
and even more flexed compared to the heels, which were more raised (table 6.30). With 
raising the heel height, the knee was gradually more extended at toe-off. 
Table 6.36: Pairwise comparisons of shoe conditions for max knee flexion at toe-off. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH 5.732* 0.755 0.000 3.222 8.241 
3.5HH 7.393* 1.034 0.000 3.955 10.832 
4.5HH 11.336* 1.083 0.000 7.736 14.937 
5.5HH 14.474* 1.125 0.000 10.732 18.216 
2.5HH 1.5HH -5.732* 0.755 0.000 -8.241 -3.222 
3.5HH 1.661 0.879 0.796 -1.262 4.584 
4.5HH 5.604* 0.819 0.000 2.882 8.327 
5.5HH 8.742* 0.858 0.000 5.890 11.594 
3.5HH 1.5HH -7.393* 1.034 0.000 -10.832 -3.955 
2.5HH -1.661 0.879 0.796 -4.584 1.262 
4.5HH 3.943* 0.609 0.000 1.918 5.968 
5.5HH 7.081* 0.927 0.000 3.997 10.164 
4.5HH 1.5HH -11.336* 1.083 0.000 -14.937 -7.736 
2.5HH -5.604* 0.819 0.000 -8.327 -2.882 
3.5HH -3.943* 0.609 0.000 -5.968 -1.918 
5.5HH 3.137* 0.904 0.038 0.129 6.146 
 
 
6.5.2 Alteration to kinetics of the knee during swing phase whilst walking in different 
heel heights 
During swing phase, a similar effect on knee kinematics was noted as seen during toe-off 
phase between footwear test conditions; where the 1.5 cm heel was significantly more 
flexed compared to the 4.5 cm and 5.5 cm heel-height shoes. The 4.5 cm and 5.5 cm heeled 
shoes were significantly more extended compared to the control shoe as shown in the table 
6.31. 
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Table 6.37: Pairwise comparisons of shoe conditions for max knee flexion during swing 
phase. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH -0.025 0.731 1.000 -2.456 2.406 
3.5HH 1.600 0.895 0.955 -1.377 4.577 
4.5HH 3.861* 0.801 0.003 1.199 6.523 
5.5HH 5.697* 1.069 0.001 2.144 9.251 
2.5HH 1.5HH 0.025 0.731 1.000 -2.406 2.456 
3.5HH 1.625 0.511 0.067 -0.075 3.326 
4.5HH 3.886* 0.353 0.000 2.711 5.061 
5.5HH 5.722* 0.806 0.000 3.042 8.403 
3.5HH 1.5HH -1.600 0.895 0.955 -4.577 1.377 
2.5HH -1.625 0.511 0.067 -3.326 0.075 
4.5HH 2.261* 0.496 0.004 0.610 3.911 
5.5HH 4.097* 0.792 0.001 1.464 6.730 
4.5HH 1.5HH -3.861* 0.801 0.003 -6.523 -1.199 
2.5HH -3.886* 0.353 0.000 -5.061 -2.711 
3.5HH -2.261* 0.496 0.004 -3.911 -0.610 
5.5HH 1.836 0.764 0.306 -0.703 4.376 
. 
6.5.3 Knee sagittal plane ROM 
Table 6.38 demonstrates the knee ROMs produced when walking with shoes adapted with 
different heel heights.  
Table 6.38: Mean values for maximum knee ROM between the point 2-3 and within 
complete stance phase for shoes with different heel heights. 
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Max Knee ROM between point 
2-3 (deg) 
50.9 (2.7) 45.6 (2.5) 43.3 (2.9) 39.9 (3.1) 37.9 (3.3) 
Max knee ROM during support 
(deg) 
55.6 (2.8) 50.8 (2.7) 48.9 (2.7) 45.1 (3.2) 42.2 (3.4) 
 
The 1.5 cm HH significantly increased knee ROM versus all test footwear conditions and it 
can be seen that with raising the heel height the knee ROM was gradually reduced between 
maximum extension at TSt and maximum flexion at toe-off phase. The 5.5 cm heel reduced 
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maximum knee ROM between points 2-3 when compared to all the other footwear 
conditions except for the 4.5 cm heel as shown in table below. 
Table 6.39: Pairwise comparisons of shoe conditions for max knee RM between point 2 and 
3. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH 5.302* 0.962 0.001 2.104 8.500 
3.5HH 7.579* 0.771 0.000 5.014 10.144 
4.5HH 11.002* 1.136 0.000 7.223 14.781 
5.5HH 12.954* 1.052 0.000 9.455 16.454 
2.5HH 1.5HH -5.302* 0.962 0.001 -8.500 -2.104 
3.5HH 2.277 0.902 0.242 -0.722 5.276 
4.5HH 5.700* 0.898 0.000 2.713 8.687 
5.5HH 7.652* 0.613 0.000 5.615 9.690 
3.5HH 1.5HH -7.579* 0.771 0.000 -10.144 -5.014 
2.5HH -2.277 0.902 0.242 -5.276 0.722 
4.5HH 3.423* 0.644 0.001 1.280 5.566 
5.5HH 5.375* 0.849 0.000 2.553 8.198 
4.5HH 1.5HH -11.002* 1.136 0.000 -14.781 -7.223 
2.5HH -5.700* 0.898 0.000 -8.687 -2.713 
3.5HH -3.423* 0.644 0.001 -5.566 -1.280 
5.5HH 1.952 0.810 0.303 -0.742 4.646 
 
The 1.5 cm HH significantly increased maximum knee ROM during stance phase versus all 
test footwear conditions. It also can be seen that with raising heel height it resulted in 
significant gradual reduction of ROM during stance phase versus lower heels (table 6.40).  
Table 6.40: Pairwise comparisons of shoe conditions for max ROM during stance phase. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH 4.785* 0.848 0.001 1.963 7.607 
3.5HH 6.780* 0.934 0.000 3.674 9.886 
4.5HH 10.521* 1.133 0.000 6.752 14.290 
5.5HH 13.393* 0.967 0.000 10.177 16.610 
2.5HH 1.5HH -4.785* 0.848 0.001 -7.607 -1.963 
3.5HH 1.995 0.856 0.353 -0.852 4.842 
4.5HH 5.736* 0.922 0.000 2.670 8.802 
5.5HH 8.608* 0.705 0.000 6.263 10.954 
3.5HH 1.5HH -6.780* 0.934 0.000 -9.886 -3.674 
2.5HH -1.995 0.856 0.353 -4.842 0.852 
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4.5HH 3.741* 0.657 0.001 1.557 5.925 
5.5HH 6.614* 0.911 0.000 3.584 9.644 
4.5HH 1.5HH -10.521* 1.133 0.000 -14.290 -6.752 
2.5HH -5.736* 0.922 0.000 -8.802 -2.670 
3.5HH -3.741* 0.657 0.001 -5.925 -1.557 
5.5HH 2.873* 0.841 0.042 .074 5.671 
 
The 1.5 cm HH significantly increased maximum knee ROM during stance phase versus all 
test footwear condition. It also can be seen that with raising heel height it resulted in 
gradual increase of knee extension during LR, an increase knee flexion during TS phase if 
compared versus negative-heeled shoes and increase extension of the knee ROM between 
maximum extension at TS and maximum flexion at toe-off phase. The 5.5 cm heel reduced 
max knee ROM between points 2-3 if compared versus all footwear conditions except for 4.5 
cm heel. 
6.5.4 Summary – sagittal plane knee joint angle for different heel heights 
 The 1.5 cm heel increased knee flexion during ICt and raised heels slightly increased 
knee extension. The results suggest that the knee was more flexed, thus shank incline 
was increased, and therefore negative profile and shank incline caused huge 
alterations to ankle joint kinematics. 
 There were no statistically significant differences demonstrated between conditions 
for maximum knee flexion during loading response. However, 1.5 cm heel caused 
premature knee flexion during LR and raised heel test conditions showed slight knee 
extension. 
 During mid-stance phase the 1.5 cm heel resulted in knee extension and considerable 
less knee extension occurred for the 2.5 cm heel test condition when compared to all 
test conditions. 
 During 40%-50% of terminal stance phase the positive heel shoes stayed longer in 
knee extension position when compared to control and the 1.5 cm heel was 
significantly more flexed. 
 The 1.5 cm heel significantly increased knee flexion ROM within 40% - 62% stance 
phase, and the opposite effect was noted for raised heels.  
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Table 6.41: Alternative hypotheses accepted/not accepted for alteration to heel height test 
conditions. 
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Knee angle at ICt accepted Not 
accepted 
control Not 
accepted 
Not 
accepted 
Maximum knee flexion angle 
during LR (Ha1h) 
Not 
accepted 
Not 
accepted 
control Not 
accepted 
Not 
accepted 
Max knee extension during 
stance  (Ha1i) 
Not 
accepted 
Not 
accepted 
control Not 
accepted 
accepted 
Max knee flexion angle at toe-
off (Ha1j) 
accepted Not 
accepted 
control accepted accepted 
Max knee flexion angle during 
swing (Ha1k) 
Not 
accepted 
Not 
accepted 
control accepted accepted 
Max Knee ROM between point 
2-3 (Ha1l) 
accepted Not 
accepted 
control accepted accepted 
Max knee ROM during support 
(Ha1m) 
accepted Not 
accepted 
control accepted accepted 
 
6.5.5 The effect of altering rocker sole apex position (AP) 
Figure 6.7 shows the average of the knee kinematics in the sagittal plane for different apex 
length shoes. 
 
Figure 6.7: Sagittal plane knee motion during the three apex position test conditions where 
the control shoe is 62.5AP. Legend 1 indicates where maximum knee flexion angle occurred 
during LR; Legend 2 indicates the point at which maximum knee extension angle occurred 
during terminal stance phase; legend 3 indicates the point at which maximum knee flexion 
angle occurred at toe-off; and legend 4 indicates the position where maximum knee flexion 
angle during swing occurred. (a) – without standard deviation (STD), (b) – with the lines 
shadowed to represent STD ranges. 
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Table 6.42 shows mean values and ROM for knee motion in sagittal conditions for different 
apex length test conditions. 
Table 6.42: Mean (±SD) sagittal plane knee motion (degs) for three different apex position, 
max ROM between point 2-3  and max knee ROM during stance phase (N=15). 
 55AP 62.5AP 70AP 
Knee angle at ICt (deg) 4.7 (1.4) 5.3 (1.4) 5.4 (1.3) 
Maximum knee flexion angle during LR (deg) 21.7 (1.3) 22.4 (1.4) 21.0 (1.2) 
Max knee extension during TSt (deg) 6.8 (1.4) 7.4 (1.3) 7.1 (1.0) 
Max knee flexion angle at toe-off (deg) 49.3 (3.1) 50.7 (2.6) 51.8 (2.5) 
Max knee flexion angle during swing (deg) 70.2 (1.0) 70.9 (0.9) 70.6 (1.2) 
Max Knee ROM between point 2-3 (deg) 42.4 (3.3) 43.3 (2.9) 44.7 (2.4) 
Max knee ROM during support (deg) 48.0 (3.3) 48.9 (2.7) 49.9 (2.7) 
 
6.5.5.1 Loading response  
Pairwise comparison between different AP conditions (table 6.36) demonstrates that the 70 
AP test condition had significantly less knee flexion (p=0.044) when compared to control 
shoe.  
 
Table 6.43: Pairwise comparisons of apex positions for mean knee flexion during LR. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
55AP 62.5AP -0.664 0.574 0.800 -2.225 0.896 
70 AP 0.657 0.630 0.944 -1.055 2.368 
62.5AP 55AP 0.664 0.574 0.800 -0.896 2.225 
70 AP 1.321* 0.475 0.044 0.029 2.613 
 
6.5.5.2 Knee range of motion 
The sagittal plane knee ROM showed that the 70AP footwear condition significantly 
increased ROM between point 2 and 3 (maximum extension during terminal stance and 
maximum flexion during toe-off phase) when compared to the 55AP footwear condition 
(p=0.024) as shown in the table 6.44.  
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Table 6.44: Pairwise comparisons of apex positions for mean knee flexion between point 2 
and 3. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
55AP 62.5AP -0.874 0.604 .510 -2.516 0.768 
70 AP -2.233* 0.723 .024 -4.197 -0.268 
62.5AP 55AP 0.874 0.604 .510 -0.768 2.516 
70 AP -1.359 0.683 .200 -3.215 0.497 
 
6.5.5.3 Summary of knee joint flexion results for different apex position conditions: 
 The 70AP footwear test condition significantly reduced knee flexion when compared 
to control (p=0.044). 
 The 70AP footwear test condition significantly increased ROM between point 2 and 3 
(maximum extension during terminal stance and maximum flexion during toe-off 
phase) when compared to 55AP footwear condition (p=0.024). 
 
 
Table 6.45: Alternative hypotheses accepted/not accepted for alteration to rocker apex 
positions. 
 55AP 62.5AP 70AP 
Max knee flexion angle during LR (Ha1h) Not accepted control accepted 
Max knee extension during stance  (Ha1i) Not accepted control Not accepted 
Max knee flexion angle at toe-off (Ha1j) Not accepted control Not accepted 
Max knee flexion angle during swing (Ha1k) Not accepted control Not accepted 
Max Knee ROM between point 2-3 (Ha1l) Not accepted control accepted 
Max knee ROM during support (Ha1m) Not accepted control Not accepted 
 
6.5.6 Toe angle (apex angle) 
Figure 6.8 shows the average data for knee kinematics in sagittal plane for different apex 
angle footwear conditions acquired during the walking trials for N=15. Figure 6.8 
demonstrates that there was a slight change in maximum knee flexion during LR phase 
where the 10° toe angle test condition produced more knee extension versus the control 
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shoe. During swing phase maximum knee flexion was reduced for the 20° toe angle test 
condition.  
 
Figure 6.8: Sagittal plane knee motion during the three apex angle test conditions where the 
control shoe is 15°. Legend 1 indicates where maximum knee flexion angle occurred during 
LR; Legend 2 indicates the point at which maximum knee extension angle occurred during 
terminal stance phase; legend 3 indicates the point at which maximum knee flexion angle 
occurred at toe-off; and legend 4 indicates the position where maximum knee flexion angle 
during swing occurred. (a) – without standard deviation (STD), (b) – with the lines shadowed 
to represent STD ranges. 
Mean values for knee kinematics in sagittal plane are shown in the table below. 
Table 6.46: Mean (±SD) sagittal plane knee motion (degs) for three different toe angle test 
footwear conditions, max ROM between point 2-3 and max knee ROM during stance phase 
(N=15). 
 10° TA 15° TA 20° TA 
Knee angle at ICt (deg) 5.3 (1.2) 5.3 (1.4) 5.2 (1.2) 
Maximum knee flexion angle during LR (deg) 21.4 (1.5) 22.4 (1.4) 21.8 (1.5) 
Max knee extension during TSt (deg) 6.9 (1.1) 7.4 (1.3) 6.6 (1.0) 
Max knee flexion angle at toe-off (deg) 50.8 (2.8) 50.7 (2.6) 50.7 (3.7) 
Max knee flexion angle during swing (deg) 70.8 (0.9) 70.9 (0.9) 69.5 (2.5) 
Max Knee ROM between point 2-3 (deg) 43.9 (2.8) 43.3 (2.9) 44.5 (2.7) 
Max knee ROM during support (deg) 49.0 (3.0) 48.9 (2.7) 49.5 (2.8) 
 
However, one-way Anova did not show any statistical significance changes for all 
parameters. All alternative hypotheses appertaining to parameters listed in table 6.46 were 
therefore not accepted.  
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6.5.7 Heel curves 
Figure 6.9 shows the average knee kinematic data in the sagittal plane for different heel-
curved shoes. The alteration caused by the full heel curve test condition resulted in a slight 
reduction in the time taken for LR. It also increased knee extension within 10-40% of the gait 
cycle and also subsequently increased knee flexion during push-off and toe-off phases. 
 
 
Figure 6.9: Sagittal plane knee motion during the three different level of heel curvature of 
test conditions where the control shoe has no curve. (a) – without standard deviation (STD), 
(b) – with the lines shadowed to represent STD ranges. 
 
Table 6.47: Mean (±SD) sagittal plane knee motion (degs) for three different heel curves, 
maximum ROM between point 2-3,  and maximum knee ROM during stance phase. 
 Full curve Half curve control 
Knee angle at ICt (deg) 6.6 (1.3) 6.5 (1.5) 5.3 (1.4) 
Maximum knee flexion angle during LR (deg) 22.0 (1.6) 21.9 (1.4) 22.4 (1.4) 
Max knee extension during TSt (deg) 6.6 (1.3) 6.7 (1.2) 7.4 (1.3) 
Max knee flexion angle at toe-off (deg) 54.5 (2.6) 54.1 (2.5) 50.7 (2.6) 
Max knee flexion angle during swing (deg) 70.4 (1.3) 70.6 (1.2) 70.9 (0.9) 
Max Knee ROM between point 2-3 (deg) 47.9 (3.0) 47.3 (2.6) 43.3 (2.9) 
Max knee ROM during support (deg) 52.7 (3.1) 52.1(2.4) 48.9 (2.7) 
 
6.5.7.1 The knee kinematics during IC 
The full heel curve footwear placed the knee into a more flexion position by 1.3 degrees 
when compared to the control shoe (p=0.049) at initial contact phase. 
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Table 6.48 Pairwise statistical significance comparisons between curved heel conditions and 
knee angle at ICt. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for 
Difference 
Lower Bound Upper Bound 
Full curve Half curve 0.023 0.463 1.000 -1.235 1.282 
No curve 1.221* 0.448 0.049 0.003 2.439 
Half curve Full curve -0.023 0.463 1.000 -1.282 1.235 
No curve 1.198 0.564 0.156 -0.334 2.729 
 
6.5.7.2 Knee range of motion 
Heel curves demonstrated a significant increase in knee ROM between points 2 -3 when 
compared to the control shoe (p<0.001) as shown in the table 6.49. 
Table 6.49: Pairwise statistical significance comparisons between shoe conditions and 
maximum knee ROM angle between point 2 and 3 of the gait cycle (N=15). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for 
Difference 
Lower Bound Upper Bound 
Full curve Half curve 0.577 0.732 1.000 -1.412 2.565 
No curve 4.570* 0.646 0.000 2.814 6.326 
Half curve Full curve -0.577 0.732 1.000 -2.565 1.412 
No curve 3.993* 0.878 0.001 1.608 6.379 
 
Similar results for maximum knee ROM angle during stance phase were demonstrated 
where curved heel profiles significantly increased maximum knee ROM (p<0.05) as show in 
the table below. 
Table 6.50: Pairwise statistical significance comparisons between shoe conditions and 
maximum knee ROM angle during stance phase (n=15). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for 
Difference 
Lower Bound Upper Bound 
Full curve Half curve 0.553 0.554 1.000 -0.952 2.059 
No curve 3.834* 0.606 0.000 2.187 5.481 
Half curve Full curve -0.553 0.554 1.000 -2.059 0.952 
No curve 3.281* 0.813 0.004 1.072 5.489 
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6.5.7.3 Summary knee kinematics for different heel curves: 
 The curvature of the heel (both shoes) resulted in an increase in maximum ROM 
during point 2-3 and stance phase to significant level when compared to the shoe 
without curve; 
 The alteration of the heel curve caused in slight reduction in the time taken for LR; 
 The curvature of the heel increased knee extension within 10-40% of the gait cycle 
and then it increased knee flexion during push-off and toe-off phases. 
 
Table 6.51: Alternative hypotheses accepted/not accepted for different heel curves. 
 Full curve Half curve control 
Maximum knee flexion angle during LR (Ha1h) Not accepted Not accepted control 
Max knee extension during stance  (Ha1i) Not accepted Not accepted control 
Max knee flexion angle at toe-off (Ha1j) Not accepted Not accepted control 
Max knee flexion angle during swing (Ha1k) Not accepted Not accepted control 
Max Knee ROM between point 2-3 (Ha1l) accepted accepted control 
Max knee ROM during support (Ha1m) accepted accepted control 
Knee flexion angle at ICt (Ha1n) accepted Not accepted control 
 
 
6.5.8 Rocker profile stiffness at the metatarsal area 
Figure 6.10 shows the average of the knee kinematics in the sagittal plane for different 
rocker profiles stiffness at metatarsal area. It shows that flexible and mid-flexible shoes 
reduced maximum knee flexion during LR and increased maximum extension during terminal 
stance versus solid (control shoe). It is also noticeable that the flexible sole increased 
maximum flexion during swing phase versus all the other footwear conditions. 
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Figure 6.10: Figure 6.6: Sagittal plane knee motion during the three different level of 
flexibility of the mid-part of the shoe where the control shoe is has solid sole.  Legend 1 
indicates where maximum knee flexion angle occurred during LR; Legend 2 indicates the 
point at which maximum knee extension angle occurred during terminal stance phase; 
legend 3 indicates the point at which maximum knee flexion angle occurred at toe-off; and 
legend 4 indicates the position where maximum knee flexion angle during swing occurred. 
(a) – without standard deviation (STD), (b) – with the lines shadowed to represent STD 
ranges. 
 
Table 6.52: Mean (±SD) sagittal plane knee motion (degs) for three different flexibility of the 
sole, maximum ROM between point 2-3, and maximum knee ROM during stance phase. 
 Flex sole Med. flex Solid 
Knee angle at ICt (deg) 5.4 (1.2) 5.4 (1.3) 5.3 (1.4) 
Maximum knee flexion angle during LR (deg) 21.1 (1.3) 21.4 (1.8) 22.4 (1.4) 
Max knee extension during TSt (deg) 6.4 (1.4) 6.2 (1.1) 7.4 (1.3) 
Max knee flexion angle at toe-off (deg) 52.7 (2.6) 50.9 (3.5) 50.7 (2.6) 
Max knee flexion angle during swing (deg) 72.0 (1.0) 70.8 (2.7) 70.9 (0.9) 
Max Knee ROM between point 2-3 (deg) 46.3 (3.1) 44.7 (3.7) 43.3 (2.9) 
Max knee ROM during support (deg) 51.0 (2.8) 49.3 (3.6) 48.9 (2.7) 
 
6.5.8.1  Maximum knee flexion at toe-off 
Max knee flexion angle at toe off did not show any statistical significance between the test 
conditions, however without Bonferroni adjustment, the flexible sole was significantly more 
flexed when compared to the stiff sole (p=0.024). 
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6.5.8.2 6.5.8.2 Knee range of motion 
The flexible sole significantly increased maximum knee ROM between points 2-3 (table 
below) when compared to the control shoe. 
Table 6.53: Pairwise statistical significance comparisons for max knee ROM between points 2 
and 3 between shoe conditions (n=15). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
Flex sole Med. flex 1.591 0.699 0.117 -0.307 3.490 
Solid 2.948* 1.070 0.047 0.039 5.857 
Med. flex Flex sole -1.591 0.699 0.117 -3.490 0.307 
Solid 1.356 0.843 0.390 -0.936 3.649 
 
Maximum ROM during stance phase did not show any statistical significance with Bonferroni 
adjustment. However, with simple pairwise test Anova it showed that the flexible shoe 
increased maximum knee ROM during stance phase versus solid shoe (p=0.028). 
 
Figure 6.10 shows the average of the knee kinematics in the sagittal plane for different 
rocker profiles stiffness at the metatarsal area. It shows that the flexible and mid-flexible 
shoes reduced maximum flexion during LR and increased maximum extension during 
terminal stance versus the solid (control) shoe. It is also noticeable that the flexible sole 
increased maximum flexion during swing phase versus all footwear conditions. 
6.5.8.3 Summary for knee kinematics: 
 The flexible and mid-flexible soled shoes slightly reduced maximum flexion during LR 
when compared to control and slightly increased maximum extension during 
terminal stance when compared to the solid soled shoe (control shoe). 
 The flexible sole produced significantly increased maximum knee ROM between 
points 2-3 when compared to control shoe (table 6.54). 
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Table 6.54: Alternative hypotheses accepted/not accepted for different shoe forepart 
flexibility. 
 Flex sole Med. flex Solid 
Maximum knee flexion angle during LR (Ha1h) Not accepted Not accepted control 
Max knee extension during stance  (Ha1i) Not accepted Not accepted control 
Max knee flexion angle at toe-off (Ha1j) Not accepted Not accepted control 
Max knee flexion angle during swing (Ha1k) Not accepted Not accepted control 
Max Knee ROM between point 2-3 (Ha1l) accepted Not accepted control 
Max knee ROM during support (Ha1m) Not accepted Not accepted control 
Knee flexion angle at ICt (Ha1n) Not accepted Not accepted control 
 
6.6 Hip kinematics  
6.6.1 The effect of walking with different heel heights 
Figure 6.11 shows the average hip kinematics in the sagittal plane for different heel height 
footwear conditions acquired during the walking trials. It can be seen that at ICt raised heels 
reduced hip flexion. During 10-40% of the gait cycle the 1.5 cm heel increased knee 
extension versus all footwear condition. Maximum extension was increased for raised heels 
and during toe-off phase raised heel shoes increased hip extension and negative heels 
increased hip flexion. 
 
Figure 6.11: Sagittal plane hip motion during the five heel height test conditions where the 
control shoe is 3.5 HH. Legend 1 indicates maximum flexion and legend 2 indicates maximum 
hip extension.  
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6.6.1.1 The hip kinematics during IC 
At ICt, the 4.5HH footwear condition reduced hip flexion by 1.1 degree when compared to 
control. The 4.5HH did not show any significant difference using the Anova test with 
Bonferroni adjustments, however with the Anova only, the significance was p=0.011. 
Table 6.55: Mean (±SD) sagittal plane hip motion (deg) for five different heel heights, 
maximum hop ROM during stance and full gait cycle (N=15). 
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Hip angle at ICt (deg) 25.9 (0.8) 25.9 (0.9) 25.9 (0.9) 24.8 (1.0) 25.0 (1.1) 
Max Hip flexion angle during LR 
(deg) 
26.7 (0.8) 26.8 (0.8) 27.2 (0.8) 26.2 (1.1) 26.6 (1.1) 
Max Hip extension (deg) -10.9 (0.9) -10.5 (0.6) -10.6 (0.8) -11.9 (0.8) -12.2 (0.8) 
Max Hip ROM during stance 
(deg) 
37.6 (1.1) 37.2 (0.9) 37.8 (1.0) 38.1 (1.1) 38.7 (1.2) 
Max Hip ROM during gait cycle 
(deg) 
42.0 (1.2) 42.0 (0.9) 41.6 (1.0) 41.5 (1.1) 42.0 (1.2) 
 
6.6.1.2  Loading response (LR) 
During LR, there were no statistically significant differences in maximum hip flexion values. 
However, with one-way Anova without Bonferroni correction the 4.5HH shoe showed 
significant reduction in knee flexion versus the control shoe (p=0.08). 
6.6.1.3  Max Hip extension 
The 5.5HH showed significant increase maximum hip extension when compared to control 
shoe (p=0.42). 
6.6.1.4 Max Hip ROM during stance 
The 2.5 cm heel height significantly reduced maximum ROM when compared to the 4.5 and 
5.5 cm heel raised shoes (p<0.035). The 5.5HH shoe increased maximum ROM when 
compared to control shoe (p=0.017) as shown in the table below. 
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Table 6.56: Pairwise comparisons of shoe conditions for max hip flexion at toe-off. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH .341 .363 1.000 -.868 1.550 
3.5HH -.257 .345 1.000 -1.403 .889 
4.5HH -.536 .425 1.000 -1.949 .877 
5.5HH -1.173 .415 .135 -2.555 .208 
2.5HH 1.5HH -.341 .363 1.000 -1.550 .868 
3.5HH -.598 .340 1.000 -1.729 .533 
4.5HH -.878* .250 .034 -1.708 -.047 
5.5HH -1.514* .347 .007 -2.670 -.359 
3.5HH 1.5HH .257 .345 1.000 -.889 1.403 
2.5HH .598 .340 1.000 -.533 1.729 
4.5HH -.279 .226 1.000 -1.030 .471 
5.5HH -.916* .236 .017 -1.701 -.132 
4.5HH 1.5HH .536 .425 1.000 -.877 1.949 
2.5HH .878* .250 .034 .047 1.708 
3.5HH .279 .226 1.000 -.471 1.030 
5.5HH -.637 .274 .358 -1.549 .275 
 
6.6.1.5 Max Hip ROM during gait cycle 
There were no significant changes in maximum hip ROM during the full gait cycle. 
6.6.1.6 Summary – sagittal plane hip joint angle for different heel heights. 
 The 5.5HH shoe increase max ROM during stance phase when compared to control 
shoe (p=0.017). 
Table 6.57: Alternative hypotheses accepted/not accepted for different shoe heights. 
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Hip angle at ICt (Halo) Not 
accepted 
Not 
accepted 
control Not 
accepted 
Not 
accepted 
Maximum Hip flexion angle 
during LR (Halp) 
Not 
accepted 
Not 
accepted 
control Not 
accepted 
Not 
accepted 
Max Hip extension (Halq) Not 
accepted 
Not 
accepted 
control Not 
accepted 
accepted 
Max Hip ROM during stance 
(Halr) 
Not 
accepted 
Not 
accepted 
control Not 
accepted 
accepted 
Max Hip ROM during gait cycle 
(Hals) 
Not 
accepted 
Not 
accepted 
control Not 
accepted 
Not 
accepted 
Maximum hip flexion at TO 
(Halt) 
Not 
accepted 
Not 
accepted 
control Not 
accepted 
Not 
accepted 
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6.6.2 The effect of altering rocker sole apex position (AP) 
Figure 6.12 shows the average of the hip kinematics in the sagittal plane for different apex 
length shoes. There was slight increase in knee flexion for the 55AP shoe during maximum 
extension when compared to the 70AP test condition. However, there were no statistically 
significant differences noted. 
 
Figure 6.12: Sagittal plane hip motion during the three apex length footwear test conditions 
where the control shoe is 62.5AP. Legend 1 indicates maximum flexion and legend 2 
indicates maximum hip extension. (a) – without standard deviation (STD), (b) – with the lines 
shadowed to represent STD ranges. 
 
Table 6.58: Mean (±SD) sagittal plane hip motion (deg.) for three different apex position, 
maximum hop ROM during stance and full gait cycle (N=15). 
 55AP 62.5AP 70AP 
Hip angle at ICt (deg) 25.4 (1.0) 25.9 (0.9) 26.0 (0.8) 
Maximum Hip flexion angle during LR (deg) 26.8 (0.9) 27.2 (0.8) 27.0 (0.9) 
Max Hip extension (deg) -11.1 (1.0) -10.6 (0.8) -10.6 (0.7) 
Max Hip ROM during stance (deg) 37.9 (1.2) 37.8 (1.0) 37.6 (1.1) 
Max Hip ROM during gait cycle (deg) 41.8 (1.1) 41.6 (1.0) 41.8 (1.1) 
 
6.6.2.1 Summary hip joint flexion results for different apex position conditions: 
 There was a slight increase in knee flexion for the 55AP shoe test condition during 
maximum extension when compared to the 70AP test condition. 
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6.6.3 Apex angle (toe angle) 
Figure 6.13 shows the average data for hip kinematics in sagittal plane for different apex 
angle footwear conditions acquired during the walking trials for N=15. Figure 6.15 
demonstrates that the 10° toe angle test condition produced a noticeable increase in hip 
extension during 0-55% of the gait cycle during when compared to the control shoe. During 
push-off and toe-off phases, the 10°TA increased knee flexion. 
 
Figure 6.13: Sagittal plane hip motion during the apex toe angle test conditions where the 
control shoe is 15° TA. Legend 1 indicates maximum flexion and legend 2 indicates maximum 
hip extension. (a) – without standard deviation (STD), (b) – with the lines shadowed to 
represent STD ranges. 
 
Table 6.59: Mean (±SD) sagittal plane hip motion (degs) for three different toe angle test 
footwear conditions, maximum hop ROM during stance and full gait cycle (N=15). 
 10° TA 15° TA 20° TA 
Hip angle at ICt (deg) 25.1 (1.0) 25.9 (0.9) 26.0 (1.0) 
Maximum Hip flexion angle during LR (deg) 26.4 (0.9) 27.2 (0.8) 27.2 (0.9) 
Max Hip extension (deg) -11.5 (0.9) -10.6 (0.8) -10.5 (1.0) 
Max Hip ROM during stance (deg) 37.9 (1.2) 37.8 (1.0) 37.7 (1.3) 
Max Hip ROM during gait cycle (deg) 41.9 (1.0) 41.6 (1.0) 41.7 (1.0) 
 
There were no significant differences noted between any of the TA test conditions for the 
parameters listed in the above table. 
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6.6.4 Curved heels 
Figure 6.14 shows the average hip kinematic data in the sagittal plane for different heel-
curved shoe test conditions. The alteration in the test condition with the full heel curve 
resulted in increased hip flexion during 0-50% of the gait cycle and then slight hip extension 
during the rest of the gait cycle when compared to the control shoe. 
 
Figure 6.14: Sagittal plane hip motion during the three different level of heel curvature of 
test conditions where the control shoe has no curve. (a) – without standard deviation (STD), 
(b) – with the lines shadowed to represent STD ranges. 
 
Table 6.60: Mean (±SD) sagittal plane hip motion (degs) for three different heel curves, 
maximum hop ROM during stance and full gait cycle (N=15). 
 Full curve Half curve control 
Hip angle at ICt  (deg) 25.1 (0.9) 26.2 (1.0) 25.9 (0.9) 
Maximum Hip flexion angle during LR (deg) 26.5 (1.0) 27.4 (1.0) 27.2 (0.8) 
Max Hip extension (deg) -11.1 (0.7) -10.5 (0.7) -10.6 (0.8) 
Max Hip ROM during stance (deg) 37.6 (1.4) 38.0 (1.1) 37.8 (1.0) 
Max Hip ROM during gait cycle (deg) 41.3 (1.0) 41.7 (1.0) 41.6 (1.0) 
 
Statistical tests did not show any significance for mean values and knee ROM shown in table 
6.60. 
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6.6.4.1  Summary of heel kinematics for different heel curves: 
 The alteration in the heel by adding a full curve resulted in increased hip flexion 
during 0-50% gait cycle and then slight hip extension during the rest gait cycle when 
compared to control shoe. 
6.6.5 Rocker profile stiffness at metatarsal area 
Figure 6.15 shows the average of the hip kinematics in the sagittal plane for different rocker 
profiles stiffnesses at the metatarsal area of the shoes. It shows that flexible shoes and those 
with medium-flexibility  increased hip extension during 0-53% of the gait cycle when 
compared to the solid (control) shoe. It is also noticeable that the flexible sole increased 
maximum flexion during swing phase versus all the other footwear conditions. Similar results 
were demonstrated for the knee flexion data. 
 
Figure 6.15: Sagittal plane hip motion during the three different level of flexibility of the mid-
part of the shoe where the control shoe has no curve (N=15). (a) – without standard 
deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
 
The results in table 6.61 show that no statistically significant alterations in hip flexion were 
produced in different footwear forepart flexibility test conditions. 
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Table 6.61: Mean (±SD) sagittal plane hip motion (degs) three different level of flexibility of 
the mid-part of the shoe, maximum hip ROM during stance and full gait cycle (N=15). 
 Flex sole Med. flex Solid 
Hip angle at ICt (deg) 25.8 (1.0) 25.4 (0.9) 25.9 (0.9) 
Maximum Hip flexion angle during LR (deg) 26.7 (1.0) 26.5 (0.9) 27.2 (0.8) 
Max Hip extension (deg) -10.9 (0.9) -11.3 (0.7) -10.6 (0.8) 
Max Hip ROM during stance (deg) 37.6 (1.3) 37.9 (1.0) 37.8 (1.0) 
Max Hip ROM during gait cycle (deg)  42.2 (1.2) 42.1 (1.0) 41.6 (1.0) 
 
6.6.5.1  Summary hip kinematics for different sole flexibilities: 
The flexible and medium-flexibility shoes increased hip extension during 0-53% of the gait 
cycle when compared to the solid (control) shoe. It is also noticeable that the flexible sole 
increased maximum flexion during swing phase versus all the other footwear conditions. 
 
6.7 Ankle Moments 
6.7.1 The effect of heel height alteration 
Figure 6.16, illustrates the alteration to external ankle moments induced by the heel height 
test conditions. It can be seen that the 1.5 cm heel significantly reduced external PF moment 
and increased the external DF moment between 12-80% of stance phase when compared to 
all the other footwear test conditions. It resulted in an increase in the overall external DF 
moment at the ankle joint experienced by the calf muscles. The negative heel profile 
produced a shorter PF external moment period and premature DF external moment 
initiation. The opposite effect was seen for raised heels. The 5.5HH increased the overall 
external PF moment and resulted in a delay of the external DF moment initiation. It also 
reduced the moment during 25-70% of stance phase as shown in figure 6.16. 
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Figure 6.16: Sagittal plane external ankle moment during the five footwear conditions 
highlighting the 2 area of interest (N=15). Legend 1 indicates maximum ankle plantarflexor 
moment; legend 2 indicates maximum ankle dorsiflexor moment. (a) – without standard 
deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
 
The mean results from the figure 6.16 are demonstrated in the table 6.62. 
Table 6.62: Mean (±SD) sagittal plane ankle moment (Nm/kg) for the five footwear 
conditions (N=15). 
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Maximum external ankle plantarflexor  
moment (Nm/kg) 
-0.22 
(0.02) 
-0.29 
(0.03) 
-0.30 
(0.03) 
-0.29 
(0.03) 
-0.31 
(0.03) 
Maximum external ankle dorsiflexor 
moment (Nm/kg) 
1.41 
(0.05) 
1.37 
(0.04) 
1.41 
(0.05) 
1.40 
(0.05) 
1.42 
(0.04) 
 
6.7.1.1  Maximum external ankle plantarflexor  moment 
The 1.5 cm heel demonstrated significant reduction in maximum external ankle moment 
versus all the other footwear conditions (table 6.63). The 2.5HH did not show any 
significance versus the 3.5HH and the 4.5HH; however it was significantly reduced when 
compared to the 5.5 cm heel. The 3.5 cm heel produced a significant increase in the 
maximum external ankle PF moment when compared to the 1.5 cm heel test condition. The 
4.5 and 5.5 cm heels showed significant increase versus 1.5 cm heel raise test condition. 
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Table 6.63: Pairwise comparison of shoe conditions for mean external ankle PF moment 
during stance phase. 
 
6.7.1.2  Maximum external ankle dorsiflexor moment 
There were no significant results demonstrated for maximum external ankle DF moment 
except for the 2.5HH test condition which showed a significant reduction when compared to 
the 5.5 cm heel raised footwear condition (p=0.027) as shown in table 6.64. 
 
Table 6.64: Pairwise comparison of shoe conditions for mean external ankle DF moment 
during stance phase. 
 
 
Cond. 
 
 
Cond. 
 
Mean 
Difference 
 
 
Std. Error 
 
 
Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH .070* .008 .000 .042 .097 
3.5HH .074* .008 .000 .045 .102 
4.5HH .064* .009 .000 .034 .094 
5.5HH .085* .011 .000 .050 .120 
2.5HH 1.5HH -.070* .008 .000 -.097 -.042 
3.5HH .004 .007 1.000 -.020 .028 
4.5HH -.006 .008 1.000 -.034 .021 
5.5HH .016 .007 .478 -.008 .039 
3.5HH 1.5HH -.074* .008 .000 -.102 -.045 
2.5HH -.004 .007 1.000 -.028 .020 
4.5HH -.010 .007 1.000 -.033 .013 
5.5HH .012 .008 1.000 -.015 .039 
4.5HH 1.5HH -.064* .009 .000 -.094 -.034 
2.5HH .006 .008 1.000 -.021 .034 
3.5HH .010 .007 1.000 -.013 .033 
5.5HH .022 .007 .101 -.003 .046 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH .048 .023 .551 -.029 .124 
3.5HH .008 .023 1.000 -.070 .086 
4.5HH .015 .027 1.000 -.077 .107 
5.5HH -.015 .026 1.000 -.102 .072 
2.5HH 1.5HH -.048 .023 .551 -.124 .029 
3.5HH -.040 .015 .233 -.092 .012 
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6.7.1.3  External ankle moment impulse values 
The results were converted to be presented as percentage difference and the control shoe 
was therefore considered to be a baseline shoe; meaning its value was 100%. The results 
were divided into area 1 – the area under the curve for external ankle PF moment, and area 
2 – the area under the curve for external ankle DF moment as shown in table 6.65. 
Table 6.65: The average of the area under the curves for the footwear test conditions.  
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Area 1 (%) 42.2 
(8.0) 
82.3 
(13.7) 
100.0 
(14.3) 
103.3 
(16.3) 
119.4 
(20.8) 
Differences between control shoe (%) -57.8 -17.7 0.0 3.3 19.4 
Area 2 (%) 128.0 
(3.8) 
104.7 
(5.5) 
100.0 
(5.9) 
95.1 
(5.4) 
95.4 
(5.1) 
Differences between control shoe (%) 28.0 4.7 0.0 -4.9 -4.6 
 
 
4.5HH -.033 .011 .077 -.069 .002 
5.5HH -.063* .017 .027 -.120 -.006 
3.5HH 1.5HH -.008 .023 1.000 -.086 .070 
2.5HH .040 .015 .233 -.012 .092 
4.5HH .006 .012 1.000 -.034 .047 
5.5HH -.023 .016 1.000 -.077 .031 
4.5HH 1.5HH -.015 .027 1.000 -.107 .077 
2.5HH .033 .011 .077 -.002 .069 
3.5HH -.006 .012 1.000 -.047 .034 
5.5HH -.029 .012 .255 -.069 .010 
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6.7.1.4 Area 1 (External PF ankle moment) 
For the heel height test conditions (1.5HH to the 5.5HH), a  significant gradual significant 
increase of external ankle PF moment area under the curve was demonstrated as shown in  
table 6.66 and table 6.67. These results clearly demonstrate that the overall work done by 
the internal DF muscles to rotate the ankle joint was significantly increased with raising heel 
heights. For example, the 1.5HH reduced the overall area 1 by 57.8%, the 2.5HH shoe by -
17.7% when compared to control shoe. The 5.5HH increased this parameter by 19.4% versus 
the control shoe. 
Table 6.66: Pairwise comparison of shoe conditions for mean values of area 1. 
 
6.7.1.5 Area 2 (External DF ankle moment) 
A significant reduction in area 1 for the 1.5HH was demonstrated, but at the same time a 
significant increase in area 2 was noted (+28%) when compared to the control shoe and was 
significantly increased compared to all the other footwear test conditions. The 2.5HH value 
for area 2 was significantly increased when compared to the 1.5HH test condition, but 
significantly reduced when compared to the 4.5 and 5.5 cm heel height shoes. The 3.5 cm 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH -40.089* 3.439 .000 -51.527 -28.650 
3.5HH -57.771* 3.719 .000 -70.141 -45.401 
4.5HH -61.038* 4.906 .000 -77.353 -44.723 
5.5HH -77.213* 7.556 .000 -102.343 -52.083 
2.5HH 1.5HH 40.089* 3.439 .000 28.650 51.527 
3.5HH -17.682* 2.999 .000 -27.658 -7.707 
4.5HH -20.949* 3.280 .000 -31.858 -10.041 
5.5HH -37.125* 6.360 .000 -58.276 -15.973 
3.5HH 1.5HH 57.771* 3.719 .000 45.401 70.141 
2.5HH 17.682* 2.999 .000 7.707 27.658 
4.5HH -3.267 4.302 1.000 -17.574 11.041 
5.5HH -19.442 6.589 .105 -41.357 2.472 
4.5HH 1.5HH 61.038* 4.906 .000 44.723 77.353 
2.5HH 20.949* 3.280 .000 10.041 31.858 
3.5HH 3.267 4.302 1.000 -11.041 17.574 
5.5HH -16.175 6.031 .179 -36.233 3.883 
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heel (control shoe) demonstrated a significant increase in area 2 versus the 1.5 cm heel 
height shoe.  
Table 6.67: Pairwise comparison of shoe conditions for mean values of area 2. 
 
6.7.1.6 Summary for heel height: 
 The low heel profiles demonstrated reductions in maximum external PF ankle 
moment when compared with higher heel profiles and the opposite effect was seen 
for high heeled shoes; 
 The 2.5 cm heel produced a significant a reduction in the maximum external DF ankle 
moment when compared with the 5.5 cm heel test condition;  
 From 1.5HH to the 5.5HH test conditions, a significant gradual increase of external 
ankle PF moment area under the curve was demonstrated which indicated that the 
internal DF muscles (tibialis anterior and others) worked less hard to generate the 
moment. The (Hal) hypothesis is therefore accepted; 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH 23.316* 3.034 .000 13.224 33.408 
3.5HH 28.030* 3.669 .000 15.828 40.233 
4.5HH 32.883* 3.620 .000 20.842 44.924 
5.5HH 32.628* 4.128 .000 18.901 46.355 
2.5HH 1.5HH -23.316* 3.034 .000 -33.408 -13.224 
3.5HH 4.714 1.900 .264 -1.606 11.034 
4.5HH 9.567* 1.361 .000 5.040 14.094 
5.5HH 9.311* 2.254 .010 1.815 16.808 
3.5HH 1.5HH -28.030* 3.669 .000 -40.233 -15.828 
2.5HH -4.714 1.900 .264 -11.034 1.606 
4.5HH 4.853 1.594 .088 -.450 10.155 
5.5HH 4.597 2.228 .581 -2.811 12.006 
4.5HH 1.5HH -32.883* 3.620 .000 -44.924 -20.842 
2.5HH -9.567* 1.361 .000 -14.094 -5.040 
3.5HH -4.853 1.594 .088 -10.155 .450 
5.5HH -.255 1.443 1.000 -5.054 4.543 
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 Negative heel profiles significantly increased the overall area under the curve for the 
external DF ankle moment (area 2) when compared to all higher heeled test 
conditions. The (Hal) hypothesis is accepted; 
 The 4.5HH and 5.5HH did not produce any significant changes when compared to 
control shoe but a significant reduction in area 2 versus the 1.5 and 2.5 cm heel 
height footwear conditions was demonstrated. The (Hal) hypothesis is rejected. 
 
6.7.2 The effect of altering rocker sole apex position (AP) 
Figure 6.17, illustrates the alteration to external ankle moments induced by the shoe apex 
length (position) footwear test conditions. A noticeable change was noted in increased 
maximum external DF ankle moment for the 70% apex length shoe test condition and a 
reduction of 55% was seen when compared to the control shoe for the 55AP test condition. . 
 
Figure 6.17: Sagittal plane external ankle moment during the three footwear conditions 
highlighting the 2 area of interest (N=15). Legend 1 indicates maximum ankle plantarflexor 
moment; legend 2 indicates maximum ankle dorsiflexor moment. (a) – without standard 
deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
Table 6.68: Mean (±SD) sagittal plane ankle moment (Nm/kg) for the three footwear 
conditions (N=15). 
 55AP 62.5AP 70AP 
Maximum ankle external plantarflexor  moment (Nm/kg) -0.29 (0.03) -0.30 (0.03) -0.28 (0.03) 
Maximum ankle external dorsiflexor moment (Nm/kg) 1.35 (0.05) 1.41 (0.05) 1.44 (0.03) 
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6.7.2.1 Maximum external ankle plantarflexor moment 
The 70% apex length showed a significant maximum external ankle PF moment reduction 
when compared to the control shoe (p=0.048) as shown in the table below.  
Table 6.69: Pairwise comparison of shoe conditions for mean external ankle PF moment 
during stance phase. 
Cond. Cond. Mean 
Difference 
Std. 
Error 
Sig.b 95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
55AP 62.5AP .011 .006 .192 -.004 .026 
70 AP -.005 .006 1.000 -.023 .012 
62.5AP 55AP -.011 .006 .192 -.026 .004 
70 AP -.016* .006 .048 -.032 .000 
70 AP 55AP .005 .006 1.000 -.012 .023 
62.5AP .016* .006 .048 .000 .032 
Based on estimated marginal means 
*. The mean difference is significant at the .05 level. 
b. Adjustment for multiple comparisons: Bonferroni. 
 
6.7.2.2 Maximum external ankle dorsiflexor moment 
The 55% apex length shoe (55AP) demonstrated a significant mean ankle DF moment 
reduction when compared to the control (p=0.04) and 70AP test conditions (p=0.008) as 
shown in table 6.70. There was no significant maximum external ankle dorsiflexor moment 
increase produced by the 70AP test condition when compared to control, however it was 
significantly higher versus the 55AP shoe test condition. 
Table 6.70: Pairwise comparison of shoe conditions for mean external ankle DF moment 
during stance phase. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
55AP 62.5AP -.058* .014 .004 -.097 -.018 
70 AP -.091* .025 .008 -.159 -.023 
62.5AP 55AP .058* .014 .004 .018 .097 
70 AP -.033 .019 .303 -.084 .018 
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6.7.2.3 External ankle moment impulse (overall area of the moment curve) 
Table 6.71 shows the results of the overall area of the moment curves for different apex 
position footwear conditions. The results for area 1 which are shown in table 6.71,  
represents the area under the curve representing the external ankle PF moment, and area 2 
is the area under the curve for the external ankle DF moment. 
 
Table 6.71: The average of the area under the curves (external ankle moments) for the 
footwear test conditions (N=15). 
 55AP 62.5AP 70AP 
Area 1 (%) 94.1 (16.3) 100.0 (14.3) 96.5  (12.3) 
Differences between control shoe (%) -5.9 0.0 -3.5 
Area 2 (%) 94.3  (5.4) 100.0 (5.9) 106.4 (5.1) 
Differences between control shoe (%) -5.7 0.0 6.4 
6.7.2.4 Area 1 (External ankle PF moment) 
The apex length (position) alteration for the test conditions did not show any significant 
difference for external ankle PF moment impulse value (area 1).  
6.7.2.5 Area 2 (External ankle DF moment) 
There were significant changes in the overall external ankle DF moment curve for all the 
footwear test conditions. It shows that the 55AP test condition significantly reduced the area 
of the moment curve when compared to the control shoe (p=0.016). The 70AP footwear test 
condition significantly increased the value calculated for area 2 versus the control shoe 
(p=0.007) and the 55AP test condition significantly reduced it when compared to the control 
shoe (p<0.001) as shown in the table below. 
Table 6.72: Pairwise comparison of the average of the area under the curves (external ankle 
DF moment) for test footwear conditions (N=15). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
55AP 62.5AP -5.655* 1.713 .016 -10.312 -.998 
70 AP -12.069* 1.618 .000 -16.465 -7.672 
62.5AP 55AP 5.655* 1.713 .016 .998 10.312 
70 AP -6.414* 1.725 .007 -11.103 -1.724 
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6.7.2.6 Summary for apex length position: 
 The 70% apex length position produced significant maximum external ankle PF 
moment reduction when compared to the control shoe (p=0.048). The (Hal) 
hypothesis is accepted; 
 The 55% apex length shoe demonstrated a significant mean ankle DF moment 
reduction when compared to the control shoe (p=0.04), and reduction when 
compared with 70AP (p=0.008). The (Hal) hypothesis is accepted; 
 The 55% apex length shoe demonstrated a significant reduction for the area under 
curve 2 when compared to the control test condition. This meant that the triceps 
surae group of muscles would have had to work less to produce the ankle moment. 
The (Hal) hypothesis is accepted; 
 The 70% apex length shoe significantly increased the external ankle DF moment 
impulse (area 2) compared to the control and 55AP shoes, which means that there 
would have been more total muscle force required for the triceps surae to produce 
the internal PF moment. The (Hal) hypothesis is accepted. 
 
6.7.3 Apex angle (toe angle-TA) 
Figure 6.18, illustrates the alteration to external ankle moments induced by the shoe apex 
toe angle. The 20° toe angle demonstrated a visible reduction of maximum external ankle DF 
moment when compared to the control and 10° toe angle test conditions. 
 
Figure 6.18: Sagittal plane external ankle moment during the three footwear conditions 
highlighting the two area of interest (N=15). Legend 1 indicates maximum ankle 
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plantarflexior moment; legend 2 indicates maximum ankle dorsiflexor moment. (a) – without 
standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
The results for mean external moments values are demonstrated in the table below. 
Table 6.73: Mean (±SD) sagittal plane ankle moment (Nm/kg) for the three footwear 
conditions (N=15). 
 10° TA 15° TA 20° TA 
Maximum ankle external plantarflexor  
moment (Nm/kg) 
-0.29 
(0.03) 
-0.30 
(0.03) 
-0.28 
(0.03) 
Maximum ankle external dorsiflexor 
moment (Nm/kg) 
1.45 
(0.05) 
1.41 
(0.05) 
1.26 
(0.04) 
6.7.3.1 Maximum external ankle plantarflexor moment 
There were no significant alterations for maximum external ankle PF moment demonstrated 
for different toe angle footwear test conditions. The (Hal) hypothesis is rejected. 
6.7.3.2 Maximum external ankle dorsiflexor moment 
The 15° toe angle (control shoe) demonstrated significant decrease in mean external ankle 
DF moment when compared to the 10 ° toe angle (p=0.009) and a significant increase when 
compared to the 20° toe angle test condition (p<0.001), as shown in table 6.74. 
Table 6.74: Pairwise comparison of shoe conditions for mean external ankle DF moment 
during stance phase. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
10° TA 15° TA .044* .012 .009 .011 .077 
20° TA .194* .021 .000 .138 .250 
15° TA 10° TA -.044* .012 .009 -.077 -.011 
20° TA .150* .021 .000 .092 .208 
 
6.7.3.3 External ankle moment impulse (overall area of the moment curve) 
Table 6.75 demonstrates the mean results of the overall area of the moment curves for 
different toe angle footwear test conditions. Area 1 represents the area under the curve for 
the external ankle PF moment. Area 2 is the area under the curve for the external ankle DF 
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moment. Table 6.75 below indicates that the 10° TA test condition increased area 2 value 
(DF moment) by 5.4% and the 20° TA decreased this parameter by 7.5% when compared to 
the control shoe. 
 
Table 6.75: The average of the area under the curves (external ankle moments) for test 
footwear conditions (N=15). 
 10° TA 15° TA 20° TA 
Area 1 (%) 97.1 (16.1) 100.0 (14.3) 101.3 (17.7) 
Differences between control shoe (%) -2.9 0.0 1.3 
Area 2 (%) 105.4 (5.4) 100.0 (5.9) 92.5 (4.1) 
Differences between control shoe (%) 5.4 0.0 -7.5 
 
6.7.3.4  Area 1 (External ankle PF moment) 
Alteration to the sole apex toe angle did not produce any significant differences for external 
ankle PF moment impulse values (area 1).  
6.7.3.5  Area 2 (External ankle DF moment) 
There were significant changes in the overall external ankle DF moment curve for all 
footwear conditions. The 10° toe angle footwear test condition significantly increased area 2 
versus the control shoe (p=0.002), but the 20° toe angle significantly reduced this parameter 
when compared to control (p=0.026) as shown in able 6.76.  
Table 6.76: Pairwise comparison of the average of the area under the curves (external ankle 
DF moment) for test footwear conditions (N=15). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
10° TA 15° TA 5.359* 1.219 .002 2.047 8.671 
20° TA 12.880* 2.545 .001 5.964 19.795 
15° TA 10° TA -5.359* 1.219 .002 -8.671 -2.047 
20° TA 7.521* 2.467 .026 .816 14.226 
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6.7.3.6  Summary for toe apex length (position): 
 The 15° toe angle (control shoe) demonstrated a significant decrease in mean 
external ankle DF moment value when compared to the 10 ° toe angle test condition 
(p=0.009), and a significant increase when compared to the 20° toe angle (p<0.001). 
The (Hal) hypothesis is accepted; 
 The 10° toe angle footwear test condition significantly increased the value of area 2 
versus the control shoe (p=0.002) and the 20° toe angle significantly reduced it when 
compared to control (p=0.026). The (Hal) hypothesis is accepted. 
6.7.4 Heel curves  
Figure 6.19, shows the alteration to external ankle moments induced by the shoe heel curve 
test conditions. It is noticeable that curved heels reduced the external ankle PF moments 
and increased DF moments between 0-75% of stance phase. There was also a visible 
reduction in the maximum mean external DF moment for curved heel test conditions. 
 
Figure 6.19: Sagittal plane external ankle moment during the three footwear conditions 
highlighting the 2 area of interest (N=15). Legend 1 indicates maximum ankle plantarflexor 
moment; legend 2 indicates maximum ankle dorsiflexor moment. (a) – without standard 
deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
 
The results for mean external moment values are demonstrated in table 6.77. 
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Table 6.77: Mean (±SD) sagittal plane ankle moment (Nm/kg) for the three footwear 
conditions (N=15). 
 Full curve Half curve control 
Maximum ankle external plantarflexor  
moment (Nm/kg) 
-0.19 
(0.02) 
-0.23 
(0.02) 
-0.30 
(0.03) 
Maximum ankle external dorsiflexor 
moment (Nm/kg) 
1.37 
(0.04) 
1.35 
(0.04) 
1.41 
(0.05) 
6.7.4.1 Maximum external ankle plantarflexor moment 
There were significant PF moment reductions for curved heels when compared to the 
control test condition (p<0.001). The full curve shoe showed a significant PF moment 
reduction when compared to the half curve test condition as shown in table 6.78. 
Table 6.78: Pairwise comparison of shoe conditions for mean external ankle PF moment 
during stance phase. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
Full curve Half curve .041* .004 .000 .029 .052 
No curve .104* .005 .000 .089 .118 
Half curve Full curve -.041* .004 .000 -.052 -.029 
No curve .063* .005 .000 .049 .077 
 
6.7.4.2 Maximum external ankle dorsiflexor moment 
The half curve shoe demonstrated a significant mean DF moment reduction when compared 
to the control shoe (p=0.04) as shown in table 6.79. 
 
Table 6.79: Pairwise comparison of shoe conditions for mean external ankle DF moment 
during stance phase. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
Full curve Half curve .024 .012 .190 -.008 .056 
No curve -.032 .017 .261 -.078 .015 
Half curve Full curve -.024 .012 .190 -.056 .008 
No curve -.055* .014 .004 -.093 -.018 
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6.7.4.3 External ankle moment impulse (overall area of the moment curve) 
The full curved heel shoe test condition reduced the PF moment curve area by 40.2% when 
compared to control shoe. The half curve reduced the PF moment curve area 1 by 25.6% 
versus the control shoe as shown in table 6.80. 
The full curve increased the DF moment area 2 by 6% when compared to the control shoe. 
Table 6.80: The average value of the area under the curves (external ankle moments) for test 
footwear conditions (N=15). 
 Full curve Half curve control 
Area 1 (%) 59.8 (11.0) 74.4 (13.1) 100.0 (14.3) 
Differences between control shoe (%) -40.2 -25.6 0.0 
Area 2 (%) 106.0 (5.3) 100.6 (5.8) 100.0 (5.9) 
Differences between control shoe (%) 6.0 0.6 0.0 
 
 
6.7.4.4 Area 1 (External ankle PF moment) 
The full and half curved heel shoes demonstrated a significant reduction in area 1 when 
compared to the control shoe and half curve as shown in the table below. 
Table 6.81: Pairwise comparison of the average of the area under the curves (external ankle 
PF moment) for test footwear conditions (N=15).  
 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
Full curve Half curve -14.697* 2.692 .000 -22.013 -7.382 
No curve -40.249* 1.806 .000 -45.158 -35.340 
Half curve Full curve 14.697* 2.692 .000 7.382 22.013 
No curve -25.552* 2.319 .000 -31.853 -19.250 
6.7.4.5 Area 2 (External ankle DF moment) 
There was a significant change in overall external ankle DF moment area curve for the full 
curve shoe versus control and the half curve shoe (p<0.013) as shown in the table below. 
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Table 6.82: Pairwise comparison of the average of the area under the curves (external ankle 
DF moment) for test footwear conditions (N=15).  
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
Full curve Half curve 5.353* 1.553 .012 1.133 9.573 
No curve 5.979* 1.302 .001 2.441 9.518 
Half curve Full curve -5.353* 1.553 .012 -9.573 -1.133 
No curve .626 1.465 1.000 -3.356 4.609 
6.7.4.6 Summary of ankle moment alterations produced by curved heel test conditions 
 Both curved heel test conditions reduced the mean external ankle PF moment when 
compared to control. This also resulted in a reduction of the overall area of PF 
moment when compared to control and therefore the muscle work by DF muscles 
were theoretically reduced to produce the ankle joint moment. The (Hal) hypothesis 
is accepted; 
 The heel curvature reduced the maximum external ankle DF moment. However, the 
curved heel reduced LR time and would have induced premature activation of PF 
muscles. It resulted in an increased overall external ankle DF moment area for the full 
curve shoe and therefore also the overall calf muscle force applied to produce the 
moment and a possible increase in oxygen consumption. 
 
6.7.5 Rocker profile stiffness at metatarsal area 
Figure 6.20 shows the alteration to external ankle moment induced by the shoe flexibility 
level. From the figure below, there was a slight noticeable change during PF moment where 
the overall area and mean values are visually reduced. There was however, no significant 
change during late stance except for during late push off phase where the flexible sole 
reduced the DF moment. 
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Figure 6.20: Sagittal plane external ankle moment during the three footwear conditions 
highlighting the 2 area of interest (N=15). Legend 1 indicates maximum ankle plantarflexor 
moment; legend 2 indicates maximum ankle dorsiflexor moment. (a) – without standard 
deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
The results for mean external moments values are demonstrated in the table below. 
Table 6.83: Mean (±SD) sagittal plane ankle moment (Nm/kg) for the three footwear 
conditions (N=15). 
 Flex sole Med. flex Solid 
Max ankle external PF moment (Nm/kg) -0.26 (0.03) -0.27 (0.03) -0.30 (0.03) 
Max ankle external DF moment (Nm/kg) 1.39 (0.04) 1.39 (0.04) 1.41 (0.05) 
 
6.7.5.1 Maximum external ankle plantarflexor moment 
There was a significant PF moment reduction demonstrated for the flexible soles when 
compared to the solid control shoe (p<0.02) as shown in the table below. 
Table 6.84: Pairwise comparison of shoe conditions for mean external ankle PF moment 
during stance phase. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
Flex sole Med. flex .004 .007 1.000 -.016 .023 
Solid .032* .009 .010 .007 .056 
Med. flex Flex sole -.004 .007 1.000 -.023 .016 
Solid .028* .006 .001 .012 .044 
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6.7.5.2 Maximum external ankle dorsiflexor moment 
There were no significant changes. The (Hal) hypothesis is rejected. 
6.7.5.3 External ankle moment impulse (overall area of the moment curve) 
The flexible sole reduced the impulse value of the PF moment curve by 14.9% and the 
medium flexibility sole by 15.7% when compared to the control shoe as shown in table 6.85. 
There were no significant changes for area 2 which is the main interest of this research. 
Table 6.85: The average of the area under the curves (external ankle moments) for test 
footwear conditions (N=15). 
 Flexible sole Medium 
flexible sole 
Solid 
Area 1 (%) 85.1 (12.1) 84.3.4 (13.0) 100.0 (14.3) 
Differences between control shoe (%) -14.9 -15.7 0.0 
Area 2 (%) 98.0 (5.3) 100.0 (5.6) 100.0 (5.9) 
Differences between control shoe (%) -2.0 0.0 0.0 
 
6.7.5.4 Area 1 (External ankle PF moment) 
The both flexible shoes significantly reduced area 1 when compared to the control shoe 
(p<0.024). 
Table 6.86: Pairwise comparison of the average of the area under the curves (external ankle 
PF moment) for test footwear conditions (N=15). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
Flex sole Med. flex .751 3.614 1.000 -9.071 10.573 
Solid -14.915* 4.798 .023 -27.956 -1.875 
Med. flex Flex sole -.751 3.614 1.000 -10.573 9.071 
Solid -15.667* 3.887 .004 -26.229 -5.104 
 
6.7.5.5 Area 2 (External ankle DF moment) 
There were no significant differences noted. The (Hal) hypothesis is rejected. 
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6.7.5.6 Summary of ankle moment alterations produced by curved heel test conditions. 
 Both flexible sole profiles significantly reduced maximum PF moment values when 
compared to control. The (Hal) hypothesis is accepted; 
 The flexible sole reduced PF moment curve area impulse by 14.9% and the medium 
flexible sole by 15.7% when compared to the control shoe; 
 There were no significant results seen between any footwear test conditions for 
external ankle DF moment. The (Hal) hypothesis is rejected. 
 
6.8 Ankle Power 
6.8.1 The effect of walking with different heel heights (HH) 
Figure 6.21 illustrates the alteration to sagittal plane external ankle joint power for the heel 
height test conditions.  
 
Figure 6.21: Sagittal plane external ankle joint power for HH test footwear conditions (N=15). 
 
The mean results for maximum area of sagittal plane external ankle joint power for different 
footwear conditions are demonstrated in table 6.87. 
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Table 6.87: Mean (±SD) area of ankle joint power for test footwear conditions. 
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Generation area % (overall area of power 
generation) 
118.9 
(11.7) 
111.6 
(9.8) 
100.0 
(9.2) 
90.6 
(12.3) 
93.5 
(11.1) 
Differences between control shoe (%) 18.9 11.6 0 -9.4 -6.5 
Absorption area % (overall area of power 
absorption) 
90.7 
(14.0) 
88.2 
(11.5) 
100.0 
(13.4) 
105.6 
(10.9) 
108.9 
(14.0) 
Differences between control shoe (%) -9.3 -11.8 0 5.6 8.9 
 
 
6.8.1.1 The ankle power generation area 
The 1.5HH increased the power generation area for the ankle joint by 18.9% versus the 
control shoe, but it did not show any significant difference versus any of the other footwear 
conditions. The 2.5HH test condition produced a significant increase in the power generation 
area when compared to the 4.5HH (21% p<0.000) and the 5.5HH (18.1% p=0.001). The 
4.5HH significantly reduced power generation area by 9.4% when compared to the control 
shoe (p=0.017) as shown in table 6.88 below. 
Table 6.88: Pairwise comparison of shoe conditions power generation area for ankle joint 
during whole stance phase (N=14). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH 7.260 10.038 1.000 -26.123 40.643 
3.5HH 18.854 8.246 .383 -8.569 46.277 
4.5HH 28.251 9.313 .089 -2.720 59.222 
5.5HH 25.317 9.994 .239 -7.921 58.554 
2.5HH 1.5HH -7.260 10.038 1.000 -40.643 26.123 
3.5HH 11.594 4.137 .141 -2.164 25.352 
4.5HH 20.991* 3.460 .000 9.483 32.498 
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6.8.1.2 The ankle power absorption area 
The results show that the 1.5HH significantly reduced the ankle power absorption area by 
18.2% when compared to the 5.5HH footwear test condition (p=0.017). The 3.5HH test 
condition significantly increased the ankle power absorption area by 11.8% when compared 
to the 2.5HH (p=0.008) (table 6.89). The 2.5HH significantly reduced the ankle power 
absorption area when compared to the 3.5HH (11.8%, p=0.08), the 4.5HH (17.7%, p<0.000) 
and the 5.5HH (20.7%, p<0.000). 
Table 6.89: Pairwise comparison of shoe conditions for average ankle joint power absorption 
area for the whole stance phase (N=15). 
5.5HH 18.056* 3.470 .001 6.515 29.598 
3.5HH 1.5HH -18.854 8.246 .383 -46.277 8.569 
2.5HH -11.594 4.137 .141 -25.352 2.164 
4.5HH 9.397* 2.424 .017 1.336 17.458 
5.5HH 6.462 3.611 .952 -5.547 18.472 
4.5HH 1.5HH -28.251 9.313 .089 -59.222 2.720 
2.5HH -20.991* 3.460 .000 -32.498 -9.483 
3.5HH -9.397* 2.424 .017 -17.458 -1.336 
5.5HH -2.935 3.166 1.000 -13.464 7.595 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH 2.510 4.179 1.000 -11.386 16.407 
3.5HH -9.281 4.521 .593 -24.316 5.754 
4.5HH -14.906 4.983 .097 -31.477 1.666 
5.5HH -18.153* 4.709 .017 -33.813 -2.494 
2.5HH 1.5HH -2.510 4.179 1.000 -16.407 11.386 
3.5HH -11.792* 2.783 .008 -21.048 -2.536 
4.5HH -17.416* 2.789 .000 -26.692 -8.140 
5.5HH -20.664* 3.488 .000 -32.263 -9.065 
3.5HH 1.5HH 9.281 4.521 .593 -5.754 24.316 
2.5HH 11.792* 2.783 .008 2.536 21.048 
4.5HH -5.624 2.622 .500 -14.343 3.095 
5.5HH -8.872 3.172 .143 -19.421 1.677 
4.5HH 1.5HH 14.906 4.983 .097 -1.666 31.477 
2.5HH 17.416* 2.789 .000 8.140 26.692 
3.5HH 5.624 2.622 .500 -3.095 14.343 
5.5HH -3.248 2.389 1.000 -11.191 4.696 
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6.8.1.3  Summary of sagittal plane ankle joint power area alteration produced by different 
heel heights: 
 The 2.5HH test condition produced a significant increase in power generation area 
(for the whole of stance phase) when compared to the 4.5HH (21% p<0.000) and the 
5.5HH (18.1% p=0.001) test conditions. The 4.5HH significantly reduced the power 
generation area by 9.4% when compared to the control shoe (p=0.017). The (Hal) 
hypothesis is accepted. 
 The results show that the 1.5HH test condition significantly reduced the ankle power 
absorption area by 18.2% when compared to the 5.5HH footwear (p=0.017).  
 The 3.5HH significantly increased the ankle power absorption area by 11.8% when 
compared to the 2.5HH (p=0.008). The (Hal) hypothesis is accepted. 
 The 2.5HH test condition significantly reduced the ankle power absorption area when 
compared to the 3.5HH (11.8%, p=0.08), the 4.5HH (17.7%, p<0.000) test conditions 
and the 5.5HH (20.7%, p<0.000). 
 
6.8.2 The effect of altering rocker sole apex position (AP) 
Figure 6.37 illustrates the alteration to sagittal plane external ankle joint power by the apex 
length sole changes.  
 
Figure 6.22: Sagittal plane external ankle joint power for AP test footwear conditions (N=15). 
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The mean results for average area of sagittal plane external ankle joint power for different 
footwear conditions are demonstrated in table 6.90. (a) – without standard deviation (STD), 
(b) – with the lines shadowed to represent STD ranges. 
Table 6.90: Mean (±SD) area of ankle joint power for test footwear conditions. 
 55AP 62.5AP 70AP 
Generation area % (overall area of power 
generation) 
104.9 
(9.5) 
100.0 
(9.2) 
94.6 
(10.2) 
Differences between control shoe (%) 4.9 0 -5.4 
Absorption area % (overall area of power 
absorption) 
91.4 
(11.4) 
100.0 
(13.4) 
113.8 
(11.5) 
Differences between control shoe (%) -8.6 0 13.8 
 
6.8.2.1 The ankle power generation area 
The 55AP footwear condition increased average ankle power generation area by 10.3% 
when compared to the 70AP (p=0.23). 
Table 6.91: Pairwise comparison of shoe conditions power generation area for ankle joint 
during whole stance phase (N=15). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
55AP 62.5AP 4.850 4.070 .760 -6.212 15.913 
70 AP 10.212* 3.277 .023 1.307 19.117 
62.5AP 55AP -4.850 4.070 .760 -15.913 6.212 
70 AP 5.362 2.792 .226 -2.226 12.949 
 
 
6.8.2.2 The ankle power absorption area 
The 55AP footwear significantly reduced the average ankle joint power absorption area by 
8.6% when compared to control 62.5AP shoe (p=0.01) and significantly reduced it by 22.4% 
when compared to the 70AP (p=0.001) as shown in the table below.  
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Table 6.92: Pairwise comparison of shoe conditions for average ankle joint power absorption 
area for the whole stance phase (N=15). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
55AP 62.5AP -8.602* 2.422 .010 -15.185 -2.019 
70 AP -22.355* 4.502 .001 -34.591 -10.119 
62.5AP 55AP 8.602* 2.422 .010 2.019 15.185 
70 AP -13.753* 4.737 .035 -26.627 -.880 
 
 
6.8.2.3  Summary of sagittal plane ankle joint power area alteration produced by AP of the 
sole: 
 The 55AP footwear condition increased the average ankle power generation area by 
10.3% when compared to the 70AP (p=0.23) footwear for the whole stance phase. 
The (Hal) hypothesis is rejected; 
 The 55AP footwear significantly reduced the average ankle joint power absorption 
area by 8.6% when compared to control 62.5AP shoe (p=0.01) and significantly 
reduced by 22.4% when compared to the 70AP (p=0.001) as shown in the table 
below. The (Hal) hypothesis is accepted. 
 
6.8.3 The effect of altering apex angle (toe angle-TA) 
Figure 6.23 illustrates the alteration to sagittal plane external ankle joint power induced by 
the apex toe angle changes.  
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Figure 6.23: Sagittal plane external ankle joint power for TA test footwear conditions (N=15). 
The mean results for average area of sagittal plane external ankle joint power for different 
footwear conditions are demonstrated in table 6.93 below. 
 
Table 6.93: Mean (±SD) area of ankle joint power for test footwear conditions. 
 10° TA 15° TA 20° TA 
Generation area % (overall area of power generation) 107.7 
(9.1) 
100.0 
(9.2) 
102.0 
(10.6) 
Differences between control shoe (%) 7.7 0 2.0 
Absorption area % (overall area of power absorption) 111.1 
(11.8) 
100.0 
(13.4) 
79.8 
(11.0) 
Differences between control shoe (%) 11.1 0 -20.2 
 
6.8.3.1 The ankle power generation area 
The results did not show any significance. The (Hal) hypothesis is rejected. 
6.8.3.2 The ankle power absorption area 
The 20°TA footwear significantly reduced ankle joint power absorption area by 20.2% when 
compared to control 15°TA shoe (p=0.007) and significantly reduced by 31.3% when 
compared to 10°TA (p<0.000). 
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Table 6.94: Pairwise comparison of shoe conditions for average ankle joint power absorption 
area for the whole stance phase (N=15). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
10° TA 15° TA 11.144* 2.999 .007 2.994 19.295 
20° TA 31.362* 2.492 .000 24.590 38.133 
15° TA 10° TA -11.144* 2.999 .007 -19.295 -2.994 
20° TA 20.217* 3.102 .000 11.788 28.646 
 
6.8.3.3 Summary for sagittal plane ankle joint power area alteration produced by 
alteration to toe angle of the sole: 
 The 20°TA footwear significantly reduced ankle joint power absorption area  by 
20.2% when compared to control 15°TA shoe (p=0.007) and significantly reduced by 
31.3% when compared to 10°TA (p<0.000). The (Hal) hypothesis is accepted. 
 
6.8.4 The effect of altering heel curve 
Figure 6.24 illustrates the alteration to sagittal plane external ankle joint power induced by 
the curvature of the heel.  
 
Figure 6.24: Sagittal plane external ankle joint power for heel-curved test footwear 
conditions where control shoe has no curved heel (N=15). (a) – without standard deviation 
(STD), (b) – with the lines shadowed to represent STD ranges. 
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The mean results for average area of sagittal plane external ankle joint power for different 
footwear conditions are demonstrated in the table below. 
Table 6.95: Mean (±SD) area of ankle joint power for test footwear conditions. 
 Full curve Half curve control 
Generation area % (overall area of power 
generation) 
95.8 
(12.1) 
93.5 
(9.8) 
100.0 
(9.2) 
Differences between control shoe (%) -4.2 -6.5 0 
Absorption area % (overall area of power 
absorption) 
83.3 
(13.1) 
90.8 
(11.5) 
100.0 
(13.4) 
Differences between control shoe (%) -16.7 -9.2 0 
 
6.8.4.1 The ankle power generation area 
There were no statistically significant differences noted in ankle power generation. The (Hal) 
hypothesis is accepted. 
6.8.4.2 The ankle power absorption area 
The control shoe without a curved heel significantly increased the ankle joint power 
absorption area by 9.2%% when compared to half curved heel shoe (p=0.006) and 
significantly increased it by 16.7% when compared to full curved heel shoe (p<0.001) as 
shown in table 6.96. 
Table 6.96: Pairwise comparison of shoe conditions for average ankle joint power absorption 
area for the whole stance phase (N=15). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
Full curve Half curve -7.493* 2.713 .046 -14.866 -.121 
No curve -16.729* 3.408 .001 -25.993 -7.466 
Half curve Full curve 7.493* 2.713 .046 .121 14.866 
No curve -9.236* 2.415 .006 -15.799 -2.673 
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6.8.4.3 Summary for sagittal plane ankle joint power area alteration produced by curved 
heel test conditions: 
 The control shoe without a curved heel significantly increased the average ankle joint 
power absorption area by 9.2%% when compared to half curve shoe (p=0.006) and 
significantly increased by 16.7% when compared to full curve heel (p<0.001). The 
(Hal) hypothesis is accepted. 
 
6.8.5 The effect of altering rocker profile stiffness at metatarsal area 
Figure 6.25 illustrates the alteration to sagittal plane external ankle joint power induced by 
the flexibility of the sole.  
 
Figure 6.25: Sagittal plane external ankle joint power for different flexibility level of the sole 
where control shoe is not flexible at the metatarsal area (N=15). (a) – without standard 
deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
The mean results for average area of sagittal plane external ankle joint power for different 
footwear conditions are demonstrated in the table below. 
Table 6.97: Mean (±SD) area of ankle joint power for test footwear conditions. 
 Flex sole Med. flex Solid 
Generation area % (overall area of power 
generation) 
116.2 
(8.3) 
111.6 
(9.3) 
100.0 
(9.2) 
Differences between control shoe (%) 16.2 11.6 0 
Absorption area % (overall area of power 
absorption) 
95.5 
(9.2) 
94.8 
(10.2) 
100.0 
(13.4) 
Differences between control shoe (%) -4.5 -5.2 0 
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6.8.5.1 The ankle power generation area 
The flexible sole produced a significant increase in the average ankle joint power generation 
area by 16.2% when compared to the solid soled shoe (p=0.25).  
6.8.5.2 The ankle power absorption area 
There were no statistically significant alterations to this parameter. The (Hal) hypothesis is 
accepted. 
6.8.5.3 Summary for sagittal plane ankle joint power area alteration produced by footwear 
stiffness level at the metatarsal area: 
 The flexible sole showed significant increases in the average ankle joint power 
generation area by 16.2% when compared to solid soled shoe (p=0.25). The (Hal) 
hypothesis is accepted. 
 
6.9 Electromyography data for ankle joint 
It important to collect EMG activity data for medial gastrocnemius and soleus muscles to 
understand the level of their activation altered by different footwear features. There were 
only 16 subjects used for EMG data, two subjects were excluded from the study, as the data 
were not good for some footwear features due to electrode movement or other artefacts. 
Therefore, N=14 in total were used for analysis of medial gastrocnemius activity.  
6.9.1 The effect of walking with different heel heights 
Figure 6.26 illustrates the alteration to the medial gastrocnemius EMG RMS values for the 
heel height test conditions. The results were converted to present as a percentage of the 
maximum in the control shoe. It can be seen that the 1.5HH increased EMG activity within 
10-40% of the stance phase versus all footwear profiles because of premature activation. 
The 2.5HH increased maximum EMG activity when compared to the rest and the 4.5 cm heel 
showed visible less activity when compared to all the other footwear conditions. 
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Figure 6.26: The medial gastrocnemius EMG activity for test footwear conditions for % 
stance phase. (a) – without standard deviation (STD), (b) – with the lines shadowed to 
represent STD ranges. 
 
The mean results for maximum EMG RMS activity for different footwear conditions during 
different part of the stance phase are demonstrated in the table below. 
Table 6.98: Mean (±SD) medial gastrocnemius EMG percentage activity for test footwear 
conditions. 
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Maximum EMG activity 
during LR (%) 
34.2 
11.2 
20.7 
(6.4) 
19.7 
(6.6) 
17.2 
(4.0) 
20.5 
(7.0) 
Maximum EMG activity 
during mid-stance (%) 
58.1 
(11.6) 
50.2 
(9.1) 
48.5 
(9.7) 
45.6 
(9.7) 
46.7 
(10.7) 
Maximum EMG activity 
during stance phase (%) 
104.2 
(13.7) 
110.1 
(11.8) 
100.0 
(8.8) 
93.5 
(9.1) 
108.1 
(9.6) 
 
6.9.1.1 Loading response 
The 1.5HH significantly increased medial gastrocnemius (MG) EMG activity when compared 
to all the other footwear conditions except for the 5.5HH footwear condition as shown in 
table 6.99. The 4.5HH significantly reduced muscle activity versus the 1.5HH but it was not 
significant versus the control shoe. 
263 
 
Table 6.99: Pairwise comparison of shoe conditions for medial gastrocnemius mean EMG 
activity during loading response (N=14). 
 
6.9.1.2 Mid-stance phase 
The 4.5 cm heel height shoe significantly reduced mean EMG activity during mid-stance 
phase when compared to the 1.5HH footwear test condition (p=0.20) as shown in table 
6.100. 
 
Table 6.100: Pairwise comparison of shoe conditions for medial gastrocnemius mean EMG 
activity during mid-stance phase. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for 
Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH 13.543* 3.367 .015 2.188 24.899 
3.5HH 14.474* 2.945 .003 4.541 24.406 
4.5HH 16.970* 3.167 .001 6.288 27.651 
5.5HH 13.749 4.174 .058 -.327 27.826 
2.5HH 1.5HH -13.543* 3.367 .015 -24.899 -2.188 
3.5HH .930 2.280 1.000 -6.758 8.619 
4.5HH 3.427 1.309 .213 -.989 7.842 
5.5HH .206 2.083 1.000 -6.818 7.230 
3.5HH 1.5HH -14.474* 2.945 .003 -24.406 -4.541 
2.5HH -.930 2.280 1.000 -8.619 6.758 
4.5HH 2.496 1.729 1.000 -3.334 8.326 
5.5HH -.724 2.508 1.000 -9.182 7.733 
4.5HH 1.5HH -16.970* 3.167 .001 -27.651 -6.288 
2.5HH -3.427 1.309 .213 -7.842 .989 
3.5HH -2.496 1.729 1.000 -8.326 3.334 
5.5HH -3.221 1.556 .589 -8.467 2.026 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for 
Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH 7.891 3.024 .216 -2.307 18.089 
3.5HH 9.569 3.332 .131 -1.668 20.807 
4.5HH 12.511* 3.243 .020 1.574 23.448 
5.5HH 11.387 4.488 .248 -3.747 26.521 
2.5HH 1.5HH -7.891 3.024 .216 -18.089 2.307 
3.5HH 1.679 2.018 1.000 -5.129 8.486 
4.5HH 4.620 1.707 .180 -1.138 10.378 
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6.9.1.3 Late stance phase 
The 4.5HH reduced MG mean EMG activity during stance phase when compared to the 2.5 
cm heel height (p=0.003). The 5.5HH footwear condition significantly increase mean EMG 
when compared to control (3.5HH) shoe. 
Table 6.101: Pairwise comparison of shoe conditions for medial gastrocnemius mean EMG 
activity during late stance phase (N=14). 
 
 
5.5HH 3.496 3.527 1.000 -8.397 15.389 
3.5HH 1.5HH -9.569 3.332 .131 -20.807 1.668 
2.5HH -1.679 2.018 1.000 -8.486 5.129 
4.5HH 2.941 2.161 1.000 -4.346 10.229 
5.5HH 1.818 2.950 1.000 -8.130 11.766 
4.5HH 1.5HH -12.511* 3.243 .020 -23.448 -1.574 
2.5HH -4.620 1.707 .180 -10.378 1.138 
3.5HH -2.941 2.161 1.000 -10.229 4.346 
5.5HH -1.124 2.754 1.000 -10.413 8.165 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for 
Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH -5.900 7.386 1.000 -30.808 19.008 
3.5HH 4.223 6.302 1.000 -17.031 25.478 
4.5HH 10.732 8.332 1.000 -17.367 38.830 
5.5HH -3.891 6.364 1.000 -25.352 17.570 
2.5HH 1.5HH 5.900 7.386 1.000 -19.008 30.808 
3.5HH 10.123 3.904 .223 -3.042 23.288 
4.5HH 16.632* 3.412 .003 5.126 28.137 
5.5HH 2.009 5.031 1.000 -14.959 18.977 
3.5HH 1.5HH -4.223 6.302 1.000 -25.478 17.031 
2.5HH -10.123 3.904 .223 -23.288 3.042 
4.5HH 6.508 3.465 .830 -5.178 18.195 
5.5HH -8.114* 2.264 .033 -15.751 -.478 
4.5HH 1.5HH -10.732 8.332 1.000 -38.830 17.367 
2.5HH -16.632* 3.412 .003 -28.137 -5.126 
3.5HH -6.508 3.465 .830 -18.195 5.178 
5.5HH -14.623 4.783 .092 -30.754 1.509 
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6.9.1.4 EMG Impulse  
The results show that the 1.5HH increased overall EMG activity by MG muscle by 14.4% 
when compared to control and the 4.5HH reduced overall EMG activity by 21.9% when 
compared to the 1.5HH. The 4.5HH reduced overall EMG area by 7.4% when compared to 
control shoe as demonstrated in the table below. 
Table 6.102: The average (±SD) of the area under the curves for medial gastrocnemius EMG 
activity for test footwear conditions (N=14). 
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
EMG impulse (overall area of 
EMG activity (%)) 
114.4 
(13.0) 
107.4 
(9.1) 
100.0 
(10.1) 
92.6 
(10.5) 
103.6 
(10.5) 
Differences between control 
shoe (%) 
14.4 7.4 0 -7.4 3.6 
 
The pairwise Anova test with Bonferroni adjustment demonstrate that the 1.5HH and 2.5HH 
significantly increased EMG area under the curve for MG muscle when compared to the 
4.5HH footwear condition (p<0.014). 
Table 6.103: Pairwise comparison of shoe conditions for medial gastrocnemius overall area 
underneath the EMG activity curve during stance phase (N=14). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for 
Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH 10.275 5.472 .849 -8.484 29.034 
3.5HH 18.130 5.589 .070 -1.034 37.293 
4.5HH 25.795* 6.212 .013 4.497 47.092 
5.5HH 15.147 5.177 .127 -2.601 32.894 
2.5HH 1.5HH -10.275 5.472 .849 -29.034 8.484 
3.5HH 7.854 4.242 .889 -6.691 22.399 
4.5HH 15.519* 2.045 .000 8.507 22.532 
5.5HH 4.871 4.130 1.000 -9.288 19.031 
3.5HH 1.5HH -18.130 5.589 .070 -37.293 1.034 
2.5HH -7.854 4.242 .889 -22.399 6.691 
4.5HH 7.665 3.859 .703 -5.565 20.895 
5.5HH -2.983 2.655 1.000 -12.086 6.120 
4.5HH 1.5HH -25.795* 6.212 .013 -47.092 -4.497 
2.5HH -15.519* 2.045 .000 -22.532 -8.507 
3.5HH -7.665 3.859 .703 -20.895 5.565 
5.5HH -10.648 3.950 .195 -24.189 2.893 
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6.9.1.5 Summary of gastrocnemius EMG activity alteration produced by different heel 
heights: 
 The 1.5HH footwear significantly increased EMG activity within 10-40% of stance 
phase when compared to all the other heel height test conditions and the maximum 
activation was seen at 20% stance phase with an 80% level of increase when 
compared to the control shoe. It positively accepted the (Ha2) hypothesis; 
 The 2.5HH increased maximum EMG activity when compared to the other footwear 
test conditions; 
 Negative heel profiles increase overall EMG activity. The 1.5HH increased the overall 
area of MG EMG activity by 14.4% when compared to control and the 4.5HH reduced 
overall EMG activity by 21.9% when compared to the 1.5HH.  The (Ha2) hypothesis is 
therefore positively accepted;  
 The slight raise if the heel height resulted in overall reduction of the area MG EMG 
activity. The 4.5HH reduced overall EMG area by 7.4% when compared to control. 
6.9.2 The effect of altering rocker sole apex position (AP) 
Figure 6.27 illustrates the alteration to medial gastrocnemius EMG activity induced by the 
apex position changes. The 55AP caused a reduction in maximum MG EMG activity when 
compared to control and more reduction when compared to the 70AP. 
 
Figure 6.27: The gastrocnemius EMG activity for test footwear conditions (N=14). 
The mean results for maximum EMG RMS activity for different footwear conditions during 
different parts of stance phase are demonstrated in the table below. (a) – without standard 
deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
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Table 6.104 Mean (±SD) medial gastrocnemius EMG activity for test footwear conditions. 
 55AP 62.5AP 70AP 
Maximum EMG activity during 
LR (%) 
18.7 
(4.4) 
19.7 
(6.6) 
17.7 
(5.5) 
Maximum EMG activity during 
mid-stance (%) 
40.9 
(9.5) 
48.5 
(9.7) 
55.0 
(10) 
Maximum EMG activity during 
stance phase (%) 
91.3 
(11.3) 
100.0 
(8.8) 
107.1 
(9.3) 
 
6.9.2.1 Mid-stance phase. 
The 55AP demonstrated significant mean EMG reduction when compared to the 70AP 
footwear test condition (p=0.02). The 62.5AP control shoe reduced EMG activity during mid-
stance phase when compared to the 70AP footwear (p=0.011) as shown in table6.105. 
Table 6.105: Pairwise comparison of shoe conditions for medial gastrocnemius mean EMG 
activity during mid-stance phase (N=14). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
55AP 62.5AP -7.613 3.017 .076 -15.897 .672 
70 AP -14.071* 3.112 .002 -22.616 -5.525 
62.5AP 55AP 7.613 3.017 .076 -.672 15.897 
70 AP -6.458* 1.823 .011 -11.464 -1.452 
 
6.9.2.2 Stance phase 
The 55AP produced a significant reduction in the MG muscle maximum EMG activity during 
stance phase when compared to the control shoe (p=0.018) and also a reduction when 
compared to the 70AP test condition (p=0.005). 
 
6.9.2.3 EMG Impulse for MG muscle  
The table below shows that the 55AP reduced overall EMG area by 8.9% when compared to 
control and reduced it by 15.6% when compared to the 70AP footwear. 
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Table 6.106: The average (±SD) of the overall area under the curves for medial 
gastrocnemius EMG activity for test footwear conditions (N=14). 
 55AP 62.5AP 70AP 
EMG impulse (overall area of EMG 
activity %) 
91.1 
(12.6) 
100.0 
(10.1) 
106.7 
(9.0) 
Differences between control shoe (%) -8.9 0 6.7 
 
The 55AP significantly reduced GM muscle overall EMG activity area when compared to the 
70AP footwear (p=0.01). 
 
6.9.2.4 Summary of gastrocnemius EMG activity alteration produced apex length of testing 
footwear conditions: 
 The 55AP produced a significant reduction in the MG muscle maximum EMG activity 
during stance phase when compared to the control shoe (p=0.018) and reduced it 
when compared to the 70AP test condition (p=0.005). It positively answered the 
(Ha2) hypothesis; 
 The 55AP reduced overall MG muscle EMG activity area by 8.9%, when compared to 
control, and reduced it by 15.6% when compared to the 70AP footwear test 
condition. 
  
6.9.3 The effect of altering apex angle (toe angle-TA) 
Figure 6.28 illustrates the alteration to the medial gastrocnemius EMG activity induced by 
the apex toe angle changes. From the figure below it can be seen that the maximum EMG 
activity reduced for the 20° angled-toe shoe versus control, with the 10° toe angle shoe 
increasing the maximum EMG activity when compared to control. 
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Figure 6.28: The gastrocnemius EMG activity for test footwear conditions. (a) – without 
standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
The mean results for maximum EMG RMS activity for different footwear conditions during 
different part of the stance phase are presented in the table below. 
Table 6.107: Mean (±SD) medial gastrocnemius EMG activity for test footwear conditions. 
 10° TA 15° TA 20° TA 
Max EMG activity during LR (%) 17.9 (4.9) 19.7 (6.6) 18.3 (5.3) 
Max EMG activity during mid-stance (%) 54.4 (11.5) 48.5 (9.7) 45.2 (8.9) 
Max EMG activity during stance phase (%) 107.2 (15.3) 100.0 (8.8) 89.4 (9.3) 
 
6.9.3.1 Mid-stance phase 
The 10° TA test condition showed a significant increase in maximum EMG activity during 
mid-stance phase when compared to control (p=0.018) and 20° TA (p=0.004). 
Table 6.108: Pairwise comparison of shoe conditions for medial gastrocnemius maximum 
EMG activity during mid-stance phase (N=14). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for 
Difference 
Lower Bound Upper Bound 
10° TA 15° TA 5.871* 1.788 .018 .961 10.781 
20° TA 9.172* 2.256 .004 2.976 15.368 
15° TA 10° TA -5.871* 1.788 .018 -10.781 -.961 
20° TA 3.301 1.576 .169 -1.026 7.628 
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6.9.3.2 Late stance phase 
The 20° TA shoe significantly reduced maximum EMG activity by 10.6% when compared to 
control shoe (p=0.006), and significantly reduced maximum EMG activity by 17.8% when 
compared to the 10° TA (p=0.007). 
 
6.9.3.3 EMG Impulse 
The 10° toe angle footwear increased the overall area of MG EMG activity by 7.2% when 
compared to the control and increased by 13.5% when compared to 20° toe angle footwear. 
The 20° toe angle footwear test condition significantly reduced area 1 for the MG EMG 
activity when compared to the 10° toe angle footwear profile. 
Table 6.109: The average (±SD) of the overall area under the curves for medial 
gastrocnemius EMG activity for test footwear conditions (N=14). 
 10° TA 15° TA 20° TA 
EMG impulse (overall area of EMG 
activity %) 
107.2 
(11.2) 
100.0 
(10.1) 
93.7 
(10.1) 
Differences between control shoe (%) 7.2 0 -6.3 
 
Table 6.110: Pairwise comparison of shoe conditions for medial gastrocnemius overall area 
EMG activity during stance phase. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for 
Difference 
Lower Bound Upper Bound 
10° TA 15° TA 7.217 3.675 .214 -2.874 17.307 
20° TA 13.548* 3.918 .013 2.788 24.308 
15° TA 10° TA -7.217 3.675 .214 -17.307 2.874 
20° TA 6.331 3.957 .401 -4.534 17.197 
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6.9.3.4 Summary of medial gastrocnemius EMG activity alteration produced by apex toe 
angle footwear conditions: 
 The 10° TA produced a significant increase in mean EMG activity during mid-stance 
phase when compared to control (p=0.018) and 20° TA (p=0.004) which is also 
accepted (Ha2) hypothesis; 
 The 20° TA shoe significantly reduced maximum EMG activity by 10.6% when 
compared to control shoe (p=0.006), and significantly reduced maximum EMG 
activity by 17.8% when compared to the 10° TA (p=0.007). This is also answered the 
hypothesis that the 20° TA place ankle more PF during terminal stance and therefore 
theoretically offloaded medial gastrocnemius muscle by reducing its EMG activity 
[and positively confirmed the general hypothesis (Ha2)]; 
 The 10° toe angle footwear increased overall area of MG EMG activity by 7.2% 
compared to control and increased it by 13.5% when compared to the 20° toe angle 
footwear. 
 
6.9.4 The effect of altering heel curves 
Figure 6.29 illustrates the alteration to the medial gastrocnemius EMG activity induced by 
the curvature of the heel. The picture visually shows that the full curve shoe increased MG 
EMG activity within 5-70% of the stance phase when compared to the other heel curve 
footwear test conditions. 
 
Figure 6.29: The gastrocnemius EMG activity for test footwear conditions (N=14). (a) – 
without standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
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The results for maximum EMG RMS activity for different footwear conditions during 
different part of the stance phase are demonstrated in the table below. 
Table 6.111: Mean (±SD) maximum medial gastrocnemius EMG activity for test footwear 
conditions. 
 Full curve Half curve control 
Max EMG activity during LR (%) 24.3 (7.0) 20.7 (6.2) 19.7 (6.6) 
Max EMG activity during mid-stance (%) 57.2 (11.3) 50.7 (10.6) 48.5 (9.7) 
Max EMG activity during stance phase (%) 102.6 (11.6) 99.9 (9.8) 100.0 (8.8) 
 
6.9.4.1 Mid-stance phase 
The control shoe (without a curved heel) showed a significant reduction in MG muscle 
maximum EMG activity during mid-stance phase when compared to the full curve shoe test 
condition (p=0.008).  
6.9.4.2 The overall summary area for EMG activity 
The full curve increased overall EMG area by 7.7% when compared to the control shoe with 
no curve added. 
Table 6.112: The average (±SD) of the overall area under the curves for medial 
gastrocnemius EMG activity for test footwear conditions (N=14). 
 Full curve Half curve control 
EMG impulse (overall area of EMG 
activity %) 
107.7 
(10.5) 
99.1 
(10.4) 
100.0 
(10.1) 
Differences between control shoe (%) 7.7 -0.9 0 
 
The full curve showed a significant increase in area 1 of EMG activity when compared to the 
half curve footwear (p=0.034). 
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6.9.4.3 Summary of gastrocnemius EMG activity alteration produced by curved heel test 
conditions. 
 The control shoe without a curved heel showed significant reductions in MG muscle 
maximum EMG activity during mid-stance phase when compared to the full curve 
shoe (p=0.008). It is positively confirmed Ha2 hypothesis; 
 The full curve showed a significant increase in EMG impulse when compared to half 
curve footwear (p=0.034) as shown in the table below. 
 
6.9.5 The effect of altering rocker profile stiffness at metatarsal area 
Figure 6.30 illustrates the alteration to the medial gastrocnemius EMG activity induced by 
the flexibility of the sole. The picture below shows that the medium flexibility footwear 
increased maximum MG muscle EMG activity when compared to all footwear conditions. 
 
Figure 6.30: The gastrocnemius EMG activity for test footwear conditions (N=14). 
The mean results for maximum EMG RMS activity for different footwear conditions during 
different part of the stance phase are presented in the table below. 
Table 6.113: Mean (±SD) medial gastrocnemius EMG activity for test footwear conditions. 
 Flexible sole Medium flexible Solid 
Max EMG activity during LR (%) 18.3 (5.2) 20.2 (6.9) 19.7 (6.6) 
Max EMG activity during mid-stance (%) 48.2 (9.2) 48.9 (9.3) 48.5 (9.7) 
Max EMG activity during stance phase (%) 100.0 (10.4) 105.3 (10.3) 100.0 (8.8) 
 
The statistical analysis did not show any statistical significance. 
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6.9.5.1 The overall summary area for EMG activity 
The table below shows that medium flexibility footwear increased overall EMG area by 4.3% 
when compared to control and reduced by 4.7 % when compared to the flexible sole 
footwear, however it was not significant. 
Table 6.114: The average (±SD) of the overall area under the curves for medial 
gastrocnemius EMG activity for test footwear conditions (N=14). 
 Flexible sole Medium 
flexibility 
Solid 
EMG impulse (overall area of EMG activity %) 99.6 (9.7) 104.3 (8.7) 100.0 (10.1) 
Differences between control shoe (%) -0.4 4.3 0 
 
6.9.5.2 Summary of gastrocnemius EMG activity alteration produced by sole flexibility 
The results did not show any statistical significant alteration for medial gastrocnemius EMG 
activity caused by flexible footwear. It positively confirmed the second overarching null 
hypothesis (Ho2) and rejected (Ha2). 
 
6.10 Soleus electromyography results  
6.10.1 The effect of walking with different heel heights 
Figure 6.31 illustrates the alteration to the soleus EMG RMS values for the heel height test 
conditions. The results were converted to present as percentage of the results demonstrated 
for the control shoe as a baseline shoe, which was deemed to be 100%. It can be seen that 
the 1.5HH increased (by premature activation) EMG activity within 10-65% of the stance 
phase versus all footwear profiles. The 5.5HH increased maximum EMG activity when 
compared to the rest and the 4.5 cm heel showed visible less activity when compared to all 
footwear conditions. Similar results were demonstrated for the medial gastrocnemius 
muscle. 
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Figure 6.31: The soleus EMG activity for test footwear conditions (N=13). (a) – without 
standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
The mean results for maximum EMG RMS activity for different footwear conditions during 
different parts of stance phase are demonstrated in the table below. 
Table 6.115: Mean (±SD) soleus EMG activity for test footwear conditions. 
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Maximum EMG activity during 
LR (%) 
49.8 
(11.8) 
37.0 
(9.0) 
31.2 
(7.2) 
30.3 
(7.8) 
32.5 
(7.7) 
Maximum EMG activity during 
mid-stance (%) 
59.0 
(9.9) 
47.6 
(7.5) 
44.1 
(7.1) 
44.0 
(8.0) 
45.0 
(7.6) 
Maximum EMG activity  during 
stance phase (%) 
104.7 
(11.0) 
105.8 
(9.0) 
100.0 
(6.5) 
91.2 
(7.3) 
107.5 
(7.4) 
 
6.10.1.1 Loading response 
The 1.5HH significantly increased soleus EMG activity when compared to all footwear 
conditions as shown in the table below.  
Table 6.116: Pairwise comparison of shoe conditions for soleus mean EMG activity during 
loading response (N=13). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH 12.846* 3.555 .036 .657 25.035 
3.5HH 18.633* 3.783 .004 5.665 31.601 
4.5HH 19.537* 3.405 .001 7.864 31.211 
5.5HH 17.361* 4.403 .020 2.267 32.456 
2.5HH 1.5HH -12.846* 3.555 .036 -25.035 -.657 
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6.10.1.2 Mid-stance phase 
The 1.5HH significantly increased maximum soleus EMG activity when compared to all 
footwear conditions (p<0.015).  
 
Table 6.117: Pairwise comparison of shoe conditions for soleus mean EMG activity during 
mid-stance phase (N=13). 
 
 
3.5HH 5.787 2.086 .168 -1.364 12.937 
4.5HH 6.691 2.637 .261 -2.350 15.733 
5.5HH 4.515 3.276 1.000 -6.716 15.746 
3.5HH 1.5HH -18.633* 3.783 .004 -31.601 -5.665 
2.5HH -5.787 2.086 .168 -12.937 1.364 
4.5HH .905 1.562 1.000 -4.449 6.258 
5.5HH -1.272 2.327 1.000 -9.249 6.706 
4.5HH 1.5HH -19.537* 3.405 .001 -31.211 -7.864 
2.5HH -6.691 2.637 .261 -15.733 2.350 
3.5HH -.905 1.562 1.000 -6.258 4.449 
5.5HH -2.176 2.062 1.000 -9.245 4.892 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH 11.401* 2.742 .013 1.999 20.804 
3.5HH 14.872* 3.048 .004 4.421 25.324 
4.5HH 14.963* 2.889 .002 5.058 24.869 
5.5HH 14.038* 3.391 .014 2.414 25.662 
2.5HH 1.5HH -11.401* 2.742 .013 -20.804 -1.999 
3.5HH 3.471 1.337 .234 -1.112 8.054 
4.5HH 3.562 1.957 .937 -3.146 10.270 
5.5HH 2.637 2.043 1.000 -4.368 9.641 
3.5HH 1.5HH -14.872* 3.048 .004 -25.324 -4.421 
2.5HH -3.471 1.337 .234 -8.054 1.112 
4.5HH .091 1.500 1.000 -5.050 5.232 
5.5HH -.834 1.798 1.000 -6.997 5.329 
4.5HH 1.5HH -14.963* 2.889 .002 -24.869 -5.058 
2.5HH -3.562 1.957 .937 -10.270 3.146 
3.5HH -.091 1.500 1.000 -5.232 5.050 
5.5HH -.925 1.306 1.000 -5.402 3.552 
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6.10.1.3 Late stance phase 
The 4.5HH significantly reduced soleus mean EMG activity during stance phase when 
compared to the 2.5, 3.5 and 5.5 cm heel heights (p<0.025).  
Table 6.118: Pairwise comparison of shoe conditions for soleus mean EMG activity during 
loading response (N=13). 
 
6.10.1.4 The overall summary area for EMG activity 
The results show that the 1.5HH increased overall soleus EMG activity by 9.6% when 
compared to control and the 4.5HH reduced overall EMG activity by 15.4% when compared 
to the 1.5HH test condition. The 4.5HH adaptation reduced overall EMG area by 5.8% when 
compared to control shoe as demonstrated in the table below. 
 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH -1.146 6.238 1.000 -22.534 20.243 
3.5HH 4.693 4.670 1.000 -11.317 20.703 
4.5HH 13.460 6.013 .449 -7.156 34.076 
5.5HH -2.826 5.406 1.000 -21.359 15.707 
2.5HH 1.5HH 1.146 6.238 1.000 -20.243 22.534 
3.5HH 5.838 4.012 1.000 -7.917 19.594 
4.5HH 14.606* 3.817 .024 1.520 27.692 
5.5HH -1.681 4.941 1.000 -18.622 15.260 
3.5HH 1.5HH -4.693 4.670 1.000 -20.703 11.317 
2.5HH -5.838 4.012 1.000 -19.594 7.917 
4.5HH 8.767* 2.167 .016 1.336 16.198 
5.5HH -7.519 2.575 .128 -16.347 1.309 
4.5HH 1.5HH -13.460 6.013 .449 -34.076 7.156 
2.5HH -14.606* 3.817 .024 -27.692 -1.520 
3.5HH -8.767* 2.167 .016 -16.198 -1.336 
5.5HH -16.286* 3.806 .011 -29.335 -3.238 
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Table 6.119: The average (±SD) of the area under the curves for medial gastrocnemius EMG 
activity for test footwear conditions (N=13).  
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
EMG impulse  (overall area of EMG 
activity) 
109.6 
(8.6) 
105.5 
(7.7) 
100.0 
(7.3) 
94.2 
(7.0) 
105.8 
(7.7) 
Differences between control shoe (%) 9.6 5.5 0 -5.8 5.8 
 
 
A pairwise Anova test with Bonferroni adjustment demonstrated that the 2.5HH significantly 
increased EMG area for soleus muscle when compared to the 4.5HH footwear test condition. 
The 4.5HH showed significant reduction in the soleus EMG area when compared to the 
control shoe (p=0.008). 
Table 6.120: Pairwise comparison of shoe conditions for soleus overall area EMG activity 
during stance phase (N=13). 
 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH 4.060 3.262 1.000 -7.123 15.243 
3.5HH 9.588 4.541 .564 -5.982 25.158 
4.5HH 15.374 4.662 .064 -.610 31.357 
5.5HH 3.814 5.936 1.000 -16.538 24.166 
2.5HH 1.5HH -4.060 3.262 1.000 -15.243 7.123 
3.5HH 5.528 3.054 .953 -4.941 15.998 
4.5HH 11.313* 3.176 .039 .423 22.204 
5.5HH -.246 4.076 1.000 -14.219 13.727 
3.5HH 1.5HH -9.588 4.541 .564 -25.158 5.982 
2.5HH -5.528 3.054 .953 -15.998 4.941 
4.5HH 5.785* 1.311 .008 1.292 10.279 
5.5HH -5.774 2.299 .273 -13.655 2.107 
4.5HH 1.5HH -15.374 4.662 .064 -31.357 .610 
2.5HH -11.313* 3.176 .039 -22.204 -.423 
3.5HH -5.785* 1.311 .008 -10.279 -1.292 
5.5HH -11.559* 2.160 .002 -18.966 -4.153 
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6.10.1.5 Summary of soleus EMG activity alteration produced heel heights of the 
sole: 
 The 1.5HH increased EMG activity within 10-65% of the stance phase versus all 
footwear profiles by initiating premature activation. The hypothesis (Ha2) is 
positively accepted; 
 During LR the 1.5HH test condition significantly increased soleus EMG activity when 
compared to all footwear conditions; 
 During mid-stance phase the 1.5HH significantly increased maximum soleus EMG 
activity when compared to all footwear conditions (p<0.015);  
 During stance phase  the 4.5HH significantly reduced soleus mean EMG activity 
during stance phase when compared to the 2.5, 3.5 and 5.5 cm heel heights 
(p<0.025). The hypothesis (Ha2) is positively accepted; 
 The results show that the 1.5HH increased overall soleus EMG activity by 9.6% when 
compared to control and the 4.5HH reduced overall EMG activity by 15.4% when 
compared to the 1.5HH. The 4.5HH reduced overall EMG area by 5.8% when 
compared to control shoe; 
 The 4.5HH showed a significant reduction of the soleus EMG area when compared to 
the control shoe (p=0.008) which positively confirmed (Ha2) hypothesis; 
 The 2.5HH significantly increased EMG area for soleus muscle when compared to the 
4.5HH footwear condition. 
 
6.10.2 The effect of altering rocker sole apex position (AP) 
Figure 6.27 illustrates the alteration to the soleus EMG activity induced by the apex length 
sole changes. The 55AP test condition caused reduction in maximum soleus EMG activity and 
slightly altered the point during stance phase where maximum EMG activity occurred when 
compared to control. 
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Figure 6.32: The soleus EMG activity for test footwear conditions (N=13). (a) – without 
standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
The mean results for maximum EMG RMS activity for different footwear conditions during 
different part of the stance phase are demonstrated in the table below. 
Table 6.121: Mean (±SD) medial gastrocnemius EMG activity for test footwear conditions. 
 55AP 62.5AP 70AP 
Maximum EMG activity during LR (%) 29.6 (6.5) 31.2 (7.1) 32.8 (8.4) 
Maximum EMG activity during mid-stance (%) 41.5 (6.8) 44.1 (7.1) 46.4 (7.4) 
Maximum EMG activity  during stance phase (%) 96.2 (9.2) 100.0 (6.5) 98.5 (8.2) 
 
Loading response 
The results did not show any statistical significantdifference between the test conditions. 
Mid-stance phase 
The 55AP demonstrated significant mean EMG reduction when compared to the 70AP 
footwear during mid-stance phase (p=0.042).  
Table 6.122 : Pairwise comparison of shoe conditions for soleus mean EMG activity during 
mid-stance phase (N=13). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for 
Difference 
Lower Bound Upper Bound 
55AP 62.5AP -2.586 1.589 .389 -7.002 1.831 
70 AP -4.824* 1.676 .042 -9.483 -.165 
62.5AP 55AP 2.586 1.589 .389 -1.831 7.002 
70 AP -2.239 1.000 .135 -5.019 .542 
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Late stance phase 
The results did not show any statistical significant difference between the test conditions. 
6.10.2.1 Overall summary area of EMG activity 
There were no significant changes in the area of EMG activity. 
Table 6.123: The average (±SD) of the overall area under the curves for soleus EMG activity 
for test footwear conditions (N=13). 
 55AP 62.5AP 70AP 
EMG impulse (overall area of EMG 
activity %) 
98.7 
(6.8) 
100.0 
(7.3) 
99.7 
(8.3) 
Differences between control shoe (%) -1.3 0 -0.3 
 
 
6.10.2.2 Summary of soleus EMG activity alteration produced apex length of testing 
footwear conditions: 
 During mid-stance phase the 55AP demonstrated significant mean EMG reduction 
when compared to the 70AP footwear during mid-stance phase (p=0.042). The (Ha2) 
hypothesis is rejected; 
 The maximum peak EMG activity was not significantly atered and so the (Ha2) 
hypothesis is rejected. 
 
6.10.3 The effect of altering apex angle (toe angle-TA) 
Figure 6.33 illustrates the alteration to the soleus EMG activity induced by the apex toe 
angle changes. From the figure below, it can be seen maximum EMG activity reduction for 
the 20° angled-toe shoe versus control. 
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Figure 6.33: The soleus EMG activity for test footwear conditions (N=13). (a) – without 
standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
The mean results for maximum EMG RMS activity for different footwear conditions during 
different part of the stance phase are presented in the table below. 
Table 6.124: Mean (±SD) soleus EMG activity for test footwear conditions. 
 10° TA 15° TA 20° TA 
Max EMG activity during LR (%) 33.3 (7.4) 31.2 (7.1) 30.9 (7.2) 
Max EMG activity during mid-stance (%) 46.4 (7.9) 44.1 (7.1) 42.5 (7.7) 
Max EMG activity during stance phase (%) 102.3 (7.6) 100.0 (6.5) 94.2 (8.0) 
 
Loading response 
The results did not show any statistically significance alterations. 
 
Mid-stance phase 
The results did not show any statistically significance alterations. 
 
Stance phase 
The 20° TA shoe significantly reduced maximum EMG activity when compared to the 10° TA 
(p=0.023). 
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Table 6.125: Pairwise comparison of shoe conditions for soleus mean EMG activity during 
stance phase (N=13). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
10° TA 15° TA 2.309 1.923 .759 -3.036 7.653 
20° TA 8.142* 2.542 .023 1.075 15.208 
15° TA 10° TA -2.309 1.923 .759 -7.653 3.036 
20° TA 5.833 2.885 .198 -2.185 13.851 
20° TA 10° TA -8.142* 2.542 .023 -15.208 -1.075 
15° TA -5.833 2.885 .198 -13.851 2.185 
 
 
The overall summary area for EMG activity 
The 10° toe angle footwear increased the overall area of soleus EMG activity by 5.7% when 
compared to the 20° toe angle footwear as demonstrated in table 6.126. 
Table 6.126: The average (±SD) of the overall area under the curves for soleus EMG activity 
for test footwear conditions (N=13). 
 10° TA 15° TA 20° TA 
EMG impulse (overall area of EMG activity %) 102.5 (7.4) 100.0 (7.3) 96.8 (8.8) 
Differences between control shoe (%) 2.5 0 -3.2 
 
Statistical results are not significant. 
 
6.10.3.1 Summary of soleus EMG activity alteration produced by apex toe angle 
footwear conditions: 
 The 20° TA shoe significantly reduced soleus maximum EMG activity when compared 
to the 10° TA (p=0.023) and positively confirmed the (Ha2) hypothesis; 
 The 10° toe angle footwear increased the overall area of soleus EMG activity by 5.7% 
when compared to the 20° toe angle footwear test condition.  
6.10.4 The effect of altering heel curves 
Figure 6.34 illustrates the alteration to the soleus EMG activity induced by the curvature of 
the heel. The figure below visually shows that the full heel curve footwear test condition 
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resulted in increase of soleus EMG activity within 0-40% of the stance phase when compared 
to the other footwear test conditions. The half curve heeled shoe reduced maximum soleus 
EMG activity when compared to control shoe and a slightly less effect was seen for the full 
curved heel. 
 
Figure 6.34: The soleus EMG activity for test footwear conditions (N=13). (a) – without 
standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
The mean results for maximum EMG RMS activity for different footwear conditions during 
different part of the stance phase are demonstrated in the table below. 
 
Table 6.127: Mean (±SD) soleus EMG activity for test footwear conditions. 
 Full curve Half curve control 
Max EMG activity during LR (%) 39.9 (8.1) 33.9 (8.4) 31.2 (7.1) 
Max EMG activity during mid-stance (%) 47.9 (9.1) 43.3 (7.1) 44.1 (7.1) 
Max EMG activity during stance phase (%) 97.5 (9.8) 92.9 (7.2) 100.0 (6.5) 
 
Loading response 
The results did not show any statistically significance alterations. 
Mid-stance phase 
The results did not show any statistically significance alterations. 
Stance phase 
The results did not show any statistically significance alterations. 
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The overall summary area for EMG activity 
The half curved heel footwear test condition reduced the overall EMG area by 5.1% when 
compared to the control shoe with no heel curve added. 
Table 6.128: The average (±SD) of the overall area under the curves for medial 
gastrocnemius EMG activity for test footwear conditions (N=14). 
 Full curve Half curve control 
EMG impulse (overall area of EMG activity %) 100.9 (7.7) 94.9 (8.1) 100.0 (7.3) 
Differences between control shoe (%) 0.9 -5.1 0 
 
The results did not show any statistically significance alterations. 
6.10.4.1 Summary of soleus EMG activity alteration produced by curved heel test 
conditions. 
 The half curve footwear reduced the overall EMG area by 5.1% when compared to 
the control shoe with no heel curve. 
 The full curved heel footwear test condition resulted in an overall increase of soleus 
EMG activity within 0-40% of the stance phase when compared to the other footwear 
test conditions. The (Ha2) hypothesis is accepted. 
6.10.5 The effect of altering rocker profile stiffness at metatarsal area 
Figure 6.35 illustrates the alteration to the soleus muscle EMG activity induced by the 
flexibility of the sole. The picture below shows that the medium flexible footwear slightly 
increased maximum soleus muscle EMG activity when compared to all footwear conditions. 
However, statistical analysis did not show any significant results for the whole stance phase. 
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Figure 6.35: The soleus EMG activity for test footwear conditions (N=13). (a) – without 
standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
 
The mean results for maximum EMG RMS activity for different footwear conditions during 
different part of the stance phase are presented in the table below. 
Table 6.129: Mean (±SD) soleus EMG activity for test footwear conditions. 
 Flex sole Med. flex Solid 
Max EMG activity during LR (%) 31.0 (6.1) 31.0 (7.9) 31.2 (7.1) 
Max EMG activity during mid-stance (%) 45.1 (7.2) 45.3 (8.4) 44.1 (7.1) 
Max EMG activity during stance phase (%) 100.4 (6.9) 103.1 (6.6) 100.0 (6.5) 
 
Loading response 
The results did not show any statistically significance alterations. 
Mid-stance phase 
The results did not show any statistically significance alterations. 
Stance phase  
The results did not show any statistically significance alterations. 
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The overall summary area for EMG activity 
Table 6.130: The average (±SD) of the overall area under the curves for soleus EMG activity 
for test footwear conditions (N=14). 
 Flex sole Med. flex Solid 
EMG impulse (overall area of EMG activity %) 99.9 (7.3) 101.7 (7.2) 100.0 (7.3) 
Differences between control shoe (%) -0.1 1.7 0 
 
The results did not show any statistical significant differences between each other and 
rejected the generated hypothesis in chapter 4 (Ho2). 
 
6.11 Tibialis anterior electromyography results 
6.11.1 The effect of walking with different heel heights 
Figure 6.36 illustrates the alteration to the tibialis anterior EMG RMS values for the heel 
height test conditions. It can be seen that negative heel profiles reduced tibialis anterior 
EMG activity when compared to higher heels. 
 
Figure 6.36: The tibialis anterior EMG activity for test footwear conditions (N=14). (a) – 
without standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
The mean results for maximum EMG RMS activity for different footwear conditions during 
different parts of stance phase are demonstrated in table 6.131. 
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Table 6.131: Mean (±SD) tibialis anterior EMG activity for test footwear conditions. 
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Maximum EMG activity during 
stance phase (%) 
88.6 
(10.2) 
96.7 
(8.0) 
100.0 
(10.3) 
101.7 
(9.9) 
112.1 
(13.5) 
EMG impulse  (overall area of 
EMG activity) 
80.1 
(10.8) 
94.3 
(12.8) 
100.0 
(12.1) 
104.3 
(11.6) 
114.2 
(12.7) 
Differences between control 
shoe (%) 
-19.9 -5.7 0 4.3 14.2 
 
Loading response 
The 1.5HH significantly reduced mean soleus EMG activity when compared to 4.5HH 
(p=0.036) and 5.5HH (p=0.003) as shown in table 6.132.  
Table 6.132: Pairwise comparison of shoe conditions for tibialis mean EMG activity during 
loading response (N=14). 
 
 
The overall summary area for EMG activity 
The results show that the 1.5HH reduced tibialis anterior area EMG activity by 19.9% when 
compared to the control shoe (p=0.001) and produced a significant reduction against the 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH -8.104 5.751 1.000 -27.500 11.292 
3.5HH -11.406 4.506 .251 -26.601 3.789 
4.5HH -13.133* 3.704 .036 -25.625 -.641 
5.5HH -23.484* 4.721 .003 -39.406 -7.563 
2.5HH 1.5HH 8.104 5.751 1.000 -11.292 27.500 
3.5HH -3.302 2.631 1.000 -12.176 5.573 
4.5HH -5.029 5.503 1.000 -23.589 13.531 
5.5HH -15.380 4.982 .087 -32.183 1.422 
3.5HH 1.5HH 11.406 4.506 .251 -3.789 26.601 
2.5HH 3.302 2.631 1.000 -5.573 12.176 
4.5HH -1.727 3.565 1.000 -13.751 10.296 
5.5HH -12.079 4.035 .104 -25.687 1.530 
4.5HH 1.5HH 13.133* 3.704 .036 .641 25.625 
2.5HH 5.029 5.503 1.000 -13.531 23.589 
3.5HH 1.727 3.565 1.000 -10.296 13.751 
5.5HH -10.351 3.200 .065 -21.142 .439 
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other test conditions; especially by 34.1% when compared with the 5.5HH test condition 
(p<0.000). The 3.5HH significantly reduced tibialis anterior area EMG activity by 14.2% when 
compared with the 5.5HH (p=0.016) as shown in the table below. 
Table 6.133: Pairwise comparison of shoe conditions for tibialis overall area EMG activity 
during stance phase (N=14). 
 
 
6.11.1.1 Summary of tibialis anterior EMG activity alteration produced heel heights 
of the sole: 
 The 1.5HH significantly reduced mean soleus EMG activity when compared to the 4.5 
and 5.5 cm heel height shoe test conditions (p<0.037) as shown in the table below. 
The (Ha2) hypothesis is rejected; 
 The results show that the low heel profile gradually reduced tibialis anterior EMG 
activity impulse value (the positive area under the curve) to a significant level by 
altering the heel to1.5 cm in depth. Higher heel profiles demonstrated an increase in 
EMG impulse for the tibialis anterior muscle. The (Ha2) hypothesis is accepted. 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH -14.250* 3.137 .006 -24.828 -3.671 
3.5HH -19.902* 3.731 .001 -32.485 -7.320 
4.5HH -24.215* 4.660 .002 -39.931 -8.500 
5.5HH -34.091* 4.092 .000 -47.893 -20.290 
2.5HH 1.5HH 14.250* 3.137 .006 3.671 24.828 
3.5HH -5.653 2.714 .575 -14.804 3.499 
4.5HH -9.966 4.233 .350 -24.243 4.312 
5.5HH -19.842* 4.165 .004 -33.887 -5.797 
3.5HH 1.5HH 19.902* 3.731 .001 7.320 32.485 
2.5HH 5.653 2.714 .575 -3.499 14.804 
4.5HH -4.313 2.885 1.000 -14.042 5.417 
5.5HH -14.189* 3.585 .016 -26.281 -2.097 
4.5HH 1.5HH 24.215* 4.660 .002 8.500 39.931 
2.5HH 9.966 4.233 .350 -4.312 24.243 
3.5HH 4.313 2.885 1.000 -5.417 14.042 
5.5HH -9.876 3.800 .221 -22.692 2.940 
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6.11.2 The effect of altering rocker sole apex position (AP) 
Figure 6.32 illustrates the alteration to the tibialis anterior EMG activity induced by the sole 
apex length (position) changes.  
 
Figure 6.37: The tibialis anterior EMG activity for test footwear conditions (N=14). (a) – 
without standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
The mean results for maximum EMG RMS activity for different footwear conditions are 
demonstrated in the table below. 
Table 6.134 Mean (±SD) tibialis anterior EMG activity for test footwear conditions. 
 55AP 62.5AP 70AP 
Max EMG activity  during stance phase 95.1 (9.2) 100.0 (10.3) 97.7 (8.7) 
EMG impulse  (overall area of EMG activity) 96.5 (12.2) 100.0 (12.1) 98.5 (12.0) 
Differences between control shoe (%) -3.5 0 -1.5 
 
The results did not show any statistically significant differences between the test conditions 
and the (Ha2) hypothesis is rejected. 
6.11.3 The effect of altering apex angle (toe angle-TA) 
Figure 6.38 illustrates the alteration to the tibialis anterior EMG activity induced by the apex 
toe angle changes. 
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Figure 6.38: The tibialis anterior EMG activity for test footwear conditions (N=14). (a) – 
without standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
The mean results for maximum EMG RMS activity for different footwear conditions are 
presented in the table below. 
Table 6.135: Mean (±SD) tibialis anterior EMG activity for test footwear conditions. 
 10° TA 15° TA 20° TA 
Max EMG activity  during stance phase 101.6 (9.4) 100.0 (10.3) 101.0 (11.5) 
EMG impulse  (overall area of EMG activity) 101.4 (11.6) 100.0 (12.1) 100.7 (12.8) 
Differences between control shoe (%) 1.4 0 0.7 
 
The results did not show any statistically significant differences between the test conditions 
and the (Ha2) hypothesis is rejected. 
6.11.4 The effect of altering heel curve 
Figure 6.39 illustrates the alteration to the tibialis anterior EMG activity induced by the 
curvature of the heel. The figure below visually shows that the curved-heel footwear 
conditions resulted in reduction of mean tibialis anterior EMG activity when compared to 
the control shoe without a heel curve.  
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Figure 6.39: The tibialis anterior EMG activity for test footwear conditions (N=14). (a) – 
without standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
The mean results for maximum EMG RMS activity for different footwear conditions are 
shown in the table below. 
Table 6.136: Mean (±SD) tibialis anterior EMG activity for test footwear conditions. 
 Full curve Half curve control 
Maxi EMG activity  during stance phase 79.9 (9.1) 83.0 (8.7) 100.0 (10.3) 
EMG impulse  (overall area of EMG activity) 84.1 (12.9) 86.3 (11.8) 100.0 (12.1) 
Differences between control shoe (%) -15.9 -13.7 0 
 
6.11.4.1 Loading response 
The control shoe without a curve significantly increased mean tibialis anterior EMG activity 
during loading response when compared to the other footwear conditions with curved heels 
(p<0.000). 
Table 6.137: Pairwise comparison of shoe conditions for tibialis mean EMG activity during 
loading response (N=14). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for 
Difference 
Lower Bound Upper Bound 
Full curve Half curve -3.038 2.766 .876 -10.635 4.559 
No curve -20.067* 2.824 .000 -27.820 -12.313 
Half curve Full curve 3.038 2.766 .876 -4.559 10.635 
No curve -17.029* 2.841 .000 -24.829 -9.228 
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The overall summary area for EMG activity 
The full heel curve footwear reduced the overall EMG area for the tibialis anterior muscle by 
15.9% (p<0.000) and the half curved-heel shoe reduced it by 13.7% (p=0.001) when 
compared to the control shoe.  
 
6.11.4.2 Summary of tibialis anterior EMG activity alteration produced by curved 
heel test conditions 
 Thecontrol shoe significantly increased mean tibialis anterior EMG activity during 
loading response when compared to footwear conditions with curved-heels 
(p<0.000); 
 The full curve footwear reduced overall EMG area by 15.9% (p<0.000) and the half 
curved-heel shoe reduced it by 13.7% (p=0.001) when compared to the control shoe 
without a curve; 
 It confirmed the hypothesis that curvature of the heel may reduce tibialis anterior 
maximum EMG activity. 
6.11.5 The effect of altering rocker profile stiffness at metatarsal area 
Figure 6.40 illustrates the alteration to the tibialis anterior muscle EMG activity induced by 
the flexibility of the sole. It shows that flexible footwear profiles reduced mean tibialis 
anterior EMG activity when compared to a solid sole (control shoe).  
 
Figure 6.40: The tibialis anterior EMG activity for test footwear conditions (N=14). (a) – 
without standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
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The mean results for maximum EMG RMS activity for different footwear conditions are 
presented in the table below. 
Table 6.138Table: Mean (±SD) tibialis anterior EMG activity for test footwear conditions. 
 Flex sole Med. flex Solid 
Max EMG activity  during stance phase 91.6 (9.6) 93.6 (12.2) 100.0 (10.3) 
EMG impulse  (overall area of EMG activity) 92.0 (12.8) 93.9 (12.5) 100.0 (7.3) 
Differences between control shoe (%) -8.0 -6.1 0 
 
The solid sole showed significant increase tibialis anterior EMG activity when compared to 
the flexible shoe (p=0.003) and medium flexibility shoe (p=0.04) as shown in the table below. 
Table 6.139: Pairwise comparison of shoe conditions for tibialis mean EMG activity during 
loading response (N=14). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
Flex sole Med. flex -1.959 2.112 1.000 -7.760 3.841 
Solid -8.382* 1.946 .003 -13.725 -3.039 
Med. flex Flex sole 1.959 2.112 1.000 -3.841 7.760 
Solid -6.423* 2.247 .040 -12.593 -.253 
 
 
The overall summary area for EMG activity 
The solid shoe significantly increased overall tiabialis anterior EMG activity by 8% when 
compared to a flexible sole profile. 
Table 6.140: Pairwise comparison of shoe conditions for tibialis overall area EMG activity 
during stance phase (N=14). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
Flex sole Med. flex -1.893 2.869 1.000 -9.772 5.985 
Solid -8.015* 2.112 .007 -13.815 -2.214 
Med. flex Flex sole 1.893 2.869 1.000 -5.985 9.772 
Solid -6.121 2.335 .063 -12.533 .290 
 
295 
 
6.11.5.1 Summary results for tibailis anterior EMG results altered by footwear 
stiffness level at metatarsal area: 
 The solid-soled showed significantly increased tibialis anterior EMG activity when 
compared to a flexible shoe (p=0.003) and a medium flexibility shoe (p=0.040). The 
(Ha2) hypothesis is accepted; 
 The solid shoe significantly increased overall tiabialis anterior EMG activity by 8% 
when compared to the flexible sole profile. 
6.12 Achilles muscle moment arm 
6.12.1 The effect of altering heel height of the sole on Achilles muscle moment arm 
Figure 6.41, illustrates the alteration produced to the Achilles muscle moment arm by the 
heel height test conditions. The results shows that low heel kept the muscle moment arm 
shorter when compared to raised heels. The red line represents the Achilles muscle moment 
arm length at barefoot standing (the natural position where the foot is parallel to the 
ground). The closest position to the barefoot standing at which muscle is not shortened or 
lengthened during powerful ankle contraction at the late stance phase is the 4.5HH footwear 
condition. 
 
Figure 6.41: The Achilles muscle moment arm length for different heel height test footwear 
conditions (N=14). Legend 1 indicates the point at which the muscle moment arm is at its 
maximum at 55% of stance phase, where the calf muscles are starting to generate force by 
eccentric contraction and gradually increasing the external DF ankle moment required for 
296 
 
ankle movement; legend 2 indicates the mean muscle moment arm at which the peak EMG 
occurs.  
The results for the Achilles muscle moment arm change within highlighted points of interest 
are demonstrated in the table below. 
 
Table 6.141: Mean (±SD) Achilles muscle moment arm (mm) for heel height test footwear 
conditions (N=14). 
Maximum ROM Achilles moment arm for all footwear conditions used for this 
study (mm) 
7.04 
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Maximum moment arm  
length during 55% of stance 
phase (mm) 
42.70 
(0.54) 
44.69 
(0.25) 
45.58 
(0.24) 
46.21 
(0.26) 
46.64 
(0.23) 
Differences between control 
3.5HH shoe (mm) 
-4.15 
(0.54) 
-0.89 
(0.25) 
0.00 
(0.24) 
0.63 
(0.26) 
1.06 
(0.23) 
Maximum moment arm 
length during peak force 
generation (mm) 
40.95 
(0.56) 
43.39 
(0.34) 
44.11 
(0.30) 
44.67 
(0.28) 
44.99 
(0.29) 
Differences between control 
3.5HH shoe (mm) 
-3.16 
(0.56) 
-0.72 
(0.34) 
0.00 
(0.30) 
0.55 
(0.28) 
0.88 
(0.29) 
 
6.12.1.1 Maximum moment arm length during 55% of stance phase. 
All heel heights showed significant changes in the Achilles muscle moment arm when 
compared to the other conditions (p<0.001). A significant gradual increase in muscle 
moment arm from low heel to high was demonstrated. The maximum length change with all 
the footwear conditions in this study was 7.04 mm for the Achilles muscle moment arm. 
6.12.1.2 Maximum moment arm length during peak force generation. 
With raising the heel the muscle moment arm was significantly increased (p<0.004) for all 
test conditions, except for the 4.5HH and the 5.5HH which did not show any significant 
difference between each other. However, it is difficult to choose level of significance for the 
muscle moment arm value because a small change can increase the internal muscle moment 
more significantly, if more muscle force was applied.  
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6.12.1.3 Summary results for Achilles muscle moment arm changes affected by heel 
heights: 
 The Achilles muscle moment arm was significantly increased with raising heel heights 
at 55% of stance phase and peak force generation by the calf muscle and the (Ha4) 
hypothesis is accepted; 
 The 4.5 heel height kept the muscle moment arm closer to its natural position at 
which there is no calf lengthening or shortening at peak calf muscle force generation. 
The (Ha4) hypothesis is accepted. 
 
6.12.2 The effect of altering rocker sole apex position (AP) on Achilles muscle moment 
arm 
Figure 6.42, illustrates the alteration to the Achilles muscle moment arm by the apex length 
of the shoe. The 55AP kept the muscle moment arm longer between 20-100% of stance 
phase versus the other apex position footwear conditions. It can be seen that the 55AP 
increased length of the Achilles muscle moment arm at propulsion performed by the calf 
muscle. 
 
Figure 6.42: The Achilles muscle moment arm length analysis for different apex length test 
footwear conditions (N=14). Legend 1 indicates maximum muscle moment arm at 55% of 
stance phase; legend 2 indicates the mean muscle moment arm at the position where the 
peak EMG occurs. (a) – without standard deviation (STD), (b) – with the lines shadowed to 
represent STD ranges. 
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Table 6.142: Mean (±SD) Achilles muscle moment arm (mm) for apex length test footwear 
conditions (N=14). 
Maximum ROM Achilles moment arm for all footwear conditions 
used for this study (mm) 
7.04 
 55AP 62.5AP 70AP 
Maximum moment arm  length during 55% 
of stance phase (mm) 
45.95 
(0.23) 
45.58 
(0.24) 
45.03 
(0.22) 
Differences between control 3.5HH shoe 
(mm) 
0.37 
(0.23) 
0.00 
(0.24) 
-0.55 
(0.22) 
Maximum moment arm length during peak 
force generation (mm) 
44.59 
(0.26) 
44.11 
(0.30) 
43.26 
(0.33) 
Differences between control 3.5HH shoe 
(mm) 
0.48 
(0.26) 
0.00 
(0.30) 
-0.86 
(0.33) 
 
6.12.2.1 Maximum moment arm length during 55% of stance phase 
The short apex length (55AP) test condition resulted in a significant increase in the Achilles 
muscle moment arm at 55% stance phase versus 62.5% and 70% (P<0.023) as shown in the 
table below. 
Table 6.143: Pairwise comparison the Achilles muscle moment arm changes at 55% stance 
phase for test footwear conditions  (N=14). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
55AP 62.5AP .374* .118 .023 .048 .699 
70 AP .929* .096 .000 .666 1.191 
62.5AP 55AP -.374* .118 .023 -.699 -.048 
70 AP .555* .109 .001 .256 .854 
 
6.12.2.2 Maximum moment arm length during peak force generation 
The 55AP footwear significantly increased the length of the moment arm at peak muscle 
force generation when compared to the 62.5AP and 70AP (p<0.021).  
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6.12.2.3 Summary results for AP changes in the Achilles muscle moment arm: 
 The 55AP test condition kept the muscle moment arm longer between 20-100% of 
stance phase versus all footwear conditions; 
 The 55AP footwear significantly increased the length of the moment arm at peak 
muscle force generation when compared to the 62.5AP and 70AP test conditions 
(p<0.021). It accepted the hypothesis that the 55AP placed ankle angle at earlier 
plantarflexion during terminal stance which resulted in increase the length of Achilles 
tendon moment arm when compared to longer apex position of the sole. The (Ha4) 
hypothesis is accepted. 
6.12.3 The effect of altering apex toe angle of the sole on Achilles muscle moment arm 
Figure 6.43, illustrates the alteration to the Achilles muscle moment arm by the toe angle 
footwear test conditions. The figure below shows that the 10 degrees toe angle reduced the 
Achilles moment arm from 20-100% of stance phase versus the 15 and 20 degrees toe-
angled footwear conditions. The 20 degrees toe angle shoe slightly increased the moment 
arm between 80-95% of stance phase when compared to the control shoe. 
 
 
Figure 6.43: The Achilles muscle moment arm length for different toe apex angle test 
footwear conditions (N=14). Legend 1 indicates maximum muscle moment arm at 55% of the 
stance; legend 2 indicates mean muscle moment arm at which the peak EMG occurs. (a) – 
without standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
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The results for the Achilles muscle moment arm change within highlighted points of interest 
are demonstrated in the table below. 
Table 6.144: Mean (±SD) Achilles muscle moment arm (mm) for toe angle test footwear 
conditions (N=14). 
Maximum ROM Achilles moment arm for all footwear conditions 
used for this study (mm) 
7.04 
 10° TA 15° TA 20° TA 
Maximum moment arm  length during 55% 
of stance phase (mm) 
45.21 
(0.26) 
45.58 
(0.24) 
45.42 
(0.28) 
Differences between control 3.5HH shoe 
(mm) 
-0.37 
(0.26) 
0.00 
(0.24) 
-0.16 
(0.28) 
Maximum moment arm length during peak 
force generation (mm) 
43.48 
(0.37) 
44.11 
(0.30) 
44.12 
(0.37) 
Differences between control 3.5HH shoe 
(mm) 
-0.64 
(0.37) 
0.00 
(0.30) 
0.01 
(0.37) 
 
6.12.3.1 Maximum moment arm length during 55% of stance phase 
The 10° TA reduced the length of the Achilles moment arm to a significant level when 
compared to the control shoe at 55% of stance phase (p=0.028). 
6.12.3.2 Maximum moment arm length during peak force generation 
The 10° TA reduced length of the Achilles moment arm to significant level when compared 
to control (p=0.01) and reduced it when compared to the 20° TA test condition (p=0.03) as 
shown in table 6.145. 
 
Table 6.145: Pairwise comparison the Achilles muscle moment arm changes during peak 
force generation of the ankle for test footwear conditions  (N=14). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
10° TA 15° TA -.635* .128 .001 -.986 -.285 
20° TA -.673* .159 .003 -1.110 -.235 
15° TA 10° TA .635* .128 .001 .285 .986 
20° TA -.037 .130 1.000 -.395 .320 
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6.12.3.3 Summary for toe angle alteration to rocker shoes: 
 The 10 degree toe angle reduced the Achilles moment arm from 20-100% of the 
stance phase versus the 15 and 20 degrees toe-angled footwear conditions; 
 The 20 degree toe angle shoe slightly increased the moment within 80-95% stance 
phase when compared to control shoe. The (Ha4) hypothesis is rejected. 
 
6.12.4 The effect of altering heel curve of the sole on Achilles muscle moment arm 
Figure 6.44, illustrates the alteration to the Achilles muscle moment arm by the heel 
curvature footwear test conditions. The curvature of the heel resulted in shortening the 
Achilles moment arm within the whole of stance phase when compared to the control shoe. 
 
 
Figure 6.44: The Achilles muscle moment arm length for the different curved-heel test 
footwear conditions where control shoe has no curve (N=14). (a) – without standard 
deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
The results for the Achilles muscle moment arm change within highlighted points of interest 
are demonstrated in the table below. 
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Table 6.146: Mean (±SD) Achilles muscle moment arm (mm) for curved-heel test footwear 
conditions (N=14). 
Maximum ROM Achilles moment arm for all footwear conditions 
used for this study (mm) 
7.04 
 Full curve Half curve control 
Maximum moment arm  length during 55% 
of stance phase (mm) 
45.09 
(0.26) 
45.12 
(0.27) 
45.58 
(0.24) 
Differences between control 3.5HH shoe 
(mm) 
-0.49 
(0.26) 
-0.46 
(0.27) 
0.00 
(0.24) 
Maximum moment arm length during peak 
force generation (mm) 
43.68 
(0.36) 
45.12 
(0.27) 
44.11 
(0.30) 
Differences between control 3.5HH shoe 
(mm) 
-0.43 
(0.36) 
-0.34 
(0.27) 
0.00 
(0.30) 
6.12.4.1 Maximum moment arm length during 55% of stance phase 
The control shoe (without curve on the heel) significantly increased the Achilles moment 
arm at 55% stance phase when compared to full and half curved heel footwear conditions 
(p<0.004). 
6.12.4.2 Maximum moment arm length during peak force generation 
The control shoe without any heel curve increased the moment arm to a significant level 
when compared to both the curved heel test conditions during the phase of peak ankle force 
generation performed by the calf muscles (p<0.048) 
6.12.4.3 Summary of results for curved heel footwear test conditions: 
 A curvature of the heel resulted in shortening of the Achilles moment arm within the 
whole of stance phase when compared to the control shoe; 
 The control shoe without a curved heel increased the moment arm to a significant 
level when compared to both the curved heel test conditions at 55% stance phase 
(p<0.004). The (Ha4) hypothesis is accepted; 
 The control shoe increased the moment arm to a significant level when compared to 
both the curved heeled shoes during the peak ankle force generation phase 
performed by the calf muscle (p<0.048). The (Ha4) hypothesis is accepted; 
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6.12.5 The effect of altering rocker profile stiffness at metatarsal area on Achilles muscle 
moment arm 
Figure 6.45, illustrates the alteration to the Achilles muscle moment arm by the flexibility of 
the sole where control shoe has solid sole. 
 
Figure 6.45: The Achilles muscle moment arm length analysis results from OpenSim software 
for different flexibility levels of the sole (N=14). Legend 1 indicates maximum muscle 
moment arm at 55% of the stance phase which approximates to the position where the calf 
muscles are starting to generate powerful force; legend 2 indicates the mean muscle 
moment arm at which the peak EMG occurs.  (a) – without standard deviation (STD), (b) – 
with the lines shadowed to represent STD ranges. 
The results for the Achilles muscle moment arm change within the highlighted points of 
interest are demonstrated in table 6.147. 
Table 6.147: Mean (±SD) Achilles muscle moment arm (mm) for different flexibility of the 
sole (N=14). 
Maximum ROM Achilles moment arm for all footwear conditions 
used for this study (mm) 
7.04 
 Flex sole Med. flex Solid 
Maximum moment arm  length during 55% 
of stance phase (mm) 
45.49 
(0.24) 
45.52 
(0.26) 
45.58 
(0.24) 
Differences between control 3.5HH shoe 
(mm) 
-0.19 
(0.24) 
-0.06 
(0.26) 
0.00 
(0.24) 
Maximum moment arm length during peak 
force generation (mm) 
43.92 
(0.34) 
43.92 
(0.35) 
44.11 
(0.30) 
Differences between control 3.5HH shoe 
(mm) 
-0.19 
(0.34) 
-0.19 
(0.35) 
0.00 
(0.30) 
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6.12.5.1 Maximum moment arm length during 55% of stance phase 
No significant differences in the data were calculated. The (Ha4) hypothesis is rejected. 
6.12.5.2 Maximum moment arm length during peak force generation 
No significant differences in the data were noted. The (Ha4) hypothesis is rejected. 
 
6.13 Gastrocnemius and Soleus fibre length alteration 
6.13.1 Heel Height (HH) 
Figure 6.46, illustrates the alteration to the MG and Soleus fibre lengths by the heel height 
test conditions. The soleus fibre length is only related to ankle joint movement but 
gastrocnemius muscle is also related to the knee flexion. The barefoot static position (red 
line) for the soleus muscle shows the neutral position (optimal position when it is not 
shortened or lengthened) of the ankle at which maximum force can be generated. The 
4.5HH placed ankle at the position where fibre length for soleus is at optimal length position 
during peak force generation (point 2). The 1.5 HH is too stretched during stance phase and 
raised heel reduce length of MG and soleus fibres during whole stance phase. 
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Figure 6.46: The fibre length alteration results data from OpenSim simulation software for 
different heel height test footwear conditions (N=14). The red line represents fibre lengths 
at the barefoot static position. Legend 1 indicates maximum fibre length at 55% of stance 
phase which approximates to where the calf muscles start to generate powerful force; 
legend 2 indicates the mean fibre length at which the peak EMG occurs. (a) – without 
standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
The average results for the changes in fibre lengths of GM and soleus muscles within the 
highlighted points of interest are demonstrated in table 6.148. 
Table 6.148: MG and soleus fibre length (mm) mean (±SD) for heel height test footwear 
conditions (N=14).  
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Medial Gastrocnemius       
Maximum fibre  length at 55% 
of stance phase (mm) 
54.93 
(1.11) 
50.57 
(0.63) 
48.07 
(0.72) 
45.88 
(0.61) 
44.31 
(0.56) 
Differences between control 
3.5HH shoe (mm) 
6.85 
(1.11) 
2.49 
(0.63) 
0.00 
(0.72) 
-2.20 
(0.61) 
-3.76 
(0.56) 
Maximum fibre  length during 
peak force generation (mm) 
56.31 
(1.29) 
52.45 
(0.88) 
50.47 
(0.83) 
48.80 
(0.63) 
47.77 
(0.77) 
Differences between control 
3.5HH shoe (mm) 
5.85 
(1.29) 
1.99 
(0.88) 
0.00 
(0.83) 
-1.66 
(0.63) 
-2.70 
(0.77) 
Soleus      
Maximum fibre  length at 55% 
of stance phase (mm) 
45.98 
(1.16) 
42.31 
(0.64) 
40.26 
(0.63) 
38.42 
(0.69) 
37.05 
(0.65) 
Differences between control 
3.5HH shoe (mm) 
5.72 
(1.16) 
2.05 
(0.64) 
0.00 
(0.63) 
-1.84 
(0.69) 
-3.21 
(0.65) 
Maximum fibre length during 
peak force generation (mm) 
47.89 
(1.07) 
44.48 
(0.77) 
42.89 
(0.69) 
41.44 
(0.75) 
40.40 
(0.81) 
Differences between control 
3.5HH shoe (mm) 
5.00 
(1.07) 
2.05 
(0.77) 
0.00 
(0.69) 
-1.84 
(0.75) 
-3.21 
(0.81) 
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6.13.1.1 Maximum fibre length during peak calf muscle force generation 
All footwear altered by using different heel heights produced significant changes in GM and 
soleus fibre lengths when compared to each other (p<0.003). A significant gradual 
lengthening (stretching) of MG and soleus fibre lengths was noted when walking from high 
heeled to low heeled shoes. 
6.13.1.2 Summary of the results for MG and soleus fibre length changes affected by 
heel heights: 
 All footwear features altered by heel height showed significant changes in GM and 
soleus fibre lengths when compared to each other (p<0.003). A significant gradual 
lengthening (stretching) of MG and soleus fibre lengths from high heels to low heels 
was demonstrated. The (Ha4) hypothesis is accepted; 
 The 4.5HH placed the ankle at the position where the fibre length for soleus is at its 
optimal length/position during peak force generation (point 2); 
 The 1.5HH shoe test condition altered soleus muscle fibres length to increase at 35% 
of the stance phase, then shortening until 50% of stance phase and then lengthening 
again. There were no similar alterations for other footwear conditions. 
 
6.13.2 Apex position (AP) 
Figure 6.47, illustrates the alteration to the MG and soleus fibre lengths by rocker apex 
position shoe test conditions. The medial gastrocnemius fibre length is stretching with a 
fairly constant and similar velocity; probably due to concurrent  knee flexion. The soleus 
fibre length changes to isometric contraction at 20% of stance phase and then rapid 
lengthens at terminal stance phase. The 55% AP footwear shows that fibre length at peak 
muscle generation at point 2 is more stretched when compared to the control and 70AP 
footwear.  
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Figure 6.47: The fibre length alteration results from OpenSim simulation software for 
different AP test footwear conditions (N=14). The red line represent fibre lengths at the 
barefoot static position. Legend 1 indicates maximum fibre length at 55% of stance phase 
which approximates to the position where the  calf muscles are starting to generate 
powerful force; legend 2 indicates mean fibre length at which the peak EMG occurs. (a) – 
without standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
The average results for the fibre lengths of GM and soleus muscles change within highlighted 
points of interest are demonstrated in table 6.149. 
Table 6.149: MG and soleus fibre length (mm) mean (±SD) for the AP test footwear 
conditions (N=14). 
 55AP 62.5AP 70AP 
Medial Gastrocnemius     
Max fibre  length at 55% of stance phase (mm) 47.04 (0.70 48.07 (0.72) 49.71 (0.37) 
Differences between control 3.5HH shoe (mm) -1.03 (0.70 0.00 (0.72) 1.64 (0.37) 
Max fibre  length during peak force generation (mm) 49.15 (0.74) 50.47 (0.83) 52.68 (0.60) 
Differences between control 3.5HH shoe (mm) -1.32 (0.74) 0.00 (0.83) 2.21 (0.60) 
Soleus    
Max fibre  length at 55% of stance phase (mm) 39.53 (0.76) 40.26 (0.63) 41.67 (0.54) 
Differences between control 3.5HH shoe (mm) -0.73 (0.76) 0.00 (0.63) 1.41 (0.54) 
Max fibre length during peak force generation (mm) 42.03 (0.73) 42.89 (0.69) 44.73 (0.74) 
Differences between control 3.5HH shoe (mm) -0.86 (0.73) 0.00 (0.69) 1.41 (0.74) 
308 
 
6.13.2.1 Maximum fibre length during peak calf muscle force generation 
The 62.5AP footwear significantly increased MG fibre length at peak calf muscle force 
generation when compared to the 55AP (p<0.001) and significantly reduced GM fibre length 
when compared to the 70AP footwear (p<0.001).  
The 55AP footwear did not reach significant shortening of soleus fibre length when 
compared to the control shoe (p=0.07) However, the significance level should be low for the 
fibres length because 10% of shortening can reduce force generation of skeletal muscles by 
50%. The 70AP footwear significantly stretched soleus fibres when compared to both 
footwear conditions (p<0.000) as shown in table 6.150. 
Table 6.150: Pairwise comparison the soleus fibre length changes during peak force 
generation of the ankle for test footwear conditions (N=14). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for 
Difference 
Lower Bound Upper Bound 
10° TA 15° TA -.857 .337 .070 -1.783 .069 
20° TA -2.700* .219 .000 -3.302 -2.098 
15° TA 10° TA .857 .337 .070 -.069 1.783 
20° TA -1.843* .261 .000 -2.560 -1.127 
 
 
6.13.2.2 Summary results for MG and soleus fibre lengths changes affected by apex 
length of the sole: 
 The 55% apex position shoe shows that the soleus fibre lengths are close to their 
natural position at which peak force is generated during push off phase; 
 The 62.5AP footwear significantly increased MG fibre length at peak calf muscle force 
generation when compared to the 55AP (p<0.001) and significantly reduced GM fibre 
length when compared to the 70AP footwear (p<0.001). This answered the 
hypothesis that shorter apex length resulted in less calf muscle stretching when 
compared to longer AP. The hypothesis (Ha4) is accepted. 
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6.13.3 Toe angle (TA) 
Figure 6.48 shows the alteration to the MG and soleus fibre lengths by toe angle of the shoe. 
Figure shows that the 10 degree toe angle footwear increased MG and soleus fibre length 
(stretched) during terminal stance and push-off phase when compared to the 15 and 20 
degree toe angle shoe test conditions. 
 
 
Figure 6.48: The fibre length alteration results data from OpenSim simulation software for 
different TA test footwear conditions (N=14). Red line represent fibre lengths at barefoot 
static position. Legend 1 indicates maximum fibre length at 55% of the stance phase where 
approximately calf muscle starting to generate powerful force; legend 2 indicates mean fibre 
length at which the peak EMG occurs. (a) – without standard deviation (STD), (b) – with the 
lines shadowed to represent STD ranges. 
The average results for the fibre lengths of GM and soleus muscles change within highlighted 
points of interest are demonstrated in table 6.151. 
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Table 6.151: MG and soleus fibre length (mm) mean (±SD) for AP test footwear conditions 
(N=14). 
 10° TA 15° TA 20° TA 
Medial Gastrocnemius     
Max fibre  length at 55% of stance phase (mm) 49.28 (0.51) 48.07 (0.72) 48.47 (0.46) 
Differences between control 3.5HH shoe (mm) 1.21(0.51) 0.00 (0.72) 0.40 (0.46) 
Max fibre  length during peak force generation (mm) 51.95 (0.65) 50.47 (0.83) 51.23 (0.81) 
Differences between control 3.5HH shoe (mm) 1.48 (0.65) 50.47 (0.83) 0.76 (0.81) 
Soleus    
Max fibre  length at 55% of stance phase (mm) 41.15 (0.58) 40.26 (0.63) 40.66 (0.61) 
Differences between control 3.5HH shoe (mm) 0.89 (0.58) 0.00 (0.63) 0.40 (0.61) 
Max fibre  length during peak force generation (mm) 44.23 (0.80) 42.89 (0.69) 43.01 (0.63) 
Differences between control 3.5HH shoe (mm) 1.34 (0.80) 0.00 (0.69) 0.12 (0.63) 
 
6.13.3.1 Maximum fibre length during peak calf muscle force generation 
The 10°TA significantly increased GM fibre length at peak force generation by calf muscle 
during late stance phase when compared to control shoe (p<0.000). 
The 10°TA significantly increased soleus fibre length at peak force generation by calf muscle 
during late stance phase when compared to the 20°TA (p<0.000). 
6.13.3.2 Summary for toe angle alteration rocker shoes: 
 The 10 degrees toe angle footwear increased MG and soleus fibre length (stretched) 
during terminal stance and push-off phases when compared to 15 and 20 degrees 
toe angle. The hypothesis (Ha4) is accepted. 
 The 10°TA significantly increased GM fibre length at peak force generation by calf 
muscle during late stance phase when compared to control shoe (p<0.000). The 
hypothesis (Ha4) is accepted. 
 The 10°TA significantly increased soleus fibre length at peak force generation by calf 
muscle during late stance phase when compared to the 20°TA (p<0.000). The 
hypothesis (Ha4) is not accepted. 
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6.13.4 Heel Curve 
Figure 6.49 shows the alteration to the MG and soleus fibre lengths by heel curve of the 
shoe where control shoe has no curve. The curved profiles resulted in lengthening MG and 
soleus fibres during whole stance phase. 
 
 
Figure 6.49: The fibre length alteration results data from OpenSim simulation software for 
different heel curve test footwear conditions (N=14). The red line represent fibre lengths at 
the barefoot static position. Legend 1 indicates maximum fibre length at 55% of stance 
phase which approximates to the position where the  calf muscles are starting to generate 
powerful force; legend 2 indicates mean fibre length at which the peak EMG occurs. (a) – 
without standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
The average results for the fibre lengths of GM and soleus muscles change within highlighted 
points of interest are demonstrated in table 6.152. 
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Table 6.152: MG and soleus fibre length (mm) mean (±SD) for curved heel test footwear 
conditions (N=14). 
 Full curve Half curve control 
Medial Gastrocnemius     
Max fibre  length at 55% of stance phase (mm) 49.73 (0.64) 49.37 (0.56) 48.07 (0.72) 
Differences between control 3.5HH shoe (mm) 1.66 (0.64) 1.30 (0.56) 0.00 (0.72) 
Max fibre  length during peak force generation (mm) 51.90 (0.85) 51.62 (0.84) 50.47 (0.83) 
Differences between control 3.5HH shoe (mm) 1.44 (0.85) 1.15 (0.84) 0.00 (0.83) 
Soleus    
Max fibre  length at 55% of stance phase (mm) 41.45(0.69) 41.34 (0.66) 40.26 (0.63) 
Differences between control 3.5HH shoe (mm) 1.19 (0.69) 1.07(0.66) 0.00 (0.63) 
Max fibre  length during peak force generation (mm) 43.72 (0.73) 43.72 (0.81) 42.89 (0.69) 
Differences between control 3.5HH shoe (mm) 0.83 (0.73) 0.83 (0.81) 42.89 (0.69) 
 
6.13.4.1 Maximum fibre length during peak calf muscle force generation 
The full heel curve and half heel curve shoe test conditions significantly increased GM and 
soleus fibre length at peak calf muscle force generation during late stance phase when 
compared to control shoe (p<0.000). 
6.13.4.2 Summary results for curved heel footwear test conditions: 
 The curved heel shoes resulted in lengthening of both MG and soleus fibres during 
the whole of stance phase. 
 The full curve and half curve rockers significantly increased GM and soleus fibre 
length at peak calf muscle force generation during late stance phase when compared 
to the control shoe (p<0.000). The hypothesis (Ha4) is accepted. 
6.13.5 Flexibility of the sole 
Figure 6.50 shows the alteration to the MG and soleus fibre lengths caused by altering the 
flexibility of the sole. 
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Figure 6.50: The fibre length alteration results data from OpenSim simulation software for 
different flexibility levels of the sole at the metatarsal area (N=14). The red line represents 
fibre lengths at the barefoot static position. Legend 1 indicates maximum fibre length at 55% 
of the stance phase where the calf muscle starts to generate powerful force; legend 2 
indicates mean fibre length at which the peak EMG occurs. 
The average results for the fibre lengths of GM and soleus muscles change within highlighted 
points of interest are demonstrated in table 6.153 below. 
Table 6.153: MG and soleus fibre length (mm) mean (±SD) for different sole flexibility level 
(N=14). 
 Flex sole Med. flex Solid 
Medial Gastrocnemius     
Max fibre  length at 55% of stance phase (mm) 48.52 (0.56) 48.54 (0.60) 48.07 (0.72) 
Differences between control 3.5HH shoe (mm) 0.44 (0.56) 0.46 (0.60) 0.00 (0.72) 
Max fibre  length during peak force generation (mm) 51.06 (0.76) 50.94 (0.75) 50.47 (0.83) 
Differences between control 3.5HH shoe (mm) 0.59 (0.76) 0.47 (0.75) 0.00 (0.83) 
Soleus    
Max fibre  length at 55% of stance phase (mm) 40.64 (0.62) 40.48 (0.68) 40.26 (0.63) 
Differences between control 3.5HH shoe (mm) 0.38 (0.62) 0.22 (0.68) 0.00 (0.63) 
Max fibre  length during peak force generation (mm) 43.37 (0.81) 43.12 (0.78) 42.89 (0.69) 
Differences between control 3.5HH shoe (mm) 0.48 (0.81) 0.23 (0.78) 0.00 (0.69) 
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Flexible and medium flexibility profiles did not show any significant differences for MG and 
soleus fibre lengths. The hypothesis (Ha4) is rejected. 
6.13.5.1 MG and soleus fibre length velocity alteration by footwear features 
6.13.6 Heel Height (HH) 
Figure 6.51 shows the alteration to the MG and soleus fibre length velocity caused by 
differing heel heights. 
The 1.5HH shoe test condition altered MG and soleus fibre velocity during 0-70% stance 
phase when compared to the other heel heighttest conditions. It resulted in higher EMG 
activity at the beginning of stance phase until terminal stance. 
 
 
Figure 6.51: The fibre length velocity alteration results data from OpenSim simulation 
software for different HH test footwear conditions (N=14). Legend 1 indicates the area (68% 
stance phase) at which maximum EMG for MG muscle was recorded; legend 2 indicates the 
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area (72% stance phase) at which maximum EMG for soleus muscle was recorded. (a) – 
without standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
The average results for the alteration to fibre length velocity of the GM and soleus muscles 
cwithin the highlighted points of interest are demonstrated in table 6.154. 
Table 6.154: MG and soleus fibre length velocity (mm/% of the stance phase) mean (±SD) for 
different heel heights (N=14). 
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Medial Gastrocnemius       
Fibre velocity at 68% stance phase 
where maximum MG EMG activity. 
0.001 
(0.080) 
0.043 
(0.060) 
0.094 
(0.054) 
0.137 
(0.040) 
0.185 
(0.054) 
Soleus      
Fibre velocity at 72% stance phase 
where maximum Sol EMG activity. 
0.07 
(0.08) 
0.09 
(0.05) 
0.12 
(0.05) 
0.14 
(0.06) 
0.15 
(0.07) 
6.13.6.1 Fibre velocity at 68% of stance phase where maximum MG EMG activity 
occurs.  
The 1.5HH test condition reduced MG lengthening velocity (as calf muscle is contracting 
eccentrically from LR until late stance phase) at 68% of stance phase to a significant level 
when compared to the 3.5HH test condition (p=0.03). The 4.5HH test condition significantly 
increased MG lengthening velocity at 68% of stance phase when compared to the 3.5HH test 
condition (p=0.007). The 5.5HH test condition significantly increased MG lengthening 
velocity at 68% of stance phase when compared to the 3.5HH test condition (p=0.000). 
There was a gradual increase in lengthening velocity of the MG muscle at 68% of the stance 
phase where ankle is in dorsiflexion. It was also noted that a  lower heel reduced the fibre 
lengthening velocity. 
Table 6.155: Pairwise comparison of medial gastrocnemius fibre velocity changes during 
maximum EMG activity at 68% of the stance phase for the test footwear conditions (N=14). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH -.042 .017 .297 -.101 .016 
3.5HH -.094* .019 .003 -.158 -.030 
4.5HH -.137* .018 .000 -.199 -.075 
5.5HH -.184* .022 .000 -.257 -.112 
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6.13.6.2 Fibre velocity at 72% stance phase where maximum soleus EMG activity 
occurs 
The 3.5HH test condition significantly increased soleus fibre lengthening velocity at 72% of 
stance phase when compared to the 1.5HH shoe (p=0.016). The 1.5HH test condition 
significantly reduced soleus lengthening velocity of fibres at 72% of stance phase when 
compared to the 4.5HH shoe (p=0.004) and the 5.5HH shoe (p=0.001) as shown in table 
6.155. 
 
Table 6.156: Pairwise comparison soleus fibre velocity changes during maximum EMG 
activity at 72% of the stance phase for test footwear conditions (N=14). 
2.5HH 1.5HH .042 .017 .297 -.016 .101 
3.5HH -.052* .010 .002 -.086 -.017 
4.5HH -.095* .011 .000 -.133 -.057 
5.5HH -.142* .016 .000 -.195 -.090 
3.5HH 1.5HH .094* .019 .003 .030 .158 
2.5HH .052* .010 .002 .017 .086 
4.5HH -.043* .010 .007 -.077 -.010 
5.5HH -.091* .010 .000 -.123 -.058 
4.5HH 1.5HH .137* .018 .000 .075 .199 
2.5HH .095* .011 .000 .057 .133 
3.5HH .043* .010 .007 .010 .077 
5.5HH -.047* .013 .033 -.092 -.003 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH -.018 .015 1.000 -.067 .032 
3.5HH -.047* .012 .016 -.087 -.007 
4.5HH -.072* .015 .004 -.124 -.021 
5.5HH -.083* .015 .001 -.132 -.034 
2.5HH 1.5HH .018 .015 1.000 -.032 .067 
3.5HH -.030 .019 1.000 -.094 .034 
4.5HH -.055 .020 .181 -.123 .014 
5.5HH -.065 .021 .089 -.137 .006 
3.5HH 1.5HH .047* .012 .016 .007 .087 
2.5HH .030 .019 1.000 -.034 .094 
4.5HH -.025 .017 1.000 -.083 .033 
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6.13.6.3 Summary of results for MG and soleus fibre velocity changes affected by 
heel heights: 
 The 1.5HH test condition reduced MG lengthening velocity at 68% stance phase to 
significant level when compared to the 3.5HH shoe(p=0.03);  
 The 4.5HH test condition significantly increased MG lengthening velocity at 68% of 
stance phase when compared to the 3.5HH shoe (p=0.007);  
 The 5.5HH test condition significantly increased MG lengthening velocity at 68% of 
stance phase when compared to the 3.5HH shoe (p=0.000). There was a gradual 
increase in lengthening velocity of the MG muscle at 68% of the stance phase where 
ankle is dorsiflexion, and it was noted that walking with lower heeled shoes resulted 
in reduced fibre lengthening velocity; 
 The 3.5HH test condition significantly increased the soleus fibre lengthening velocity 
at 72% of stance phase when compared to the 1.5HH test condition (p=0.016);  
 The 1.5HH test condition significantly reduced soleus lengthening velocity of fibres at 
72% of stance phase when compared to the 4.5HH and 5.5HH test conditions 
(p<0.005).  
6.13.7 Apex position (AP) 
Figure 6.52 shows the alteration to the MG and soleus fibre length velocity by AP. The 70AP 
test condition increased soleus fibre lengthening velocity between 35% and 68% of stance 
phase; however there was no significant alteration demonstrated for soleus muscle length 
changes.  
5.5HH -.035 .016 .456 -.089 .019 
4.5HH 1.5HH .072* .015 .004 .021 .124 
2.5HH .055 .020 .181 -.014 .123 
3.5HH .025 .017 1.000 -.033 .083 
5.5HH -.010 .012 1.000 -.050 .029 
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Figure 6.52: The fibre length velocity alteration results from OpenSim simulation software 
for different AP test footwear test conditions (N=14). Legend 1 indicates the area (68% 
stance phase) at which maximum EMG for MG muscle was recorded; legend 2 indicates the 
area (72% stance phase) at which maximum EMG for soleus muscle was recorded. (a) – 
without standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
The average results for the changes to fibre length velocity of GM and soleus muscles within 
the highlighted points of interest are demonstrated in table 1.157. 
Table 6.157: MG and soleus fibre length velocity (mm/% of the stance phase) mean (±SD) for 
different apex lengths of the sole (N=14). 
 55AP 62.5AP 70AP 
Medial Gastrocnemius     
Fibre velocity at 68% stance phase where max MG 
EMG activity. 
0.094 
(0.059) 
0.094 
(0.054) 
0.135 
(0.053) 
Soleus    
Fibre velocity at 72% stance phase where max Sol 
EMG activity. 
0.13 
(0.08) 
0.12 
(0.05) 
0.10 
(0.07) 
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6.13.7.1 Fibre velocity at 68% stance phase where maximum MG EMG activity occurs 
The 62.5AP footwear showed significant reduction of MG fibre lengthening velocity at 68% 
stance phase when compared to the 70AP test condition (p=0.045).  
Table 6.158: Pairwise comparison medial gastrocnemius fibre velocity changes during 
maximum EMG activity at 68% of the stance phase for test footwear conditions (N=14). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
55AP 62.5AP .000 .018 1.000 -.050 .049 
70 AP -.041 .027 .442 -.114 .032 
62.5AP 55AP .000 .018 1.000 -.049 .050 
70 AP -.041* .015 .045 -.081 -.001 
 
6.13.7.2 Fibre velocity at 72% stance phase where maximum soleus EMG activity 
occurs 
There were no  significant alterations demonstrated. The hypothesis (Ha4) is rejected. 
6.13.7.3 Summary results for MG and soleus fibre velocity changes affected by AP: 
 The 62.5AP footwear test condition produced a significant reduction in MG fibre 
lengthening velocity at 68% stance phase when compared to the 70AP test condition 
(p=0.045). This may have resulted in increased EMG activity for the MG muscle. The 
hypothesis (Ha4) is accepted. 
6.13.8 Toe angle (TA) 
Figure 6.53 shows the alteration to the MG and soleus fibre length velocity by toe angle. The 
10° TA test condition increased MG fibre lengthening velocity within 30-55% stance phase, 
therefore it may have resulted in an EMG activity increase within 35-70% of  stance phase.  
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Figure 6.53: The fibre length velocity alteration results data from OpenSim simulation 
software for different toe angle test footwear conditions (N=14). Legend 1 indicates the area 
(68% stance phase) at which maximum EMG for MG muscle was recorded; legend 2 
indicates the area (72% stance phase) at which maximum EMG for soleus muscle was 
recorded. (a) – without standard deviation (STD), (b) – with the lines shadowed to represent 
STD ranges. 
The average results for the alterations demonstrated for fibre length velocity of GM and 
soleus muscles within the highlighted points of interest are demonstrated in  table 6.159 
below. 
Table 6.159 Table: MG and soleus fibre length velocity (mm/% of stance phase) mean (±SD) 
for different toe angles of the sole (N=14). 
 10° TA 15° TA 20° TA 
Medial Gastrocnemius     
Fibre velocity at 68% stance phase where maximum 
MG EMG activity. 
0.120 
(0.051) 
0.094 
(0.054) 
0.097 
(0.067) 
Soleus    
Fibre velocity at 72% stance phase where maximum Sol 
EMG activity. 
0.14 
(0.08) 
0.12 
(0.05) 
0.09 
(0.07) 
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6.13.8.1 Fibre velocity at 68% stance phase where maximum MG EMG activity 
occurs. 
The 10° TA footwear produced an increase in MG fibre lengthening velocity at 68% of stance 
phase when compared to the control footwear; however it did not reach a level of 
significance (p=0.053).  
6.13.8.2 Fibre velocity at 72% stance phase where maximum soleus EMG activity 
occurs 
The alterations to this parameter were not significant. The hypothesis (Ha4) is not accepted. 
6.13.8.3 Summary of results for MG and soleus fibre velocity changes affected by 
alteration to rocker sole toe angle: 
 The 10° TA test condition increased MG fibre lengthening velocity during 30-55% of 
stance phase; therefore, it may resulted in an EMG activity increase within 35-70% of 
stance phase. This willbe discussed in the discussion chapter.  
 
  
6.13.9 Heel Curve 
Figure 6.54 shows the alteration to the MG and soleus fibre length velocity by heel curve. 
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Figure 6.54: The fibre length velocity alteration results data from OpenSim simulation 
software for different heel curve test footwear conditions (N=14). Legend 1 indicates the 
area (68% stance phase) at which maximum EMG for MG muscle was recorded; legend 2 
indicates the area (72% stance phase) at which maximum EMG for soleus muscle was 
recorded. (a) – without standard deviation (STD), (b) – with the lines shadowed to represent 
STD ranges. 
The average results for alteration to the fibre length velocity of GM and soleus muscles 
within highlighted points of interest are demonstrated in the table below. 
Table 6.160: MG and soleus fibre length velocity (mm/% of the stance phase) mean (±SD) for 
different heel curves (N=14). 
 Full curve Half curve control 
Medial Gastrocnemius     
Fibre velocity at 68% stance phase where maximum 
MG EMG activity. 
0.060 
(0.050) 
0.070 
(0.052) 
0.048 
(0.050) 
Soleus    
Fibre velocity at 72% stance phase where maximum 
Sol EMG activity. 
0.08 
(0.07) 
0.09 
(0.06) 
0.12 
(0.05) 
 
6.13.9.1 Summary results for MG and soleus fibre velocity changes affected by heel 
curves: 
There were no significant changes and therefore the hypothesis (Ha4) is rejected. 
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6.13.10 Flexibility of the sole 
Figure 6.55 shows the alteration to the MG and soleus fibre length velocity by the flexibility 
of the sole. The flexible profiles increased MG and soleus fibre lengthening velocity within 5-
18% stance phase. However, the calf muscle was not active at LR. 
 
 
Figure 6.55: The fibre length velocity alteration results data from OpenSim simulation 
software for different level flexibly of the sole (N=14). Legend 1 indicates the area (68% 
stance phase) at which maximum EMG for MG muscle was recorded; legend 2 indicates the 
area (72% stance phase) at which maximum EMG for soleus muscle was recorded. (a) – 
without standard deviation (STD), (b) – with the lines shadowed to represent STD ranges. 
There were nosignificant changes demonstrated at points 1 and 2 for MG and soleus fibre 
length and therefore, the hypothesis (Ha4) is rejected. 
6.14 Tendon force 
The active fibre force data shows what is the internal active fibre force required to produce 
the ankle moment. Different footwear features require different force because the muscle 
moment arm changes. However, it does not give the information how hard the muscle has 
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to work as it is also related to fibre length and velocity of contraction. However, the data 
demonstrates what maximum MG active fibre force is required when subjects walk in 
different footwear conditions. Figure 6.56 shows the example for active fibre force produced 
through the tendon for medial gastrocnemius muscle. Similar results were demonstrated for 
the soleus muscle. However, the force, which is generated by soleus muscle is higher in 
magnitude at approximately 4000N. 
 
Figure 6.56: The required tendon force (medial gastrocnemius) which is transmitted through 
the tendon for the ankle joint to oppose the external dorsiflexor moment for different 
footwear features. Legend 1 indicates the area at which maximum EMG activity for MG was 
recorded. 
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Figure 6.57: The required active tendon force (medial gastrocnemius) which is transmitted 
through the tendon to enable  the ankle joint to oppose the externally-applied moment for 
different footwear features. (a) – without standard deviation (STD), (b) – with the lines 
shadowed to represent STD ranges. 
 
Table 6.161 demonstrates the maximum active tendon force produced by medial 
gastrocnemius for different footwear features. 
Table 6.161: Active tendon force of MG muscle for different footwear features (N=14). 
 1.5HH 2.5HH 3.5HH 
control 
4.5HH 5.5HH 55AP 70AP 10° TA 20° TA Full 
curve 
Half 
curve 
Medial Gastrocnemius  
Force required 
(N) at peak 
EMG 
2107.9 
(13.7) 
2078.6 
(18.2) 
2046.6 
(19.0) 
2010.9 
(15.0) 
1983.9 
(21.7) 
2019.0 
(18.2) 
2088.0 
(9.2) 
2074.8 
(10.5) 
2060.5 
(21.7) 
2068.2 
(19.8) 
 
2067.1 
(17.5) 
 
Differences 
between 
control 3.5HH 
shoe (N) 
61.3 
(13.7) 
32.0 
(18.2) 
0.0 
(19.0) 
-35.7 
(15.0) 
-62.7 
(21.7) 
-27.5 
(18.2) 
41.4 
(9.2) 
28.2 
(10.5) 
14.0 
(21.7) 
21.6 
(19.8) 
 
19.8 
(17.5) 
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The results demonstrated that the 1.5HH required 61.3 (13.7)N more  MG muscle force 
when compared to the control shoe. The 4.5HH required less [35.7 (15.0)N] to perform the 
task versus control. The 5.5HH test condition reduced the force generated by 62.7N. The 
55AP required less fibre force [27.8 (18.2)N]. A longer apex position (i.e. more distal) 
resulted in an increased force requirement by MG which was 41.4 (9.2)N for the 70AP 
footwear. 
6.15 Tibialis anterior fibre lengthening/shortening velocity 
6.15.1 Heel Height (HH) 
Figure 6.58 shows the alteration to the tibialis anterior fibre length,  active fibre force and 
EMG activity caused by varying heel heights. It can be seen that by raising the heel, fibres 
were also lengthened, and that resulted in increases in active fibre force requirement to 
dorsiflex the ankle as well as an increasein EMG activity. 
 
Figure 6.58: The tibialis anterior alterations for fibre length (mm), fibre length velocity, 
tibialis anterior active fibre force (N) and EMG overall area for different heel heights. Legend 
1 and 2 indicate the area during LR at which maximum EMG activity occurs; legend 3 
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indicates the maximum active fibre force required for internal DF moment. The red line 
represents the barefoot static position. (a) – without standard deviation (STD), (b) – with the 
lines shadowed to represent STD ranges. 
Exactly the same graphs from figure 6.58, but with standard deviations added are 
demonstrated below. 
 
Figure 6.59: The tibialis anterior alterations in fibre length (mm), fibre length velocity, tibialis 
anterior active fibre force (N), EMG activity and standard deviation for different heel curves. 
 
The average results for the tibialis anterior fibre length velocity change within highlighted 
points of interest, are presented in table 6.162. 
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Table 6.162: The tibialis anterior fibre length, fibre length, active fibre force and EMG activity 
mean (±SD) for different heel heights (N=14). 
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Tibialis anterior       
Max fibre length during LR (mm) 74.86 
(1.16) 
79.98 
(0.78) 
81.33 
(0.97) 
83.02 
(0.86) 
84.28 
(1.13) 
Fibre length difference versus control 
(mm) 
-6.47 
(1.16) 
-1.35 
(0.78) 
0.00 
(0.97) 
1.69 
(0.86) 
2.95 
(1.13) 
Max fibre length velocity (mm/% 
stance phase) 
0.78 
(0.15) 
1.03 
(0.11) 
1.07 
(0.14) 
1.16 
(0.11) 
1.08 
(1.12) 
Active fibre force (N) 673.73 
(7.28) 
701.91 
(4.35) 
708.81 
(5.1) 
714.56 
(4.28) 
721.15 
(4.34) 
Active fibre force difference versus 
control (N) 
-35.08 
(7.28) 
-6.90 
(4.35) 
0.00 
(5.1) 
5.10 
(4.28) 
12.35 
(4.34) 
Overall EMG area (%) 80.1 
(10.8) 
94.3 
(12.8) 
100.0 
(12.1) 
104.3 
(11.6) 
114.2 
(12.7) 
Differences EMG area versus control 
shoe (%) 
-19.9 -5.7 0.0 4.3 14.2 
 
6.15.1.1 Max fibre length during LR (mm) 
Raising the heel height gradually but also significantly increased the maximum length of 
tibialis anterior fibres during LR when compared to lower heels (p<0.000). 
Table 6.163: Pairwise comparison of shoe conditions for average maximum length of tibialis 
anterior fibres during LR (N=14). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH -5.114* .536 .000 -6.922 -3.307 
3.5HH -6.466* .444 .000 -7.964 -4.967 
4.5HH -8.160* .486 .000 -9.800 -6.519 
5.5HH -9.412* .653 .000 -11.615 -7.210 
2.5HH 1.5HH 5.114* .536 .000 3.307 6.922 
3.5HH -1.352* .256 .001 -2.214 -.489 
4.5HH -3.045* .327 .000 -4.147 -1.944 
5.5HH -4.298* .302 .000 -5.315 -3.281 
3.5HH 1.5HH 6.466* .444 .000 4.967 7.964 
2.5HH 1.352* .256 .001 .489 2.214 
4.5HH -1.694* .272 .000 -2.613 -.775 
5.5HH -2.947* .350 .000 -4.125 -1.768 
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6.15.1.2 Max fibre length velocity (mm/% stance phase) 
The 1.5HH footwear test condition significantly reduced tibialis anterior fibre length velocity 
when compared to the other footwear heel height conditions (p<0.021) as shown in table 
6.164. 
 
Table 6.164: Pairwise comparison of shoe conditions for average maximum length velocity of 
tibialis anterior fibres during LR (N=14). 
 
 
 
4.5HH 1.5HH 8.160* .486 .000 6.519 9.800 
2.5HH 3.045* .327 .000 1.944 4.147 
3.5HH 1.694* .272 .000 .775 2.613 
5.5HH -1.253* .298 .010 -2.257 -.249 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1.5HH 2.5HH -.270* .049 .001 -.439 -.101 
3.5HH -.316* .058 .001 -.514 -.117 
4.5HH -.307* .078 .020 -.575 -.040 
5.5HH -.324* .075 .009 -.580 -.069 
2.5HH 1.5HH .270* .049 .001 .101 .439 
3.5HH -.046 .038 1.000 -.176 .085 
4.5HH -.037 .062 1.000 -.249 .174 
5.5HH -.055 .059 1.000 -.256 .147 
3.5HH 1.5HH .316* .058 .001 .117 .514 
2.5HH .046 .038 1.000 -.085 .176 
4.5HH .008 .054 1.000 -.177 .194 
5.5HH -.009 .062 1.000 -.221 .203 
4.5HH 1.5HH .307* .078 .020 .040 .575 
2.5HH .037 .062 1.000 -.174 .249 
3.5HH -.008 .054 1.000 -.194 .177 
5.5HH -.017 .040 1.000 -.155 .121 
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6.15.1.3 Summary for tibialis anterior muscle properties: 
 Raised heels significantly increased the maximum length of tibialis anterior fibres 
during LR when compared to lower heels (p<0.000). The hypothesis (Ha4) is 
accepted; 
 Stretching tibialis anterior resulted in increased muscle work. When fibre length were 
close it neutral position, the EMG activity and overall EMG were significantly 
reduced; 
 The 1.5HH footwear test condition significantly reduced tibialis anterior fibre length 
velocity when compared to the other footwear conditions (p<0.021). The hypothesis 
(Ha4) is accepted. 
6.15.2 Curved heels 
Figure 6.59 shows the alteration to the tibialis anterior fibre length, active fibre force and 
EMG activity by adding heel curves. The curved heels reduced maximum tibialis anterior 
fibre length during LR, which resulted in a reduction in the eccentric velocity contraction of 
the tibialis anterior muscle. Therefore, less force would be required to dorsiflex the ankle, 
and tibialis anterior EMG activity was therefore reduced for curved heels when compared to 
the control shoe without a heel curve. 
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Figure 6.60: The tibialis anterior alterations for fibre length (mm), fibre length velocity, 
tibialis anterior active fibre force (N) and EMG overall area for curved heels. Legends 1 and 2 
indicate the area during LR at which maximum EMG activity occurs; legend 3 indicates the 
maximum active fibre force required for internal dorsiflexor moment. The red line 
represents the barefoot static position. 
 
The graphs with standard deviation added are demonstrated in figure 6.61. 
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Figure 6.61: The tibialis anterior alteration tofibre length (mm), fibre length velocity, tibialis 
anterior active fibre force (N), EMG activity and standard deviation for different heel curves. 
 
The average results for the tibialis anterior fibre length velocity change within highlighted 
points of interest which are presented in table 6.165. 
Table 6.165: The tibialis anterior fibre length, fibre length velocity, active fibre force and 
EMG activity mean (±SD) for different heel curves (N=14). 
 Full curve Half curve control 
Tibialis anterior     
Max fibre length during LR (mm) 78.77 (0.94) 80.47 (0.88) 81.33 (0.97) 
Fibre length difference versus control (mm) -2.56 (0.94) -0.86 (0.88) 0.00 (0.97) 
Max fibre length velocity (mm/% stance phase) 0.91 (0.14) 1.04 (0.17) 1.07 (0.14) 
Active fibre force (N) 696.64 (6.28) 705.94 (5.18) 708.81 (5.1) 
Active fibre force difference versus control (N) -12.16 (6.28) -2.87 (5.18) 0.00 (5.1) 
Overall EMG area (%) 84.1 (12.9) 86.3 (11.8) 100.0 (12.1) 
Differences EMG area versus control shoe (%) -15.9 -13.7 0.0 
333 
 
6.15.2.1 Maximum tibialis anterior fibre length during LR 
The full curve significantly reduced maximum tibialis anterior fibre length during LR when 
compared to the other footwear conditions (p<0.000). 
Table 6.166: Pairwise comparison of shoe conditions for average maximum length of tibialis 
anterior fibres during LR (N=14). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
Full curve Half curve -1.702* .321 .000 -2.583 -.821 
No curve -2.558* .397 .000 -3.648 -1.468 
Half curve Full curve 1.702* .321 .000 .821 2.583 
No curve -.856 .368 .110 -1.865 .154 
 
6.15.2.2 Maximum tibialis anterior fibre length velocity (mm/% stance phase) 
The full curve and half curve footwear conditions significantly reduced the velocity of tibialis 
anterior fibre eccentric contraction (p<0.030) as shown in table 6.167. 
Table 6.167: Pairwise comparison of shoe conditions for maximum tibialis anterior fibre 
length velocity during LR (N=14). 
Cond. Cond. 
Mean 
Difference Std. Error Sig. 
95% Confidence Interval for Difference 
Lower Bound Upper Bound 
Full curve Half curve -.155* .051 .030 -.296 -.014 
No curve -.315* .042 .000 -.431 -.199 
Half curve Full curve .155* .051 .030 .014 .296 
No curve -.160* .052 .029 -.306 -.015 
 
6.15.2.3 Summary of results for tibialis anterior muscle. 
 The full curved heel test condition significantly reduced maximum tibialis anterior 
fibre length during LR when compared to the other footwear conditions (p<0.000). 
The hypothesis (Ha4) is accepted; 
 The full curve and half curve footwear conditions significantly reduced the velocity of 
tibialis anterior fibre eccentric contraction when compared to control (p<0.030). The 
hypothesis (Ha4) is accepted; 
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 A curvature of the heel resulted in less active fibre force required to dorsiflex the 
ankle at LR when compared to a sole without a heel curve; 
 The total tibialis anterior EMG activity area was significantly reduced for shoes with 
curved heels. 
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CHAPTER 7 
7 DISCUSSION 
7.1 Sagittal plane ankle kinematics 
The results from this study demonstrated that statistically significant alterations to ankle 
kinematics can be induced by introducing variations to rocker sole designs in footwear. 
Previous studies analysing the effects of kinematics and kinetics on the more commonly seen 
rocker sole interventions (Long et al 2004, Myers et al 2005, van Bogart 2005) did not 
demonstrate any significant alteration to ankle kinematics during stance phase of gait. 
Myers et al (2005), confirmed the findings of this study in that a negatively- heeled rocker 
sole profile produced an increase in dorsiflexion both at the ankle during LR and 
plantarflexion at terminal stance, but in their study, these outcome measures were not 
significant. However, the pitch of the shoe (i.e. the heel-sole differential) was not accurately 
defined in that study, which makes it difficult to provide a direct comparison with the results 
of this study.    
 
Chapter 4 described newly published designs of rocker-soled shoes, which were developed 
in an attempt to reduce ankle joint rotation or accommodate limited ankle joint rotation 
during the whole of the gait cycle, but particularly during stance phase of gait (Arazpour et al  
2013, Wang and Hansen 2010). This was done to improve gait for patients suffering from 
conditions such as paraplegia; necessitating the need to wear cosmetic knee ankle foot 
orthoses (KAFOs) with AFO sections, which are designed to support the foot and ankle but 
restrict motion in all planes by providing an ankle blocking function. They were also used to 
provide restriction to ankle joint sagittal plane rotation in the presence of pain associated 
with joint degeneration and arthritic changes. In both these cases, there was a need to 
facilitate forward rotation of the shank during stance phase. The designs illustrated that a 
rocker sole can indeed be designed to significantly reduce sagittal plane motion whilst being 
suitable for ambulation by specific patient groups. Both the studies not involving an AFO 
reduced total ankle ROM to below 18 degrees. Rocker soles have also been recently studied 
as an adjunct treatment in the reduction of pain experienced with plantar fasciitis in 
association with FFOs, by using a toe-only rocker sole to utilise its proven effect of pressure 
shunting extra loading to the midfoot and helping the effect of the FFO (Fong et al 2012). 
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The rocker sole test conditions utilised in this study were chosen following an analysis of the 
literature. Traditional (angled) rocker soles were originally tested for use by claudicants, but 
the three studies which did so produced conflicting results. The efficacy of traditional rocker 
soles in reducing forefoot plantar pressures by utilising an anterior-placed apex position 
indicated that they may be useful in offloading the ankle plantarflexors. A small pilot 
feasibility study was performed prior to the main testing phase to ensure that data could be 
reliably obtained for the chosen primary outcome measures using the gait analysis 
equipment available, and to also confirm that alteration to shoe outsole features could 
provide meaningful differences in the data. The shoe conditions tested in the pilot study 
were an ortho-wedge negatively-heeled shoe with an apex angle of 35 degrees, a control 
shoe with no rocker sole but a heel height of 3cm, and a three curve rocker shoe which had 
previously been shown to induce plantarflexion compared to the control shoe (Hutchins et al 
2008). The results of this trial gave the author confidence to proceed using the test 
conditions chosen for this study. 
 
7.1.1 The effect of walking with rocker soles incorporating different heel heights  
7.1.1.1  The effect of different heel heights on ankle joint kinematics 
The concept of this thesis was to inform the indications for using rocker-soled shoes by 
claudicants and those subjects suffering from other pathologies who would benefit from 
walking with a reduced power requirement by the ankle plantarflexors; especially during the 
propulsive phase of gait.  
 
One hypothesis of this thesis was, that by placing the ankle in an advantageous position, 
both in regards to maximising the Achilles tendon ankle joint moment arm, but also by 
reducing the ankle sagittal plane ROM around an optimal position, then this could prove 
potentially beneficial for claudicants when tested during future walking trials, if a traditional 
rocker sole could be developed to achieve this. Traditional rocker soles also have the 
advantage that they cause the GRF to “hesitate” at the angled rocker fulcrum position, and 
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therefore the GRF does not move forwards as quickly as when walking with known curved 
rocker designs. 
 
The experimental design protocol developed for this thesis was therefore intended to 
demonstrate which design features would be recommended to achieve calf muscle 
unloading during stance phase. To achieve this, the features of the rearfoot (posterior) 
section of a rocker profile design needed to be determined.  
 
The testing of five different heel heights (varying from 1.5 to 5.5 cm in depth) induced 
significant alterations to ankle joint kinematics in this study as shown in the figure 7.1. 
 
Figure 7.1: Sagittal plane ankle motion during the five heel height test conditions with 
standard deviation where the control shoe is 3.5 HH. 
Shoes with lower heel heights kept the ankle joint relatively dorsiflexed and in those with 
raised heels the ankle joint shifted into a more plantarflexed position compared to the 
control shoe test condition (denoted as 3.5HH) during the whole of stance phase. The 3.5cm 
heel height test condition was the transition height between producing a relatively 
plantarflexed or dorsiflexed ankle during LR which continued during stance phase of gait. All 
test conditions were significantly different from each other for the maximum ankle 
plantarflexion angle during LR (p=0.00). The maximal ankle dorsiflexion during stance was 
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also significantly altered between all the test conditions with an 11.10 degree difference in 
the range of values. The maximal plantarflexion position was not significantly different 
between the 2.5, 3.5 and 4.5 cm heel heights. The 1.5 cm (negative heel) induced a relatively 
dorsiflexed position throughout swing phase also, whilst the other test conditions did not. 
With respect to the total sagittal plane ankle ROM, the 1.5 cm and 2.5cm heel test 
conditions both significantly reduced ankle ROM during LR compared to all the other heel 
height test conditions (table 6.9). The 3.5cm, 4.5 cm and 5.5 cm heeled shoes did not show 
any significant increase in ROM between themselves, with only a 10 degree maximal 
difference in range. 
7.1.1.2 The effect of varying heel height on knee joint kinematics 
The 1.5cm negative heel test condition significantly increased knee flexion at toe-off 
(p=0.00) by 2.9° (SD:1.4°) when compared with the control shoe (table 6.30). The 5.5 cm heel 
test condition kept the knee more extended when compared to the negative heels tested 
and the control shoe (p=0.00). During LR, there were no statistically significant differences in 
maximum knee flexion values. Premature knee flexion occurred when walking with the 1.5 
cm heel and slightly increased knee extension for the high-heeled shoes. During late stance, 
the 5.5 cm heel height produced significantly increased knee extension compared to the 
control shoe (p=0.025) and the maximum extension phase was delayed versus the control 
and the negative-heel test footwear conditions. At toe-off, the 1.5 cm heel test condition 
produced a significantly more flexed knee when compared to the 3.5 cm heel (p=0.00). The 
evidence therefore demonstrated that lower heeled shoes produce statistically significantly 
more knee flexion during mid to late stance and swing than higher heeled ones.  
 
To offload the calf muscles it would be advantageous to have a more flexed knee to reduce 
the extension loading on the proximal insertion of the gastrocnemius muscle during 
propulsion. However, the negative heel which produced this effect also placed the ankle into 
a significantly more dorsiflexed position during mid stance. There were no statistically 
significant differences between the 2.5 and 3.5 cm heel in knee flexion angle during 
propulsive phase, but these were still significantly more flexed than wearing the lower 
heeled shoe (p=0.00). 
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7.1.1.3 The effect of varying heel height on hip joint kinematics 
 
With regards to the hip, the 5.5cm increased maximum hip extension significantly by 1.6 
deg.(p=0.042) compared to the control shoe and also increased the total hip ROM. Lower 
heeled shoes produced increased hip extension during stance and increased hip flexion 
during swing, but did not produce the maximal hip extension. Total hip ROM was not 
significantly altered between the heel height test conditions. 
7.2 The effect of altering footwear on calf muscle functioning 
7.2.1 Introduction  
 
The shape of the sole changes the way in which the foot moves relative to the ground. A 
negative heel keeps foot more dorsiflexed through the whole gait cycle and a raised heel 
keeps ankle more plantarflexed. Therefore, the point of application and direction of GRF 
changes as well, which results in compensation by the other parts of the body to keep 
balance during walking in the joints. This causes an alteration to shank, thigh and hip 
movement. If the ankle angle is too plantarflexed, the fibres in the calf muscle lose force 
generation capabilities and it then requires the use of more motor units to provide 
propulsion. However, the moment arm is also lengthening with ankle plantarflexion to 
compensate for it. There is a specific range at which the calf muscle starts to loose efficient 
force generation capabilities and this makes the muscle work harder with a lower ankle 
moment. The 5.5HH demonstrated that effect. The 1.5 cm differences in heel height 
significantly reduced MG and soleus mean EMG values when compared to lower heeled 
profiles. However, with raising the heel height beyond the point of 4.5 cm, the calf muscles 
work harder to compensate for the disadvantageous fibre length-force relationship. 
Therefore, just a 1cm raise of the heel height from 4.5cm increased the calf mean EMG 
activity (the 5.5HH increased by 14.6% for MG muscle and increase by 17.3% for soleus 
muscle when compared to the 4.5HH) and resulted in increase the area underneath the EMG 
curve (5.5HH increased by 11.0% (MG muscle) and increase by 11.6% for soleus muscle 
when compared to the 4.5HH). Therefore, if a footwear profile were to be carefully designed 
according to proven muscle-tendon force capabilities, it could be possible to produce the 
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ideal footwear, which would not alter knee, hip kinematics and kinetics, but offload calf 
muscle, as their fibres would be at their optimal position during the walking. This may also 
result in efficient lower limb body movement without firing up muscles and therefore 
potentially reduce overall oxygen consumption. The 55% apex length shoe test position 
proved to be the most effective footwear to offload the calf muscle. It did not significantly 
change hip and knee kinematics but reduced EMG and ankle moments when compared to 
the control or 70% apex shoe.  
 
Chapter 6 demonstrated the individual alterations in gait parameters produced by the 
footwear test conditions. The following sections summarise all the effects of the medial 
gastrocnemius and soleus force generation changes caused by different footwear features. 
The results for the flexible forepart shoe were not included as there were no significant 
alterations compared to the other test conditions. Footwear with flexible foreparts did not 
demonstrate any significant alterations to the primary outcome measures; probably due to 
walking speed being kept within strict limits during the walking trials. However, if the 
participants had chosen their own self-selected walking speed, their gait pattern might have 
adapted to the most comfortable walking speed and footwear with flexible sole might not 
limit their walking pattern as a more solid shoe would, as the sole may resist the ankle 
movement.  
 
Theoretically it could be postulated that a shoe which gave the least resistance to 
plantarflexion during stance would be the most effective in offloading the calf muscles even 
if was designed into a solid rocker sole profile – and this may be why the 55% apex shoe 
position was the most effective in doing this during the walking trials. Indeed this apex 
position, as stated above, has been shown to be very effective in reducing forefoot plantar 
pressures; which may be explained by the fact that it did this by reducing the activity of the 
ankle plantarflexors, which if excessive, could increase forefoot loading. However, a 
definitive link between forefoot plantar pressures and ankle plantarflexor muscle 
parameters is as yet unproven, and requires further investigation. 
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7.2.2 The effect of heel height alteration 
Whilst it is important to understand the external measurable effects caused by walking in 
different shoes, (such as plantar pressures, externally applied moments, kinetics and 
kinematics), it is becoming increasingly important to also analyse and determine what effect 
this has on the internal structures of the lower limb; especially when developing footwear 
for specific applications such as reduction in the calf pain symptoms experienced by 
claudicants. 
 
Figure 7.2 summarises the alterations to the MG and SOL muscles for different external 
parameters when walking in shoes with different heel heights. The maximum externally 
applied ankle dorsiflexion moment at which point the calf muscle works the most is denoted 
by legend 1. It did not show any significance differences except for the 1.5HH test condition 
when compared to the other footwear conditions. This demonstrates that the mean 
externally applied ankle DF moment was similar for all footwear conditions in this study. The 
extent to which this result applies to other rocker profiles needs to be determined in future 
studies. 
 
The internal ankle moment is correlated to muscle force generation and the internal MTU 
moment arm. Therefore, it is not clear without further clarification, if the muscle is applying 
higher or lower magnitudes of force for a given moment value. Legend 2 in figure 7.1, shows 
that there was a significant change in the Achilles tendon moment arm between all footwear 
conditions caused by the heel height change as shown in table 7.1. It can be seen that with 
the 1.5HH test condition, the muscle moment arm was significantly reduced and it required 
an additional 61.3N of force generation to produce ankle motion when compared to the 
control shoe. However, there were no significant changes seen to the EMG data when 
comparing all the footwear test conditions even though the MG and soleus muscles were 
significantly stretched which would have resulted in passive force compensation. The 2.5HH 
required almost 50% less MG fibre force generation [32.0 (18.2) N], but significantly 
increased its EMG activity when compared to the 4.5HH. It can therefore be suggested that 
the muscle moment arm was short in length and the MG muscle was not stretched or close 
to its optimal length position, therefore the fibres were working harder to produce that 
force.  
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Muscle force generation is also related to the velocity of muscle contraction (Delp, 1990). 
Another reason for offloading calf muscle whilst walking in the 4.5 cm heel test condition 
when compared to lower heels is that velocity of eccentric contraction was significantly 
increased during terminal stance as shown in the table below. The muscle length started to 
eccentrically contract at a good position and ended at the optimal fibre length position, 
which is close to the barefoot static. It allowed generating force to be more efficient when 
compared to all shoes. The medial gastrocnemius barefoot static position fibre length is also 
related to the knee flexion, therefore the barefoot static natural position might not be close 
to optimal fibre length positions but the soleus barefoot static is not affected my knee and 
therefore it shows natural position.  
 
Another additional factor, which influenced a reduction of overall EMG activity whilst 
walking in the 4.5 cm heel height, is that heel height altered the external PF moment and 
increased the duration of it. Therefore it resulted in delaying the activation of the external 
ankle DF moment. It also resulted in reduction of overall calf muscle force generation. 
However, this effect has been seen for the 4.5HH condition, and the 5.5HH delayed the 
external ankle DF moment to occur. However, the muscle length was too short; which 
resulted in recruiting more motor units and having to work even harder. This leads to the 
conclusion that even a small change in muscle length may significantly result in force 
generation capabilities which can be altered by footwear features.  
 
The triceps surae is formed from a combined group comprising of the gastrocnemius and 
soleus muscles. Table 7.1 shows that a 1.5 cm change in heel height from 3.5 to 4.5mm 
resulted in a reduction in the area underneath the curve for EMG activity. For the MG 
muscle, this reduction was 7.3% when compared to the 3.5HH condition and for soleus (SOL) 
this reduction was 5.8%. If both results were to be combined, it would induce significant 
alteration to the overall work done by the calf muscles. EMG does not show the magnitude 
of the force but it does show how many motor units are recruited to perform the task. It 
clearly indicates that muscle works harder or less hard, and therefore it is related to oxygen 
consumption. 
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The 1.5HH shoe significantly increased MG and soleus EMG activity during 5-40% of  stance 
phase and it added to the overall work done by the muscle fibre units work and therefore 
would have potentially affected oxygen consumption. The reason for activation timing can 
be due to the premature ending of external ankle PF moment and an increase in ankle 
moment magnitude caused by the heel alteration.  
 
Figure 7.2: Summary of alteration to muscle function by different heel heights. 
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Table 7.1: Summary of comparison of factors which resulted in muscle function alteration by 
differing the heel heights. 
 1.5 HH 2.5 HH 3.5 HH 4.5 HH 5.5 HH 
Test conditions [significant when in 
superscript (p<0.05)] 
1 2 3 4 5 
Medial Gastrocnemius and Soleus       
1. Max internal ankle PF moment (Nm/kg) 1.41 2,3,4,5 
(0.05) 
1.371 
(0.04) 
1.411 
(0.05) 
1.401 
(0.05) 
1.421 
(0.04) 
1.1 Area underneath the curve for 
external ankle DF moment (%) 
128.02,3,4,5  
(3.8) 
104.71,4,5   
(5.5) 
100.01 
(5.9) 
95.11,2 
(5.4) 
95.41 
(5.1) 
2. Achilles tendon moment arm (mm) 40.952,3,4,5 
(0.56) 
43.391,3,4,5 
(0.34) 
44.111,3,4,5 
(0.30) 
44.671,2,3,5 
(0.28) 
44.991,2,3,4 
(0.29) 
3. Max MG EMG activity (%) 104.2 
(13.7) 
110.14 
(11.8) 
100.05 
(8.8) 
93.52 
(9.1) 
108.13 
(9.6) 
3.1 Area underneath the curve for MG 
EMG activity (%) 
114.44 
(13.0) 
107.44 
(9.1) 
100.0 
(10.1) 
92.61,2 
(10.5) 
103.6 
(10.5) 
4. Max soleus EMG activity (%) 104.7 
(11.0) 
105.84 
(9.0) 
100.04 
(6.5) 
91.22,3,5 
(7.3) 
107.54 
(7.4) 
4.1 Area underneath the curve for soleus 
EMG activity (%) 
109.6 
(8.6) 
105.54 
(7.7) 
100.04 
(7.3) 
94.22,3,5 
(7.0) 
105.84 
(7.7) 
5. Max MG fibre length during TS phase 
(mm) 
56.312,3,4,5 
(1.29) 
52.451,3,4,5 
(0.88) 
50.471,3,4,5 
(0.83) 
48.801,2,3,5 
(0.63) 
47.771,2,3,4 
(0.77) 
6. Max soleus fibre length at TS phase 
(mm) 
56.312,3,4,5 
(1.29) 
52.451,3,4,5 
(0.88) 
50.471,3,4,5 
(0.83) 
48.801,2,3,5 
(0.63) 
47.771,2,3,4 
(0.77) 
7. MG fibre length velocity at 68% stance 
phase (mm/% stance phase) 
0.0013,4,5 
(0.080) 
0.0433,4,5 
(0.060) 
0.0941,3,4,5 
(0.054) 
0.1371,2,3,5 
(0.040) 
0.1851,2,3,4 
(0.054) 
8. Soleus fibre length velocity at 72% 
stance phase (mm/% stance phase) 
0.073,4,5 
(0.08) 
0.09 
(0.05) 
0.121 
(0.05) 
0.141 
(0.06) 
0.151 
(0.07) 
9. MG tendon force required  differences 
versus control shoe to produce the ankle 
moment (N) 
61.3 
(13.7) 
32.0 
(18.2) 
0.0 
(19.0) 
-35.7 
(15.0) 
-62.7 
(21.7) 
 
There is also a gap in the understanding of how the velocity of muscle contraction would 
affect the force generation. For example, two different footwear conditions may only alter 
the velocity of muscle contraction, but the MTU lengths may be similar. Therefore, it is hard 
to tell if the velocity of contraction has greater impact on muscle force generation rather 
than its length. The results of this study suggest that the length of the muscle-tendon units 
are the main force factor, which influence the force generation by the muscle and it may 
also influence the oxygen demand. It can be seen from the summary table for heel heights 
that the MG and soleus muscle generate force by eccentric contraction and if it ends at the 
point where maximum force is required with optimal muscle-tendon length, it may 
guarantee an offloading the calf muscle. Overall calf muscle offloading can be achieved with 
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heel height alteration which resulted in a delay of the internal ankle PF moment phase as 
well as reduction of the ankle moment. Conversely, alteration to the heel height produced 
kinematic changes in the knee and hip and that gives the indication that the footwear can be 
altered and adjusted to compensate for that change to improve the gait pattern without 
altering it.  
7.2.2.1 Comment  
The overarching hypothesis that rocker soles (incorporating different heel heights) can 
significantly alter sagittal plane kinematics (at the hip, knee and ankle) is therefore accepted. 
7.2.3 Conclusion 
The 4.5 cm heel raise reduced the overall external ankle DF moment. It also placed the ankle 
at a more natural position where it could generate more force during late stance phase. 
However, the alteration to the heel height also produced alteration to the toe angle, and it 
may have resulted in resisting the ankle to plantarflex and may also have resulted in 
increasing the plantar pressures in the metatarsal head area. It was important to understand 
separate footwear features, and further research is needed to look at a combination of 
different footwear features to achieve desirable effects.  
 
7.3 The effect of walking with rocker soles incorporating different apex positions 
As previously stated, optimal rocker sole apex position has been the subject of numerous 
investigations by various authors when analysing the position to maximally offload the 
forefoot to relieve the symptoms associated with excessive plantar foot pressures. This 
becomes particularly pertinent for subjects with “at-risk” feet suffering from pathologies 
such as diabetic peripheral neuropathy, rheumatoid arthritis or spina bifida. 
 
An analysis of maximal reduction in plantar foot pressures when walking in rocker-soled 
shoes has shown that the recommended optimal apex positions vary but most recommend a 
position proximal to the first metatarsal head area. Cavanagh et al (1996), demonstrated 
that an apex position of 55% of shoe length was the optimal position for offloading the  
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forefoot with an angled rocker sole; which would indicate that it may prove to also be a 
position that would be a natural pivot point for a solid traditionally shaped angled rocker 
sole. The maximum offloading of the forefoot at this position could have been due to the 
fact that the rocker position met “minimal resistance” to plantarflexion rotational motion at 
the pivot point; meaning that the posterior structures such as the ankle plantarflexors may 
have been offloaded by not offering so much resistance to ankle plantarflexion as other apex 
position. However, this is as yet unknown and is only conjecture; but this is why it was of 
interest for this thesis. 
 
 
The results from the gait laboratory walking trials demonstrated that the shoe with a 55% 
apex rocker position (55AP), shifted the ankle into a more plantarflexed position during LR 
(1.30) (p=0.001) compared to the control shoe (where the control shoe is 62.5AP) and also 
produced less maximum dorsiflexion during second rocker of gait (1.60). Additionally, it 
placed the ankle into more plantarflexion during and at the end of third rocker of gait (1.90) 
compared to both the control condition and the 70AP test condition. It therefore produced a 
plantarflexion shift during stance phase compared to the control shoe.  
 
 
7.4 The effect of different rocker apex positions (APs) on muscle function. 
The following section demonstrates the effect of altering the apex position of the rocker sole 
on muscle function. Figure 7.3 summarises the alterations to the MG and SOL muscles for 
different external parameters when walking in shoes with different apex positions.  
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Figure 7.3: Summary of alteration to muscle function caused by alteration to the rocker sole 
apex position 
 
The apex position variation produced changes in the kinematic data in the ankle but there 
were no significant changes demonstrated at the hip and knee. A more proximal apex 
position resulted in a reduction of maximum ankle DF at 50% of the gait cycle, but no 
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significant changes to the maximum PF angle during LR when compared to the control shoe 
as shown in the figure 7.4.  
 
Figure 7.4: Sagittal plane ankle motion when walking with the three-apex position test 
conditions with standard deviation where the control shoe is 62.5AP. 
From the figure above, it can be also seen that the 70AP resulted in a rapid increase ankle 
ROM being produced between 20-50% of the gait cycle, and therefore an increase in velocity 
of eccentric contraction by the calf muscle. The soleus EMG results showed that the 70AP 
test condition did not increase maximum EMG activity when compared to the control shoe - 
and even slightly reduced it. However, the Achilles tendon moment arm was significantly 
shorter versus the control footwear test condition (62.5AP) footwear as shown in table 7.2 
and figure 7.4. The internal ankle PF moment was significantly increased which means it 
requires more muscle force to produce the moment about ankle. Figure 7.3 shows that  
soleus fibre length range was increased from 20-80% of the stance phase, which means the 
soleus muscle was stretched more than all footwear conditions This evidence suggests that 
the eccentric velocity of soleus muscle was increased, and therefore this compensation 
resulted in more force generation by  the 70AP footwear condition.  
However, there were different effects noted for the medial gastrocnemius muscle. The 70AP 
footwear increased maximum EMG activity by 7.1% versus control and 15.8% versus the 
55AP condition. The area under the curve for MG EMG was also increased for the 70AP by 
6.7% versus control and 15.6% versus the 55AP footwear. The medial gastrocnemius muscle 
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force generation is also related to the knee flexion position. There was a slight alteration to 
knee flexion for the 70AP between 10-40% of the gait cycle (figure 7.4). In figure 7.3 it is 
noticeable that there is less MG fibre lengthening from 20-80% of stance phase, which could 
have resulted in reducing the MG maximum eccentric lengthening velocity, and therefore it 
could have resulted in a reduction of the tension generation and more motor units were 
recruited to produce the required force. Thus, a significant increase in MG muscle work for 
the 70AP footwear test condition was produced. 
 
Figure 7.5: Sagittal plane knee motion during the three apex position test conditions where 
the control shoe is 62.5AP. 
Table 7.2: Summary of alteration on muscle function produced by altering the rocker sole 
apex position. 
 55AP 62.5AP 70AP 
Test conditions [significant when in 
superscript (p<0.05)] 
1 2 3 
Medial Gastrocnemius and Soleus     
1. Max internal ankle PF moment 
(Nm/kg) 
1.35 2,3 
(0.05)  
1.411,3   
(0.05) 
1.44 1,2 
(0.03) 
1.1 Area underneath the curve for 
external ankle DF moment (%) 
94.32,3 
 (5.4) 
100.0 1,3   
(5.9) 
106.4 1,2 
(5.1) 
2. Achilles tendon moment arm (mm) 44.592,3 
(0.26) 
44.111,3   
(0.30) 
43.261,2 
(0.33) 
3. Max MG EMG activity (%) 91.3 2,3 
(11.3) 
100.0 1 
(8.8) 
107.11  
(9.3) 
3.1 Area underneath the curve for 
MG EMG activity (%) 
91.1 
(12.6) 
100.0 
(10.1) 
106.71 
(9.0) 
4. Max soleus EMG activity (%) 94.7 
(9.4) 
100.0  
(6.5) 
98.2 
(8.3) 
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4.1 Area underneath the curve for 
soleus EMG activity (%) 
97.6 
(6.8) 
100.0 
(7.3) 
99.4 
(8.3) 
5. Max MG fibre length during TS 
phase (mm) 
49.15 2,3 
(0.74) 
50.47 1,3 
(0.83) 
52.68 1,2 
(0.60) 
6. Max soleus fibre length at TS phase 
(mm) 
42.03 3 
(0.73) 
42.89 
(0.69) 
44.73 1 
(0.74) 
7. MG fibre length velocity at 68% 
stance phase (mm/% stance phase) 
0.094 
(0.059) 
0.094 
(0.054) 
0.1352 
(0.053) 
8. Soleus fibre length velocity at 72% 
stance phase (mm/% stance phase) 
0.13 
(0.08) 
0.12 
(0.05) 
0.10 
(0.07) 
9. MG tendon force required  
differences versus control shoe to 
produce the ankle moment (N) 
-27.5 
(18.2) 
0.0 
(19.0) 
41.4 
(9.2) 
 
7.4.1 Conclusion 
There were significant increases demonstrated in MG EMG activity for the 70AP. This was 
due to a shorter muscle moment arm, longer fibre length (which was far from its optimal 
length), a reduced range of eccentric lengthening, and a greater internal ankle PF moment 
requirement due to the alteration of the sole.   
The 55AP footwear increased the length of the Achilles tendon moment arm when more 
force is required, kept the fibre length closer to its optimal length (the natural position of the 
lower limb), reduced the force required for producing moments by the ankle, and it needed 
27 N less force production when compared to the control shoe and 68.9 N less when 
compared to 70AP. However, the results suggest that if the 55AP increased eccentric 
lengthening range and kept fibres closer to optimal length, it could potentially offload calf 
muscle even more.  
The results demonstrated that velocity of soleus contraction influenced its EMG activity. 
The 55AP footwear condition is therefore perceived to be the best option for offloading calf 
muscle between the different apex position test conditions analysed in this research, and it 
may also reduce muscle oxygen demand. Patients with intermittent claudication experience 
pain in the gastrocnemius muscle, and therefore a 55% apex position may produce a more 
significant reduction in symptoms for claudicants than the other test conditions, but this is 
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as yet unproven. However, there were only three apex length rockers were tested and it 
could be possible that 50% or 52% may have greater effect rather than the 55AP footwear. 
 
 
7.5 The effect of different toe apex angles on muscle function 
The 20°TA significantly reduced maximum EMG activity for MG and soleus muscles when 
compared to the control and the 10° TA footwear condition. The results suggest that the 
Achilles moment arm for 20°TA was slightly increased during 75-95% of the stance phase. It 
may have therefore resulted in greater moments produced by the calf muscles. The results 
also demonstrated that the maximum internal ankle PF moment was also significantly 
reduced at 80% of the stance phase. The 10°TA showed a significant increase in maximum 
EMG activity for the MG and soleus muscles when compared to the 20°TA. The muscle 
moment arm was also significantly shorter at maximum EMG activity for the 10°TA, which 
caused more force requirement to produce the internal ankle PF moment (figure 7.6). 
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Figure 7.6: Alteration to muscle function demonstrated by altering rocker apex angle. 
The 10°TA test condition did not produce any significant changes in maximum soleus EMG 
activity when compared to the control shoe even though the muscle tendon was far from its 
natural position. As previously discussed, for the 70AP position, the soleus muscle fibre 
lengthening range was increased and therefore so was the velocity of eccentric contraction 
and that was the reason for more muscle force generation. 
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Table 7.3: Summary comparison factors which resulted in muscle functioning alteration by 
the rocker apex toe angle. 
 10° TA 15° TA 20° TA 
Test conditions [significant when in 
superscript (p<0.05)] 
1 2 3 
Medial Gastrocnemius and Soleus     
1. Max internal ankle PF moment 
(Nm/kg) 
1.45 2,3 
(0.05) 
1.411,3  
(0.05) 
1.26 1,2  
(0.04) 
1.1 Area underneath the curve for 
external ankle DF moment (%) 
105.42,3 
(5.4) 
100.0 1,3 
(5.9) 
92.5 1,2 
(4.1) 
2. Achilles tendon moment arm (mm) 43.482,3 
(0.37) 
44.111 
(0.30) 
44.12 1 
(0.37) 
3. Max MG EMG activity (%) 107.2 3 
(9.2) 
100.03 
(8.8) 
89.4 1,2 
(9.9) 
3.1 Area underneath the curve for 
MG EMG activity (%) 
108.03 
(11.2) 
100.0 
(10.1) 
93.61 
(10.1) 
4. Max soleus EMG activity (%) 101.43 
(7.6) 
100.03 
(6.5) 
92.21,2 
(8.0) 
4.1 Area underneath the curve for 
soleus EMG activity (%) 
102.2 
(7.7) 
100.0 
(7.3) 
96.3 
(9.1) 
5. Max MG fibre length during TS 
phase (mm) 
51.952 
(0.65) 
50.47 1 
(0.83) 
51.23 
(0.81) 
6. Max soleus fibre length at TS phase 
(mm) 
44.233 
(0.80) 
42.89 
(0.69) 
43.011 
(0.63) 
7. MG fibre length velocity at 68% 
stance phase (mm/% stance phase) 
0.120 
(0.051) 
0.094 
(0.054) 
0.097 
(0.067) 
8. Soleus fibre length velocity at 72% 
stance phase (mm/% stance phase) 
0.14 
(0.08) 
0.12 
(0.05) 
0.09 
(0.07) 
9. MG tendon force required  
differences versus control shoe to 
produce the ankle moment (N) 
28.2 
(10.5) 
0.0 
(19.0) 
14.0 
(21.7) 
 
 
7.6 The effect of different curved heels on muscle function 
 
A curvature of the heel altered the ankle kinematics and put the ankle into a more DF 
position throughout the entire stance phase. It therefore increased calf muscle lengthening. 
The full curved heel changed the point of application of the GRF and therefore caused a 
premature external ankle DF moment to occur and also increased the ankle moment from 
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20-70% of the stance phase. At 80% of stance phase the full curve heel reduced the 
maximum external ankle DF moment when compared to the heel without a curve. However, 
the full curve footwear increased the area underneath the curve for external ankle DF 
moment by 6% due to the premature application of the external ankle DF moment with 
increased magnitude within 20-70% stance phase. That also resulted in increased EMG 
activity from 10-65% of stance phase for medial gastrocnemius muscle and an increased 
EMG activity within 0-40% stance phase for soleus.  
The results did not show any statistical significance for maximum EMG activity for soleus and 
MG muscles whilst walking in curved heels. However, the full curve heel increased EMG 
activity during 5-70% stance phase, which resulted in an increase of the area underneath the 
curve for maximum EMG activity for the medial gastrocnemius muscle when compared to 
the half curve test condition. 
It can therefore be postulated that a greater curve may alter kinematics, kinetics, and muscle 
tendon length during 5-70% of the stance phase and therefore overall EMG activity. The half 
curve or even less should therefore be used for patients with intermittent claudication to 
offload the calf muscle. 
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Figure 7.7: The effect of different heel curves on fibre lengths. 
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Table 7.4: Summary and comparison of factors which resulted in muscle function alteration 
by altering heel curvature. 
 Full curve Half curve control 
Test conditions [significant when in 
superscript (p<0.05)] 
1 2 3 
Medial Gastrocnemius and Soleus     
1. Max internal ankle PF moment 
(Nm/kg) 
1.37 
 (0.04) 
1.35 3   
(0.04) 
1.41 2  
(0.05) 
1.1 Area underneath the curve for 
external ankle DF moment (%) 
106.0 2,3   
(5.3) 
100.6 1   
(5.8) 
100.0 1   
(5.9) 
2. Achilles tendon moment arm (mm) 43.68 3 
(0.36) 
43.77 3 
(0.38) 
45.121,2 
(0.27) 
3. Max MG EMG activity (%) 102.6 
(11.6) 
99.9 
(9.8) 
100.0 
(8.8) 
3.1 Area underneath the curve for 
MG EMG activity (%) 
107.7 2 
(10.5) 
99.11 
(10.4) 
100.0 
(10.1) 
4. Max soleus EMG activity (%) 97.5 
(9.8) 
92.9 
(7.2) 
100.0 
(6.5) 
4.1 Area underneath the curve for 
soleus EMG activity (%) 
100.9 
(7.7) 
94.9 
(8.1) 
100.0 
(7.3) 
5. Max MG fibre length during TS 
phase (mm) 
51.90 
(0.85) 
51.62 
(0.84) 
50.47 
(0.83) 
6. Max soleus fibre length at TS phase 
(mm) 
43.72 3 
(0.73) 
43.72 3 
(0.81) 
42.89 1,2 
(0.69) 
7. MG fibre length velocity at 68% 
stance phase (mm/% stance phase) 
0.060 
(0.050) 
0.070 
(0.052) 
0.048 
(0.050) 
8. Soleus fibre length velocity at 72% 
stance phase (mm/% stance phase) 
0.08 
(0.07) 
0.09 
(0.06) 
0.12 
(0.05) 
9. MG tendon force required to 
produce the ankle moment (N) 
21.6 
(19.8) 
 
19.8 
(17.5) 
 
0.0 
(19.0) 
 
7.7 Limitations to the methodology and the approach adopted 
7.7.1 The walking trials 
There were certain limitations to this study. Even though the overall test duration was kept 
to a minimum for each subject, the gait laboratory trials typically took a number of hours in 
some cases in order to ensure the quality of the data collection in the gait laboratory was at 
an acceptable standard to be used for subsequent analysis. This had ramifications for using 
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the EMG electrodes over a protracted period, as there is a possibility that electrode 
performance could have altered during the prolonged testing periods. 
 
The test conditions were randomised during the testing. Due to the fact that the test 
subjects were all fit young males, fatigue was not deemed to be a problem. Rest periods 
were allowed during the test condition trials in order to ensure that fatigue was not a 
problem. This also allowed the researcher to check the data collected for the previous test 
conditions to ensure the requisite number of trials of acceptable quality were acquired prior 
to proceeding on to the next test condition. In addition, time was needed to alter the 
footwear test conditions and allow a short period of habituation prior to commencement of 
the walking trials for the specific rocker-soled shoe test condition. However, rocker sole 
carry-over effects have been shown to be insignificant in previous publications.  
The fact that the walking trials speed of walking was closely controlled meant that it was 
possible to compare the test conditions without the complication of introducing significantly 
different walking speeds. The age and gender of the volunteer able-bodied subjects who 
performed the walking trials in this study, did not reflect that published for the general 
claudicant population. However, this was necessary to ensure confounding variables such as 
large age differences and fitness levels between the subjects, which could have affected the 
results and negated a direct comparison between the test conditions was kept to a 
minimum. It is the intention, however, to utilise the findings of this research to develop 
footwear for trial use by a population of volunteer claudicants in the future. 
The EMG data collection equipment available was not capable of acquiring data for all the 
muscle groups in the lower leg. It would have been advantageous to test the activity of the 
hip flexors and extensors, as these have been recently shown to be weak in claudicants. 
Nevertheless the data quality obtained for the muscles tested was of acceptable quality to 
provide meaningful results. 
7.7.2 Kinetic and Kinematic data 
In any data collection utilising retro-reflective markers and electrodes for EMG data 
collection, there will have been some soft tissue artefacts occurring during ambulation; 
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especially on skin-mounted electrodes or those situated near joints. Whilst these could not 
be totally eliminated, care was taken to ensure that the leads connecting the EMG 
electrodes to the acquisition system and the thermoplastic plates used to mount the clusters 
on the anterior aspect of the thigh and shin, as well as on the pelvis, were kept to a 
minimum using taping and elastic strapping. 
The markers used to define the first and fifth metatarsal heads and the posterior aspect of 
the calcaneus bilaterally, were attached directly onto the skin of the foot. This meant that 
during each change of shoe condition, these reflective markers had to be removed and 
replaced to allow the next set of shoes to be tested shoes to be donned and the previous 
ones taken off utilising apertures cut into the shoe uppers for the base plates of the markers 
to be placed through. The use of cut-outs in the shoe uppers was, however, deemed to be 
important, as markers placed on the uppers of the shoes cannot delineate the position of 
the first and fifth metatarsal heads as accurately. The anatomical position of the markers on 
each foot was marked on the skin by marking the position of the mounting plate for each 
marker concerned, and to reduce inaccuracies to a minimum. 
Overall sources of error were kept to a minimum by utilising same-session testing for all 
subjects and using the subjects as their own control. The only variable for the gait laboratory 
trials for each subject was therefore the shoe condition; as walking speed was also 
controlled. 
7.7.3 OpenSim limitation 
The Gait2392 model was based on old muscle architecture data collected in 1990. There are 
new modern techniques to obtain that data and today there is an updated lower limb 
model. The new model describes muscle architecture (i.e., muscle fibre lengths, pennation 
angles, and physiological cross-sectional area) more precisely; based on data obtained from 
21 cadavers. However, exported motion data from Visual3D cannot be used accurately with 
that model. Another method of marker placement should be used to scale body segments 
for each subject. This method was not integrated into the method of data collection used for 
this study, as it would require extensive investigations into the development of marker 
placement with different rocker profiles in order to improve the technique to be able to 
remove static shift effects caused by different shapes of the rocker shoes, which would 
359 
 
directly affect muscle-tendon properties data. OpenSim is an open source and therefore 
each model can be customised for subjects’ demographics, muscle property data can be 
used according to the subjects’ age, muscle architecture and anthropometric data. For 
example, for elderly subjects, average pennation angle of skeletal muscle such as 
gastrocnemius medialis muscle alters with aging (Binzoni et al., 2001).  
7.7.4 The OpenSim velocity of muscle-tendon length calculation limitations 
The velocity data were normalised to 100% stance phase. Therefore, it resulted in stretching 
the curves by time scale and it could have resulted in interpolating the data and a possible 
increase/decrease the muscle-tendon lengths. That could theoretically affect the velocity 
data. If the muscle-tendon units for each trial were not normalised to 100% time scale, in 
this case it would not be possible to define the same time scale points of interest during 
stance phase or gait cycle. 
 
7.7.5 External foot marker placement and rigid foot model  
For the purpose of the thesis foot kinematics were recorded using markers placed externally 
on the shoe and on the skin through windows cut in the shoe as described in method 
chapter. A recent study has demonstrated that there were significant differences in discrete 
kinematic parameters between skin and shoe mounted marker test conditions, at the 
midfoot-calcaneus, forefoot-midfoot and forefoot-calcaneus articulations during walking 
(Sinclair et al., 2013). It also showed that shoe mounted markers do not fully represent true 
foot movement, and should therefore be interpreted with caution during examination of 
multiple-segment foot kinematics. In the current PhD research markers were placed on the 
skin, however a rigid model of the foot was recorded. It was not practically possible to 
collect multisegment foot data for 16 pairs of shoes and be able to place markers on the 
exact same positions due to high numbers of markers needed meaning that there would 
have been too many holes cut in the upper of the shoes. It would also take more time to 
collect data for each subject and may introduce more possible errors especially within EMG 
data. Therefore, this was a limitation in this research and kinematic data could be affected 
by it. Another recent study which compared the reliability and repeatability of three 
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different multisegment foot models demonstrated that reliability of segmental kinematics 
varied, with low repeatability (Intraclass correlation coefficient <0.4) found for 14.3% of the 
Oxford Foot Model angles, 22.7% of 3DFoot angles and 37.6% of Kinfoot angles (Mahaffey et 
al., 2013). However, the literature research performed for all previous footwear studies 
presented in this thesis used a rigid foot model and markers were placed direct onto the 
shoe. It would be adventitious, if the foot was analysed as a multisegmental model. It could 
show more movement of the foot and can be related to plantar pressures as well as offering 
the possibility of investigating the effect of rocker soles on specific foot structures and 
articulations. However, ankle angle was the main interest in the study. All footwear 
conditions were inflexible in the rearfoot and midfoot areas due to the addition of the rocker 
soles and the shoes were fit snuggly and laced properly which meant that there was limited 
movement in those areas.  
7.7.6 The walking speed limitation 
The investigation of the effect of walking speed on muscle function has been previously 
studied (Hof et al., 2002, den Otter et al., 2004, van Hedel et al., 2006, Byrne et al., 2007, 
Chiu and Wang, 2007, Stoquart et al., 2008, Chung and Wang, 2010, Sousa and Tavares, 
2012) (Sousa and Tavares, 2012). The results suggest that gait speeds such as fast walking 
and slow walking influence not only EMG activity levels but also relative muscle activity 
patterns. The walking speed therefore was controlled to ensure that it would minimise the 
possible effect on kinematic, kinetic and EMG data. It was important to understand how 
footwear features change walking patterns, but not the influence of waking speed, in this 
study. However, different footwear test conditions produce alteration to walking speed due 
to the sole design. For instance, a stiff soled shoe would resist bending at the metatarsal 
head area which can result in reduction of step length during gait. This was one of the 
limitations in this research. 
7.7.7 Conclusion and future work 
In regards to the offloading of the calf muscles, the footwear features such as the 4.5 cm 
heel, the 55AP, the 20°TA demonstrated significant offloading to the calf muscle. The 55AP 
has a significant offloading influence on the calf muscles whilst at the same time not 
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significantly altering knee and hip kinematics. This would be perceived to be a viable option 
for individuals with intermittent claudication as one would hope with the results found in 
this study that this would translate to this population, and help to reduce the onset of 
walking pain in the posterior compartment.  
Everyday walking requires to adapt to different speed of walking depending on the 
environment. For example, rapid stopping before the traffic light or walking accelerating 
when a pedestrian crosses the road or following the speed of large group of pedestrians in 
the city. Very stiff soles may have some limitations in being able to adapt to different levels 
of walking speed. The foot has more than 30 joints and it helps us to have better gait. Well-
known high street footwear brands have designed comfortable shoes for running and 
walking by making sole of the shoe very flexible (almost as barefoot walking), and it does not 
limit the motion of the foot as much as a stiff–soled shoe.  
Most of the footwear studies examined for this thesis did not consider the effect of walking 
speed on muscle changes and it not always clear whether the changes were due to sole 
design or walking speed. With slower walking, the calf requires less power to enable walking, 
and the velocity of muscle contractions is reduced, which would result in muscle function 
change (force generation). 
A solid soled shoe may also increase chance for patients with diabetes to get blisters at the 
area of the heel. If there is a resistance in the metatarsals area, the heel will be forced to 
move up during late stance phase, if more plantaflexion power required (faster walking). 
Therefore, it may produce frictions. However, a flexible sole can increase pressure 
distribution in metatarsal area. If the sole is flexible, there will be less area of contact with a 
ground during foot flexion at metatarsal joint and it may apply more pressure on metatarsal 
region of the feet. 
The figure below demonstrates one of the possible designs which may offload calf muscle 
during walking. 
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Figure 7.8: The example of estimated final design to offload the calf muscle. 
 
The heel height was chosen to be 4.5 cm as there is strong evidence in this research that it 
places ankle during late stance at the position at which muscle can generate more force and 
therefore reduce muscle work (external DF moment, EMG activity). However, the heel 
height can be slightly varied for a different aged population. Older people tend to have 
stiffer muscles, and for this purpose, it is necessary to test older population for optimal heel 
pitch related to age. Healthy and young subjects were tested in this PhD to minimise age 
factors on the data acquired.  
The small heel curve was added to the shoe to make the heel transaction smoother and 
slightly offload tibialis anterior muscle as the results from this research demonstrated that a 
curved heel reduced velocity of TA muscle contraction and significantly reduced EMG 
activity. 
The apex position was chosen between 55% and 62.5% of the shoe length. Results 
demonstrated that 4.5 cm heel height significantly offloaded calf muscle work with 62.5% 
apex position. However, a lower heel height of 3.5 cm reduced calf work with 55% apex 
position as well. It helped ankle to plantarflex earlier and placed the calf fibre lengths at a 
more natural position (resting size) at which it can generate more efficient force. More 
research is also required on identifying the optimal rocker sole apex position in relation to 
muscle work and speed of walking. 
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The has addition of a flexible area at metatarsals to allow adaption of foot to any walking 
speed without significant sole bending resistance could potentially increase the work done 
by calf muscles during faster walking speeds. 
The 20 degree toe angle showed a slight reduction of MG muscle activity, and therefore a 
different toe angle may produce the same angle, if the metatarsal area bends when it is 
required for adaptive walking. The flexible shoe did not show any significant increase or 
decrease in calf muscle work, thus there were no adverse effects on this parameter, 
however it may help to allow the skeletal system to adapt during walking speed changes. 
There maybe be a more optimal rocker apex position and toe angle which would improve 
the gait kinematics and kinetics to feasibly to improve claudicant symptoms, but this needs 
to be explored in a future study. This could include moving the rocker apex position further 
forwards and back centred on your best position found in the thesis (55% apex position) plus 
some small alterations to the rocker angle (up to 10 degrees either side of the optimal angle 
in this study). The materials of the shoes can be also investigated as it can produce the shape 
of the shoe during the load and return some energy when person walks. There is a new 
material  developed by Adidas to produce ‘boost’ shoe. This shoe has a very good cushioning 
system, it also mimics barefoot walking and it returns some energy by pushing the material 
back when it compressed. 
There is a need of further work done and older population testing to understand muscle 
function better and then specific footwear can be designed. If it requires less pitch of the 
heel the apex position can help as well to place ankle into advantageous position to offload 
calf muscle and reduce oxygen consumption. 
To the authors knowledge, there is no previous study published which has investigated the 
effect of different footwear features on muscle-tendon properties and EMG for the muscles 
action on the ankle. It is felt that when trying to identify optimal footwear features for a 
clinical population, muscle-tendon properties should be assessed and not only rely on 
kinematic and kinetic data or surface EMG data.  This research demonstrated other 
important factors, which should be included to analyse the influence of footwear features on 
gait patterns in future studies. 
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Every single person has a different walking pattern and gait. Therefore, there is a need to 
expand the database of knowledge in understanding the possible effects of footwear 
adaption and outsole designs, which could influence gait and muscle function. However, the 
research presented in this thesis, is novel in that it not only investigated and interpreted 
kinematic and kinetic data, but also other important factors, which influence muscle force 
generation to more fully understand the alteration to muscle function and gait parameters, 
which may be expected when walking with footwear incorporating specific footwear 
features more clearly. The additional factors which were taken into account, which could 
possibly influenced the data such as: walking speed, age and previous injuries of the 
participants were factored out of the study so that the results were not influenced by them. 
Future studies are needed which should combine different footwear features based on the 
results of this study to achieve desirable effects and help in reducing symptoms experienced 
by various patient groups. There could be more future studies to understand gait alteration 
effects in more details by varying the apex length, heel height or toe angle of the sole, shoe 
weight, cushioned shoe, materials of the sole and the gait pattern changes in the footwear 
conditions whilst walking with different speed. 
There could be potential in building up a database in the future with anthropometric data, 
which should be age and weight related to describe and define the effects of footwear 
features on gait and walking patterns for a diverse range of patient groups and ages. This 
would mean that it may be possible for muscle function to be accurately predicted and 
footwear with known desirable effects could be designed for each person to achieve 
maximum effects for individual patients.  
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APENDICES 
APPENDIX ONE 
CONSENT FORM 
 
Rocker shoe study: Consent form 
Title of Research study:  
The effects of different footwear features on walking biomechanics and muscles. 
 
Name of Researchers:  Andrey Aksenov 
Identification Number for this trial:               Subject………………………………. 
Date of Birth ………             Weight…………             Height…………                   Shoe size………… 
                                                                                                                      Please initial box 
1 I confirm that I have read and understand the information sheet for the 
above study and have had the opportunity to ask questions and have been 
given 24 hours to decide on participation in the study after reading the 
information. 
 
2 I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical care 
or legal rights being affected. 
 
 
3 I agree to take part in the above study.  
 
 
--------------------------------------- -----------           ---------------------- 
Name of Participant   Date    Signature 
 
--------------------------------------- -----------  ---------------------- 
Name of Person taking consent Date    Signature 
(if different from researcher)   
 
--------------------------------------  -----------  ---------------------- 
Researcher                      Date                Signature 
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APPENDIX TWO 
PATIENT INFORMATION SHEET 
Rocker shoe study: Information sheet 
 
The study 
This current research is aimed at systematically understanding the precise effects of 
different footwear profiles on kinematics, kinetics linked to muscle activity changes in the 
lower limbs (especially for the calf group of muscles and anterior leg muscles) 
 
What is involved?  
Your part in the study will involve just one 3-4 hours visit to the University of Salford 
Podiatry gait laboratory. The researcher and an academic member of stuff will also be 
present. Feel free to withdraw from the study whenever you want. 
 
In the laboratory movement analysis (kinematic, kinetic) and muscle activity will be recorded 
wearing 13 different footwear conditions. 
Measurements to be taken: 
Anthropometry - height, weight. These are standard measurements and will not cause any 
discomfort.  
Movement analysis 
Your walking will be analysed by computer in a similar way to how human movement is 
reproduced in computer games. You will be required to wear retro-reflective markers placed 
on landmarks of the lower limb.  These are attached to the skin using double sided tape 
picture 1.  This procedure will not cause any discomfort. Special infrared cameras see these 
markers as you move in front of the cameras. The computer then produces a special 3D 
image of your movement and tells us how your joints moved. You’ll have to wear short 
shorts to be able to attach marker and EMG electrodes on your legs. 
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Figure 1. 
Ground reaction force   
You will be asked to walk over two force plates secured in a walkway on the floor. 
Muscle activity  
The activity of muscles that work the foot will also be recorded by computer; this is called 
Electromyography (EMG). This is done by attaching small electrodes to the skin on the back 
of your calf muscles, tibialis anterior, Rectus femoris and Biceps Femoris and lower back 
muscles. Electrodes would be attached only to the right leg. To achieve low impedance of 
the skin, it will be cleaned, hair will be shaved if necessary (with a new shaver for every 
subjects) in the small are of the electrodes which will be placed on the muscle according to 
the SENIAM guidelines.  
These are the same electrodes that are used to monitor heart beats in hospital. The 
electrodes detect electrical activity in muscles which is produced whenever they contract. 
This will indicate which muscles are working when you are walking, and how your muscle 
activity might relate to the movements we have recorded. Wires from the electrodes 
connected to your skin are attached to a box that is worn on your waist figure 2. There is no 
danger from electrical shock because the electrodes only measure electrical activity and do 
not themselves have any electricity in them. 
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Figure 2. 
Marker arrangement 
Reflective markers of 14.5 mm diameter will be used in the data collection in the gate lab. 
The markers will be attached to the skin using standard double sealer tape which is 
commonly used in the gate lab. 
Markers will be attached to the following anatomical locations for the left and right sides: 
heel, 5th metatarsal, 1st metatarsal, ankle lateral, ankle medial, knee lateral, knee medial, 
ASIS, PSIS, ILI, hip, spine, sternum, acronium figure 3. There will be 3 additional marker 
clasters attached to thigh and shank for each leg figure 3. 
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Figure 3. 
What will you be asked to do? 
You will be asked to walk along a 10 metre walkway wearing 13 different types of shoes 
which we will be provided. For each pair of shoes you will be asked to walk 10 metres 
approximately 10 times, and you will be able to take a break at any time. At the end you will 
be asked to give your opinion on each type of shoe after you have walked with them. We 
value you opinion as it will help us with future shoe designs. 
Please be aware markers and electrodes need to be attached to your lower legs therefore 
your legs need to be exposed from the knee down, so wearing shorts (which we can provide) 
will be ideal for the study. 
These tests will take approximately three to four hours to complete. 
You will be required to wear tight fitting garments such as lycra shorts or swimwear so that 
there is a limited amount of movement caused by the clothing which may bring inaccuracies 
into the results of the study 
 
Withdrawal from the study 
You can withdraw from the study at any time without explanation. 
Confidentiality 
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All your personal details will be confidential and the data collected will be totally 
anonymous. 
Results from the study 
The results from the study will be used to help the researchers in understanding how these 
rocker soled shoes have on normal walking . Findings of the study will be published in 
scientific journals and may be used in press releases to newspapers and magazines. All 
participants will remain anonymous.  
 Consent 
If you are happy to take part, and understand all the information provided, please sign the 
attached consent form. This shows that you have read and understood this information 
sheet and agree to take part in the study.  
 
Thank you for your time it is greatly appreciated. 
 
Researcher contact details 
Andrey Aksenov 
University of Salford 
1 Runnymeade 
Salford 
M6 7PJ 
Tel : +447818250960 
E-mail : andreynet83@hotmail.com 
 
